{"text_format":"3","workbook":"xls","n_sheets":1,"sheets":["浙江省医保药品编码库变更"],"not_rendered":{"external_links":1,"defined_names":1},"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"浙江省医保药品编码库变更","index":0,"n_rows":1250,"n_cols":19,"rows_kept":1250,"merged":[[0,0,0,18]],"flags":["formulas_cached_only"]}
["浙江省医保药品编码库变更一览表"]
["序号","医保编码","分类","医保中文名称","医保文件剂型","备注","招标药品ID","招标药品通用名","商品名","剂型","规格","单位","转换比","包装材质","药品企业","支付标准","变更","变更原因","药品类型（供参考）"]
[1,"J330106001250058","2","归芪益肾颗粒","颗粒剂","","","","","","10g","盒","10","","杭州市中医院","72.03 ","启用","省医保局医药服务管理处函","医院制剂"]
[2,"J330106001250059","2","健脾安胎颗粒","颗粒剂","","","","","","10g","盒","10","","杭州市中医院","117.40 ","启用","省医保局医药服务管理处函","医院制剂"]
[3,"J330105006360005","2","解毒祛瘀滋阴颗粒","颗粒剂","","","","","","20g","盒","10","","浙江中医药大学附属第二医院","116.35 ","启用","省医保局医药服务管理处函","医院制剂"]
[4,"J330105006360006","2","祛浊通痹颗粒","颗粒剂","","","","","","15g","盒","10","","浙江中医药大学附属第二医院","113.23 ","启用","省医保局医药服务管理处函","医院制剂"]
[5,"J330106001420015","2","复方氨搽剂","搽剂","","","","","","60ml","瓶","1","","中国人民解放军联勤保障部队第九○三医院","12.40 ","启用","省医保局医药服务管理处函","医院制剂"]
[6,"J330203000360004","2","石膏解毒散","散剂","","","","","","15g","盒","6","","宁波市中医院","67.92 ","启用","省医保局医药服务管理处函","医院制剂"]
[7,"J330502008010020","2","复方紫草油","涂剂","","","","","","100mL","瓶","1","","陆军第七十二集团军医院","56.60 ","启用","省医保局医药服务管理处函","医院制剂"]
[8,"J330482000990006","2","润肺膏","煎膏剂","","","","","","100g","瓶","1","","平湖市沈燕君中医诊所（有限公司）","93.92 ","启用","省医保局医药服务管理处函","医院制剂"]
[9,"J330624000330001","2","归芍养血止痛颗粒","颗粒剂","","","","","","10g","盒","20","","新昌县中医院","185.55 ","启用","省医保局医药服务管理处函","医院制剂"]
[10,"J330783002580011","2","九味头膏","煎膏剂","","","","","","400g","瓶","1","","东阳市中医院","78.90 ","启用","省医保局医药服务管理处函","医院制剂"]
[11,"J330802000640001","2","妇炎宁颗粒","颗粒剂","","","","","","10g","盒","12","","衢州市中医医院","53.66 ","启用","省医保局医药服务管理处函","医院制剂"]
[12,"J330802000640002","2","痛伤宁颗粒","颗粒剂","","","","","","15g","盒","12","","衢州市中医医院","62.64 ","启用","省医保局医药服务管理处函","医院制剂"]
[13,"J331102004210015","2","消疳健胃合剂","合剂","","","","","","250ml","瓶","1","","丽水市中医院","33.00 ","启用","省医保局医药服务管理处函","医院制剂"]
[14,"T331704132","1","炒党参","","单味不予支付","","","","","","","","","","","启用","省医保局医药服务管理处函"]
[15,"T331703597","1","麸温山药","","","","","","","","","","","","","修改（医保药品名称）","省医保局医药服务管理处函"]
[16,"T331707595","1","温山药","","","","","","","","","","","","","启用","省医保局医药服务管理处函"]
[17,"XA02ADL177X002010100232","2","缓解消化道不适症状的复方OTC制剂","","◇","206009","铝镁口服混悬液","无","口服混悬剂","15ml(每克含氢氧化铝72mg;氢氧化镁21.25mg;硅酸镁铝10mg)","盒","6","塑料袋装","史达德药业(北京)有限公司","68.00 ","停用","医保发〔2024〕33号",""]
[18,"XD08AXG053P002010103352","2","高锰酸钾","局部用散剂","","208278","高锰酸钾","无","散剂","每瓶装20g","盒","10","口服固体药用高密度聚乙烯瓶","吉林省东盟制药有限公司","998.00 ","停用","医保发〔2024〕33号",""]
[19,"ZA09ABX0145010100347","2","香砂六君片","","","200608","香砂六君片","无","片剂","0.46g","瓶","48","塑料瓶","广东万年青制药股份有限公司","39.00 ","停用","医保发〔2024〕33号",""]
[20,"ZA09ABX0145010100974","2","香砂六君片","","","172972","香砂六君片","无","素片","0.46g","盒","50","高密度聚乙烯","太极集团重庆桐君阁药厂有限公司","98.00","停用","医保发〔2024〕33号",""]
[21,"ZA09ABX0145020100347","2","香砂六君片","","","209514","香砂六君片","无","片剂","每片重0.46g","盒","36","铝塑包装","广东万年青制药股份有限公司","29.56 ","停用","医保发〔2024〕33号",""]
[22,"ZA13BAX0158010101912","2","香砂枳术丸","","","210023","香砂枳术丸","无","水丸","每袋装10g","盒","4","本品采用聚酯/铝/聚乙烯药品包装用复合膜袋包装","李时珍医药集团有限公司","86.00 ","停用","医保发〔2024〕33号",""]
[23,"XA10ABL029B002010200227","2","赖脯胰岛素","注射剂","","117180","赖脯胰岛素注射液","无","注射剂","3ml:300单位/支(笔芯)","盒","1","卡式瓶,复合铝盖,溴化丁基底塞","甘李药业股份有限公司","35.55 ","修改（医保信息）","医保发〔2024〕33号",""]
[24,"XJ05AXL400A001010179325","2","来特莫韦片","","限用于接受异基因造血干细胞移植(HSCT)的巨细胞病毒(CMV)血清学阳性的成人受者[R+]预防巨细胞病毒感染和巨细胞病毒病。","310071","来特莫韦片","普瑞明","片剂","240mg","盒","28","铝/铝泡罩","MSD International GmbH T/A MSD Ireland (Ballydine)","11760.00","修改（医保信息）","医保发〔2024〕33号",""]
[25,"XJ05AXL400A001010201606","2","来特莫韦片","","限用于接受异基因造血干细胞移植(HSCT)的巨细胞病毒(CMV)血清学阳性的成人受者[R+]预防巨细胞病毒感染和巨细胞病毒病。","208833","来特莫韦片","无","片剂(薄膜衣片)","240mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","南京正大天晴制药有限公司","5126.15 ","修改（医保信息）","医保发〔2024〕33号",""]
[26,"XJ05AXL400A001010301606","2","来特莫韦片","","限用于接受异基因造血干细胞移植(HSCT)的巨细胞病毒(CMV)血清学阳性的成人受者[R+]预防巨细胞病毒感染和巨细胞病毒病。","208834","来特莫韦片","无","片剂(薄膜衣片)","240mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","南京正大天晴制药有限公司","9996.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[27,"XL04AAB233A001010178403","2","巴瑞替尼片","","限：1.诊断明确的类风湿关节炎经传统DMARDs治疗3-6个月疾病活动度下降低于50%者；2.对一种或多种既往传统合成或生物DMARDs应答不佳或不耐受的2岁及以上活动性幼年特发性关节炎患者，包括：(1)多关节型幼年特发性关节炎(多关节型类风湿因子阳性[RF+]或阴性[RF-]，扩展型少关节炎),(2)附着点炎相关关节炎,(3)幼年银屑病关节炎。可单药使用或与甲氨蝶呤联合用药。","165821","巴瑞替尼片","艾乐明","薄膜衣片","2.0mg","盒","28","铝箔","波多黎各Lilly del Caribe, Inc.（国外公司 Eli Lilly Nederland B.V.）","1064.00","修改（医保信息）","医保发〔2024〕33号",""]
[28,"XN05CMY189L025010100675","2","盐酸右美托咪定鼻喷雾剂","","限：1.成人术前镇静/抗焦虑；2.2-6周岁儿童全麻手术前的镇静/抗焦虑。","203185","盐酸右美托咪定鼻喷雾剂","无","鼻用制剂","1ml:500μg,8喷,每喷25μg(按C₁₃H₁₆N₂计)","盒","1","硼硅玻璃模制药瓶,药用聚丙烯瓶盖和低密度聚乙烯密封垫片。配备药用喷雾剂定量泵。","上海恒瑞医药有限公司","110.77 ","修改（医保信息）","医保发〔2024〕33号",""]
[29,"XN05CMY189L025010181590","2","盐酸右美托咪定鼻喷雾剂","","限：1.成人术前镇静/抗焦虑；2.2-6周岁儿童全麻手术前的镇静/抗焦虑。","209063","盐酸右美托咪定鼻喷雾剂","无","鼻用喷雾剂","1ml:500μg,8喷,每喷25μg(按C₁₃H₁₆N₂计)","盒","1","中硼硅玻璃管制注射与吸入剂用内胆瓶、药用喷雾剂定量泵。","四川普锐特药业有限公司","110.76 ","修改（医保信息）","医保发〔2024〕33号",""]
[30,"XL01XEA298A001020279096","2","甲磺酸奥希替尼片","","限：1.IB-IIIA期存在表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的非小细胞肺癌(NSCLC)患者的治疗，患者须既往接受过手术切除治疗，并由医生决定接受或不接受辅助化疗；2.具有表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗；3.既往经EGFR酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性NSCLC成人患者的治疗；4.联合培美曲塞和铂类化疗药物用于具有表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗。","164539","甲磺酸奥希替尼片","泰瑞沙","薄膜衣片","80mg","盒","30","双铝","瑞典AstraZeneca AB","4966.20","修改（医保信息）","医保发〔2024〕33号",""]
[31,"XN01BBL054V006010100156","2","利多卡因凝胶贴膏","","限带状疱疹患者。","163570","利多卡因凝胶贴膏","无","贴膏剂","每贴(14.0cm×10.0cm)含膏量14g,含利多卡因700mg","袋","4","纸/聚乙烯/铝/聚乙烯药品包装用复合袋","北京泰德制药股份有限公司","70.40","修改（医保信息）","医保发〔2024〕33号",""]
[32,"XN01BBL054V006010105782","2","利多卡因凝胶贴膏","","限带状疱疹患者。","207771","利多卡因凝胶贴膏","无","贴膏剂","每贴(14cm×10cm)含膏体14g,含利多卡因700mg","盒","3","纸/铝/聚乙烯药品包装用复合膜、袋。","海南回元堂药业有限公司","52.50","修改（医保信息）","医保发〔2024〕33号",""]
[33,"XJ01DDT199B001010105025","2","注射用头孢噻肟钠他唑巴坦钠","","","210080","注射用头孢噻肟钠他唑巴坦钠","无","注射剂","1.17g(C₁₆H₁₇N₅O₇S₂ 1.0g与C₁₀H₁₂N₄O₅S 0.17g)","瓶","1","低硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖","湘北威尔曼制药股份有限公司","60.98 ","修改（医保信息）","医保发〔2024〕33号",""]
[34,"XJ01DDT199B001010180542","2","注射用头孢噻肟钠他唑巴坦钠","","","206591","注射用头孢噻肟钠他唑巴坦钠","无","注射剂","1.17g(C16H17N5O7S2 1.0g与C10H12N4O5S 0.17g)","盒","1","低硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞和抗生素瓶用铝塑组合盖。","南京优科制药有限公司","61.18","修改（医保信息）","医保发〔2024〕33号",""]
[35,"XJ01DDT199B001020105025","2","注射用头孢噻肟钠他唑巴坦钠","","","209560","注射用头孢噻肟钠他唑巴坦钠","无","注射剂","1.75g(C₁₆H₁₇N₅O₇S₂ 1.5g与C₁₀H₁₂N₄O₅S 0.25g)","瓶","1","低硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖","湘北威尔曼制药股份有限公司","82.99 ","修改（医保信息）","医保发〔2024〕33号",""]
[36,"XJ01DDT199B001020180542","2","注射用头孢噻肟钠他唑巴坦钠","","","206592","注射用头孢噻肟钠他唑巴坦钠","无","注射剂","2.34g(C16H17N5O7S2 2.0g与C10H12N4O5S 0.34g)","盒","1","低硼硅玻璃管制注射剂瓶、注射用无菌粉末用卤化丁基橡胶塞和抗生素瓶用铝塑组合盖。","南京优科制药有限公司","104.00","修改（医保信息）","医保发〔2024〕33号",""]
[37,"XA10BDE082A001010103204","2","二甲双胍恩格列净片(Ⅰ)","","","208886","二甲双胍恩格列净片 ( Ⅰ )","无","片剂(薄膜衣片)","每片含盐酸二甲双胍500mg与恩格列净5mg","盒","60","药品包装用铝箔和聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","遂成药业股份有限公司","60.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[38,"XA10BDE082A001010183058","2","二甲双胍恩格列净片(Ⅰ)","","","208820","二甲双胍恩格列净片(Ⅰ)","无","片剂(薄膜衣片)","每片含盐酸二甲双胍500mg与恩格列净5mg","瓶","60","口服固体药用高密度聚乙烯瓶装","北京百奥药业有限责任公司","59.98 ","修改（医保信息）","医保发〔2024〕33号",""]
[39,"XA10BDE082A001010203204","2","二甲双胍恩格列净片(Ⅰ)","","","208874","二甲双胍恩格列净片 ( Ⅰ )","无","片剂(薄膜衣片)","每片含盐酸二甲双胍500mg与恩格列净5mg","盒","30","药品包装用铝箔和聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","遂成药业股份有限公司","30.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[40,"XA10BDE082A001010204021","2","二甲双胍恩格列净片(Ⅰ)","","","209829","二甲双胍恩格列净片(Ⅰ)","无","薄膜衣片","每片含盐酸二甲双胍500mg与恩格列净5mg","盒","60","口服固体药用高密度聚乙烯瓶和固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","58.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[41,"XA10BDE082A001010204520","2","二甲双胍恩格列净片(Ⅰ)","","","174275","二甲双胍恩格列净片(Ⅰ)","无","薄膜衣片","盐酸二甲双胍0.5g与恩格列净5mg","盒","30","铝箔","杭州中美华东制药有限公司","30.90","修改（医保信息）","医保发〔2024〕33号",""]
[42,"XA10BDE082A001010304520","2","二甲双胍恩格列净片(Ⅰ)","","","174330","二甲双胍恩格列净片(Ⅰ)","无","薄膜衣片","盐酸二甲双胍0.5g与恩格列净5mg","盒","60","铝箔","杭州中美华东制药有限公司","61.80","修改（医保信息）","医保发〔2024〕33号",""]
[43,"XH01BAQ117X001010184206","2","去氨加压素口服溶液","","","206539","去氨加压素口服溶液","无","口服溶液剂","15ml:5.4mg( 按C₄₆H₆₄N₁₄O₁₂S₂ 计)","盒","1","钠钙玻璃模制药瓶、药用低密度聚乙烯瓶盖和口服液体药用高密度聚乙烯瓶盖包装","浙江康恩贝制药股份有限公司","299.00","修改（医保信息）","医保发〔2024〕33号",""]
[44,"XB02BXA307A001010101397","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","210872","艾曲泊帕乙醇胺片","无","片剂(薄膜衣片)","25mg(按C₂₅H₂₂N₄O₄计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔","常州制药厂有限公司","1280.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[45,"XB02BXA307A001010101425","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","207655","艾曲泊帕乙醇胺片","无","薄膜衣片","25mg(按C₂₅H₂₂N₄O₄计)","盒","14","铝/铝泡罩包装","江苏奥赛康药业有限公司","1498.00","修改（医保信息）","医保发〔2024〕33号",""]
[46,"XB02BXA307A001010104021","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","207636","艾曲泊帕乙醇胺片","无","薄膜衣片","25mg(按C₂₅H₂₂N₄O₄计)","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片\\药用铝箔","齐鲁制药有限公司","2925.00","修改（医保信息）","医保发〔2024〕33号",""]
[47,"XB02BXA307A001010104565","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","211103","艾曲泊帕乙醇胺片","无","片剂","25mg(按C₂₅H₂₂N₄O₄计)","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","宁波美诺华天康药业有限公司","2268.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[48,"XB02BXA307A001010178679","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","167212","艾曲泊帕乙醇胺片","瑞弗兰","薄膜衣片","25mg","盒","14","铝塑","Siegfried Barbera, S.L.","1890.00","修改（医保信息）","医保发〔2024〕33号",""]
[49,"XB02BXA307A001010184393","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","210690","艾曲泊帕乙醇胺片","无","片剂(薄膜衣片)","25mg(按C₂₅H₂₂N₄O₄计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","广东隆赋药业股份有限公司","1497.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[50,"XB02BXA307A001010201523","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","207677","艾曲泊帕乙醇胺片","无","薄膜衣片","25mg(按C₂₅H₂₂N₄O₄计)","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","正大天晴药业集团股份有限公司","2579.00","修改（医保信息）","医保发〔2024〕33号",""]
[51,"XB02BXA307A001010202180","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","207657","艾曲泊帕乙醇胺片","无","薄膜衣片","25mg(按C₂₅H₂₂N₄O₄计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔","四川科伦药业股份有限公司","1288.00","修改（医保信息）","医保发〔2024〕33号",""]
[52,"XB02BXA307A001010204021","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","207637","艾曲泊帕乙醇胺片","无","薄膜衣片","25mg(按C₂₅H₂₂N₄O₄计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片\\药用铝箔","齐鲁制药有限公司","1500.00","修改（医保信息）","医保发〔2024〕33号",""]
[53,"XB02BXA307A001010278679","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","165604","艾曲泊帕乙醇胺片","瑞弗兰","薄膜衣片","25mg","盒","28","铝塑","Siegfried Barbera, S.L.","3780.00","修改（医保信息）","医保发〔2024〕33号",""]
[54,"XL04AXB245E001010104021","2","泊马度胺胶囊","","限既往接受过至少两种治疗(包括来那度胺和一种蛋白酶体抑制剂)，且在最后一次治疗期间或治疗结束后60天内发生疾病进展的成年多发性骨髓瘤患者。","209472","泊马度胺胶囊","无","胶囊剂","1mg","盒","21","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔组成的泡罩包装,外套聚酯/铝/聚乙烯药用复合袋。","齐鲁制药有限公司","1377.16 ","修改（医保信息）","医保发〔2024〕33号",""]
[55,"XL04AXB245E001010301523","2","泊马度胺胶囊","","限既往接受过至少两种治疗(包括来那度胺和一种蛋白酶体抑制剂)，且在最后一次治疗期间或治疗结束后60天内发生疾病进展的成年多发性骨髓瘤患者。","171494","泊马度胺胶囊","无","硬胶囊剂","1.0mg","盒","21","双铝","正大天晴药业集团股份有限公司","1620.36","修改（医保信息）","医保发〔2024〕33号",""]
[56,"XL04AXB245E001020301523","2","泊马度胺胶囊","","限既往接受过至少两种治疗(包括来那度胺和一种蛋白酶体抑制剂)，且在最后一次治疗期间或治疗结束后60天内发生疾病进展的成年多发性骨髓瘤患者。","171495","泊马度胺胶囊","无","硬胶囊剂","4mg","盒","21","双铝","正大天晴药业集团股份有限公司","4683.00","修改（医保信息）","医保发〔2024〕33号",""]
[57,"XL04AXB245E001030104021","2","泊马度胺胶囊","","限既往接受过至少两种治疗(包括来那度胺和一种蛋白酶体抑制剂)，且在最后一次治疗期间或治疗结束后60天内发生疾病进展的成年多发性骨髓瘤患者。","209473","泊马度胺胶囊","无","胶囊剂","4mg","盒","21","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔组成的泡罩包装,外套聚酯/铝/聚乙烯药用复合袋。","齐鲁制药有限公司","3980.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[58,"XN07XXA364A010010283283","2","氨吡啶缓释片","","限多发性硬化合并步行障碍(EDSS评分4-7分)的成年患者。","174288","氨吡啶缓释片","无","缓释片","10mg","盒","56","铝箔","爱尔兰Alkermes Pharma Ireland Ltd.","901.60","修改（医保信息）","医保发〔2024〕33号",""]
[59,"XN05ALA161X001010181979","2","氨磺必利口服溶液","","","206487","氨磺必利口服溶液","无","口服溶液剂","60ml:6g","盒","1","钠钙玻璃模制药瓶和口服药用聚烯烃安全盖,本品附带口服液体药用聚丙烯量杯。","浙江康恩贝制药股份有限公司","136.00","修改（医保信息）","医保发〔2024〕33号",""]
[60,"XN05AXA028M002010104021","2","阿立哌唑口溶膜","","","206374","阿立哌唑口溶膜","无","膜剂","10mg","盒","14","聚酯/铝/流延聚乙烯药用复合膜","齐鲁制药有限公司","64.54","修改（医保信息）","医保发〔2024〕33号",""]
[61,"XN05AXA028M002010104859","2","阿立哌唑口溶膜","","","207644","阿立哌唑口溶膜","无","膜剂","10mg","盒","10","聚酯/铝/聚乙烯药用易揭复合膜包装","厦门力卓药业有限公司","46.00","修改（医保信息）","医保发〔2024〕33号",""]
[62,"XN05AXA028M002010180923","2","阿立哌唑口溶膜","","","207385","阿立哌唑口溶膜","无","膜剂","5mg","盒","20","聚酯/铝/聚乙烯药用易揭复合膜包装。","厦门力卓药业有限公司","54.20","修改（医保信息）","医保发〔2024〕33号",""]
[63,"XA12BAL208X001010104670","2","氯化钾口服溶液","","","204918","氯化钾口服溶液","无","口服溶液","100ml:10g","盒","1","口服液体药用高密度聚乙烯压旋式安全瓶","浙江康恩贝制药股份有限公司","16.88","修改（医保信息）","医保发〔2024〕33号",""]
[64,"XA12BAL208X001010182209","2","氯化钾口服溶液","","","209057","氯化钾口服溶液","无","口服溶液剂","100ml:10g","盒","1","口服液体药用聚酯瓶","北京诚济制药股份有限公司","16.78 ","修改（医保信息）","医保发〔2024〕33号",""]
[65,"XB05BAF705B002010101949","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","208902","复方氨基酸注射液(18AA-Ⅴ-SF)","无","注射液","250ml: 8.06g(总氨基酸)与12.5g木糖醇","瓶","1","中硼硅玻璃输液瓶","武汉久安药业有限公司","42.13 ","修改（医保信息）","医保发〔2024〕33号",""]
[66,"XB05BAF705B002010102001","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165720","复方氨基酸注射液(18AA-Ⅴ-SF)","无","注射液","100ml:3.224g(总氨基酸)＋5g(木糖醇)","瓶","1","玻璃瓶","湖北一半天制药有限公司","20.90","修改（医保信息）","医保发〔2024〕33号",""]
[67,"XB05BAF705B002010106932","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165718","复方氨基酸注射液(18AA-Ⅴ-SF)","立命","注射液","250ml:8.06g(总氨基酸)＋12.5g(木糖醇)","瓶","1","玻璃瓶","湖北一半天制药有限公司","42.15","修改（医保信息）","医保发〔2024〕33号",""]
[68,"XB05BAF705B002020102001","2","复方氨基酸注射液(18AA-Ⅴ-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165719","复方氨基酸注射液(18AA-Ⅴ-SF)","无","注射液","500ml:16.12g(总氨基酸)＋25g(木糖醇)","瓶","1","玻璃瓶","湖北一半天制药有限公司","71.65","修改（医保信息）","医保发〔2024〕33号",""]
[69,"XB05BAF703B002010101927","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","171767","复方氨基酸注射液(14AA-SF)","无","注射液","250ml:21.2g(总氨基酸)","瓶","1","玻璃瓶","湖北一半天制药有限公司","102.98","修改（医保信息）","医保发〔2024〕33号",""]
[70,"XB05BAF703B002010104688","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","209114","复方氨基酸注射液(14AA-SF)","无","注射液","250ml:21.2g(总氨基酸)","瓶","1","钠钙玻璃输液瓶和注射液用卤化丁基橡胶塞包装","广州绿十字制药股份有限公司","102.68 ","修改（医保信息）","医保发〔2024〕33号",""]
[71,"XB05BAF703B002010106932","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","165717","复方氨基酸注射液(14AA-SF)","无","注射液","50ml:4.2g(总氨基酸)","瓶","1","玻璃瓶","湖北一半天制药有限公司","29.82","修改（医保信息）","医保发〔2024〕33号",""]
[72,"XB05BAF703B002020106932","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","209502","复方氨基酸注射液(14AA-SF)","无","注射剂","100ml:8.48g(总氨基酸)","瓶","1","玻璃输液瓶","湖北一半天制药有限公司","51.06 ","修改（医保信息）","医保发〔2024〕33号",""]
[73,"XB05BAF703B002030106932","2","复方氨基酸注射液(14AA-SF)","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","209529","复方氨基酸注射液(14AA-SF)","无","注射剂","500ml:42.4g(总氨基酸)","瓶","1","玻璃输液瓶","湖北一半天制药有限公司","175.07 ","修改（医保信息）","医保发〔2024〕33号",""]
[74,"XC02KXM170A001010101606","2","马昔腾坦片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","206144","马昔腾坦片","无","薄膜衣片","10mg","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯(PVC/PE/PVDC)固体药用复合硬片和药用铝箔包装","南京正大天晴制药有限公司","2968.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[75,"XC02KXM170A001010104021","2","马昔腾坦片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","210355","马昔腾坦片","无","薄膜衣片","10mg","盒","30","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","2940.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[76,"XC02KXM170A001010104520","2","马昔腾坦片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","206179","马昔腾坦片","无","薄膜衣片","10mg","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片/药用铝箔","杭州中美华东制药有限公司","2960.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[77,"XC02KXM170A001010178189","2","马昔腾坦片","","限WHO功能分级II级-III级的肺动脉高压(WHO第1组)的患者。","163217","马昔腾坦片","傲朴舒","片剂","10mg","盒","30","铝塑包装","Excella GmbH & Co. KG","4036.50","修改（医保信息）","医保发〔2024〕33号",""]
[78,"XR03ACB127L020010181251","2","盐酸丙卡特罗吸入溶液","","","209034","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃· HCl·1/2H₂O计)","盒","8","内包材为低密度聚乙烯瓶,密封于聚酯/铝/聚乙烯药用复合袋","津药永光(河北)制药有限公司","83.28 ","修改（医保信息）","医保发〔2024〕33号",""]
[79,"XR03ACB127L020010182770","2","盐酸丙卡特罗吸入溶液","","","205429","盐酸丙卡特罗吸入溶液","无","吸入用溶液剂","0.5ml:50μg( 按C₁₆H₂₂N₂O₃· HCl·½H₂O计)","盒","10","吸入溶液用低密度聚乙烯瓶,密封于聚酯/铝/聚乙烯药品包装用复合袋。","南京华盖制药有限公司","154.00","修改（医保信息）","医保发〔2024〕33号",""]
[80,"XR03ACB127L020010183798","2","盐酸丙卡特罗吸入溶液","","","211186","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.5ml:50μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","10","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合膜袋","深圳市贝美药业有限公司","152.60 ","修改（医保信息）","医保发〔2024〕33号",""]
[81,"XR03ACB127L020010184221","2","盐酸丙卡特罗吸入溶液","","","210809","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","10","内包装为低密度聚乙烯安瓿，密封于聚酯/铝/聚乙烯药用复合袋","浙江赛默制药有限公司","103.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[82,"XR03ACB127L020010281251","2","盐酸丙卡特罗吸入溶液","","","209070","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃· HCl·1/2H₂O计)","盒","16","内包材为低密度聚乙烯瓶,密封于聚酯/铝/聚乙烯药用复合袋","津药永光(河北)制药有限公司","166.56 ","修改（医保信息）","医保发〔2024〕33号",""]
[83,"XR03ACB127L020010481251","2","盐酸丙卡特罗吸入溶液","","","209068","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃· HCl·1/2H₂O计)","盒","56","内包材为低密度聚乙烯瓶,密封于聚酯/铝/聚乙烯药用复合袋","津药永光(河北)制药有限公司","582.96 ","修改（医保信息）","医保发〔2024〕33号",""]
[84,"XR03ACB127L020020184221","2","盐酸丙卡特罗吸入溶液","","","211164","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.5ml:50μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","10","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合袋","浙江高跖医药科技股份有限公司","153.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[85,"XR03ACB127L020020283798","2","盐酸丙卡特罗吸入溶液","","","211187","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","10","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合膜袋。","深圳市贝美药业有限公司","103.20 ","修改（医保信息）","医保发〔2024〕33号",""]
[86,"XR05CBX169X001010104293","2","盐酸溴己新口服溶液","","","200882","盐酸溴己新口服溶液","无","口服溶液剂","40ml:80mg","盒","1","钠钙玻璃模制药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯","江西亿友药业有限公司","17.76","修改（医保信息）","医保发〔2024〕33号",""]
[87,"XR05CBX169X001010104360","2","盐酸溴己新口服溶液","","","210992","盐酸溴己新口服溶液","无","口服溶液剂","100ml：0.2g","盒","1","钠钙玻璃模制药瓶(棕色)＋口服药用聚丙烯压旋盖＋口服液体用聚乙烯/聚乙烯/聚乙烯密封垫片，配备有带刻度的量杯。100ml/瓶，1瓶/盒。","安徽新世纪药业有限公司","35.30 ","修改（医保信息）","医保发〔2024〕33号",""]
[88,"XR05CBX169X001010181644","2","盐酸溴己新口服溶液","","","208449","盐酸溴己新口服溶液","无","口服溶液剂","100ml:0.2g","盒","1","钠钙玻璃模制药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯。","精诚徽药药业股份有限公司","35.82 ","修改（医保信息）","医保发〔2024〕33号",""]
[89,"XR05CBX169X001010183033","2","盐酸溴己新口服溶液","","","207743","盐酸溴己新口服溶液","无","口服溶液剂","100ml:0.2g","盒","1","钠钙玻璃模制药瓶和口服液瓶用铝盖,配备有带刻度的量杯","河北仁合益康药业有限公司","35.60 ","修改（医保信息）","医保发〔2024〕33号",""]
[90,"XR05CBX169X001010204293","2","盐酸溴己新口服溶液","","","206675","盐酸溴己新口服溶液","无","口服溶液剂","40ml:80mg","盒","2","钠钙玻璃模制药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯","江西亿友药业有限公司","35.52","修改（医保信息）","医保发〔2024〕33号",""]
[91,"XR05CBX169X001010304293","2","盐酸溴己新口服溶液","","","206676","盐酸溴己新口服溶液","无","口服溶液剂","40ml:80mg","盒","3","钠钙玻璃模制药瓶＋口服液瓶用扭断式防盗铝盖,配备有带刻度的量杯","江西亿友药业有限公司","53.28","修改（医保信息）","医保发〔2024〕33号",""]
[92,"XR01ACA210N001010100151","2","盐酸奥洛他定颗粒","","","206567","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","10","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","20.75","修改（医保信息）","医保发〔2024〕33号",""]
[93,"XR01ACA210N001010101503","2","盐酸奥洛他定颗粒","","","203763","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","4","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","8.32","修改（医保信息）","医保发〔2024〕33号",""]
[94,"XR01ACA210N001010200151","2","盐酸奥洛他定颗粒","","","206569","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","12","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","24.90","修改（医保信息）","医保发〔2024〕33号",""]
[95,"XR01ACA210N001010201503","2","盐酸奥洛他定颗粒","","","206563","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","2","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","4.16","修改（医保信息）","医保发〔2024〕33号",""]
[96,"XR01ACA210N001010300151","2","盐酸奥洛他定颗粒","","","206564","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","6","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","12.45","修改（医保信息）","医保发〔2024〕33号",""]
[97,"XR01ACA210N001010301503","2","盐酸奥洛他定颗粒","","","206565","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","6","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","12.48","修改（医保信息）","医保发〔2024〕33号",""]
[98,"XR01ACA210N001010400151","2","盐酸奥洛他定颗粒","","","206766","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","24","双向拉伸聚酯/聚乙烯药用复合膜为内包装,聚酯/铝/聚乙烯药用复合袋为外包装","北京四环科宝制药股份有限公司","49.80","修改（医保信息）","医保发〔2024〕33号",""]
[99,"XR01ACA210N001010401503","2","盐酸奥洛他定颗粒","","","206566","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","8","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","16.64","修改（医保信息）","医保发〔2024〕33号",""]
[100,"XR01ACA210N001010484276","2","盐酸奥洛他定颗粒","","","210036","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","24","聚酯/铝/聚乙烯药用复合膜为内包装；双向拉伸聚酯/铝/聚乙烯药品包装用复合膜袋为外包装,","江苏万高药业股份有限公司","49.44 ","修改（医保信息）","医保发〔2024〕33号",""]
[101,"XR01ACA210N001010501503","2","盐酸奥洛他定颗粒","","","206568","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","10","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","20.80","修改（医保信息）","医保发〔2024〕33号",""]
[102,"XR01ACA210N001010601503","2","盐酸奥洛他定颗粒","","","206570","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","12","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","24.96","修改（医保信息）","医保发〔2024〕33号",""]
[103,"XR01ACA210N001010701503","2","盐酸奥洛他定颗粒","","","206783","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","24","纸/铝/聚乙烯药用复合膜内包装,聚酯/铝/聚乙烯药用复合膜外包装","江苏万高药业股份有限公司","49.92","修改（医保信息）","医保发〔2024〕33号",""]
[104,"XR01ACA210N001010784276","2","盐酸奥洛他定颗粒","","","210039","盐酸奥洛他定颗粒","无","颗粒剂","2.5mg","盒","20","聚酯/铝/聚乙烯药用复合膜为内包装；双向拉伸聚酯/铝/聚乙烯药品包装用复合膜袋为外包装,","江苏万高药业股份有限公司","41.20 ","修改（医保信息）","医保发〔2024〕33号",""]
[105,"XC09DXS255A001010101751","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","207675","沙库巴曲缬沙坦钠片","无","薄膜衣片","按沙库巴曲缬沙坦计100mg(沙库巴曲49mg/缬沙坦51mg)","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔。","德全药品(江苏)股份有限公司","38.92","修改（医保信息）","医保发〔2024〕33号",""]
[106,"XC09DXS255A001010181522","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","205571","沙库巴曲缬沙坦钠片","无","薄膜衣片","100mg(沙库巴曲49mg/缬沙坦51mg)","盒","12","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔","江苏宣泰药业有限公司","30.84 ","修改（医保信息）","医保发〔2024〕33号",""]
[107,"XC09DXS255A001010202180","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","206950","沙库巴曲缬沙坦钠片","无","薄膜衣片","50mg(沙库巴曲24mg/缬沙坦26mg)","盒","28","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","四川科伦药业股份有限公司","44.80","修改（医保信息）","医保发〔2024〕33号",""]
[108,"XC09DXS255A001010478679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","206786","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计100mg(沙库巴曲 49mg/缬沙坦 51mg)","盒","28","PVC/PVDC包装","Novartis Farma S.p.A","85.12","修改（医保信息）","医保发〔2024〕33号",""]
[109,"XC09DXS255A001020101751","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","207676","沙库巴曲缬沙坦钠片","无","薄膜衣片","按沙库巴曲缬沙坦计 50mg(沙库巴曲24mg/缬沙坦26mg)","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔。","德全药品(江苏)股份有限公司","45.79","修改（医保信息）","医保发〔2024〕33号",""]
[110,"XC09DXS255A001020102180","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","206951","沙库巴曲缬沙坦钠片","无","薄膜衣片","100mg(沙库巴曲49mg/缬沙坦51mg)","盒","14","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","四川科伦药业股份有限公司","39.06","修改（医保信息）","医保发〔2024〕33号",""]
[111,"XC09DXS255A001020181522","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","205572","沙库巴曲缬沙坦钠片","无","薄膜衣片","200mg(沙库巴曲97mg/缬沙坦103mg)","盒","12","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔","南京一心和医药科技有限公司","52.44 ","修改（医保信息）","医保发〔2024〕33号",""]
[112,"XC09DXS255A001030378679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","171728","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计200mg(沙库巴曲97mg/缬沙坦103mg)","盒","7","PVC/PVDC包装","Novartis Farma S.p.A","36.12","修改（医保信息）","医保发〔2024〕33号",""]
[113,"XC09DXS255A001050178679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","310161","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计200mg(沙库巴曲97mg/缬沙坦103mg)","盒","28","PVC/PVDC包装","Novartis Farma S.p.A","144.48","修改（医保信息）","医保发〔2024〕33号",""]
[114,"XB03XAL373E001010102777","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","210656","罗沙司他胶囊","无","胶囊剂","50mg","盒","3","铝/铝泡罩包装(聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔)","石药集团中诺药业(石家庄)有限公司","129.90 ","修改（医保信息）","医保发〔2024〕33号",""]
[115,"XB03XAL373E001010180523","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","165682","罗沙司他胶囊","爱瑞卓","胶囊剂","20mg","盒","3","铝/铝泡罩","珐博进(中国)医药技术开发有限公司","74.70","修改（医保信息）","医保发〔2024〕33号",""]
[116,"XB03XAL373E001010202013","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","210598","罗沙司他胶囊","无","胶囊剂","20mg","盒","3","铝/铝泡罩(聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔)包装","成都倍特药业股份有限公司","66.94 ","修改（医保信息）","医保发〔2024〕33号",""]
[117,"XB03XAL373E001020102013","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","210600","罗沙司他胶囊","无","胶囊剂","50mg","盒","3","铝/铝泡罩(聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔)包装","成都倍特药业股份有限公司","135.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[118,"XB03XAL373E001020180523","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","165671","罗沙司他胶囊","爱瑞卓","胶囊剂","50mg","盒","3","铝/铝泡罩","珐博进(中国)医药技术开发有限公司","150.66","修改（医保信息）","医保发〔2024〕33号",""]
[119,"XB03XAL373E001020202777","2","罗沙司他胶囊","","限慢性肾脏病(CKD)引起的贫血。","210657","罗沙司他胶囊","无","胶囊剂","20mg","盒","3","铝/铝泡罩包装(聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔)","石药集团中诺药业(石家庄)有限公司","64.41 ","修改（医保信息）","医保发〔2024〕33号",""]
[120,"XA02BCY338B001010101425","2","注射用右兰索拉唑","","限伴有出血的胃、十二指肠溃疡。","210086","注射用右兰索拉唑","无","注射剂","15mg","盒","1","中硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)及抗生素瓶用铝塑组合盖","江苏奥赛康药业有限公司","28.46 ","修改（医保信息）","医保发〔2024〕33号",""]
[121,"XA02BCY338B001010182416","2","注射用右兰索拉唑","","限伴有出血的胃、十二指肠溃疡。","206595","注射用右兰索拉唑","无","注射剂","20mg","盒","1","中性硼硅玻璃管制镀聚二甲基硅氧烷膜注射剂瓶＋冷冻干燥注射用局部覆聚 四氟乙烯膜卤化丁基橡胶塞(溴化) ＋抗生素瓶用铝塑组合盖","盛禾(中国)生物制药有限公司","35.48","修改（医保信息）","医保发〔2024〕33号",""]
[122,"XS01EDB212G010010178672","2","布林佐胺噻吗洛尔滴眼液","","限二线用药。","162668","布林佐胺噻吗洛尔滴眼液","无","滴眼剂","5ml:布林佐胺50mg,马来酸噻吗洛尔25mg(以噻吗洛尔计)","盒","1","低密度聚乙烯","比利时s.a. ALCON-COUVREUR n.v.","41.00","修改（医保信息）","医保发〔2024〕33号",""]
[123,"XS01ECB234G010010178672","2","布林佐胺溴莫尼定滴眼液","","限二线用药。","171069","布林佐胺溴莫尼定滴眼液","无","滴眼剂","5ml:布林佐胺50mg,酒石酸溴莫尼定10mg","支","1","低密度聚乙烯","比利时s.a. ALCON-COUVREUR n.v.","63.00","修改（医保信息）","医保发〔2024〕33号",""]
[124,"XJ05ARN113A001010100648","2","奈韦拉平齐多拉米双夫定片","","限艾滋病病毒感染。","171775","奈韦拉平齐多拉米双夫定片","无","片剂","每片含奈韦拉平0.2g,齐多夫定0.3g和拉米夫定0.15g","瓶","60","塑料瓶","上海迪赛诺医药集团股份有限公司","726.00","修改（医保信息）","医保发〔2024〕33号",""]
[125,"XJ05ARA311B001010182358","2","注射用艾博韦泰","","限艾滋病病毒感染。","165165","注射用艾博韦泰","艾可宁","冻干粉针剂","0.16g","瓶","1","玻璃瓶","前沿生物药业(南京)股份有限公司","532.00","修改（医保信息）","医保发〔2024〕33号",""]
[126,"XJ02ACA370B001010101425","2","注射用硫酸艾沙康唑","","限侵袭性曲霉病或侵袭性毛霉病的成人患者。","208813","注射用硫酸艾沙康唑","无","注射剂","0.2g(按C₂₂H₁₇F₂N₅OS计)","盒","1","高硼硅玻璃管制注射剂瓶、冷冻干燥注射用局部覆聚四氟乙烯膜卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖包装","江苏奥赛康药业有限公司","1166.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[127,"XJ02ACA370B001010183103","2","注射用硫酸艾沙康唑","","限侵袭性曲霉病或侵袭性毛霉病的成人患者。","176507","注射用硫酸艾沙康唑","无","注射剂","200mg(按C22H17F2N5OS计)","盒","1","采用高硼硅玻璃管制注射剂瓶、注射制剂用覆聚乙烯－四氟乙烯膜丁基橡胶塞和注射制剂瓶用铝塑组合盖包装。","Baxter Pharmaceutical Solutions,LLC","1458.00","修改（医保信息）","医保发〔2024〕33号",""]
[128,"XJ01DCT187B002010100108","2","注射用头孢呋辛钠/氯化钠注射液","","","166514","注射用头孢呋辛钠/氯化钠注射液","无","注射剂","粉体室:0.75g(按C16H16N4O8S计)；液体室:100ml:氯化钠0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","27.70","修改（医保信息）","医保发〔2024〕33号",""]
[129,"XJ01DCT187B002020100108","2","注射用头孢呋辛钠/氯化钠注射液","","","310066","注射用头孢呋辛钠/氯化钠注射液","无","注射剂","粉体室:1.5g(按C16H16N4O8S计)；液体室:100ml∶氯化钠0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","36.59","修改（医保信息）","医保发〔2024〕33号",""]
[130,"XJ01DDT187B002010204948","2","注射用头孢呋辛钠/氯化钠注射液","","","205341","注射用头孢呋辛钠/氯化钠注射液","无","注射剂","粉体室:0.75g(按C₁₆H₁₆N₄O₈S计)；液体室:100ml∶0.9g","袋","1","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","27.69","修改（医保信息）","医保发〔2024〕33号",""]
[131,"XJ01DDT187B002020204948","2","注射用头孢呋辛钠/氯化钠注射液","","","205342","注射用头孢呋辛钠/氯化钠注射液","无","注射剂","粉体室:1.5g(按C₁₆H₁₆N₄O₈S计)；液体室:100ml∶0.9g","袋","1","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","36.57","修改（医保信息）","医保发〔2024〕33号",""]
[132,"XN01AXA327B002010201445","2","盐酸艾司氯胺酮注射液","","限用于与镇静麻醉药联合诱导和实施全身麻醉。","171720","盐酸艾司氯胺酮注射液","无","注射剂","2ml:50mg(按C13H16ClNO计)","瓶","1","中硼硅玻璃管制注射剂瓶","江苏恒瑞医药股份有限公司","91.80","修改（医保信息）","医保发〔2024〕33号",""]
[133,"XA10BFA025A005010104520","2","阿卡波糖咀嚼片","","","166524","阿卡波糖咀嚼片","无","咀嚼片","50mg","盒","30","铝塑","杭州中美华东制药有限公司","13.95","修改（医保信息）","医保发〔2024〕33号",""]
[134,"XA10BFA025A005010204520","2","阿卡波糖咀嚼片","","","166565","阿卡波糖咀嚼片","无","咀嚼片","50mg","盒","60","铝塑","杭州中美华东制药有限公司","27.90","修改（医保信息）","医保发〔2024〕33号",""]
[135,"XA10BFA025A005010304520","2","阿卡波糖咀嚼片","","","166953","阿卡波糖咀嚼片","无","咀嚼片","50mg","盒","90","铝塑","杭州中美华东制药有限公司","41.85","修改（医保信息）","医保发〔2024〕33号",""]
[136,"XL04AAX246A001010178677","2","西尼莫德片","","限成人复发型多发性硬化的患者。","171727","西尼莫德片","万立能","薄膜衣片","0.25mg","盒","12","双铝","瑞士Novartis Pharma Stein AG","591.12","修改（医保信息）","医保发〔2024〕33号",""]
[137,"XL04AAX246A001020178677","2","西尼莫德片","","限成人复发型多发性硬化的患者。","171080","西尼莫德片","万立能","薄膜衣片","2.0mg","盒","28","双铝","瑞士Novartis Pharma Stein AG","6776.00","修改（医保信息）","医保发〔2024〕33号",""]
[138,"XL04AAF715E001010100100","2","盐酸芬戈莫德胶囊","","限10岁及以上患者复发型多发性硬化(RMS)的患者。","166622","盐酸芬戈莫德胶囊","捷灵亚","硬胶囊剂","0.5mg","盒","28","空","瑞士Novartis Pharma Stein AG","6384.00","修改（医保信息）","医保发〔2024〕33号",""]
[139,"XN03AXB239A001010101463","2","吡仑帕奈片","","","207686","吡仑帕奈片","无","薄膜衣片","12mg","盒","12","铝塑包装,包装材料为聚三氟氯乙烯/聚氯乙烯固体药用复合硬片与药用包 装用铝箔。","江苏康缘药业股份有限公司","213.72","修改（医保信息）","医保发〔2024〕33号",""]
[140,"XN03AXB239A001010102469","2","吡仑帕奈片","","","210717","吡仑帕奈片","无","片剂","4mg","盒","28","聚氯乙烯固体药用硬片和药用铝箔","西安远大德天药业股份有限公司","191.83 ","修改（医保信息）","医保发〔2024〕33号",""]
[141,"XN03AXB239A001010183050","2","吡仑帕奈片","","","176240","吡仑帕奈片","卫克泰","薄膜衣片","2.0mg","盒","28","铝塑","日本Eisai Co.,Ltd.(Kawashima Factory)","126.56","修改（医保信息）","医保发〔2024〕33号",""]
[142,"XN03AXB239A001010184736","2","吡仑帕奈片","","","208339","吡仑帕奈片","无","片剂(薄膜衣片)","4mg","盒","28","铝塑(药用铝箔、聚氯乙烯固体药用硬片)泡罩包装","江西科睿药业有限公司","191.42 ","修改（医保和招标信息）","医保发〔2024〕33号",""]
[143,"XN03AXB239A001020102469","2","吡仑帕奈片","","","210718","吡仑帕奈片","无","片剂","2mg","盒","28","聚氯乙烯固体药用硬片和药用铝箔","西安远大德天药业股份有限公司","112.84 ","修改（医保信息）","医保发〔2024〕33号",""]
[144,"XN03AXB239A001020183050","2","吡仑帕奈片","","","176239","吡仑帕奈片","卫克泰","薄膜衣片","4mg","盒","28","铝塑","日本Eisai Co.,Ltd.(Kawashima Factory)","215.04","修改（医保信息）","医保发〔2024〕33号",""]
[145,"XN03AXB239A001030101463","2","吡仑帕奈片","","","209585","吡仑帕奈片","无","片剂(薄膜衣片)","2mg","盒","14","铝塑包装,包装材料为聚三氟氯乙烯/聚氯乙烯固体药用复合硬片与药用包装用铝箔","江苏康缘药业股份有限公司","63.14 ","修改（医保信息）","医保发〔2024〕33号",""]
[146,"XL04AXE092E005010183283","2","富马酸二甲酯肠溶胶囊","","限成人复发型多发性硬化(RMS)。","173566","富马酸二甲酯肠溶胶囊","无","胶囊剂","120mg","盒","14","PVC / PE / PVDC-PVC铝泡罩包装。","Janssen Cilag SpA","500.64","修改（医保信息）","医保发〔2024〕33号",""]
[147,"XL04AXE092E005010184827","2","富马酸二甲酯肠溶胶囊","","限成人复发型多发性硬化(RMS)。","205175","富马酸二甲酯肠溶胶囊","无","胶囊剂","240mg","盒","56","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装。","四川宏明博思药业有限公司","3348.80","修改（医保信息）","医保发〔2024〕33号",""]
[148,"XL04AXE092E005020183283","2","富马酸二甲酯肠溶胶囊","","限成人复发型多发性硬化(RMS)。","173567","富马酸二甲酯肠溶胶囊","无","胶囊剂","240mg","盒","56","PVC / PE / PVDC-PVC铝泡罩包装。","Janssen Cilag SpA","3404.80","修改（医保信息）","医保发〔2024〕33号",""]
[149,"XC01EBR118B002010181812","2","瑞加诺生注射液","","","174704","瑞加诺生注射液","无","注射剂","5ml:0.4mg(以C15H18N8O5计)","盒","1","中硼硅玻璃安瓿","南京海融制药有限公司","798.00","修改（医保信息）","医保发〔2024〕33号",""]
[150,"XN05CCS273S003010101587","2","水合氯醛灌肠剂","","限儿童。","167257","水合氯醛灌肠剂","无","灌肠剂","1.34g:0.5g","瓶","1","玻璃瓶","特丰制药有限公司","17.00","修改（医保信息）","医保发〔2024〕33号",""]
[151,"XN05CCS273S003010201587","2","水合氯醛灌肠剂","","限儿童。","171759","水合氯醛灌肠剂","无","灌肠剂","1.34g:0.5g","瓶","2","玻璃瓶","特丰制药有限公司","34.00","修改（医保信息）","医保发〔2024〕33号",""]
[152,"XR03ACB127L003010102132","2","盐酸丙卡特罗粉雾剂","","","163967","盐酸丙卡特罗粉雾剂","无","吸入粉雾剂","10μg/吸,200吸","支","1","内配给药器具","四川大冢制药有限公司","68.90","修改（医保信息）","医保发〔2024〕33号",""]
[153,"XC07ABA330B002010100628","2","盐酸艾司洛尔氯化钠注射液","","","171111","盐酸艾司洛尔氯化钠注射液","无","注射剂","100ml:盐酸艾司洛尔2g与氯化钠0.41g","盒","1","三层共挤输液袋","上海百特医疗用品有限公司","305.66","修改（医保信息）","医保发〔2024〕33号",""]
[154,"XC07ABA330B002010100841","2","盐酸艾司洛尔氯化钠注射液","","","206427","盐酸艾司洛尔氯化钠注射液","无","注射液","100ml:盐酸艾司洛尔2g与氯化钠0.41g","袋","1","五层共挤输液用袋包装系统","扬子江药业集团上海海尼药业有限公司","305.65 ","修改（医保信息）","医保发〔2024〕33号",""]
[155,"XC07ABA330B002010102763","2","盐酸艾司洛尔氯化钠注射液","","","209788","盐酸艾司洛尔氯化钠注射液","无","注射剂","100ml:盐酸艾司洛尔2g与氯化钠0.41g","袋","1","直立式聚丙烯输液袋","石家庄四药有限公司","305.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[156,"XC07ABA330B002020100628","2","盐酸艾司洛尔氯化钠注射液","","","310057","盐酸艾司洛尔氯化钠注射液","无","注射剂","50ml:盐酸艾司洛尔1g与氯化钠0.205g","盒","1","三层共挤输液袋","上海百特医疗用品有限公司","179.80","修改（医保信息）","医保发〔2024〕33号",""]
[157,"XB01ACL311A001010204066","2","铝镁匹林片(Ⅱ)","","","163093","铝镁匹林片(Ⅱ)","无","素片","阿司匹林81mg,重质碳酸镁22mg,甘羟铝11mg","盒","12","铝塑","山东中健康桥制药有限公司","18.00","修改（医保信息）","医保发〔2024〕33号",""]
[158,"XB01ACL311A001010304066","2","铝镁匹林片(Ⅱ)","","","168141","铝镁匹林片(Ⅱ)","无","素片","阿司匹林81mg,重质碳酸镁22mg,甘羟铝11mg","盒","15","铝塑","山东中健康桥制药有限公司","22.50","修改（医保信息）","医保发〔2024〕33号",""]
[159,"XB01ACL311A001010504066","2","铝镁匹林片(Ⅱ)","","","171491","铝镁匹林片(Ⅱ)","无","素片","阿司匹林81mg,重质碳酸镁22mg,甘羟铝11mg","盒","30","铝塑","山东中健康桥制药有限公司","45.00","修改（医保信息）","医保发〔2024〕33号",""]
[160,"XC07FBB249A001010183599","2","比索洛尔氨氯地平片","","","173848","比索洛尔氨氯地平片","无","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按氨氯地平计)5mg","盒","10","双铝泡罩包装","Egis Pharmaceuticals PLC","15.40","修改（医保信息）","医保发〔2024〕33号",""]
[161,"XC07FBB249A001010383830","2","比索洛尔氨氯地平片","","","209095","比索洛尔氨氯地平片","无","片剂","富马酸比索洛尔5mg与苯磺酸氨氯地平(按氨氯地平计)5mg","盒","15","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔","成都硕德药业有限公司","22.95 ","修改（医保信息）","医保发〔2024〕33号",""]
[162,"XA16AAY312A001010179282","2","盐酸乙酰左卡尼汀片","","限临床确诊的糖尿病周围神经病变患者。","165663","盐酸乙酰左卡尼汀片","无","素片","0.25g","盒","16","铝塑","海思科制药(眉山)有限公司","9.28","修改（医保信息）","医保发〔2024〕33号",""]
[163,"XA16AAY312A001010279282","2","盐酸乙酰左卡尼汀片","","限临床确诊的糖尿病周围神经病变患者。","171961","盐酸乙酰左卡尼汀片","无","素片","0.25g","盒","50","铝塑","海思科制药(眉山)有限公司","29.00","修改（医保信息）","医保发〔2024〕33号",""]
[164,"XA06AXL374E001010278450","2","利那洛肽胶囊","","限成人便秘型肠易激综合征(IBS-C)。","173150","利那洛肽胶囊","令泽舒","胶囊剂","290μg","瓶","7","塑料瓶","英国Almac Pharma Services Limited","90.16 ","修改（医保信息）","医保发〔2024〕33号",""]
[165,"XH01CBA213B015010104021","2","注射用醋酸奥曲肽微球","","限胃肠胰内分泌肿瘤、肢端肥大症。","205185","注射用醋酸奥曲肽微球","无","注射剂","20mg(按C₄₉H₆₆N₁₀O₁₀S₂计)","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞。1支/盒,内附1支装有2mL混悬用溶剂的预灌封注射器、1个无菌注射针和1个药瓶适配器。","齐鲁制药有限公司","3800.00","修改（医保信息）","医保发〔2024〕33号",""]
[166,"XH01CBA213B015010178679","2","注射用醋酸奥曲肽微球","","限胃肠胰内分泌肿瘤、肢端肥大症。","141283","注射用醋酸奥曲肽微球","善龙","粉针剂","20mg","盒","1","预充式(预灌封)注射器","奥地利山德士Sandoz GmbH","4761.00","修改（医保信息）","医保发〔2024〕33号",""]
[167,"XH01CBA213B015020104021","2","注射用醋酸奥曲肽微球","","限胃肠胰内分泌肿瘤、肢端肥大症。","205186","注射用醋酸奥曲肽微球","无","注射剂","30mg(按C₄₉H₆₆N₁₀O₁₀S₂计)","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞。1支/盒,内附1支装有2mL混悬用溶剂的预灌封注射器、1个无菌注射针和1个药瓶适配器。","齐鲁制药有限公司","5183.08","修改（医保信息）","医保发〔2024〕33号",""]
[168,"XH01CBA213B015020178679","2","注射用醋酸奥曲肽微球","","限胃肠胰内分泌肿瘤、肢端肥大症。","132298","注射用醋酸奥曲肽微球","善龙","粉针剂","30mg","盒","1","预充式(预灌封)注射器","奥地利山德士Sandoz GmbH","6493.85","修改（医保信息）","医保发〔2024〕33号",""]
[169,"XL01CDZ046B017010101586","2","注射用紫杉醇脂质体","","限：1.卵巢癌的一线化疗及以后卵巢转移性癌的治疗、作为一线化疗，也可与顺铂联合应用；2.用于曾用过含阿霉素标准化疗的乳腺癌患者的后续治疗或复发患者的治疗；3.可与顺铂联合用于不能手术或放疗的非小细胞肺癌患者的一线化疗。","137750","注射用紫杉醇脂质体","力扑素","冻干粉针剂","30mg","瓶","1","西林瓶","南京绿叶制药有限公司","228.00","修改（医保信息）","医保发〔2024〕33号",""]
[170,"XA04ADA285B002010102777","2","阿瑞匹坦注射液","","限放化疗且吞咽困难的患者。","211242","阿瑞匹坦注射液","无","注射剂","18ml:130mg","盒","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖。","石药集团中诺药业(石家庄)有限公司","138.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[171,"XA04ADA285B002010104021","2","阿瑞匹坦注射液","","限放化疗且吞咽困难的患者。","176649","阿瑞匹坦注射液","无","注射剂","18ml:130mg","瓶","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖","齐鲁制药有限公司","139.13","修改（医保信息）","医保发〔2024〕33号",""]
[172,"XA04ADA285B002010183607","2","阿瑞匹坦注射液","","限放化疗且吞咽困难的患者。","206845","阿瑞匹坦注射液","无","注射剂","18ml∶130mg","瓶","1","中硼硅玻璃管制注射剂瓶、注射液用局部覆聚四氟乙烯膜溴化丁基橡胶塞与抗生素瓶用铝塑组合盖包装","江苏康禾生物制药有限公司","138.59","修改（医保信息）","医保发〔2024〕33号",""]
[173,"XL01XED333A001010378724","2","达可替尼片","","限表皮生长因子受体(EGFR)19号外显子缺失突变或21号外显子L858R置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)患者的一线治疗。","165890","达可替尼片","多泽润","薄膜衣片","15mg","瓶","30","塑料瓶","德国Pfizer Manufacturing Deutschland GMBH","931.50","修改（医保信息）","医保发〔2024〕33号",""]
[174,"XL01EHN120A001010100647","2","马来酸奈拉替尼片","","限人类表皮生长因子受体2(HER2)阳性的早期乳腺癌成年患者，在接受含曲妥珠单抗辅助治疗之后的强化辅助治疗。","206139","马来酸奈拉替尼片","无","薄膜衣片","40mg(按C30H29ClN6O3计)","瓶","180","包装于带有儿童安全聚丙烯瓶盖的高密度聚乙烯瓶中,内装含1g硅胶的高密度聚乙烯干燥剂罐","上海创诺制药有限公司","5661.00","修改（医保信息）","医保发〔2024〕33号",""]
[175,"XL01EHN120A001010184136","2","马来酸奈拉替尼片","","限人类表皮生长因子受体2(HER2)阳性的早期乳腺癌成年患者，在接受含曲妥珠单抗辅助治疗之后的强化辅助治疗。","210226","马来酸奈拉替尼片","无","薄膜衣片","40mg(按C₃₀H₂₉ClN₆O₃计)","瓶","180","包装于口服固体药用高密度聚乙烯瓶及聚丙烯儿童安全组合瓶盖系统重,内装含2个1g固体药用高密度聚乙烯筒装硅胶干燥剂","药源生物科技(启东)有限公司","5660.98 ","修改（医保信息）","医保发〔2024〕33号",""]
[176,"XL01XEN120A001010182949","2","马来酸奈拉替尼片","","限人类表皮生长因子受体2(HER2)阳性的早期乳腺癌成年患者，在接受含曲妥珠单抗辅助治疗之后的强化辅助治疗。","173246","马来酸奈拉替尼片","贺俪安","薄膜衣片","40mg(按C30H29ClN6O3计)","瓶","180","高密度聚乙烯","德国Excella GmbH & Co.KG","6660.00","修改（医保信息）","医保发〔2024〕33号",""]
[177,"XL04AAY270A001010178679","2","依维莫司片","","限：1.既往接受舒尼替尼或索拉非尼治疗失败的晚期肾细胞癌成人患者；2.不可切除的、局部晚期或转移性的、分化良好的(中度分化或高度分化)进展期胰腺神经内分泌瘤成人患者；3.无法手术切除的、局部晚期或转移性的、分化良好的、进展期非功能性胃肠道或肺源神经内分泌肿瘤(NET)成人患者；4.需要治疗干预但不适于手术切除的结节性硬化症(TSC)相关的室管膜下巨细胞星形细胞瘤(SEGA)成人和儿童患者；5.不需立即手术治疗的结节性硬化症相关的肾血管平滑肌脂肪瘤(TSC-AML)成人患者；6.来曲唑或阿那曲唑治疗失败后的激素受体阳性、表皮生长因子受体-2阴性、绝经后晚期女性乳腺癌患者。","162916","依维莫司片","飞尼妥","素片","2.5mg","盒","30","铝塑","瑞士Novartis Pharma Stein AG","2064.60","修改（医保信息）","医保发〔2024〕33号",""]
[178,"XL04AAY270A001010201523","2","依维莫司片","","限：1.既往接受舒尼替尼或索拉非尼治疗失败的晚期肾细胞癌成人患者；2.不可切除的、局部晚期或转移性的、分化良好的(中度分化或高度分化)进展期胰腺神经内分泌瘤成人患者；3.无法手术切除的、局部晚期或转移性的、分化良好的、进展期非功能性胃肠道或肺源神经内分泌肿瘤(NET)成人患者；4.需要治疗干预但不适于手术切除的结节性硬化症(TSC)相关的室管膜下巨细胞星形细胞瘤(SEGA)成人和儿童患者；5.不需立即手术治疗的结节性硬化症相关的肾血管平滑肌脂肪瘤(TSC-AML)成人患者；6.来曲唑或阿那曲唑治疗失败后的激素受体阳性、表皮生长因子受体-2阴性、绝经后晚期女性乳腺癌患者。","207678","依维莫司片","无","片剂","2.5mg","盒","28","本品采用聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","正大天晴药业集团股份有限公司","1573.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[179,"XL04AAY270A001020178679","2","依维莫司片","","限：1.既往接受舒尼替尼或索拉非尼治疗失败的晚期肾细胞癌成人患者；2.不可切除的、局部晚期或转移性的、分化良好的(中度分化或高度分化)进展期胰腺神经内分泌瘤成人患者；3.无法手术切除的、局部晚期或转移性的、分化良好的、进展期非功能性胃肠道或肺源神经内分泌肿瘤(NET)成人患者；4.需要治疗干预但不适于手术切除的结节性硬化症(TSC)相关的室管膜下巨细胞星形细胞瘤(SEGA)成人和儿童患者；5.不需立即手术治疗的结节性硬化症相关的肾血管平滑肌脂肪瘤(TSC-AML)成人患者；6.来曲唑或阿那曲唑治疗失败后的激素受体阳性、表皮生长因子受体-2阴性、绝经后晚期女性乳腺癌患者。","153764","依维莫司片","飞尼妥","素片","5mg","盒","30","铝塑","瑞士Novartis Pharma Stein AG","3510.00","修改（医保信息）","医保发〔2024〕33号",""]
[180,"XB02BXA336A001010101565","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","210832","马来酸阿伐曲泊帕片","无","薄膜衣片","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","盒","10","药用铝箔和聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片包装","南京恒生制药有限公司","3600.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[181,"XB02BXA336A001010102013","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","210187","马来酸阿伐曲泊帕片","无","片剂(薄膜衣片)","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","盒","10","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","成都倍特药业股份有限公司","3880.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[182,"XB02BXA336A001010104021","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","210579","马来酸阿伐曲泊帕片","无","薄膜衣片","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","盒","30","口服固体药用高密度聚乙烯瓶和固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","3960.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[183,"XB02BXA336A001010182938","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","169544","马来酸阿伐曲泊帕片","苏可欣","薄膜衣片","20mg","盒","10","双铝","日本Kawashima Plant, Eisai Co.,Ltd.","4760.00","修改（医保信息）","医保发〔2024〕33号",""]
[184,"XB02BXA336A001010183055","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","210487","马来酸阿伐曲泊帕片","无","片剂(薄膜衣片)","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","盒","10","药用铝箔、聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片","天津药物研究院药业有限责任公司","3868.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[185,"XB02BXA336A001010201606","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","206763","马来酸阿伐曲泊帕片","无","薄膜衣片","20mg(按C₂₉H₃₄C₁₂N₆O₃S₂计)","盒","10","药用铝箔和聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片包装。","南京正大天晴制药有限公司","3960.00","修改（医保信息）","医保发〔2024〕33号",""]
[186,"XB02BXA336A001010282938","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","169545","马来酸阿伐曲泊帕片","苏可欣","薄膜衣片","20mg","盒","15","双铝","日本Kawashima Plant, Eisai Co.,Ltd.","7140.00","修改（医保信息）","医保发〔2024〕33号",""]
[187,"XB02BXA336A001010401606","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","206764","马来酸阿伐曲泊帕片","无","薄膜衣片","20mg(按C₂₉H₃₄C₁₂N₆O₃S₂计)","盒","15","药用铝箔和聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片包装。","南京正大天晴制药有限公司","5852.68","修改（医保信息）","医保发〔2024〕33号",""]
[188,"XA10BKA338A001010280716","2","艾托格列净片","","限二线用药。","171739","艾托格列净片","捷诺妥","薄膜衣片","5mg(以艾托格列净计)","盒","14","双铝","德国Pfizer Manufacturing Deutschland GMBH","48.44","修改（医保信息）","医保发〔2024〕33号",""]
[189,"XJ01DIX240N001010182311","2","小儿法罗培南钠颗粒","","限头孢菌素耐药或重症感染儿童患者。","168215","小儿法罗培南钠颗粒","菲若姆","颗粒剂","0.05g(按C12H15NO5S计)","盒","6","复合膜","CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. Tainan Plant IV","91.80","修改（医保信息）","医保发〔2024〕33号",""]
[190,"XJ01DIX240N001010282311","2","小儿法罗培南钠颗粒","","限头孢菌素耐药或重症感染儿童患者。","172190","小儿法罗培南钠颗粒","菲若姆","颗粒剂","0.05g(按C12H15NO5S计)","盒","3","复合袋","CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. Tainan Plant IV","45.90","修改（医保信息）","医保发〔2024〕33号",""]
[191,"XJ01DIX240N001010382311","2","小儿法罗培南钠颗粒","","限头孢菌素耐药或重症感染儿童患者。","172189","小儿法罗培南钠颗粒","菲若姆","颗粒剂","0.05g(按C12H15NO5S计)","盒","9","复合袋","CHINA CHEMICAL & PHARMACEUTICAL CO., LTD. Tainan Plant IV","137.70","修改（医保信息）","医保发〔2024〕33号",""]
[192,"XA04ADF719B001010101425","2","注射用福沙匹坦双葡甲胺","","限放化疗且吞咽困难的患者。","209942","注射用福沙匹坦双葡甲胺","无","注射剂","0.15g(按C₂₃H₂₂F₇N₄O₆P计)","盒","1","中硼硅玻璃管制注射剂瓶＋注射用冷冻干燥无菌粉末用卤化丁基橡胶塞(溴化)包装。","江苏奥赛康药业有限公司","116.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[193,"XA04ADF719B001010101444","2","注射用福沙匹坦双葡甲胺","","限放化疗且吞咽困难的患者。","166054","注射用福沙匹坦双葡甲胺","无","注射剂","0.15g(按C23H22F7N4O6P计)","盒","1","中硼硅玻璃管制注射剂瓶灌封分装,冷冻干燥用溴化丁基橡胶塞6720GC封口,抗生素瓶用铝塑组合盖密封","江苏豪森药业集团有限公司","118.00","修改（医保信息）","医保发〔2024〕33号",""]
[194,"XA04ADF719B001010101523","2","注射用福沙匹坦双葡甲胺","","限放化疗且吞咽困难的患者。","166142","注射用福沙匹坦双葡甲胺","无","注射剂","150mg(按C23H22F7N4O6P计)","盒","1","中硼硅玻璃管制注射剂瓶和注射制剂用溴化丁基橡胶塞装","正大天晴药业集团股份有限公司","136.00","修改（医保信息）","医保发〔2024〕33号",""]
[195,"XA04ADF719B001010104141","2","注射用福沙匹坦双葡甲胺","","限放化疗且吞咽困难的患者。","176293","注射用福沙匹坦双葡甲胺","无","注射剂","0.15g(按C23H22F7N4O6P计)","盒","1","中硼硅玻璃管制注射剂瓶和注射用冷冻干燥用卤化丁基橡胶塞(溴化)包装","山东罗欣药业集团股份有限公司","115.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[196,"XA04ADF719B001010104488","2","注射用福沙匹坦双葡甲胺","","限放化疗且吞咽困难的患者。","205849","注射用福沙匹坦双葡甲胺","无","注射剂","0.15g(按C23H22F7N4O6P计)","盒","1","中硼硅玻璃管制注射剂瓶＋注射制剂用氯化丁基橡胶塞包装","杭州九源基因工程股份有限公司","116.00","修改（医保信息）","医保发〔2024〕33号",""]
[197,"XA04ADF719B001010204021","2","注射用福沙匹坦双葡甲胺","","限放化疗且吞咽困难的患者。","171799","注射用福沙匹坦双葡甲胺","无","注射剂","0.15g(以C23H22F7N4O6P计)","盒","1","安瓿","齐鲁制药有限公司","118.00","修改（医保信息）","医保发〔2024〕33号",""]
[198,"XA06ADL397X019010101453","2","硫酸镁钠钾口服用浓溶液","","","174940","硫酸镁钠钾口服用浓溶液","无","口服溶液剂","177ml:硫酸镁(以MgSO4计)1.6g、硫酸钠17.5g和硫酸钾3.13g","盒","2","口服液体药用聚酯瓶及药用聚酯/铝/聚酯封口垫片包装","济川药业集团有限公司","96.00","修改（医保信息）","医保发〔2024〕33号",""]
[199,"XA06ADL397X019010101747","2","硫酸镁钠钾口服用浓溶液","","","175802","硫酸镁钠钾口服用浓溶液","无","口服溶液剂","177ml:硫酸镁(按MgSO4计)1.6g、硫酸钠17.5g和硫酸钾3.13g","盒","2","口服液体药用聚酯瓶","扬子江药业集团江苏制药股份有限公司","96.00","修改（医保信息）","医保发〔2024〕33号",""]
[200,"XA06ADL397X019010183508","2","硫酸镁钠钾口服用浓溶液","","","205421","硫酸镁钠钾口服用浓溶液","无","口服溶液剂","176ml:硫酸镁3.276g、硫酸钠17.510g与硫酸钾3.130g","盒","2","淡棕色圆形聚乙烯对苯二酸酯(PET)瓶和带感应密封的防儿童螺旋盖包装,","BEAUFOUR IPSEN INDUSTRIE","95.90 ","修改（医保信息）","医保发〔2024〕33号",""]
[201,"XA12BAF601B002010104929","2","复合磷酸氢钾注射液","","","204978","复合磷酸氢钾注射液","无","注射剂","2ml:磷酸二氢钾(KH2PO4)0.4354g与磷酸氢二钾(K2HPO4·3H2O)0.639g","支","1","中硼硅玻璃安瓿","湖南华纳大药厂股份有限公司","12.50","修改（医保信息）","医保发〔2024〕33号",""]
[202,"XA12BAF601B002010200874","2","复合磷酸氢钾注射液","","","126143","复合磷酸氢钾注射液","无","注射液","2ml","支","1","安瓿","津药和平（天津）制药有限公司","12.50","修改（医保信息）","医保发〔2024〕33号",""]
[203,"XA12BAF601B002010202044","2","复合磷酸氢钾注射液","","","310094","复合磷酸氢钾注射液","无","注射液","2ml:含磷酸二氢钾(KH2PO4)0.4354g、磷酸氢二钾三水合物(K2HPO4·3H2O)0.639g","支","1","玻璃安瓿","成都利尔药业有限公司","12.50","修改（医保信息）","医保发〔2024〕33号",""]
[204,"XA12BAF601B002010202918","2","复合磷酸氢钾注射液","","","130894","复合磷酸氢钾注射液","无","小容量注射剂","2ml","支","1","安瓿","山西普德药业有限公司","12.50","修改（医保信息）","医保发〔2024〕33号",""]
[205,"XA12BAF601B002010207478","2","复合磷酸氢钾注射液","","","134215","复合磷酸氢钾注射液","无","注射液","2ml","支","1","玻璃瓶","安徽恒星制药有限公司","12.50","修改（医保信息）","医保发〔2024〕33号",""]
[206,"XA12BAF601B002010301669","2","复合磷酸氢钾注射液","","","140190","复合磷酸氢钾注射液","无","注射液","2ml","支","1","安瓿瓶","苏州天马医药集团天吉生物制药有限公司","12.50","修改（医保信息）","医保发〔2024〕33号",""]
[207,"XB05BAF726B002010102180","2","复方氨基酸(15AA-II)/葡萄糖(10%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","172571","复方氨基酸(15AA-II)/葡萄糖(10%)电解质注射液","无","注射剂","1000ml(复方氨基酸(15AA-II)注射液500ml/葡萄糖(10%)电解质注射液500ml)","瓶","1","三层共挤双室输液袋","四川科伦药业股份有限公司","114.80","修改（医保信息）","医保发〔2024〕33号",""]
[208,"XB05BAF726B002010106155","2","复方氨基酸(15AA-II)/葡萄糖(10%)电解质注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","173882","复方氨基酸(15AA-II)/葡萄糖(10%)电解质注射液","无","注射剂","1000ml[复方氨基酸(15AA-II)注射液500ml；葡萄糖(10%)电解质注射液500ml]","袋","1","外阻隔袋三层共挤输液用双室袋","辽宁海思科制药有限公司","114.80","修改（医保信息）","医保发〔2024〕33号",""]
[209,"XB05BBT183B002010100967","2","碳酸氢钠林格注射液","","","203749","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","内包装袋和外包装袋的双层包装,内包装袋为(聚丙烯/聚丙烯/聚丙烯)三层共挤输液用袋,外包装袋为高阻隔外包袋。","中国大冢制药有限公司","14.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[210,"XB05BBT183B002010101445","2","碳酸氢钠林格注射液","","","165572","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","本品选用五层共挤输液用膜(Ⅰ)制袋分装,加高阻隔外袋密封","江苏恒瑞医药股份有限公司","14.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[211,"XB05BBT183B002010102180","2","碳酸氢钠林格注射液","","","165687","碳酸氢钠林格注射液","无","注射剂","1000ml","袋","1","直立式聚丙烯输液袋外加阻隔袋","四川科伦药业股份有限公司","25.16","修改（医保信息）","医保发〔2024〕33号",""]
[212,"XB05BBT183B002010102189","2","碳酸氢钠林格注射液","","","204081","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","外阻隔袋五层共挤膜输液袋,外袋内侧贴有可监测二氧化碳气体的指示剂。","四川美大康佳乐药业有限公司","14.60","修改（医保信息）","医保发〔2024〕33号",""]
[213,"XB05BBT183B002010102525","2","碳酸氢钠林格注射液","","","176876","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","多层共挤输液袋","西安万隆制药股份有限公司","14.80","修改（医保信息）","医保发〔2024〕33号",""]
[214,"XB05BBT183B002010102763","2","碳酸氢钠林格注射液","","","207910","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","五层共挤输液用膜(Ⅰ)制袋＋外阻隔袋＋二氧化碳指示剂","石家庄四药有限公司","14.50","修改（医保信息）","医保发〔2024〕33号",""]
[215,"XB05BBT183B002010104127","2","碳酸氢钠林格注射液","","","208559","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","外阻隔袋五层共挤输液用袋","辰欣药业股份有限公司","14.80 ","修改（医保信息）","医保发〔2024〕33号",""]
[216,"XB05BBT183B002010104145","2","碳酸氢钠林格注射液","","","207172","碳酸氢钠林格注射液","无","大容量注射液","500ml","袋","1","外阻隔袋三层共挤输液用袋包装系统包装","山东齐都药业有限公司","14.59","修改（医保信息）","医保发〔2024〕33号",""]
[217,"XB05BBT183B002010106652","2","碳酸氢钠林格注射液","","","200858","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","五层共挤输液用袋包装,外加高阻隔外袋和二氧化碳指示剂。","湖北多瑞药业有限公司","14.80","修改（医保信息）","医保发〔2024〕33号",""]
[218,"XB05BBT183B002010283033","2","碳酸氢钠林格注射液","","","210420","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","三层共挤输液用袋包装,外加高阻隔外袋和二氧化碳指示剂","河北仁合益康药业有限公司","14.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[219,"XB05BBT183B002010283083","2","碳酸氢钠林格注射液","","","210115","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","外阻隔袋五层共挤输液用袋","山东华鲁制药有限公司","14.80 ","修改（医保信息）","医保发〔2024〕33号",""]
[220,"XB05BBT183B002020102180","2","碳酸氢钠林格注射液","","","165686","碳酸氢钠林格注射液","无","注射剂","500ml","袋","1","直立式聚丙烯输液袋外加阻隔袋","四川科伦药业股份有限公司","14.60","修改（医保信息）","医保发〔2024〕33号",""]
[221,"XB05BBT183B002020104145","2","碳酸氢钠林格注射液","","","207173","碳酸氢钠林格注射液","无","大容量注射液","1000ml","袋","1","外阻隔袋三层共挤输液用袋包装系统包装","山东齐都药业有限公司","25.16","修改（医保信息）","医保发〔2024〕33号",""]
[222,"XB05BAA346B020010104177","2","氨基酸(15)腹膜透析液","","","175119","氨基酸(15)腹膜透析液","无","注射剂","2000ml:22.41g(按总氨基酸计)","袋","1","本品采用双联双袋外套阻隔袋的包装系统,包括三层共挤腹膜透析液/冲洗液用袋、一次性使用腹透引流袋、连接二者的Y形导管、塑料输液容器用聚碳酸酯加药塞、注射液用聚碳酸酯折断塞、脱氧剂和阻隔袋。","山东威高药业股份有限公司","55.80","修改（医保信息）","医保发〔2024〕33号",""]
[223,"XB05DAA346B020010100952","2","氨基酸(15)腹膜透析液","","","310095","氨基酸（15）腹膜透析液","无","注射剂","2000ml ∶ 22.41g （总氨基酸）","袋","1","三层共挤输液用 膜（I） 制袋 、一次性使用腹膜透析引流袋、输液袋用聚碳酸酯加药塞、注射液用聚碳酸酯折断塞、输液袋用高密度聚乙烯非织造布袋装铁基吸氧剂、高阻隔外袋。","天津金耀药业有限公司","55.80","修改（医保信息）","医保发〔2024〕33号",""]
[224,"XB05DAA346B020010102180","2","氨基酸(15)腹膜透析液","","","176181","氨基酸(15)腹膜透析液","无","注射剂","2.0L:22.41g(总氨基酸)","袋","1","三层共挤腹膜透析液用袋。本品的包装系统为三层共挤腹膜透析液用袋,由外袋、内袋、引流袋组成,配件有三层共挤输液用管、塑料输液容器用聚碳酸酯加药塞、注射液用聚碳酸酯折断塞。","成都青山利康药业股份有限公司","55.80","修改（医保信息）","医保发〔2024〕33号",""]
[225,"XB05DAA346B020020102180","2","氨基酸(15)腹膜透析液","","","310105","氨基酸(15)腹膜透析液","无","注射剂","2.5L:28.01g(总氨基酸)","袋","1","三层共挤腹膜透析液用袋。 本品的包装系统为三层共挤腹膜透析液用袋,由外袋、内袋、引流袋组成,配件有三层共挤输液用管、塑料输液容器用聚碳酸酯加药塞、注射液用聚碳酸酯折断塞。","四川科伦药业股份有限公司","66.19","修改（医保信息）","医保发〔2024〕33号",""]
[226,"XC03XAT151A001010101445","2","托伐普坦片","","","172186","托伐普坦片","无","片剂","15mg","盒","10","复合膜","江苏恒瑞医药股份有限公司","301.80","修改（医保信息）","医保发〔2024〕33号",""]
[227,"XC03XAT151A001010101606","2","托伐普坦片","","","173179","托伐普坦片","无","片剂","15mg","盒","7","聚氯乙烯固体药用硬片和药用铝箔组成的铝塑泡罩包装","南京正大天晴制药有限公司","211.89","修改（医保信息）","医保发〔2024〕33号",""]
[228,"XC03XAT151A001010102013","2","托伐普坦片","","","203047","托伐普坦片","无","片剂","15mg","盒","8","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔","成都倍特药业股份有限公司","241.52","修改（医保信息）","医保发〔2024〕33号",""]
[229,"XC03XAT151A001010104619","2","托伐普坦片","","","140131","托伐普坦片","苏麦卡","片剂","15mg","盒","5","双铝","浙江大冢制药有限公司","151.35","修改（医保信息）","医保发〔2024〕33号",""]
[230,"XC03XAT151A001010106725","2","托伐普坦片","","","203820","托伐普坦片","无","片剂","15mg","盒","10","聚氯乙烯/ 聚乙烯/ 聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","四川宏明博思药业有限公司","301.80","修改（医保信息）","医保发〔2024〕33号",""]
[231,"XC03XAT151A001010180537","2","托伐普坦片","","","207715","托伐普坦片","无","片剂","15mg","盒","10","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","南京海纳制药有限公司","301.00","修改（医保信息）","医保发〔2024〕33号",""]
[232,"XC03XAT151A001010201445","2","托伐普坦片","","","173912","托伐普坦片","无","片剂","15mg","盒","5","聚氯乙烯/聚偏二氯乙烯固体药用硬片加纸/铝药品包装用复合膜","江苏恒瑞医药股份有限公司","150.90","修改（医保信息）","医保发〔2024〕33号",""]
[233,"XC03XAT151A001010280537","2","托伐普坦片","","","207716","托伐普坦片","无","片剂","15mg","盒","7","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","南京海纳制药有限公司","210.70","修改（医保信息）","医保发〔2024〕33号",""]
[234,"XC03XAT151A001020101445","2","托伐普坦片","","","172187","托伐普坦片","无","片剂","30mg","盒","10","复合膜","江苏恒瑞医药股份有限公司","513.40","修改（医保信息）","医保发〔2024〕33号",""]
[235,"XC03XAT151A001020104619","2","托伐普坦片","","","162906","托伐普坦片","苏麦卡","片剂","30mg","盒","5","双铝","浙江大冢制药有限公司","257.30","修改（医保信息）","医保发〔2024〕33号",""]
[236,"XC03XAT151A001020180537","2","托伐普坦片","","","210864","托伐普坦片","无","片剂","30mg","盒","10","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","南京海纳制药有限公司","514.60 ","修改（医保信息）","医保发〔2024〕33号",""]
[237,"XC03XAT151A001020280537","2","托伐普坦片","","","210910","托伐普坦片","无","片剂","30mg","盒","7","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","南京海纳制药有限公司","360.22 ","修改（医保信息）","医保发〔2024〕33号",""]
[238,"XJ01XBD355B001010101425","2","注射用多黏菌素E甲磺酸钠","","","174053","注射用多黏菌素E甲磺酸钠","无","注射剂","200万单位","盒","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥无菌粉末用氯化丁基橡胶塞","江苏奥赛康药业有限公司","697.99","修改（医保信息）","医保发〔2024〕33号",""]
[239,"XJ01XBD355B001010101523","2","注射用多黏菌素E甲磺酸钠","","","173948","注射用多黏菌素E甲磺酸钠","无","注射剂","150mg(按多黏菌素E计)","盒","1","中硼硅玻璃管制注射剂瓶＋注射用冷冻干燥用溴化丁基橡胶塞","正大天晴药业集团股份有限公司","1298.56","修改（医保信息）","医保发〔2024〕33号",""]
[240,"XJ02ACB206A012010102180","2","泊沙康唑肠溶片","","限13岁和13岁以上重度免疫缺陷患者。","200795","泊沙康唑肠溶片","无","片剂","100mg","盒","24","铝塑泡罩包装(聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔)","四川科伦药业股份有限公司","2280.00","修改（医保信息）","医保发〔2024〕33号",""]
[241,"XJ02ACB206A012010105345","2","泊沙康唑肠溶片","","限13岁和13岁以上重度免疫缺陷患者。","205419","泊沙康唑肠溶片","无","薄膜包衣片","100mg","盒","24","铝塑泡罩包装(聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔)","江西山香药业有限公司","2268.00","修改（医保信息）","医保发〔2024〕33号",""]
[242,"XJ02ACB206A012010105847","2","泊沙康唑肠溶片","","限13岁和13岁以上重度免疫缺陷患者。","205177","泊沙康唑肠溶片","无","薄膜衣片","100mg","盒","24","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔","齐鲁制药(海南)有限公司","2052.00","修改（医保信息）","医保发〔2024〕33号",""]
[243,"XJ02ACB206A012010180007","2","泊沙康唑肠溶片","","限13岁和13岁以上重度免疫缺陷患者。","174677","泊沙康唑肠溶片","无","片剂","100mg","盒","24","铝箔","荷兰欧加农公司N.V.Organon","2280.00","修改（医保信息）","医保发〔2024〕33号",""]
[244,"XJ02ACB206A012010181522","2","泊沙康唑肠溶片","","限13岁和13岁以上重度免疫缺陷患者。","171896","泊沙康唑肠溶片","无","片剂","100mg","盒","24","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","江苏宣泰药业有限公司","2280.00","修改（医保信息）","医保发〔2024〕33号",""]
[245,"XJ02ACB206B002010101003","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","209487","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚乙烯-四氟乙烯膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","重庆华邦制药有限公司","708.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[246,"XJ02ACB206B002010101425","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","172750","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶","江苏奥赛康药业有限公司","748.50","修改（医保信息）","医保发〔2024〕33号",""]
[247,"XJ02ACB206B002010101523","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","207168","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶、注射制剂用氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","正大天晴药业集团股份有限公司","738.00","修改（医保信息）","医保发〔2024〕33号",""]
[248,"XJ02ACB206B002010101594","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","204383","泊沙康唑注射液","无","注射液","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","杭州澳亚生物技术股份有限公司","588.00","修改（医保信息）","医保发〔2024〕33号",""]
[249,"XJ02ACB206B002010101957","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","203694","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖包装","武汉启瑞药业有限公司","738.00","修改（医保信息）","医保发〔2024〕33号",""]
[250,"XJ02ACB206B002010104948","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","206778","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃模制注射剂瓶、注射液用乙烯-四氟乙烯共聚物覆膜卤化丁基橡胶塞 (溴化)和抗生素瓶用铝塑组合盖包装","湖南科伦制药有限公司","710.00","修改（医保信息）","医保发〔2024〕33号",""]
[251,"XJ02ACB206B002010105337","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","206138","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","江西科睿药业有限公司","735.00","修改（医保信息）","医保发〔2024〕33号",""]
[252,"XJ02ACB206B002010105791","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","203711","泊沙康唑注射液","无","注射液","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶,注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞(配方FM259),抗生素瓶和输液瓶用铝塑组合盖","海南倍特药业有限公司","748.00","修改（医保信息）","医保发〔2024〕33号",""]
[253,"XJ02ACB206B002010105847","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","204721","泊沙康唑注射液","无","注射剂","16.7ml:0.3g","盒","1","中硼硅玻璃管制注射剂瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖","齐鲁制药(海南)有限公司","673.00","修改（医保信息）","医保发〔2024〕33号",""]
[254,"XJ02ACB206B002010178642","2","泊沙康唑注射液","","限18岁和18岁以上重度免疫缺陷患者。","310003","泊沙康唑注射液","无","注射剂","16.7ml:300mg","盒","1","I型玻璃瓶","FAREVA Mirabel","748.50","修改（医保信息）","医保发〔2024〕33号",""]
[255,"XL01EFP135E001010100156","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","202890","哌柏西利胶囊","无","胶囊剂","125mg","瓶","21","口服固体药用高密度聚乙烯瓶包装。","北京泰德制药股份有限公司","3688.00","修改（医保信息）","医保发〔2024〕33号",""]
[256,"XL01EFP135E001010100647","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","205357","哌柏西利胶囊","无","胶囊剂","125mg","瓶","21","口服固体药用高密度聚乙烯瓶包装系统","上海创诺制药有限公司","3598.00","修改（医保信息）","医保发〔2024〕33号",""]
[257,"XL01EFP135E001010101425","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","200005","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","盒","江苏奥赛康药业有限公司","3616.20","修改（医保信息）","医保发〔2024〕33号",""]
[258,"XL01EFP135E001010101523","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207170","哌柏西利胶囊","无","胶囊剂","100mg","盒","21","口服固体药用高密度聚乙烯瓶","正大天晴药业集团股份有限公司","2950.39","修改（医保信息）","医保发〔2024〕33号",""]
[259,"XL01EFP135E001010103356","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","208768","哌柏西利胶囊","无","胶囊剂","100mg","盒","21","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片,药品包装用铝箔","吉林敖东洮南药业股份有限公司","3026.26 ","修改（医保信息）","医保发〔2024〕33号",""]
[260,"XL01EFP135E001010104948","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207446","哌柏西利胶囊","无","胶囊剂","75mg","盒","21","口服固体药用高密度聚乙烯(HDPE)瓶,使用防儿童开启瓶盖密封","湖南科伦制药有限公司","2367.20","修改（医保信息）","医保发〔2024〕33号",""]
[261,"XL01EFP135E001010105345","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","200914","哌柏西利胶囊","无","胶囊剂","75mg","盒","21","铝塑泡罩包装","江西山香药业有限公司","2556.58","修改（医保信息）","医保发〔2024〕33号",""]
[262,"XL01EFP135E001010178724","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","165001","哌柏西利胶囊","爱博新","硬胶囊","75mg","瓶","21","带聚丙烯(PP)盖的高密度聚乙烯(HDPE)瓶包装","德国Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg","2891.70","修改（医保信息）","医保发〔2024〕33号",""]
[263,"XL01EFP135E001010183690","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207201","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","铝塑泡罩包装","河北道恩药业有限公司","3798.00","修改（医保信息）","医保发〔2024〕33号",""]
[264,"XL01EFP135E001010183755","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","206744","哌柏西利胶囊","无","胶囊剂","125mg","瓶","21","口服固体药用高密度聚乙烯瓶","江西艾施特制药有限公司","3495.00","修改（医保信息）","医保发〔2024〕33号",""]
[265,"XL01EFP135E001010184758","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","209232","哌柏西利胶囊","无","胶囊剂","125mg","瓶","21","带聚丙烯(PP)盖的高密度聚乙烯(HDPE)瓶包装","先声药业有限公司","3486.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[266,"XL01EFP135E001010301066","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","208296","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","氯乙烯固体药用硬片和药用铝箔","重庆药友制药有限责任公司","3490.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[267,"XL01EFP135E001020101425","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","206931","哌柏西利胶囊","无","胶囊剂","75mg","盒","21","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯/铝泡罩包装","江苏奥赛康药业有限公司","2445.79","修改（医保信息）","医保发〔2024〕33号",""]
[268,"XL01EFP135E001020101523","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207171","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","口服固体药用高密度聚乙烯瓶","正大天晴药业集团股份有限公司","3500.00","修改（医保信息）","医保发〔2024〕33号",""]
[269,"XL01EFP135E001020103356","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","208769","哌柏西利胶囊","无","胶囊剂","75mg","盒","21","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片,药品包装用铝箔。","吉林敖东洮南药业股份有限公司","2428.07 ","修改（医保信息）","医保发〔2024〕33号",""]
[270,"XL01EFP135E001020104021","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","177235","哌柏西利胶囊","无","胶囊剂","100mg","瓶","21","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","3051.55","修改（医保信息）","医保发〔2024〕33号",""]
[271,"XL01EFP135E001020104948","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207448","哌柏西利胶囊","无","胶囊剂","100mg","盒","21","口服固体药用高密度聚乙烯(HDPE)瓶,使用防儿童开启瓶盖密封","湖南科伦制药有限公司","2950.39","修改（医保信息）","医保发〔2024〕33号",""]
[272,"XL01EFP135E001020105345","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","200917","哌柏西利胶囊","无","胶囊剂","100mg","盒","21","铝塑泡罩包装","江西山香药业有限公司","3186.43","修改（医保信息）","医保发〔2024〕33号",""]
[273,"XL01EFP135E001020178724","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","165003","哌柏西利胶囊","爱博新","硬胶囊","100mg","瓶","21","带聚丙烯(PP)盖的高密度聚乙烯(HDPE)瓶包装","德国Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg","3604.23","修改（医保信息）","医保发〔2024〕33号",""]
[274,"XL01EFP135E001030101425","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","206935","哌柏西利胶囊","无","胶囊剂","100mg","盒","21","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯/铝泡罩包装","江苏奥赛康药业有限公司","3048.34","修改（医保信息）","医保发〔2024〕33号",""]
[275,"XL01EFP135E001030101444","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","202824","哌柏西利胶囊","无","胶囊剂","125mg","瓶","21","/","江苏豪森药业集团有限公司","3799.00","修改（医保信息）","医保发〔2024〕33号",""]
[276,"XL01EFP135E001030101523","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207169","哌柏西利胶囊","无","胶囊剂","75mg","盒","21","口服固体药用高密度聚乙烯瓶","正大天晴药业集团股份有限公司","2367.20","修改（医保信息）","医保发〔2024〕33号",""]
[277,"XL01EFP135E001030103356","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","208770","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片,药品包装用铝箔。","吉林敖东洮南药业股份有限公司","3590.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[278,"XL01EFP135E001030104021","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","177236","哌柏西利胶囊","无","胶囊剂","125mg","瓶","21","口服固体药用高密度聚乙烯瓶","齐鲁制药有限公司","3620.00","修改（医保信息）","医保发〔2024〕33号",""]
[279,"XL01EFP135E001030104948","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","207449","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","口服固体药用高密度聚乙烯(HDPE)瓶,使用防儿童开启瓶盖密封","湖南科伦制药有限公司","3500.00","修改（医保信息）","医保发〔2024〕33号",""]
[280,"XL01EFP135E001030105345","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","200918","哌柏西利胶囊","无","胶囊剂","125mg","盒","21","铝塑泡罩包装","江西山香药业有限公司","3780.00","修改（医保信息）","医保发〔2024〕33号",""]
[281,"XL01EFP135E001030178724","2","哌柏西利胶囊","","限激素受体(HR)阳性、人表皮生长因子受体2(HER2)阴性的局部晚期或转移性乳腺癌。","165004","哌柏西利胶囊","爱博新","胶囊剂","125mg","瓶","21","带聚丙烯(PP)盖的高密度聚乙烯(HDPE)瓶","德国Pfizer Manufacturing Deutschland GmbH, Betriebsstatte Freiburg","4275.60","修改（医保信息）","医保发〔2024〕33号",""]
[282,"XL04AAT163A010010102000","2","枸橼酸托法替布缓释片","","","205851","枸橼酸托法替布缓释片","无","片剂","11mg(按C16H20N6O计)","瓶","30","口服固体药用高密度聚乙烯瓶","宜昌人福药业有限责任公司","446.18 ","修改（医保信息）","医保发〔2024〕33号",""]
[283,"XL04AAT163A010010104021","2","枸橼酸托法替布缓释片","","","175763","枸橼酸托法替布缓释片","无","片剂","11mg(按C16H20N6O计)","瓶","30","口服固体药用高密度聚乙烯瓶,内加固体药用纸袋装硅胶干燥剂。","齐鲁制药有限公司","478.00","修改（医保信息）","医保发〔2024〕33号",""]
[284,"XL04AAT163A010010202770","2","枸橼酸托法替布缓释片","","","310096","枸橼酸托法替布缓释片","无","缓释片","11mg(按C₁₆H₂₀N₆O计)","盒","14","药用铝箔、聚氯乙烯固体药用硬片包装","石药集团欧意药业有限公司","207.20 ","修改（医保信息）","医保发〔2024〕33号",""]
[285,"XL04AAT163A010010278718","2","枸橼酸托法替布缓释片","","","310045","枸橼酸托法替布缓释片","无","缓释片","11 mg","盒","30","高密度聚乙烯瓶装。","Pfizer Pharmaceuticals LLC","498.00","修改（医保信息）","医保发〔2024〕33号",""]
[286,"XL04AAT163A010010302180","2","枸橼酸托法替布缓释片","","","206289","枸橼酸托法替布缓释片","无","片剂","11mg(按C₁₆H₂₀N₆O计)","盒","30","药用铝箔、聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片包装","四川科伦药业股份有限公司","447.00","修改（医保信息）","医保发〔2024〕33号",""]
[287,"XL04AAT163A010010483135","2","枸橼酸托法替布缓释片","","","206824","枸橼酸托法替布缓释片","无","缓释片","11mg(以C₁₆H₂₀N₆O计)","瓶","30","口服固体药用高密度聚乙烯瓶,口服固体药用高密度聚乙烯干燥剂罐包装","江苏宣泰药业有限公司","446.40","修改（医保信息）","医保发〔2024〕33号",""]
[288,"XN02BGP112X001010100371","2","普瑞巴林口服溶液","","","176451","普瑞巴林口服溶液","无","口服溶液剂","2％（100ml:2000mg）","盒","1","口服液体药用高密度聚乙烯瓶","广东众生药业股份有限公司","89.78","修改（医保信息）","医保发〔2024〕33号",""]
[289,"XN02BGP112X001010100548","2","普瑞巴林口服溶液","","","204603","普瑞巴林口服溶液","无","口服溶液剂","200ml:4g","盒","1","口服液体药用高密度聚乙烯压旋式安全瓶","南京星银药业集团有限公司","152.00","修改（医保信息）","医保发〔2024〕33号",""]
[290,"XN02BGP112X001010104649","2","普瑞巴林口服溶液","","","176238","普瑞巴林口服溶液","无","口服溶液剂","473ml(473ml:9.46g(2%))","盒","1","口服液体药用高密度聚乙烯瓶","贝克诺顿(浙江)制药有限公司","295.00","修改（医保信息）","医保发〔2024〕33号",""]
[291,"XN02BGP112X001010105337","2","普瑞巴林口服溶液","","","202843","普瑞巴林口服溶液","无","口服溶液剂","473ml(473ml:9.46g(2%))","盒","1","口服液体药用高密度聚乙烯瓶","江西科睿药业有限公司","295.00","修改（医保信息）","医保发〔2024〕33号",""]
[292,"XN02BGP112X001010110237","2","普瑞巴林口服溶液","","","206997","普瑞巴林口服溶液","无","口服溶液剂","100ml:2g","盒","1","口服液体药用高密度聚乙烯瓶,配备有带刻度的聚乙烯给药器以及聚丙烯盛药杯","合肥恩瑞特药业有限公司","87.80","修改（医保信息）","医保发〔2024〕33号",""]
[293,"XN02BGP112X001010110323","2","普瑞巴林口服溶液","","","310097","普瑞巴林口服溶液","无","口服溶液剂","2％(200ml:4000mg)","盒","1","口服液体药用高密度聚乙烯瓶","山东朗诺制药有限公司","152.63","修改（医保信息）","医保发〔2024〕33号",""]
[294,"XN02BGP112X001010182314","2","普瑞巴林口服溶液","","","206851","普瑞巴林口服溶液","无","口服溶液剂","473ml:9.46g","盒","1","口服液体药用高密度聚乙烯瓶","保定爱晖药业有限公司","295.00","修改（医保信息）","医保发〔2024〕33号",""]
[295,"XN02BGP112X001010183529","2","普瑞巴林口服溶液","","","203136","普瑞巴林口服溶液","无","口服溶液剂","100ml:2g","盒","1","口服液体药用高密度聚乙烯瓶和口服液体药用高密度聚乙烯揿压瓶盖","成都迪康药业股份有限公司","89.78","修改（医保信息）","医保发〔2024〕33号",""]
[296,"XN02BGP112X001020104649","2","普瑞巴林口服溶液","","","310108","普瑞巴林口服溶液","无","口服溶液剂","100ml(473ml:9.46g(2%))","盒","1","口服液体药用高密度聚乙烯瓶","贝克诺顿(浙江)制药有限公司","89.78","修改（医保信息）","医保发〔2024〕33号",""]
[297,"XN03AXL371B002010102763","2","拉考沙胺注射液","","","310132","拉考沙胺注射液","无","注射剂","20ml:0.2g","支","1","中硼硅玻璃安瓿","石家庄四药有限公司","199.50","修改（医保信息）","医保发〔2024〕33号",""]
[298,"XN03AXL371B002010102770","2","拉考沙胺注射液","","","310023","拉考沙胺注射液","无","注射剂","20ml:0.2g","支","1","无色中硼硅玻璃管制注射剂瓶,注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖","石药集团欧意药业有限公司","199.30 ","修改（医保信息）","医保发〔2024〕33号",""]
[299,"XN03AXL371B002010102918","2","拉考沙胺注射液","","","209573","拉考沙胺注射液","无","注射剂","20ml:0.2g","盒","1","中硼硅玻璃管制注射剂瓶、注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖","山西普德药业有限公司","205.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[300,"XN03AXL371B002010178930","2","拉考沙胺注射液","","","207182","拉考沙胺注射液","维派特","注射液","20ml:0.2g,20ml/支","盒","1","无色I型玻璃西林瓶和含氟聚合物涂层的氯化丁基橡胶塞。","UCB Pharma S.A.","215.00","修改（医保信息）","医保发〔2024〕33号",""]
[301,"XN03AXL371B002010182719","2","拉考沙胺注射液","","","210241","拉考沙胺注射液","无","注射剂","20ml:0.2g","瓶","1","中性硼硅玻璃管制注射剂瓶,注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞,抗生素瓶用铝塑组合盖","合肥亿帆生物制药有限公司","205.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[302,"XN03AXL371B002010202044","2","拉考沙胺注射液","","","310152","拉考沙胺注射液","无","注射剂","20ml:0.2g","支","1","中硼硅玻璃安瓿","成都利尔药业有限公司","200.00","修改（医保信息）","医保发〔2024〕33号",""]
[303,"XN03AXL371B002010205337","2","拉考沙胺注射液","","","171681","拉考沙胺注射液","欣抗","注射剂","20ml:0.2g","支","1","中硼硅玻璃管制注射剂瓶","江西科睿药业有限公司","205.00","修改（医保信息）","医保发〔2024〕33号",""]
[304,"XN03AXL371B002010283337","2","拉考沙胺注射液","","","209852","拉考沙胺注射液","无","注射剂","20ml:0.2g","支","1","中硼硅玻璃安瓿","四川美大康佳乐药业有限公司","196.80 ","修改（医保信息）","医保发〔2024〕33号",""]
[305,"XN05AHA204M002010104021","2","奥氮平口溶膜","","","200164","奥氮平口溶膜","无","膜剂","5mg","盒","14","聚酯/铝/流延聚乙烯药用复合膜包装","齐鲁制药有限公司","54.60","修改（医保信息）","医保发〔2024〕33号",""]
[306,"XN05AHA204M002010201444","2","奥氮平口溶膜","","","172011","奥氮平口溶膜","无","膜剂","5mg","盒","14","聚酯/铝/聚乙烯药用复合膜热合密封","江苏豪森药业集团有限公司","54.60","修改（医保信息）","医保发〔2024〕33号",""]
[307,"XN05AHA204M002020101444","2","奥氮平口溶膜","","","172010","奥氮平口溶膜","无","膜剂","10mg","盒","7","聚酯/铝/聚乙烯药用复合膜热合密封","江苏豪森药业集团有限公司","46.41","修改（医保信息）","医保发〔2024〕33号",""]
[308,"XN05AHA204M002020104021","2","奥氮平口溶膜","","","200167","奥氮平口溶膜","无","膜剂","10mg","盒","7","聚酯/铝/流延聚乙烯药用复合膜包装","齐鲁制药有限公司","46.41","修改（医保信息）","医保发〔2024〕33号",""]
[309,"XN06AXA331A010010102000","2","盐酸安非他酮缓释片(Ⅱ)","","","176406","盐酸安非他酮缓释片(Ⅱ)","无","片剂","150mg","瓶","30","口服固体药用高密度聚乙烯瓶","宜昌人福药业有限责任公司","133.50","修改（医保信息）","医保发〔2024〕33号",""]
[310,"XN06AXA331A010010104494","2","盐酸安非他酮缓释片(Ⅱ)","","","176340","盐酸安非他酮缓释片(Ⅱ)","无","片剂","150mg","瓶","30","口服固体药用高密度聚乙烯瓶装","杭州民生滨江制药有限公司","133.50","修改（医保信息）","医保发〔2024〕33号",""]
[311,"XN06AXA331A010010104685","2","盐酸安非他酮缓释片(Ⅱ)","","","206187","盐酸安非他酮缓释片(Ⅱ)","无","缓释片","300mg","瓶","30","口服固体药用高密度聚乙烯瓶包装系统包装(含干燥剂罐)","浙江普洛康裕制药有限公司","220.00","修改（医保信息）","医保发〔2024〕33号",""]
[312,"XN06AXA331A010010182990","2","盐酸安非他酮缓释片(Ⅱ)","","","202834","盐酸安非他酮缓释片(Ⅱ)","无","片剂","150mg","瓶","30","口服固体药用高密度聚乙烯瓶包装","石药集团欧意药业有限公司","132.00","修改（医保信息）","医保发〔2024〕33号",""]
[313,"XN06AXA331A010020102000","2","盐酸安非他酮缓释片(Ⅱ)","","","203072","盐酸安非他酮缓释片(Ⅱ)","无","片剂","300mg","瓶","30","口服固体药用高密度聚乙烯瓶","宜昌人福药业有限责任公司","227.10","修改（医保信息）","医保发〔2024〕33号",""]
[314,"XN06AXA331A010020104494","2","盐酸安非他酮缓释片(Ⅱ)","","","310098","盐酸安非他酮缓释片(Ⅱ)","无","片剂","300mg","瓶","30","口服固体药用高密度聚乙烯瓶装","杭州民生滨江制药有限公司","227.10","修改（医保信息）","医保发〔2024〕33号",""]
[315,"XV03ABS250B002010101066","2","舒更葡糖钠注射液","","","208297","舒更葡糖钠注射液","无","注射液","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算 5ml:500mg","支","1","中性硼硅玻璃安瓿","重庆药友制药有限责任公司","443.67 ","修改（医保信息）","医保发〔2024〕33号",""]
[316,"XV03ABS250B002010101495","2","舒更葡糖钠注射液","","","207305","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","瓶","1","中硼硅玻璃管制注射剂瓶,带有注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞以及抗生素瓶用铝塑组合盖密封。","江苏迪赛诺制药有限公司","225.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[317,"XV03ABS250B002010101606","2","舒更葡糖钠注射液","","","209764","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算,2ml:200mg","瓶","1","中硼硅玻璃管制注射剂瓶和注射液用卤化丁基橡胶塞(溴化),外压抗生素瓶用铝塑组合盖","南京正大天晴制药有限公司","224.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[318,"XV03ABS250B002010102181","2","舒更葡糖钠注射液","","","176219","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计2ml:200mg","支","1","2ml中硼硅玻璃安瓿","成都苑东生物制药股份有限公司","225.00","修改（医保信息）","医保发〔2024〕33号",""]
[319,"XV03ABS250B002010102482","2","舒更葡糖钠注射液","","","201117","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","支","1","中硼硅玻璃安瓿","西安汉丰药业有限责任公司","134.50 ","修改（医保信息）","医保发〔2024〕33号",""]
[320,"XV03ABS250B002010104948","2","舒更葡糖钠注射液","","","310017","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","瓶","1","中硼硅玻璃管制注射剂瓶,注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞以及抗生素瓶用铝塑组合盖密封。","湖南科伦制药有限公司","134.90","修改（医保信息）","医保发〔2024〕33号",""]
[321,"XV03ABS250B002010105549","2","舒更葡糖钠注射液","","","176480","舒更葡糖钠注射液","无","注射液","2ml:0.2g(按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算)","支","1","玻璃瓶","贵州益佰制药股份有限公司","225.36","修改（医保信息）","医保发〔2024〕33号",""]
[322,"XV03ABS250B002010105847","2","舒更葡糖钠注射液","","","206755","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","支","1","中硼硅玻璃管制注射剂瓶和氯化丁基橡胶塞,外压抗生素瓶用铝塑组合盖。","齐鲁制药(海南)有限公司","216.00","修改（医保信息）","医保发〔2024〕33号",""]
[323,"XV03ABS250B002010182745","2","舒更葡糖钠注射液","","","175782","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","支","1","中硼硅玻璃安瓿","江苏海岸药业有限公司","225.37","修改（医保信息）","医保发〔2024〕33号",""]
[324,"XV03ABS250B002010200156","2","舒更葡糖钠注射液","","","210196","舒更葡糖钠注射液","无","注射剂","2ml:200mg(按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计)","瓶","1","中性硼硅玻璃安瓿","北京泰德制药股份有限公司","224.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[325,"XV03ABS250B002010280716","2","舒更葡糖钠注射液","","","163103","舒更葡糖钠注射液","布瑞亭","注射剂","2ml:200mg","支","1","玻璃瓶","美国Patheon Manufacturing Services LLC","225.37","修改（医保信息）","医保发〔2024〕33号",""]
[326,"XV03ABS250B002010282745","2","舒更葡糖钠注射液","","","202555","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 5ml:500mg","支","1","中硼硅玻璃安瓿","江苏海岸药业有限公司","454.50","修改（医保信息）","医保发〔2024〕33号",""]
[327,"XV03ABS250B002010283339","2","舒更葡糖钠注射液","","","203400","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","支","1","中性硼硅玻璃安瓿","亚邦医药股份有限公司","225.00","修改（医保信息）","医保发〔2024〕33号",""]
[328,"XV03ABS250B002010283606","2","舒更葡糖钠注射液","","","210204","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基 舒更葡糖钠活性实体的总量计 2ml: 200mg","支","1","中硼硅玻璃安瓿","江苏悦兴药业有限公司","224.98 ","修改（医保信息）","医保发〔2024〕33号",""]
[329,"XV03ABS250B002010283710","2","舒更葡糖钠注射液","","","210302","舒更葡糖钠注射液","无","注射液","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 2ml:200mg","盒","1","内包装为中硼硅玻璃管制注射剂瓶(无色)＋注射制剂用氯化丁基橡胶塞,外锁抗生素瓶用铝塑组合盖,次级包装采用纸盒","湖南五洲通药业股份有限公司","224.98 ","修改（医保信息）","医保发〔2024〕33号",""]
[330,"XV03ABS250B002010383592","2","舒更葡糖钠注射液","","","210814","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计2ml:200mg","支","1","中硼硅玻璃安瓿","国药集团国瑞药业有限公司","201.80 ","修改（医保信息）","医保发〔2024〕33号",""]
[331,"XV03ABS250B002020101066","2","舒更葡糖钠注射液","","","208298","舒更葡糖钠注射液","无","注射液","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算 2ml:200mg","支","1","中性硼硅玻璃安瓿","重庆药友制药有限责任公司","220.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[332,"XV03ABS250B002020101606","2","舒更葡糖钠注射液","","","209766","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算,5ml:500mg","瓶","1","中硼硅玻璃管制注射剂瓶和注射液用卤化丁基橡胶塞(溴化),外压抗生素瓶用铝塑组合盖","南京正大天晴制药有限公司","451.74 ","修改（医保信息）","医保发〔2024〕33号",""]
[333,"XV03ABS250B002020102482","2","舒更葡糖钠注射液","","","200002","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 5ml:500mg","支","1","中硼硅玻璃安瓿","西安汉丰药业有限责任公司","272.25","修改（医保信息）","医保发〔2024〕33号",""]
[334,"XV03ABS250B002020283339","2","舒更葡糖钠注射液","","","203403","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 5ml:500mg","支","1","中性硼硅玻璃安瓿","亚邦医药股份有限公司","453.75","修改（医保信息）","医保发〔2024〕33号",""]
[335,"XV03ABS250B002020283710","2","舒更葡糖钠注射液","","","210303","舒更葡糖钠注射液","无","注射液","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计 5ml:500mg","盒","1","内包装为中硼硅玻璃管制注射剂瓶(无色)＋注射制剂用氯化丁基橡胶塞,外锁抗生素瓶用铝塑组合盖,次级包装采用纸盒","长沙市如虹医药科技股份有限公司","453.75 ","修改（医保信息）","医保发〔2024〕33号",""]
[336,"ZV01AAJ0737010103291","2","蒺藜皂苷胶囊","","限中风病中经络（轻中度脑梗死）恢复期患者。","166089","蒺藜皂苷胶囊","无","硬胶囊剂","65mg(含蒺藜皂苷提取物56.7mg)","盒","12","铝塑","长白山制药股份有限公司","36.84","修改（医保信息）","医保发〔2024〕33号",""]
[337,"ZA09FAB0148010104520","2","百令胶囊","","限慢性支气管炎、慢性肾功能不全的患者。","126585","百令胶囊","无","硬胶囊剂","0.5g","盒","42","铝塑","杭州中美华东制药有限公司","43.26","修改（医保信息）","医保发〔2024〕33号",""]
[338,"ZA09FAB0148010104761","2","百令胶囊","","限慢性支气管炎、慢性肾功能不全的患者。","207661","百令胶囊","无","硬胶囊","每粒装0.5g","盒","72","铝塑板","浙江佐力药业股份有限公司","71.28","修改（医保信息）","医保发〔2024〕33号",""]
[339,"ZA09FAB0148010204761","2","百令胶囊","","限慢性支气管炎、慢性肾功能不全的患者。","207660","百令胶囊","无","硬胶囊","每粒装0.5g","盒","48","铝塑板包装","浙江佐力药业股份有限公司","47.52","修改（医保信息）","医保发〔2024〕33号",""]
[340,"ZA09FAB0148030204520","2","百令胶囊","","限慢性支气管炎、慢性肾功能不全的患者。","171732","百令胶囊","无","硬胶囊剂","0.5g","盒","70","铝塑","杭州中美华东制药有限公司","72.10","修改（医保信息）","医保发〔2024〕33号",""]
[341,"ZA09AAL0469010101463","2","苓桂术甘颗粒","","温阳化饮，健脾利湿。用于中阳不足之痰饮。症见胸胁支满，目眩心悸，短气而咳，舌苔白滑，脉弦滑。","206528","苓桂术甘颗粒","无","颗粒剂","每袋装16g(相当于饮片55.2g)","盒","9","聚酯/铝/聚乙烯药用复合膜","江苏康缘药业股份有限公司","169.20","修改（医保信息）","医保发〔2024〕33号",""]
[342,"ZI01AAA0052010105934","2","安儿宁颗粒","","","118229","安儿宁颗粒(人工牛黄)","无","颗粒剂","3g","盒","9","复合膜","金诃藏药股份有限公司","17.82","修改（医保信息）","医保发〔2024〕33号",""]
[343,"ZI01AAA0052010205934","2","安儿宁颗粒","","","152071","安儿宁颗粒(人工牛黄)","无","颗粒剂","3g","盒","12","复合膜","金诃藏药股份有限公司","23.76","修改（医保信息）","医保发〔2024〕33号",""]
[344,"ZI01AAA0052010305934","2","安儿宁颗粒","","","171760","安儿宁颗粒(人工牛黄)","无","颗粒剂","3g","盒","18","复合膜","金诃藏药股份有限公司","35.64","修改（医保信息）","医保发〔2024〕33号",""]
[345,"ZA01BAC0296010101749","2","柴芩清宁胶囊","","","171725","柴芩清宁胶囊(人工牛黄)","无","硬胶囊剂","0.3g","盒","9","铝塑","扬子江药业集团江苏龙凤堂中药有限公司","13.50","修改（医保信息）","医保发〔2024〕33号",""]
[346,"ZA01BAC0296010201749","2","柴芩清宁胶囊","","","171726","柴芩清宁胶囊(人工牛黄)","无","硬胶囊剂","0.3g","盒","18","铝塑","扬子江药业集团江苏龙凤堂中药有限公司","27.00","修改（医保信息）","医保发〔2024〕33号",""]
[347,"ZA01BAC0296010301749","2","柴芩清宁胶囊","","","151761","柴芩清宁胶囊(人工牛黄)","无","硬胶囊剂","0.3g","盒","24","铝塑","扬子江药业集团江苏龙凤堂中药有限公司","36.00","修改（医保信息）","医保发〔2024〕33号",""]
[348,"ZA15EAC0442010101453","2","川芎清脑颗粒","","","134769","川芎清脑颗粒","无","颗粒剂","10g","盒","6","复合膜","济川药业集团有限公司","19.98","修改（医保信息）","医保发〔2024〕33号",""]
[349,"ZA15EAC0442010501453","2","川芎清脑颗粒","","","171770","川芎清脑颗粒","无","颗粒剂","10g","盒","15","复合膜","济川药业集团有限公司","49.95","修改（医保信息）","医保发〔2024〕33号",""]
[350,"ZI01AAH0116010105851","2","红花如意丸","","","105713","红花如意丸(天然熊胆粉)","无","水丸","2g/10丸","盒","30","铝塑","甘肃佛阁藏药有限公司","21.00","修改（医保信息）","医保发〔2024〕33号",""]
[351,"ZI01AAH0116010205851","2","红花如意丸","","","153277","红花如意丸(天然熊胆粉)","无","水丸","2g/10丸","盒","45","铝塑","甘肃佛阁藏药有限公司","31.50","修改（医保信息）","医保发〔2024〕33号",""]
[352,"ZI01AAH0116020105851","2","红花如意丸","","","171750","红花如意丸(天然熊胆粉)","无","水丸","2g/10丸","盒","60","铝塑","甘肃佛阁藏药有限公司","42.00","修改（医保信息）","医保发〔2024〕33号",""]
[353,"ZA08BAH0466010203904","2","缓痛止泻软胶囊","","","171119","缓痛止泻软胶囊","无","软胶囊(胶丸)","0.65g","盒","36","铝塑","康臣药业(内蒙古)有限责任公司","107.28","修改（医保信息）","医保发〔2024〕33号",""]
[354,"ZA04CCL0076010105721","2","利胆止痛胶囊","","","149646","利胆止痛胶囊","无","硬胶囊剂","0.4g","盒","36","铝塑","云南永孜堂制药有限公司","14.76","修改（医保信息）","医保发〔2024〕33号",""]
[355,"ZA04CCL0076010405721","2","利胆止痛胶囊","","","171769","利胆止痛胶囊","无","硬胶囊剂","0.4g","盒","48","铝塑","云南永孜堂制药有限公司","19.68","修改（医保信息）","医保发〔2024〕33号",""]
[356,"ZA04AAQ0494010303302","2","清胃止痛微丸","","","171738","清胃止痛微丸(浓缩微丸)","无","浓缩丸","3.2g","盒","9","复合膜","吉林华康药业股份有限公司","31.95","修改（医保信息）","医保发〔2024〕33号",""]
[357,"ZA04AAQ0494010403302","2","清胃止痛微丸","","","128171","清胃止痛微丸(浓缩微丸)","无","浓缩丸","3.2g","盒","12","复合膜","吉林华康药业股份有限公司","42.60","修改（医保信息）","医保发〔2024〕33号",""]
[358,"ZA04AAQ0494010503302","2","清胃止痛微丸","","","171756","清胃止痛微丸(浓缩微丸)","无","浓缩丸","3.2g","盒","15","复合膜","吉林华康药业股份有限公司","53.25","修改（医保信息）","医保发〔2024〕33号",""]
[359,"ZA04BAR0016010102349","2","热炎宁合剂","","","119379","热炎宁合剂","无","合剂(含口服液)","100ml(每1ml相当于饮片1.30g)","瓶","1","塑料瓶","清华德人西安幸福制药有限公司","17.96","修改（医保信息）","医保发〔2024〕33号",""]
[360,"ZA04BAR0016020102349","2","热炎宁合剂","","","171700","热炎宁合剂","无","合剂(含口服液)","100ml(每1ml相当于饮片1.30g)","盒","2","塑料瓶","清华德人西安幸福制药有限公司","35.92","修改（医保信息）","医保发〔2024〕33号",""]
[361,"ZA04BAR0016020202349","2","热炎宁合剂","","","171699","热炎宁合剂","无","合剂(含口服液)","100ml(每1ml相当于饮片1.30g)","盒","3","塑料瓶","清华德人西安幸福制药有限公司","53.88","修改（医保信息）","医保发〔2024〕33号",""]
[362,"ZA10CAS1079010100941","2","芍麻止痉颗粒","","","171302","芍麻止痉颗粒","无","颗粒剂","5g(相当于饮片18.8g)","盒","9","复合膜","天士力医药集团股份有限公司","202.50","修改（医保信息）","医保发〔2024〕33号",""]
[363,"ZA15BAS1079010200941","2","芍麻止痉颗粒","","","171757","芍麻止痉颗粒","无","颗粒剂","2.5g(相当于饮片9.4g)","盒","18","复合膜","天士力医药集团股份有限公司","238.32","修改（医保信息）","医保发〔2024〕33号",""]
[364,"ZA01BAS0788010403373","2","疏清颗粒","","","122834","疏清颗粒","无","颗粒剂","6g","盒","12","复合膜","吉林华康药业股份有限公司","26.16","修改（医保信息）","医保发〔2024〕33号",""]
[365,"ZA01BAS0788010603373","2","疏清颗粒","","","171755","疏清颗粒","无","颗粒剂","6g","盒","16","复合膜","吉林华康药业股份有限公司","34.88","修改（医保信息）","医保发〔2024〕33号",""]
[366,"ZA01BAS0788010703373","2","疏清颗粒","","","171754","疏清颗粒","无","颗粒剂","6g","盒","18","复合膜","吉林华康药业股份有限公司","39.24","修改（医保信息）","医保发〔2024〕33号",""]
[367,"ZA01BAS0788030203373","2","疏清颗粒","","","175672","疏清颗粒","无","颗粒剂","3g","盒","32","复合膜","吉林华康药业股份有限公司","40.96","修改（医保信息）","医保发〔2024〕33号",""]
[368,"ZA01BAS0788030403373","2","疏清颗粒","","","176185","疏清颗粒","无","颗粒剂","3g","盒","36","复合膜","吉林华康药业股份有限公司","46.08","修改（医保信息）","医保发〔2024〕33号",""]
[369,"ZA04CDW0366010100221","2","五味苦参肠溶胶囊","","","171695","五味苦参肠溶胶囊","无","肠溶胶囊","0.4g","盒","36","铝塑","北京中惠药业有限公司","96.48","修改（医保信息）","医保发〔2024〕33号",""]
[370,"ZA04CDW0366010200221","2","五味苦参肠溶胶囊","","","171696","五味苦参肠溶胶囊","无","肠溶胶囊","0.4g","盒","48","铝塑","北京中惠药业有限公司","128.64","修改（医保信息）","医保发〔2024〕33号",""]
[371,"ZA12AAX0632020105693","2","心脉隆注射液","","限二级及以上医疗机构慢性心力衰竭患者。","127038","心脉隆注射液","无","注射剂","2ml:100mg","支","1","安瓿瓶装","云南腾药制药股份有限公司","26.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[372,"ZA04AAX0772010105671","2","熊胆舒肝利胆胶囊","","","171768","熊胆舒肝利胆胶囊","无","硬胶囊剂","0.5g","盒","48","铝塑","云南名扬药业有限公司","47.04","修改（医保信息）","医保发〔2024〕33号",""]
[373,"ZA04CCX0772010205671","2","熊胆舒肝利胆胶囊","","","133244","熊胆舒肝利胆胶囊","无","硬胶囊剂","0.5g","盒","24","铝塑","云南名扬药业有限公司","23.52","修改（医保信息）","医保发〔2024〕33号",""]
[374,"ZA04CCX0772010305671","2","熊胆舒肝利胆胶囊","","","133245","熊胆舒肝利胆胶囊","无","硬胶囊剂","0.5g","盒","36","铝塑","云南名扬药业有限公司","35.28","修改（医保信息）","医保发〔2024〕33号",""]
[375,"ZA09ABG0009010202545","2","甘海胃康胶囊","","","130823","甘海胃康胶囊","无","硬胶囊剂","0.4g","盒","60","铝塑","陕西东科制药有限责任公司","24.00","修改（医保信息）","医保发〔2024〕33号",""]
[376,"ZA09ABG0009010302545","2","甘海胃康胶囊","","","171773","甘海胃康胶囊","无","硬胶囊剂","0.4g","盒","120","铝塑","陕西东科制药有限责任公司","48.00","修改（医保信息）","医保发〔2024〕33号",""]
[377,"ZA04CCJ0003010305172","2","鸡骨草胶囊","","","102876","鸡骨草胶囊","无","硬胶囊剂","0.5g","瓶","100","塑料瓶","广西玉林制药集团有限责任公司","56.00","修改（医保信息）","医保发〔2024〕33号",""]
[378,"ZG02BAJ0746010101463","2","筋骨止痛凝胶","","","171749","筋骨止痛凝胶","无","凝胶剂","15g(每1g相当于饮片1g,含薄荷脑3.6mg)","支","1","复合管","江苏康缘药业股份有限公司","55.00","修改（医保信息）","医保发〔2024〕33号",""]
[379,"ZA06BCL0468010202767","2","连花清咳片","","","169686","连花清咳片","无","薄膜衣片","0.46g(相当于饮片1.84g)","盒","36","铝箔","石家庄以岭药业股份有限公司","46.44","修改（医保信息）","医保发〔2024〕33号",""]
[380,"XJ01DCT098B001010105821","2","头孢替安","注射剂","","174041","注射用盐酸头孢替安","无","注射剂","按C18H23N9O4S3计0.25g","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末覆聚酯膜溴化丁基橡胶塞","海南通用三洋药业有限公司","4.48 ","修改（医保备注）","医保发〔2024〕33号",""]
[381,"XJ01DCT098B001010106155","2","头孢替安","注射剂","","150931","注射用盐酸头孢替安","无","粉针剂","0.5g","瓶","1","玻璃瓶","辽宁海思科制药有限公司","5.59","修改（医保备注）","医保发〔2024〕33号",""]
[382,"XJ01DCT098B001010300792","2","头孢替安","注射剂","","134092","注射用盐酸头孢替安","锋替新","注射剂","0.25g","瓶","1","模制瓶","上海上药新亚药业有限公司","13.70","修改（医保备注）","医保发〔2024〕33号",""]
[383,"XJ01DCT098B001010305826","2","头孢替安","注射剂","","107858","注射用盐酸头孢替安","无","注射剂","按C18H23N9O4S3计0.25g","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞","海南全星制药有限公司","4.42 ","修改（医保备注）","医保发〔2024〕33号",""]
[384,"XJ01DCT098B001020105821","2","头孢替安","注射剂","","174043","注射用盐酸头孢替安","无","注射剂","按C18H23N9O4S3计0.5g","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末覆聚酯膜溴化丁基橡胶塞。","海南通用三洋药业有限公司","7.62 ","修改（医保备注）","医保发〔2024〕33号",""]
[385,"XJ01DCT098B001020106155","2","头孢替安","注射剂","","150932","注射用盐酸头孢替安","无","粉针剂","1.0g","瓶","1","玻璃瓶","辽宁海思科制药有限公司","9.50","修改（医保备注）","医保发〔2024〕33号",""]
[386,"XJ01DCT098B001020200792","2","头孢替安","注射剂","","134093","注射用盐酸头孢替安","锋替新","注射剂","0.5g","瓶","1","钠钙玻璃模制注射剂瓶,药用复膜丁基橡胶塞","上海上药新亚药业有限公司","21.05 ","修改（医保备注）","医保发〔2024〕33号",""]
[387,"XJ01DCT098B001020305826","2","头孢替安","注射剂","","107867","注射用盐酸头孢替安","无","注射剂","按C18H23N9O4S3计0.5g","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞","海南全星制药有限公司","7.52 ","修改（医保备注）","医保发〔2024〕33号",""]
[388,"XJ01DCT098B001030104751","2","头孢替安","注射剂","","144167","注射用盐酸头孢替安","无","溶媒结晶粉针剂","1.0g","瓶","1","玻璃瓶","浙江永宁药业股份有限公司","4.76","修改（医保备注）","医保发〔2024〕33号",""]
[389,"XJ01DCT098B001030105821","2","头孢替安","注射剂","","174044","注射用盐酸头孢替安","无","注射剂","按C18H23N9O4S3计1.0g","盒","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末覆聚酯膜溴化丁基橡胶塞。","海南通用三洋药业有限公司","12.97 ","修改（医保备注）","医保发〔2024〕33号",""]
[390,"XJ01DCT098B001030200792","2","头孢替安","注射剂","","134094","注射用盐酸头孢替安","锋替新","注射剂","1.0g","瓶","1","模制瓶","上海上药新亚药业有限公司","36.59 ","修改（医保备注）","医保发〔2024〕33号",""]
[391,"XJ01DCT098B001030305826","2","头孢替安","注射剂","","107882","注射用盐酸头孢替安","无","注射剂","按C18H23N9O4S3计1.0g","瓶","1","中硼硅玻璃管制注射剂瓶、注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞","海南全星制药有限公司","12.78 ","修改（医保备注）","医保发〔2024〕33号",""]
[392,"XJ01DCT098B001050303712","2","头孢替安","注射剂","","119255","注射用盐酸头孢替安","萨兰欣","注射剂","按C18H23N9O4S3计算0.5g","瓶","1","注射剂玻璃瓶","哈药集团制药总厂","11.07 ","修改（医保备注）","医保发〔2024〕33号",""]
[393,"XJ01DCT098B001050403712","2","头孢替安","注射剂","","119265","注射用盐酸头孢替安","萨兰欣","注射剂","按C18H23N9O4S3计算1.0g","支","1","注射剂玻璃瓶","哈药集团制药总厂","18.84 ","修改（医保备注）","医保发〔2024〕33号",""]
[394,"XJ01DCT098B013010104141","2","头孢替安","注射剂","","115952","注射用盐酸头孢替安","无","粉针剂","0.5g","瓶","1","玻璃瓶","山东罗欣药业集团股份有限公司","9.53","修改（医保备注）","医保发〔2024〕33号",""]
[395,"XJ01DHE007B001010104019","2","厄他培南","注射剂","限头孢菌素耐药或重症感染患者。","310149","注射用厄他培南钠","无","注射剂","1.0g(按C₂₂H₂₅N₃O₇S计)","盒","1","中硼硅玻璃管制注射剂瓶","齐鲁安替制药有限公司","288.00","修改（医保备注）","医保发〔2024〕33号",""]
[396,"XJ01DHE007B001010104495","2","厄他培南","注射剂","限头孢菌素耐药或重症感染患者。","152578","注射用厄他培南","怡万之","冻干粉针剂","1.0g","瓶","1","西林瓶","法国Laboratoires Merck Sharp & Dohme Chibret (Mirabel)","289.25","修改（医保备注）","医保发〔2024〕33号",""]
[397,"XJ01DHY002B001010100599","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","104867","注射用亚胺培南西司他丁钠(1:1)","无","注射剂","0.5g(C12H17N3O4S 0.25g与C16H26N2O5S 0.25g)","盒","1","玻璃瓶","珠海联邦制药股份有限公司","40.50","修改（医保备注）","医保发〔2024〕33号",""]
[398,"XJ01DHY002B001010104495","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","146049","注射用亚胺培南西司他丁钠(1:1)","泰能","注射剂","亚胺培南500mg和西司他丁500mg","盒","1","玻璃瓶","Merck Sharp & Dohme LLC","129.55","修改（医保备注）","医保发〔2024〕33号",""]
[399,"XJ01DHY002B001010104641","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","144130","注射用亚胺培南西司他丁钠(1:1)","无","粉针剂","0.5g(0.25g/0.25g)","瓶","1","玻璃瓶","瀚晖制药有限公司","51.30","修改（医保备注）","医保发〔2024〕33号",""]
[400,"XJ01DHY002B001010200523","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","105686","注射用亚胺培南西司他丁钠(1:1)","无","注射剂","0.5g(C12H17N3O4S 0.25g 与 C16H26N2O5S 0.25g)","盒","1","玻璃瓶","深圳市海滨制药有限公司","44.99 ","修改（医保备注）","医保发〔2024〕33号",""]
[401,"XJ01DHY002B001010278341","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","142014","注射用亚胺培南西司他丁钠(1:1)","谱能","粉针剂","1.0g(0.5g/0.5g)","瓶","1","玻璃瓶","韩国江泰制药株式会社JW PHARMACEUTICAL CORPORATION","70.80","修改（医保备注）","医保发〔2024〕33号",""]
[402,"XJ01DHY002B001020100599","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","104870","注射用亚胺培南西司他丁钠","无","注射剂","1.0g(亚胺培南 0.5g与西司他丁 0.5g)","盒","1","玻璃瓶装","珠海联邦制药股份有限公司","68.85 ","修改（医保备注）","医保发〔2024〕33号",""]
[403,"XJ01DHY002B001020104641","2","亚胺培南西司他丁","注射剂","限头孢菌素耐药或重症感染患者。","144131","注射用亚胺培南西司他丁钠(1:1)","无","粉针剂","1.0g(0.5g/0.5g)","瓶","1","玻璃瓶","瀚晖制药有限公司","87.83","修改（医保备注）","医保发〔2024〕33号",""]
[404,"XJ01DIF005N001010104929","2","法罗培南","颗粒剂","限头孢菌素耐药或重症感染患者。","152277","法罗培南钠颗粒","忾林","颗粒剂","0.1g","盒","6","复合膜","湖南华纳大药厂股份有限公司","130.00","修改（医保备注）","医保发〔2024〕33号",""]
[405,"XJ01DIF005N001010304929","2","法罗培南","颗粒剂","限头孢菌素耐药或重症感染患者。","205802","法罗培南钠颗粒","忾林","颗粒剂","0.1g(按C12H15NO5S计)","盒","3","聚酯/铝/聚乙烯药用复合膜袋包装","湖南华纳大药厂股份有限公司","65.00","修改（医保备注）","医保发〔2024〕33号",""]
[406,"XN05AEQ010B001010101435","2","齐拉西酮","注射剂","","151730","注射用甲磺酸齐拉西酮","思贝格","冻干粉针剂","20mg(按齐拉西酮计)","支","1","西林瓶","江苏恩华药业股份有限公司","146.90","修改（医保备注）","医保发〔2024〕33号",""]
[407,"XA12BAM074A001010179164","2","门冬氨酸钾镁","口服常释剂型","","144546","门冬氨酸钾镁片","潘南金","薄膜衣片","0.298g(0.158g/0.14g)","瓶","50","塑料瓶","匈牙利吉瑞大药厂Gedeon Richter Plc.","28.54","修改（医保备注）","医保发〔2024〕33号",""]
[408,"XA12BAM074A001010279164","2","门冬氨酸钾镁","口服常释剂型","","200086","门冬氨酸钾镁片","潘南金","片剂","门冬氨酸镁0.140g和门冬氨酸钾0.158g","盒","100","铝塑泡罩包装","匈牙利吉瑞大药厂Gedeon Richter Plc.","55.65","修改（医保备注）","医保发〔2024〕33号",""]
[409,"XA12BAM074A017010100785","2","门冬氨酸钾镁","口服常释剂型","","135368","门冬氨酸钾镁片","无","薄膜衣片","0.149g(79mg/70mg)","瓶","100","塑料瓶","上海现代制药股份有限公司","12.00","修改（医保备注）","医保发〔2024〕33号",""]
[410,"XA11CCG111B002010278184","2","骨化三醇","注射剂","","147286","骨化三醇注射液","溉纯","注射液","1ml:1ug","支","1","琥珀色安瓿瓶装","Avara Liscate Pharmaceutical Services S.p.A.","33.99","修改（医保备注）","医保发〔2024〕33号",""]
[411,"XV03AET152A005010105001","2","碳酸镧","咀嚼片","","168457","碳酸镧咀嚼片","无","咀嚼片","500mg(以镧计)","瓶","20","口服固体药用高密度聚乙烯瓶包装","湖南明瑞制药股份有限公司","84.80","修改（医保备注）","医保发〔2024〕33号",""]
[412,"XV03AET152A005010181555","2","碳酸镧","咀嚼片","","175611","碳酸镧咀嚼片","无","片剂","0.5g(以镧计)","瓶","20","口服固体药用高密度聚乙烯瓶","四川自豪时代药业有限公司","59.60","修改（医保备注）","医保发〔2024〕33号",""]
[413,"XV03AET152A005010201287","2","碳酸镧","咀嚼片","","202823","碳酸镧咀嚼片","无","片剂","500mg(以镧计)","盒","24","药品包装用铝箔/聚氯乙烯固体药用硬片","沈阳福宁药业有限公司","134.64","修改（医保备注）","医保发〔2024〕33号",""]
[414,"XV03AET152A005010201606","2","碳酸镧","咀嚼片","","207286","碳酸镧咀嚼片","无","片剂","500mg(以镧计)","瓶","45","口服固体药用高密度聚乙烯瓶包装","南京正大天晴制药有限公司","129.15","修改（医保备注）","医保发〔2024〕33号",""]
[415,"XV03AET152A005010205001","2","碳酸镧","咀嚼片","","203272","碳酸镧咀嚼片","无","咀嚼片","500mg（以镧计）","盒","20","聚酯/铝/聚乙烯药用复合膜包装","湖南明瑞制药股份有限公司","84.80","修改（医保备注）","医保发〔2024〕33号",""]
[416,"XV03AET152A005010279538","2","碳酸镧","咀嚼片","","147471","碳酸镧咀嚼片","福斯利诺","片剂","500mg","瓶","20","塑料瓶","英国Hamol Limited","222.20","修改（医保备注）","医保发〔2024〕33号",""]
[417,"XV03AET152A005020201287","2","碳酸镧","咀嚼片","","205785","碳酸镧咀嚼片","无","片剂","250mg(以镧计)","盒","30","药品包装用铝箔/聚氯乙烯固体药用硬片","沈阳福宁药业有限公司","98.19","修改（医保备注）","医保发〔2024〕33号",""]
[418,"XA02BCA081X006010104655","2","艾司奥美拉唑镁肠溶干混悬剂","","","202339","艾司奥美拉唑镁肠溶干混悬剂","无","干混悬剂","40mg(按C17H19N3O3S计)","盒","7","聚酯/铝/聚乙烯药用复合膜","浙江尖峰药业有限公司","52.94","修改（医保备注）","医保发〔2024〕33号",""]
[419,"XA02BCA081X006010182990","2","艾司奥美拉唑镁肠溶干混悬剂","","","208418","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C₁₇H₁₉N₃O₃S计)","盒","14","聚酯/铝/聚乙烯药用复合膜袋","青岛百洋制药有限公司","60.48 ","修改（医保备注）","医保发〔2024〕33号",""]
[420,"XA02BCA081X006020182990","2","艾司奥美拉唑镁肠溶干混悬剂","","","208420","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","10mg(按C₁₇H₁₉N₃O₃S计)","盒","14","聚酯/铝/聚乙烯药用复合膜袋","青岛百洋制药有限公司","35.58 ","修改（医保备注）","医保发〔2024〕33号",""]
[421,"XA02BCA294X006010201425","2","艾司奥美拉唑镁肠溶干混悬剂","","","203930","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","10mg(按C₁₇H₁₉N₃O₃S计)","盒","14","聚酯/铝/聚乙烯药品包装用复合膜包装","扬州市三药制药有限公司","36.64","修改（医保备注）","医保发〔2024〕33号",""]
[422,"XA02BCA294X006010302181","2","艾司奥美拉唑镁肠溶干混悬剂","","","206606","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C₁₇H₁₉N₃O₃S计)","盒","14","聚酯/铝/聚乙烯药用复合膜包装","成都苑东生物制药股份有限公司","60.68 ","修改（医保备注）","医保发〔2024〕33号",""]
[423,"XA02BCA294X006010379537","2","艾司奥美拉唑镁肠溶干混悬剂","","","206128","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","10mg(按C₁₇H₁₉N₃O₃S计)","盒","14","四层药用复合膜","Cipla Ltd.","36.64","修改（医保备注）","医保发〔2024〕33号",""]
[424,"XA02BCA294X006020179537","2","艾司奥美拉唑镁肠溶干混悬剂","","","206254","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C₁₇H₁₉N₃O₃S计)","盒","7","四层药用复合膜","Cipla Ltd.","31.14","修改（医保备注）","医保发〔2024〕33号",""]
[425,"XA02BCA294X006020202181","2","艾司奥美拉唑镁肠溶干混悬剂","","","206607","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","40mg(按C₁₇H₁₉N₃O₃S计)","盒","14","聚酯/铝/聚乙烯药用复合膜包装","成都苑东生物制药股份有限公司","103.16 ","修改（医保备注）","医保发〔2024〕33号",""]
[426,"XA02BCA294X006020279537","2","艾司奥美拉唑镁肠溶干混悬剂","","","206255","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","20mg(按C₁₇H₁₉N₃O₃S计)","盒","14","四层药用复合膜","Cipla Ltd.","62.28","修改（医保备注）","医保发〔2024〕33号",""]
[427,"XA02BCA294X006030179537","2","艾司奥美拉唑镁肠溶干混悬剂","","","206129","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","40mg(按C₁₇H₁₉N₃O₃S计)","盒","7","四层药用复合膜","Cipla Ltd.","52.94","修改（医保备注）","医保发〔2024〕33号",""]
[428,"XA02BCA294X006030379537","2","艾司奥美拉唑镁肠溶干混悬剂","","","206253","艾司奥美拉唑镁肠溶干混悬剂","无","口服混悬剂","40mg(按C₁₇H₁₉N₃O₃S计)","盒","14","四层药用复合膜","Cipla Ltd.","105.88","修改（医保备注）","医保发〔2024〕33号",""]
[429,"XA05BAG145B002010103282","2","甘草酸单铵半胱氨酸氯化钠注射液","","限AST或ALT大于120U/L的患者。","152827","甘草酸单铵半胱氨酸氯化钠注射液","无","注射液","100ml","瓶","1","玻璃瓶","弘和制药有限公司","40.00","修改（医保备注）","医保发〔2024〕33号",""]
[430,"XA05BAG145B002020103282","2","甘草酸单铵半胱氨酸氯化钠注射液","","限AST或ALT大于120U/L的患者。","153761","甘草酸单铵半胱氨酸氯化钠注射液","无","注射液","250ml","瓶","1","玻璃瓶","弘和制药有限公司","81.16","修改（医保备注）","医保发〔2024〕33号",""]
[431,"XH01BAT027B001010101601","2","特利加压素","注射剂","","200765","注射用特利加压素","无","注射剂","1mg(相当于0.86mg特利加压素)","盒","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用溴化丁基橡胶塞","南京星银药业集团有限公司","26.14","修改（医保备注）","医保发〔2024〕33号",""]
[432,"XH01BAT027B001010101669","2","特利加压素","注射剂","","170768","注射用特利加压素","无","注射剂","1mg(相当于0.86mg特利加压素)","盒","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用卤化丁基橡胶塞(溴化)、抗生素瓶用铝塑组合盖。 1瓶/盒。 每瓶附带注射用溶剂1支（5ml），中硼硅玻璃安瓿包装。","苏州天马医药集团天吉生物制药有限公司","14.98","修改（医保备注）","医保发〔2024〕33号",""]
[433,"XH01BAT027B001010104470","2","特利加压素","注射剂","","208211","注射用特利加压素","无","注射剂","1mg( 相当于0.86mg特利加压素)","盒","1","中硼硅玻璃管制注射剂瓶＋注射用冷冻干燥用卤化丁基橡胶塞(溴化)＋抗生素瓶用铝塑组合盖","杭州澳亚生物技术股份有限公司","26.58","修改（医保备注）","医保发〔2024〕33号",""]
[434,"XH01BAT027B001010104799","2","特利加压素","注射剂","","205988","注射用特利加压素","无","注射剂","1mg(相当于0.86mg特利加压素)","瓶","1","中硼硅玻璃管制注射剂瓶＋注射用冷冻干燥用溴化丁基橡胶塞＋铝塑组合盖","福建省闽东力捷迅药业股份有限公司","25.95 ","修改（医保备注）","医保发〔2024〕33号",""]
[435,"XH01BAT027B001010105821","2","特利加压素","注射剂","","203395","注射用特利加压素","无","注射剂","1mg","盒","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用覆聚乙烯四氟乙烯膜氯化丁基橡胶塞。","海南通用康力制药有限公司","23.97 ","修改（医保备注）","医保发〔2024〕33号",""]
[436,"XH01BAT027B001010178423","2","特利加压素","注射剂","","141574","注射用特利加压素","可利新","注射剂","1mg","盒","1","配溶媒","辉凌(德国)制药有限公司Ferring GmbH","118.14","修改（医保备注）","医保发〔2024〕33号",""]
[437,"XH01BAT027B001010205781","2","特利加压素","注射剂","","210290","注射用特利加压素","无","注射剂","1mg(相当于0.86mg特利加压素)","盒","1","中硼硅玻璃管制注射剂瓶、冷冻干燥注射用无菌粉末用溴化丁基橡胶塞。每瓶附带无菌稀释溶剂1支(5ml:45mg),安瓿包装","海南皇隆制药股份有限公司","26.82 ","修改（医保备注）","医保发〔2024〕33号",""]
[438,"XH01BAT027B001010283237","2","特利加压素","注射剂","","207767","注射用特利加压素","无","冻干粉针剂","1mg(相当于特利加压素0.86mg)","瓶","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用覆聚乙烯-四氟乙烯膜溴化丁基橡胶塞","海南中玉药业有限公司","26.70","修改（医保备注）","医保发〔2024〕33号",""]
[439,"XH01BAT027B001020100526","2","特利加压素","注射剂","","207287","注射用特利加压素","无","注射剂","1mg(相当于特利加压素0.86mg)","盒","1","中硼硅玻璃管制注射剂瓶＋注射用冷冻干燥用溴化丁基橡胶塞＋铝塑组合盖。每瓶附带注射用溶剂1支(5ml)，中硼硅玻璃安瓿包装。","深圳翰宇药业股份有限公司","16.56","修改（医保备注）","医保发〔2024〕33号",""]
[440,"XH01BAT027B002010105801","2","特利加压素","注射剂","","201846","特利加压素注射液","无","注射剂","8.5ml :0.85mg(按C₅₂H₇₄N₁₆O₁₅S₂计)","支","1","中硼硅玻璃管制注射剂瓶、注射制剂用氯化丁基橡胶塞","海南普利制药股份有限公司","117.00 ","修改（医保备注）","医保发〔2024〕33号",""]
[441,"XH01BAT027B002010279260","2","特利加压素","注射剂","","210136","特利加压素注射液","无","注射剂","8.5ml :0.85mg(按C₅₂H₇₄N₁₆O₁₅S₂计)","支","1","中硼硅玻璃安瓿","甘肃成纪生物药业有限公司","312.00 ","修改（医保备注）","医保发〔2024〕33号",""]
[442,"XH01BAT027B002010280213","2","特利加压素","注射剂","","210117","特利加压素注射液","无","注射剂","8.5ml :0.85mg(按C₅₂H₇₄N₁₆O₁₅S₂计)","盒","1","中硼硅玻璃管制注射剂瓶、注射制剂用溴化丁基橡胶塞","深圳市健翔生物制药有限公司","382.80 ","修改（医保备注）","医保发〔2024〕33号",""]
[443,"XH01BAT027B002010284135","2","特利加压素","注射剂","","206972","特利加压素注射液","无","注射剂","8.5ml : 0.85mg(按C₅₂H₇₄N₁₆O₁₅S₂计)","支","1","中硼硅玻璃安瓿","山西威奇达光明制药有限公司","27.72 ","修改（医保备注）","医保发〔2024〕33号",""]
[444,"XL04AXL344E001010100148","2","来那度胺","口服常释剂型","","163161","来那度胺胶囊","无","硬胶囊","10mg","瓶","28","塑料瓶","北京双鹭药业股份有限公司","281.31","修改（医保备注）","医保发〔2024〕33号",""]
[445,"XL04AXL344E001010101523","2","来那度胺","口服常释剂型","","165230","来那度胺胶囊","无","胶囊剂","25mg","盒","21","双铝","正大天晴药业集团南京顺欣制药有限公司","582.00","修改（医保备注）","医保发〔2024〕33号",""]
[446,"XL04AXL344E001010101749","2","来那度胺","口服常释剂型","","171162","来那度胺胶囊","无","胶囊剂","25mg","盒","21","铝箔","扬子江药业集团有限公司","427.46","修改（医保备注）","医保发〔2024〕33号",""]
[447,"XL04AXL344E001010102087","2","来那度胺","口服常释剂型","","206311","来那度胺胶囊","无","胶囊剂","25mg","盒","21","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片/药用铝箔泡罩包装","四川美大康华康药业有限公司","373.00","修改（医保备注）","医保发〔2024〕33号",""]
[448,"XL04AXL344E001010102770","2","来那度胺","口服常释剂型","","310122","来那度胺胶囊","无","胶囊剂","25mg(以C₁₃H₁₃N₃O₃计","盒","21","铝铝泡罩包装(聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片,药用铝箔)","石药集团欧意药业有限公司","2980.00","修改（医保备注）","医保发〔2024〕33号",""]
[449,"XL04AXL344E001010104021","2","来那度胺","口服常释剂型","","165580","来那度胺胶囊","无","胶囊剂","25mg","盒","21","铝塑","齐鲁制药有限公司","472.50","修改（医保备注）","医保发〔2024〕33号",""]
[450,"XL04AXL344E001010201444","2","来那度胺","口服常释剂型","","176780","来那度胺胶囊","无","硬胶囊剂","25mg","盒","21","铝塑","江苏豪森药业集团有限公司","187.90","修改（医保备注）","医保发〔2024〕33号",""]
[451,"XL04AXL344E001010278377","2","来那度胺","口服常释剂型","","175717","来那度胺胶囊","无","胶囊剂","10mg","瓶","28","高密度聚乙烯瓶包装","印度Dr. Reddy`s Laboratories Limited","419.49","修改（医保备注）","医保发〔2024〕33号",""]
[452,"XL04AXL344E001010279563","2","来那度胺","口服常释剂型","","149807","来那度胺胶囊","瑞复美","胶囊剂","10mg","盒","21","铝塑包装","瑞士Celgene International Sarl","10732.00","修改（医保备注）","医保发〔2024〕33号",""]
[453,"XL04AXL344E001010301397","2","来那度胺","口服常释剂型","","176173","来那度胺胶囊","无","胶囊剂","5mg","盒","21","铝塑包装，外加复合膜袋","常州制药厂有限公司","38.65","修改（医保备注）","医保发〔2024〕33号",""]
[454,"XL04AXL344E001020100148","2","来那度胺","口服常释剂型","","163162","来那度胺胶囊","无","硬胶囊","25mg","瓶","21","塑料瓶","北京双鹭药业股份有限公司","429.99","修改（医保备注）","医保发〔2024〕33号",""]
[455,"XL04AXL344E001020101523","2","来那度胺","口服常释剂型","","166505","来那度胺胶囊","无","胶囊剂","10mg","盒","21","双铝","正大天晴药业集团南京顺欣制药有限公司","288.59","修改（医保备注）","医保发〔2024〕33号",""]
[456,"XL04AXL344E001020101749","2","来那度胺","口服常释剂型","","173048","来那度胺胶囊","无","胶囊剂","10mg","盒","21","铝箔","扬子江药业集团有限公司","211.96","修改（医保备注）","医保发〔2024〕33号",""]
[457,"XL04AXL344E001020278377","2","来那度胺","口服常释剂型","","175719","来那度胺胶囊","无","胶囊剂","25mg","瓶","21","高密度聚乙烯瓶包装","印度Dr. Reddy`s Laboratories Limited","641.18","修改（医保备注）","医保发〔2024〕33号",""]
[458,"XL04AXL344E001020279563","2","来那度胺","口服常释剂型","","149810","来那度胺胶囊","瑞复美","硬胶囊剂","25mg","盒","21","铝塑","瑞士Celgene International Sarl","21643.00","修改（医保备注）","医保发〔2024〕33号",""]
[459,"XL04AXL344E001020301397","2","来那度胺","口服常释剂型","","176174","来那度胺胶囊","无","胶囊剂","10mg","盒","21","铝塑包装，外加复合膜袋","常州制药厂有限公司","65.71","修改（医保备注）","医保发〔2024〕33号",""]
[460,"XL04AXL344E001030100148","2","来那度胺","口服常释剂型","","163163","来那度胺胶囊","无","硬胶囊","5mg","瓶","28","塑料瓶","北京双鹭药业股份有限公司","165.48","修改（医保备注）","医保发〔2024〕33号",""]
[461,"XL04AXL344E001030101523","2","来那度胺","口服常释剂型","","166531","来那度胺胶囊","无","胶囊剂","5mg","盒","21","双铝","正大天晴药业集团南京顺欣制药有限公司","169.76","修改（医保备注）","医保发〔2024〕33号",""]
[462,"XL04AXL344E001030104021","2","来那度胺","口服常释剂型","","169692","来那度胺胶囊","无","硬胶囊剂","10mg","盒","21","铝塑","齐鲁制药有限公司","234.30","修改（医保备注）","医保发〔2024〕33号",""]
[463,"XL04AXL344E001030301397","2","来那度胺","口服常释剂型","","176175","来那度胺胶囊","无","胶囊剂","25mg","盒","21","铝塑包装，外加复合膜袋","常州制药厂有限公司","132.52","修改（医保备注）","医保发〔2024〕33号",""]
[464,"XL04AXL344E001040104021","2","来那度胺","口服常释剂型","","169820","来那度胺胶囊","无","硬胶囊剂","15mg","盒","21","铝塑","齐鲁制药有限公司","319.57","修改（医保备注）","医保发〔2024〕33号",""]
[465,"XB05AAH027B002010103402","2","琥珀酰明胶","注射剂","","123853","琥珀酰明胶注射液","长源雪安","注射液","500ml:20g","瓶","1","玻璃瓶","吉林省长源药业有限公司","70.88","修改（医保备注）","医保发〔2024〕33号",""]
[466,"XB05AAH027B002010279246","2","琥珀酰明胶","注射剂","","144533","琥珀酰明胶注射液","无","注射液","500ml:20g","袋","1","直立式输液袋(聚丙烯、聚乙烯)","贝朗医疗(苏州)有限公司","68.88","修改（医保备注）","医保发〔2024〕33号",""]
[467,"XB05AAQ165B002010100033","2","羟乙基淀粉130/0.4电解质","注射剂","","150281","羟乙基淀粉130/0.4电解质注射液","无","注射液","500ml","袋","1","多层共挤输液袋","北京费森尤斯卡比医药有限公司","69.00","修改（医保备注）","医保发〔2024〕33号",""]
[468,"XB05AAQ165B002020104948","2","羟乙基淀粉130/0.4电解质","注射剂","","166831","羟乙基淀粉130/0.4电解质注射液","无","注射剂","500ml","袋","1","直立式输液袋(聚丙烯)","湖南科伦制药有限公司","61.00","修改（医保备注）","医保发〔2024〕33号",""]
[469,"ZA07AAA0061010104481","1","安宫牛黄丸","","限急诊或住院患者。","120674","安宫牛黄丸(体外培育牛黄、人工麝香)","无","大蜜丸","3g","盒","1","塑料壳","杭州胡庆余堂药业有限公司","87.00","修改（医保备注）","医保发〔2024〕33号",""]
[470,"ZA07AAA0061040102884","1","安宫牛黄丸","","限急诊或住院患者。","112335","安宫牛黄丸(体外培育牛黄、人工麝香)","无","大蜜丸","每丸重3g","盒","1","空","山西广誉远国药有限公司","","修改（医保备注）","医保发〔2024〕33号","供应紧张药品"]
[471,"ZA10AAJ0638010100014","2","九味镇心颗粒","","限广泛性焦虑症心脾两虚证。","105936","九味镇心颗粒","无","颗粒剂","6g","盒","10","复合膜","北京北陆药业股份有限公司","54.73","修改（医保备注）","医保发〔2024〕33号",""]
[472,"ZA10AAJ0638010200014","2","九味镇心颗粒","","限广泛性焦虑症心脾两虚证。","105942","九味镇心颗粒","无","颗粒剂","6g","盒","20","复合膜","北京北陆药业股份有限公司","109.46","修改（医保备注）","医保发〔2024〕33号",""]
[473,"ZA12GAX0006010104152","2","西红花总苷片","","限化疗产生的胸痹心痛(冠心病、心绞痛)心血瘀阻证患者。","163391","西红花总苷片","无","片剂","西红花总苷12mg(以西红花苷-1计)","盒","24","药品包装用铝箔聚氯乙烯固体药用硬片","瑞阳制药股份有限公司","396.00","修改（医保备注）","医保发〔2024〕33号",""]
[474,"ZA12HAS0790010103827","2","疏血通注射液","","限二级及以上医疗机构急性脑梗塞患者。","114373","疏血通注射液","无","注射液","2ml","支","1","安瓿","牡丹江友搏药业有限责任公司","33.37","修改（医保备注）","医保发〔2024〕33号",""]
[475,"XL01XCT181B002010181823","2","特瑞普利单抗注射液","","限：1.既往接受全身系统治疗失败的不可切除或转移性黑色素瘤的治疗；2.含铂化疗失败包括新辅助或辅助化疗12个月内进展的局部晚期或转移性尿路上皮癌的治疗；3.既往接受过二线及以上系统治疗失败的复发/转移性鼻咽癌患者的治疗；4.局部复发或转移性鼻咽癌患者的一线治疗；5.不可切除局部晚期/复发或转移性食管鳞癌的一线治疗；6.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗；7.联合化疗围手术期治疗，继之本品单药作为辅助治疗，用于可切除ⅢA-ⅢB期非小细胞肺癌(NSCLC)的成人患者；8.联合阿昔替尼用于中高危的不可切除或转移性肾细胞癌患者的一线治疗；9.联合依托泊苷和铂类用于广泛期小细胞肺癌(ES-SCLC)的一线治疗；10.联合注射用紫杉醇(白蛋白结合型)用于经充分验证的检测评估PD-L1阳性(CPS≥1)的复发或转移性三阴性乳腺癌(TNBC)的一线治疗。","165280","特瑞普利单抗注射液","拓益","注射液","240mg(6ml)/瓶","盒","1","中硼硅玻璃管制注射剂瓶,注射液用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞","上海君实生物工程有限公司","1884.86","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[476,"XL01XCT181B002020181823","2","特瑞普利单抗注射液","","限：1.既往接受全身系统治疗失败的不可切除或转移性黑色素瘤的治疗；2.含铂化疗失败包括新辅助或辅助化疗12个月内进展的局部晚期或转移性尿路上皮癌的治疗；3.既往接受过二线及以上系统治疗失败的复发/转移性鼻咽癌患者的治疗；4.局部复发或转移性鼻咽癌患者的一线治疗；5.不可切除局部晚期/复发或转移性食管鳞癌的一线治疗；6.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗；7.联合化疗围手术期治疗，继之本品单药作为辅助治疗，用于可切除ⅢA-ⅢB期非小细胞肺癌(NSCLC)的成人患者；8.联合阿昔替尼用于中高危的不可切除或转移性肾细胞癌患者的一线治疗；9.联合依托泊苷和铂类用于广泛期小细胞肺癌(ES-SCLC)的一线治疗；10.联合注射用紫杉醇(白蛋白结合型)用于经充分验证的检测评估PD-L1阳性(CPS≥1)的复发或转移性三阴性乳腺癌(TNBC)的一线治疗。","171735","特瑞普利单抗注射液","拓益","注射液","80mg(2ml)/瓶","盒","1","中硼硅玻璃管制注射剂瓶,注射液用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞","上海君实生物工程有限公司","812.88","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[477,"XL01XEZ104E001010182282","2","泽布替尼胶囊","","限：1.既往至少接受过一种治疗的成人套细胞淋巴瘤(MCL)患者；2.成人慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)患者；3.成人华氏巨球蛋白血症(WM)患者；4.联合奥妥珠单抗用于既往接受过至少二线系统性治疗的复发或难治性滤泡性淋巴瘤(FL)成人患者。","170843","泽布替尼胶囊","百悦泽","胶囊剂","80mg","盒","64","高密度聚乙烯瓶","百济神州(苏州)生物科技有限公司","5336.96","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[478,"XL01FFK131B001010181825","2","注射用卡瑞利珠单抗","","限：1.至少经过二线系统化疗的复发或难治性经典型霍奇金淋巴瘤患者的治疗；2.既往接受过索拉非尼治疗和/或仑伐替尼治疗和/或含奥沙利铂系统化疗的晚期肝细胞癌患者的治疗；3.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性的、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)的一线治疗；4.既往接受过一线化疗后疾病进展或不可耐受的局部晚期或转移性食管鳞癌患者的治疗；5.既往接受过二线及以上化疗后疾病进展或不可耐受的晚期鼻咽癌患者的治疗；6.局部复发或转移性鼻咽癌患者的一线治疗；7.不可切除局部晚期/复发或转移性食管鳞癌患者的一线治疗；8.局部晚期或转移性鳞状非小细胞肺癌患者的一线治疗；9.不可切除或转移性肝细胞癌患者的一线治疗。","165683","注射用卡瑞利珠单抗","艾瑞卡","注射剂","200mg","瓶","1","玻璃瓶","苏州盛迪亚生物医药有限公司","2576.64","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[479,"XL01FGN048B002010107857","2","尼妥珠单抗注射液","","限：1.与放疗联合治疗表皮生长因子受体(EGFR)表达阳性的Ⅲ/Ⅳ期鼻咽癌；2.与同步放化疗联合治疗局部晚期头颈部鳞癌。","122606","尼妥珠单抗注射液","泰欣生","注射液","50mg/瓶(10ml)","盒","1","硼硅玻璃管制注射剂瓶","百泰生物药业有限公司","1230.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[480,"XB03ACS292B002010178941","2","羧基麦芽糖铁注射液","","限治疗≥1周岁儿童及成人缺铁患者：口服铁剂治疗无效时；无法口服补铁时；临床上需要快速补充铁时。","206604","羧基麦芽糖铁注射液","菲新捷","注射剂","按Fe计 2mL:100mg","瓶","1","本品采用 I 型玻璃管型瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞、抗生素 瓶和输液瓶用铝塑组合盖包装。","IDT Biologika GmbH","85.34","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[481,"XB03ACS292B002020178941","2","羧基麦芽糖铁注射液","","限治疗≥1周岁儿童及成人缺铁患者：口服铁剂治疗无效时；无法口服补铁时；临床上需要快速补充铁时。","206602","羧基麦芽糖铁注射液","菲新捷","注射剂","按Fe计 10mL:500mg","瓶","1","本品采用 I 型玻璃管型瓶、注射液和注射用无菌粉末用涂膜溴化丁基橡胶塞、抗生素瓶和输液瓶用铝塑组合盖包装。","IDT Biologika GmbH","292.56","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[482,"XD05AXB232F002010180536","2","本维莫德乳膏","","限成人轻至中度稳定性寻常型银屑病的局部治疗。","165945","本维莫德乳膏","欣比克","乳膏剂","10g:0.1g(1%)","支","1","铝管","广东中昊药业有限公司","138.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[483,"XH01CBL032B029010178274","2","醋酸兰瑞肽缓释注射液(预充式)","","限：1.肢端肥大症患者；2.不可切除、高分化或中分化、局部晚期或转移性胃肠胰神经内分泌瘤(GEP-NETs)的成人患者；3.类癌综合征成人患者。","171733","醋酸兰瑞肽缓释注射液(预充式)","无","注射液","90mg(以兰瑞肽计)","支","1","预充式(预灌封)注射器","法国IPSEN PHARMA BIOTECH","4780.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[484,"XH01CBL032B029020178274","2","醋酸兰瑞肽缓释注射液(预充式)","","限：1.肢端肥大症患者；2.不可切除、高分化或中分化、局部晚期或转移性胃肠胰神经内分泌瘤(GEP-NETs)的成人患者；3.类癌综合征成人患者。","171734","醋酸兰瑞肽缓释注射液(预充式)","无","注射液","0.12g(以兰瑞肽计)","支","1","预充式(预灌封)注射器","法国IPSEN PHARMA BIOTECH","5957.62","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[485,"XL01ELA387E001010184513","2","阿可替尼胶囊","","限：1.既往至少接受过一种治疗的成人慢性淋巴细胞白血病(CLL)/小淋巴细胞淋巴瘤(SLL)患者；2.既往至少接受过一种治疗的成人套细胞淋巴瘤(MCL)患者。","203674","阿可替尼胶囊","康可期","胶囊剂","100mg","盒","56","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片＋药用铝箔的泡罩包装。","AstraZeneca AB","10006.08","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[486,"XL01XXF723E001010101445","2","氟唑帕利胶囊","","限：1.既往经过二线及以上化疗的伴有胚系BRCA突变(gBRCAm)的铂敏感复发性卵巢癌、输卵管癌或原发性腹膜癌的患者；2.铂敏感的复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在含铂化疗达到完全缓解或部分缓解后的维持治疗；3.晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在一线含铂化疗达到完全缓解或部分缓解后的维持治疗。","171697","氟唑帕利胶囊","艾瑞颐","硬胶囊剂","50mg","盒","36","铝箔","江苏恒瑞医药股份有限公司","1928.16","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[487,"XL01XXF723E001010201445","2","氟唑帕利胶囊","","限：1.既往经过二线及以上化疗的伴有胚系BRCA突变(gBRCAm)的铂敏感复发性卵巢癌、输卵管癌或原发性腹膜癌的患者；2.铂敏感的复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在含铂化疗达到完全缓解或部分缓解后的维持治疗；3.晚期上皮性卵巢癌、输卵管癌或原发性腹膜癌成人患者在一线含铂化疗达到完全缓解或部分缓解后的维持治疗。","207377","氟唑帕利胶囊","艾瑞颐","胶囊剂","50mg","盒","60","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","江苏恒瑞医药股份有限公司","3213.60","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[488,"XL02AEG063B015010104139","2","注射用戈舍瑞林微球","","限：1.需要雄激素去势治疗的前列腺癌患者；2.可用激素治疗的绝经前期及围绝经期妇女的乳腺癌。","206584","注射用戈舍瑞林微球","无","注射剂","3.6mg","盒","1","注射用戈舍瑞林微球:中性硼硅玻璃管制注射剂瓶＋注射制剂用氯化丁基橡胶塞包装。 注射用微球专用溶剂:预灌封注射器组合件＋预灌封注射器用溴化丁基橡胶活塞包装。","山东绿叶制药有限公司","1028.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[489,"XL01XCT190B002010182097","2","替雷利珠单抗注射液","","限：1.至少经过二线系统化疗的复发或难治性经典型霍奇金淋巴瘤的治疗；2.PD-L1高表达的含铂化疗失败包括新辅助或辅助化疗12个月内进展的局部晚期或转移性尿路上皮癌的治疗；3.不可手术切除的局部晚期或转移性鳞状非小细胞肺癌的一线治疗；4.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非鳞状非小细胞肺癌的一线治疗；5.表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、既往接受过含铂方案化疗后疾病进展或不可耐受的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)成人患者，以及EGFR和ALK阴性或未知的，既往接受过含铂方案化疗后疾病进展或不可耐受的局部晚期或转移性鳞状NSCLC成人患者；6.联合依托泊苷和铂类化疗用于广泛期小细胞肺癌(ES-SCLC)的一线治疗；7.用于不可切除或转移性肝细胞癌患者的一线治疗；8.至少经过一种全身治疗的肝细胞癌的治疗；9.不可切除或转移性微卫星高度不稳定型(MSI-H)或错配修复基因缺陷型(dMMR)的成人晚期实体瘤患者：既往经过氟尿嘧啶类、奥沙利铂和伊立替康治疗后出现疾病进展的晚期结直肠癌患者；既往治疗后出现疾病进展且无满意替代治疗方案的其他晚期实体瘤患者；10.既往接受过一线标准化疗后进展或不可耐受的局部晚期或转移性食管鳞状细胞癌的治疗；11.不可切除的局部晚期、复发或转移性食管鳞状细胞癌的一线治疗；12.复发或转移性鼻咽癌的一线治疗；13.联合氟尿嘧啶类和铂类药物化疗用于局部晚期不可切除的或转移性的胃或胃食管结合部腺癌的一线治疗。","169149","替雷利珠单抗注射液","百泽安","注射剂","10ml:100mg","盒","1","西林瓶","广州百济神州生物制药有限公司","1253.53","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[490,"XD11AHK139F001010182999","2","克立硼罗软膏","","限3月龄及以上的轻度至中度特应性皮炎患者。","171287","克立硼罗软膏","舒坦明","软膏剂","30g:0.6g(2%)","支","1","空","美国Pharmacia & Upjohn Company LLC","158.80","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[491,"XR03AKF717L031010282760","2","氟替美维吸入粉雾剂","","限慢性阻塞性肺疾病。","166608","氟替美维吸入粉雾剂","无","吸入粉雾剂","糠酸氟替卡松0.1mg,乌美溴铵(以乌美铵计)62.5μg,三苯乙酸维兰特罗(以维兰特罗计)25μg,30吸","盒","1","铝箔","英国Glaxo Operations UK Ltd (trading as Glaxo Wellcome Operations)","239.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[492,"XL04AAW118B001010179422","2","注射用维得利珠单抗","","限：1.对传统治疗或肿瘤坏死因子α(TNFα)抑制剂应答不充分、失应答或不耐受的中度至重度活动性溃疡性结肠炎的成年患者；2.对传统治疗或TNFα抑制剂应答不充分、失应答或不耐受的中度至重度活动性克罗恩病的成年患者。","171358","注射用维得利珠单抗","安吉优","冻干粉针剂","0.3g","盒","1","玻璃瓶","日本Takeda Pharmaceutical Company Ltd.","4980.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[493,"XL01XXS286A001010183951","2","塞利尼索片","","限：1.既往接受过治疗且对至少一种蛋白酶体抑制剂，一种免疫调节剂以及一种抗CD38单抗难治的复发或难治性多发性骨髓瘤成人患者；2.既往接受过至少两线系统性治疗的复发或难治性弥漫性大B细胞淋巴瘤(DLBCL)成人患者。","176749","塞利尼索片","希维奥","片剂","20mg","盒","12","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","Catalent CTS, LLC","4656.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[494,"XL01XXS286A001010283951","2","塞利尼索片","","限：1.既往接受过治疗且对至少一种蛋白酶体抑制剂，一种免疫调节剂以及一种抗CD38单抗难治的复发或难治性多发性骨髓瘤成人患者；2.既往接受过至少两线系统性治疗的复发或难治性弥漫性大B细胞淋巴瘤(DLBCL)成人患者。","206541","塞利尼索片","希维奥","片剂","20mg","盒","16","聚氯乙烯/聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","Catalent CTS, LLC","6208.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[495,"XL01EDE091E001010104611","2","盐酸恩沙替尼胶囊","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性的非小细胞肺癌(NSCLC)患者。","171625","盐酸恩沙替尼胶囊","贝美纳","胶囊剂","25mg(按C26H27Cl2FN6O3计)","盒","7","口服固体药用高密度聚乙烯瓶及高密度聚乙烯/聚丙烯儿童安全防潮组合瓶盖系统包装。","贝达药业股份有限公司","343.91","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[496,"XL01EDE091E001020104611","2","盐酸恩沙替尼胶囊","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性的非小细胞肺癌(NSCLC)患者。","171626","盐酸恩沙替尼胶囊","贝美纳","胶囊剂","100mg(按C26H27Cl2FN6O3计)","盒","14","口服固体药用高密度聚乙烯瓶及高密度聚乙烯/聚丙烯儿童安全防潮组合瓶盖系统包装。","贝达药业股份有限公司","1988.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[497,"XJ05AXL400B002010179325","2","来特莫韦注射液","","限用于接受异基因造血干细胞移植(HSCT)的巨细胞病毒(CMV)血清学阳性的成人受者[R+]预防巨细胞病毒感染和巨细胞病毒病。","310072","来特莫韦注射液","无","注射剂","12ml:240mg","盒","1","中性硼硅玻璃管制注射剂瓶","MSD International GmbH T/A MSD Ireland (Carlow)","430.00","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[498,"XA02BCF721A001010110289","2","富马酸伏诺拉生片","","限：1.反流性食管炎；2.与适当的抗生素联用以根除幽门螺杆菌。","169316","富马酸伏诺拉生片","沃克","薄膜衣片","20mg","盒","7","铝塑","日本Takeda Pharmaceutical Company Limited, Hikari Plant","69.30","修改（医保备注）","医保发〔2024〕33号",""]
[499,"XS01LAK119B023010109681","2","康柏西普眼用注射液","","\"限:1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)(视网膜分支静脉阻塞(BRVO)或视网膜中央静脉阻塞(CRVO)的黄斑水肿引起的视力损伤。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","155169","康柏西普眼用注射液","朗沐","注射液","0.2ml:2.0mg","支","1","玻璃瓶","成都康弘生物科技有限公司","3452.80","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[500,"XS01LAK119B023020109681","2","康柏西普眼用注射液","","\"限:1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)(视网膜分支静脉阻塞(BRVO)或视网膜中央静脉阻塞(CRVO)的黄斑水肿引起的视力损伤。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","310116","康柏西普眼用注射液","朗沐","眼用注射液","10mg/ml,0.05ml/支(预充式)","盒","1","一次性预充式注射器包装","成都康弘生物科技有限公司","3452.80","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[501,"XS01LAL328B002010104021","2","雷珠单抗注射液","","\"限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)的黄斑水肿引起的视力损害。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","210931","雷珠单抗注射液","安卓明","注射剂","10mg/ml,每瓶装量0.20ml。","盒","1","中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞，外轧抗生素瓶用铝塑组合盖。内附2个针头和1支注射器(1个1ml无菌注射器；1个18G，5μm过滤针头，用于抽取瓶内容物；","齐鲁制药有限公司","2570.00 ","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[502,"XS01LAL328B002010178679","2","雷珠单抗注射液","","\"限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)的黄斑水肿引起的视力损害。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","162662","雷珠单抗注射液","诺适得","注射液","0.165ml:1.65mg","盒","1","预充式(预灌封)注射器","德国Vetter Pharma-Fertigung GmbH & Co.KG","3673.50","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[503,"XS01LAL328B002020178679","2","雷珠单抗注射液","","\"限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害；3.脉络膜新生血管(CNV)导致的视力损害；4.继发于视网膜静脉阻塞(RVO)的黄斑水肿引起的视力损害。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","147710","雷珠单抗注射液","诺适得","注射液","0.2ml:2mg","盒","1","内附2个针头与1支注射器","瑞士Novartis Pharma Stein AG","3673.50","修改（医保备注）","医保发〔2024〕33号","国谈药品"]
[504,"XS01LAA308G003010104021","2","阿柏西普眼内注射溶液","","\"限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","206748","阿柏西普眼内注射溶液","卓初明","注射剂","40 mg/ml,每瓶可抽取体积为0.1ml,相当于4mg阿柏西普","瓶","1","中硼硅玻璃管制注射剂瓶","齐鲁制药有限公司","2970.00","修改（医保备注）","医保发〔2024〕33号",""]
[505,"XS01LAA308G003010178269","2","阿柏西普眼内注射溶液","","\"限：1.50岁以上的湿性年龄相关性黄斑变性(AMD)；2.糖尿病性黄斑水肿(DME)引起的视力损害。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","163371","阿柏西普眼内注射溶液","艾力雅","注射液","0.1ml:4mg","盒","1","玻璃瓶(每盒附一个过滤针头)","德国Vetter Pharma-Fertigung GmbH & Co.KG","4100.00","修改（医保备注）","医保发〔2024〕33号",""]
[506,"ZA07AAZ0514010100426","1","紫雪、紫雪胶囊（散、颗粒）","","限高热惊厥急救、抢救时使用。","120600","紫雪(人工麝香)","无","散剂","1.5g","盒","10","塑料瓶","广州粤华制药有限公司","55.00","修改（医保信息）","医保发〔2024〕33号",""]
[507,"ZA07AAZ0514010101833","1","紫雪、紫雪胶囊（散、颗粒）","","限高热惊厥急救、抢救时使用。","169710","紫雪(人工麝香)","无","散剂","1.5g","盒","2","塑料瓶","湖北民康制药有限公司","168.00","修改（医保信息）","医保发〔2024〕33号",""]
[508,"ZA07AAZ0514020101833","1","紫雪、紫雪胶囊（散、颗粒）","","限高热惊厥急救、抢救时使用。","206182","紫雪","无","散剂","每瓶装1.5g(人工麝香)","盒","1","塑料瓶","湖北民康制药有限公司","84.00 ","修改（医保信息）","医保发〔2024〕33号",""]
[509,"ZA10AAA0099010104584","2","安神补心丸(片、胶囊、颗粒)","","","102119","安神补心片","无","薄膜衣片","0.32g","盒","60","铝塑泡罩","太极集团浙江东方制药有限公司","52.97 ","启用","招采变更",""]
[510,"XN05AHA204A022020101066","2","奥氮平","口腔崩解片","","211067","奥氮平口崩片","无","片剂","5mg","盒","30","双铝泡罩包装","湖南洞庭药业股份有限公司","16.68 ","启用","招采变更",""]
[511,"XC09DBA313A001010100841","2","奥美沙坦酯氨氯地平","口服常释剂型","","206287","奥美沙坦酯氨氯地平片","无","薄膜衣片","每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg(以氨氯地平计)","盒","30","口服固体药用高密度聚乙烯瓶,口服固体药用聚丙烯/低密度聚乙烯儿童安全防潮组合瓶盖","扬子江药业集团上海海尼药业有限公司","22.95 ","启用","招采变更",""]
[512,"XJ01XDA222B002020109910","2","奥硝唑","注射剂","","209139","奥硝唑注射液","无","注射剂","3ml∶0.5g","支","1","中硼硅玻璃安瓿","华夏生生药业(北京)有限公司","1.99 ","启用","招采变更",""]
[513,"ZD03AAB0051020105046","1","八珍益母丸(片、胶囊)","","","211501","八珍益母片","无","片剂(薄膜衣片)","每片重0.35g","盒","54","聚氯乙烯固体药用硬片、铝塑泡罩包装","株洲千金药业股份有限公司","44.93 ","启用","招采变更",""]
[514,"XM03BXB006A001010178679","2","巴氯芬","口服常释剂型","","147328","巴氯芬片","力奥来素","片剂","10mg","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装","Hemony Pharmaceutical Switzerland GmbH","75.85","修改（招标信息）","招采变更",""]
[515,"XH02ABB044B002010182338","2","倍他米松","注射剂","","210828","倍他米松磷酸钠注射液","无","注射剂","1ml:4mg(按C₂₂H₂₉FO₅计)","支","1","中硼硅玻璃安瓿","成都倍特得诺药业有限公司","16.30 ","启用","招采变更",""]
[516,"XH02ABB044B002010201003","2","倍他米松","注射剂","","210695","倍他米松磷酸钠注射液","无","注射剂","1ml꞉4mg(按C₂₂H₂₉FO₅计)","瓶","1","中硼硅玻璃管制注射剂瓶＋注射液用卤化丁基橡胶塞(溴化)包装,抗生素瓶用铝塑组合盖密封。","重庆华邦制药有限公司","23.50 ","启用","招采变更",""]
[517,"XJ01CFB083E001010204152","1","苯唑西林","口服常释剂型","","206130","苯唑西林钠胶囊","无","硬胶囊","0.25g","盒","36","铝塑泡罩","瑞阳制药股份有限公司","41.38 ","启用","招采变更",""]
[518,"XN07XXB221A001020104251","2","吡拉西坦(乙酰胺吡咯烷酮)","口服常释剂型","","208584","吡拉西坦片","无","片剂","0.8g","盒","36","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装","福安药业集团烟台只楚药业有限公司","91.19 ","启用","招采变更",""]
[519,"XJ04AKB103A001010101518","1","吡嗪酰胺","口服常释剂型","","152792","吡嗪酰胺片","无","片剂","0.25g","瓶","100","塑料瓶","苏州弘森药业股份有限公司","19.38 ","修改（招标信息）","招采变更",""]
[520,"XN01AXB123B002010102763","2","丙泊酚中/长链脂肪乳","注射剂","","207785","丙泊酚中/长链脂肪乳注射液","无","注射剂","20ml: 0.2g","支","1","中硼硅玻璃安瓿","石家庄四药有限公司","9.86 ","修改（支付标准）","招采变更",""]
[521,"XN01AXB123B002020102763","2","丙泊酚中/长链脂肪乳","注射剂","","207786","丙泊酚中/长链脂肪乳注射液","无","注射剂","10ml: 0.1g","支","1","中硼硅玻璃安瓿","石家庄四药有限公司","5.80 ","修改（支付标准）","招采变更",""]
[522,"XN01AXB123B002030200469","2","丙泊酚中/长链脂肪乳","注射剂","","154151","丙泊酚中/长链脂肪乳注射液","无","注射剂","20ml:200mg","支","1","中硼硅玻璃安瓿","广东嘉博制药有限公司","13.24 ","修改（支付标准）","招采变更",""]
[523,"XN01AXB123B002010200469","2","丙泊酚中/长链脂肪乳","注射剂","","167784","丙泊酚中/长链脂肪乳注射液","无","注射剂","10ml:100mg","支","1","中硼硅玻璃安瓿","广东嘉博制药有限公司","7.79 ","修改（招标信息）","招采变更",""]
[524,"XN01AXB123B002040200469","2","丙泊酚中/长链脂肪乳","注射剂","","163086","丙泊酚中/长链脂肪乳注射液","无","注射剂","50ml:500mg","瓶","1","中硼硅玻璃输液瓶及注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞","广东嘉博制药有限公司","31.20 ","修改（招标信息）","招采变更",""]
[525,"XN01AXB123B002050100469","2","丙泊酚中/长链脂肪乳","注射剂","","167786","丙泊酚中/长链脂肪乳注射液","无","注射剂","100ml:1g","瓶","1","中硼硅玻璃输液瓶及注射液用溴化丁基橡胶塞","广东嘉博制药有限公司","49.89 ","修改（招标信息）","招采变更",""]
[526,"XD07ACF095F002010180651","2","氟替卡松","软膏剂","","211142","丙酸氟替卡松乳膏","无","乳膏剂","0.05％(15g∶7.5mg)","盒","1","铝质药用软膏管","福元药业有限公司","33.30 ","启用","招采变更",""]
[527,"XR01ADF095L026010283672","2","氟替卡松","吸入剂","","209991","丙酸氟替卡松雾化吸入用混悬液","无","吸入制剂","2ml:0.5mg","盒","10","吸入溶液用低密度聚乙烯瓶, 外加聚酯/铝/聚乙烯药品包装用复合膜、袋","健康元药业集团股份有限公司","118.00 ","修改（招标信息）","招采变更",""]
[528,"XN03AGB140X001010104186","2","丙戊酸钠","口服液体剂","","209056","丙戊酸钠口服溶液","无","口服溶液剂","300ml:12g","盒","1","钠钙玻璃模制药瓶装,口服液瓶用铝盖","翔宇药业股份有限公司","56.09 ","修改（支付标准）","招采变更",""]
[529,"XN03AGB140X001010183033","2","丙戊酸钠","口服液体剂","","211216","丙戊酸钠口服溶液","无","口服溶液剂","300ml:12g","盒","1","棕色玻璃瓶","仁合益康集团有限公司","70.00 ","启用","招采变更",""]
[530,"XN03AGB140X001010109554","2","丙戊酸钠","口服液体剂","","211226","丙戊酸钠口服溶液","无","口服溶液剂","100ml:4g","盒","1","口服液体药用聚酯瓶","福安药业集团湖北人民制药有限公司","30.54 ","启用","招采变更",""]
[531,"XS01KAB146G010010183315","2","玻璃酸钠","滴眼剂","","209543","玻璃酸钠滴眼液","无","眼用制剂","0.1%(0.4ml:0.4mg)","盒","15","低密度聚乙烯药用滴眼剂瓶,外加聚酯/铝/聚乙烯药用包装复合膜袋","中山万远新药研发有限公司","33.00 ","启用","招采变更",""]
[532,"XS01KAB146G010010283315","2","玻璃酸钠","滴眼剂","","209837","玻璃酸钠滴眼液","无","眼用制剂","0.1%(0.4ml:0.4mg)","盒","10","低密度聚乙烯药用滴眼剂瓶,外加聚酯/铝/聚乙烯药用包装复合膜袋","中山万远新药研发有限公司","22.00 ","启用","招采变更",""]
[533,"XM01AEB173E003010705846","2","布洛芬","缓释控释剂型","","136875","布洛芬缓释胶囊","无","胶囊剂","0.3g","盒","20","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","海南妙音春制药有限公司","6.47 ","修改（支付标准）","招采变更",""]
[534,"XM01AEB173X004010100734","2","布洛芬","口服液体剂","","137453","布洛芬混悬滴剂","美林","口服混悬剂","15ml:0.6g","瓶","1","塑料瓶","上海强生制药有限公司","9.55","停用","招采国码变更",""]
[535,"XM01AEB173X012010200734","2","布洛芬","口服液体剂","","137453","布洛芬混悬滴剂","美林","滴剂","15ml/瓶(15ml:0.6g)","盒","1","口服液体药用聚丙烯瓶装(附刻度滴管)","上海强生制药有限公司","9.55","启用","招采国码变更",""]
[536,"XR05XXB174N001010104131","2","缓解感冒症状的复方OTC制剂","","◇","208828","布洛伪麻颗粒","无","颗粒剂","布洛芬0.2g,盐酸伪麻黄碱30mg","盒","6","铝塑复合袋","山东鲁抗医药集团赛特有限责任公司","29.50 ","启用","招采变更",""]
[537,"XC03CAB176A001010105206","2","布美他尼","口服常释剂型","","116587","布美他尼片","无","片剂","1mg","盒","10","药用铝箔＋聚氯乙烯固体药用硬片包装","桂林南药股份有限公司","55.14 ","启用","招采变更",""]
[538,"XN06ABA225X001010104634","2","草酸艾司西酞普兰口服溶液","","","205285","草酸艾司西酞普兰口服溶液","无","口服溶液剂","按C₂₀H₂₁FN₂O计:5ml:5mg","盒","10","聚酯/铝/流延聚丙烯口服液体药用复合膜","浙江国镜药业有限公司","31.80","修改（包装材质）","招采变更","竞价药品"]
[539,"XN06ABA225X001020104634","2","草酸艾司西酞普兰口服溶液","","","205286","草酸艾司西酞普兰口服溶液","无","口服溶液剂","按C₂₀H₂₁FN₂O计:10ml:10mg","盒","10","聚酯/铝/流延聚丙烯口服液体药用复合膜包装","浙江国镜药业有限公司","54.00","修改（包装材质）","招采变更","竞价药品"]
[540,"XN06ABA225A001010103454","1","艾司西酞普兰","口服常释剂型","","168861","草酸艾司西酞普兰片","无","薄膜衣片","10mg","盒","7","药品包装用PTP铝箔、聚氯乙烯固体药用硬片","吉林省西点药业科技发展股份有限公司","21.34 ","修改（支付标准）","招采变更",""]
[541,"XS01BCX230G010020109920","2","溴芬酸钠","滴眼剂","限眼部手术后炎症。","209836","溴芬酸钠滴眼液","无","眼用制剂","0.1%(5ml:5mg,按C₁₅H₁₁BrNNaO₃•1½H₂O计)(5ml/支)","盒","1","低密度聚乙烯药用滴眼剂瓶装","中山万汉制药有限公司","44.80 ","启用","招采变更",""]
[542,"XH01BXC048B002010201598","1","垂体后叶","注射剂","","142154","垂体后叶注射液","无","注射剂","1ml:6单位","支","1","低硼硅玻璃安瓿包装","南京新百药业有限公司","80.00 ","修改（招标信息）","招采变更",""]
[543,"XH01BXC048B002030104373","1","垂体后叶","注射剂","","175893","垂体后叶注射液","无","注射液","0.5ml:3单位","支","1","易折安瓿","安徽宏业药业有限公司","47.06 ","修改（招标信息）","招采变更",""]
[544,"ZA03BAC0508010105880","2","苁蓉通便口服液","","","201928","苁蓉通便口服液","无","合剂","100ml","盒","1","药用塑料瓶","甘肃天水岐黄药业有限责任公司","59.50 ","修改（企业名称）","招采变更",""]
[545,"XH01CBA213B002010202066","2","奥曲肽","注射剂","","211244","醋酸奥曲肽注射液","益谱柠","注射液","1ml:0.1mg(按C49H66N10O10S2计)","支","1","中硼硅玻璃安瓿","成都天台山制药股份有限公司","8.97 ","启用","招采变更",""]
[546,"XL01EAD246A001010105847","2","达沙替尼","口服常释剂型","","210879","达沙替尼片","无","片剂","20mg","盒","60","口服固体药用高密度聚乙烯瓶，内加固体药用纸袋装硅胶干燥剂。","齐鲁制药(海南)有限公司","742.81 ","启用","招采变更",""]
[547,"XL01EAD246A001020105847","2","达沙替尼","口服常释剂型","","210880","达沙替尼片","无","片剂","50mg","盒","60","口服固体药用高密度聚乙烯瓶，内加固体药用纸袋装硅胶干燥剂。","齐鲁制药(海南)有限公司","1498.00 ","启用","招采变更",""]
[548,"ZI01AAD0051010105737","2","大月晶丸","","","211495","大月晶丸","无","丸剂","每丸重0.6克","盒","16","内包材为铝塑泡罩","西藏仙露藏药有限公司","123.00 ","启用","招采变更",""]
[549,"XA10AED356B002010178997","2","德谷胰岛素利拉鲁肽注射液","","限血糖控制不佳的成人2型糖尿病患者。","174851","德谷胰岛素利拉鲁肽注射液","诺和益","注射剂","每支3ml,含300单位德谷胰岛素和10.8mg利拉鲁肽","盒","1","本品为聚丙烯、聚碳酸酯和丙烯腈-丁二烯苯乙烯制成的一次性预填充多剂量注射笔，内含装有3ml溶液的玻璃套筒(Ⅰ型玻璃)。玻璃套筒带有一个活塞(溴化丁基橡胶)，由橡胶垫片(溴化丁基橡胶/聚异戊二烯)密封。","Novo Nordisk A/S","217.60","修改（招标信息）","招采变更","国谈药品"]
[550,"XB05DAD257B020010100687","1","腹膜透析液","注射剂","","209804","低钙腹膜透析液(乳酸盐-G1.5%)","无","注射剂","含1.5%葡萄糖(2000ml/袋)","袋","1","本品采用三层共挤透析液用袋作为内包装,与注射液用聚碳酸酯折断塞、一次性使用腹膜透析液引流器(一次性使用腹透引流袋)连接后,外套高密度聚乙烯袋","上海长征富民金山制药有限公司","28.47 ","启用","招采变更",""]
[551,"XB05DAD257B020020100687","1","腹膜透析液","注射剂","","209805","低钙腹膜透析液(乳酸盐-G2.5%)","无","注射剂","含2.5%葡萄糖(2000ml/袋)","袋","1","本品采用三层共挤透析液用袋作为内包装,与注射液用聚碳酸酯折断塞、一次性使用腹膜透析液引流器(一次性使用腹透引流袋)连接后,外套高密度聚乙烯袋","上海长征富民金山制药有限公司","28.47 ","启用","招采变更",""]
[552,"XB05DAD257B020030100687","1","腹膜透析液","注射剂","","209806","低钙腹膜透析液(乳酸盐-G4.25%)","无","注射剂","含4.25%葡萄糖(2000ml/袋)","袋","1","本品采用三层共挤透析液用袋作为内包装,与注射液用聚碳酸酯折断塞、一次性使用腹膜透析液引流器(一次性使用腹透引流袋)连接后,外套高密度聚乙烯袋","上海长征富民金山制药有限公司","28.47 ","启用","招采变更",""]
[553,"XG03DBD331A001010183510","2","地诺孕素","口服常释剂型","","208366","地诺孕素片","无","片剂","2mg","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包裝。","培力药品工业股份有限公司","248.00 ","启用","招采变更",""]
[554,"XG03DBD331A001010102521","2","地诺孕素","口服常释剂型","","211472","地诺孕素片","无","片剂","2mg","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","西安太极药业有限公司","248.00 ","启用","招采变更",""]
[555,"XN04BAD164A001010304646","1","多巴丝肼","口服常释剂型","","210794","多巴丝肼片","无","片剂","左旋多巴200mg与苄丝肼50mg(相当于盐酸苄丝肼57mg)","盒","24","双铝包装","浙江花园药业有限公司","43.53 ","启用","招采变更",""]
[556,"XN04BAD164A001010202763","1","多巴丝肼","口服常释剂型","","210789","多巴丝肼片","无","片剂","左旋多巴200mg与苄丝肼50mg(相当于盐酸苄丝肼57mg)","盒","40","双铝包装","石家庄四药有限公司","71.00 ","启用","招采变更",""]
[557,"XV02DXD201B002010183885","2","\"多种微量元素多种微量元素Ⅰ多种微量元素Ⅱ\"","注射剂","限配合肠外营养用。","210835","多种微量元素注射液(Ⅰ)","无","注射剂","10ml","支","1","聚丙烯安瓿","洋浦京泰药业有限公司","96.69 ","启用","招采变更",""]
[558,"XC09DAE004A001010305356","2","厄贝沙坦氢氯噻嗪","口服常释剂型","","209662","厄贝沙坦氢氯噻嗪片","无","片剂(薄膜衣片)","每片含厄贝沙坦150mg,氢氯噻嗪12.5mg","盒","14","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用硬片、药用铝箔)","河北新石制药有限公司","9.62 ","启用","招采变更",""]
[559,"XC09DAE004A001010105356","2","厄贝沙坦氢氯噻嗪","口服常释剂型","","209146","厄贝沙坦氢氯噻嗪片","无","片剂(薄膜衣片)","每片含厄贝沙坦150mg,氢氯噻嗪12.5mg","盒","28","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔)","河北新石制药有限公司","18.76 ","启用","招采变更",""]
[560,"XN01ABE010W004010102671","1","恩氟烷","液体剂","","115463","恩氟烷","无","液体剂","150ml","盒","1","棕色玻璃瓶","河北一品制药股份有限公司","1877.00 ","启用","招采变更",""]
[561,"XN04BXE068A001010102763","2","\"恩他卡朋双多巴恩他卡朋双多巴Ⅱ恩他卡朋双多巴Ⅲ恩他卡朋双多巴Ⅳ\"","口服常释剂型","限二线用药。","210796","恩他卡朋双多巴片(Ⅱ)","无","片剂(薄膜衣片)","左旋多巴100mg、卡比多巴25mg、恩他卡朋200mg","瓶","30","口服固体药用高密度聚乙烯瓶包装","石家庄四药有限公司","225.00 ","启用","招采变更",""]
[562,"XM04AAF670A001010304647","2","非布司他","口服常释剂型","","211052","非布司他片","无","薄膜衣片","40mg","盒","14","铝塑包装","浙江华海药业股份有限公司","28.72 ","启用","招采变更",""]
[563,"XM04AAF670A001010204647","2","非布司他","口服常释剂型","","211051","非布司他片","无","薄膜衣片","40mg","盒","28","铝塑包装","浙江华海药业股份有限公司","56.00 ","启用","招采变更",""]
[564,"XC08CAF017A010010202902","2","\"非洛地平非洛地平Ⅱ\"","缓释控释剂型","","211395","非洛地平缓释片","康宝得维","片剂","10mg","盒","20","铝塑","山西康宝生物制品股份有限公司","39.12 ","启用","招采变更",""]
[565,"XR05XXF033E001020103594","2","缓解感冒症状的复方OTC制剂","","◇","209519","酚咖麻敏胶囊","无","胶囊剂","复方","盒","14","铝塑包装","修正药业集团股份有限公司","34.57 ","启用","招采变更",""]
[566,"XJ02ACF059X006010182922","2","伏立康唑","口服液体剂","限有明确的重度免疫缺陷诊断并发严重真菌感染的临床证据；曲霉菌肺炎或中枢神经系统感染。","206250","伏立康唑干混悬剂","无","干混悬剂","45g:3g,配制成混悬液后伏立康唑浓度为40mg/ml","盒","1","高密度聚乙烯(HDPE)瓶(配有一个聚丙烯儿童安全阻开盖),内含45g干混悬剂。制成的混悬液体积为75ml,其中可用体积为70ml。还包括一个给药器,内塞","浙江普利药业有限公司","998.00 ","修改（支付标准）","招采变更",""]
[567,"XJ02ACF059X006010100601","2","伏立康唑","口服液体剂","限有明确的重度免疫缺陷诊断并发严重真菌感染的临床证据；曲霉菌肺炎或中枢神经系统感染。","207895","伏立康唑干混悬剂","无","口服混悬剂","45g:3g,配制成混悬液后伏立康唑浓度为40mg/ml","盒","1","一个体积为100ml的口服固体药用高密度聚乙烯瓶,内含45g干混悬剂。还包括一个口服液体药用聚丙烯量杯、规格为5ml的给药器。","珠海润都制药股份有限公司","988.00 ","修改（支付标准）","招采变更",""]
[568,"XJ02ACF624B002030102261","2","氟康唑氯化钠","注射剂","","208893","氟康唑氯化钠注射液","无","注射剂","100ml:氟康唑0.2g与氯化钠0.9g","袋","1","三层共挤输液用膜制袋","四川太平洋药业有限责任公司","32.00 ","启用","招采变更",""]
[569,"XL01BCF082A001010304340","1","氟尿嘧啶","口服常释剂型","","200259","氟尿嘧啶片","无","片剂","50mg","瓶","18","口服固体药用高密度聚乙烯瓶装","海南海和制药有限公司","486.00 ","修改（招标信息）","招采变更",""]
[570,"XB05BAF155B002010102180","2","复方氨基酸(18AA-Ⅶ)","注射剂","需经营养风险筛查,明确具有营养风险,且不能经饮食或使用\"肠内营养剂\"补充足够营养的住院患者方予支付。","209690","复方氨基酸注射液(18AA-Ⅶ)","无","注射剂","200ml:20.650g(总氨基酸)","袋","1","外阻隔袋三层共挤输液用膜制袋装","四川科伦药业股份有限公司","30.50 ","启用","招采变更",""]
[571,"ZA04BAF0298010102057","2","复方板蓝根颗粒","","","166044","复方板蓝根颗粒","无","颗粒剂","每袋装15g(相当原生药15g)","袋","20","药用复合袋","四川成都同道堂制药有限责任公司","15.62 ","修改（招标信息）","招采变更",""]
[572,"XA05BAF632E001010504152","2","复方甘草甜素（复方甘草酸苷）","口服常释剂型","","115970","复方甘草酸苷胶囊","无","硬胶囊","甘草酸苷25mg,甘氨酸25mg,蛋氨酸25mg","盒","36","铝塑包装","瑞阳制药股份有限公司","32.88 ","修改（招标信息）","招采变更",""]
[573,"XA05BAF632E001010704152","2","复方甘草甜素（复方甘草酸苷）","口服常释剂型","","156473","复方甘草酸苷胶囊","无","硬胶囊","甘草酸苷25mg,甘氨酸25mg,蛋氨酸25mg","盒","45","铝塑包装","瑞阳制药股份有限公司","40.77 ","修改（招标信息）","招采变更",""]
[574,"XJ01EEF309B002010183529","2","复方磺胺甲噁唑","注射剂","","210780","复方磺胺甲噁唑注射液","无","注射剂","5ml:磺胺甲噁唑0.4g与甲氧苄啶80mg","支","1","中硼硅玻璃安瓿","成都慧德医药科技有限公司","585.00 ","启用","招采变更",""]
[575,"XA06ADF679P001010102732","2","\"复方聚乙二醇电解质Ⅰ复方聚乙二醇电解质Ⅱ复方聚乙二醇电解质Ⅲ复方聚乙二醇电解质Ⅳ\"","口服散剂","","211429","复方聚乙二醇电解质散(Ⅲ)","无","散剂","本品为复方制剂,每袋含:聚乙二醇400064g,硫酸钠5.7g,氯化钠1.46g,氯化钾0.75g,碳酸氢钠1.68g","盒","4","纸/铝/聚乙烯药用复合膜、袋","石家庄东方药业股份有限公司","108.00 ","启用","招采变更",""]
[576,"XB05BBF628B002010102001","2","复方乳酸钠葡萄糖","注射剂","","173201","复方乳酸钠葡萄糖注射液","无","注射液","500ml","瓶","1","玻璃瓶","宜昌三峡制药有限公司","128.00 ","启用","招采变更",""]
[577,"XA07FAF478A001010903560","2","缓解消化道不适症状的复方OTC制剂","","◇","211209","复方嗜酸乳杆菌片","无","素片","0.5g(每1g含嗜酸乳杆菌10^7个)","盒","90","铝塑包装","通化金马药业集团股份有限公司","131.85 ","启用","招采变更",""]
[578,"XV02DEF113A001010300177","2","复方α-酮酸","口服常释剂型","","133728","复方α-酮酸片","无","片剂","0.63g","盒","100","铝塑包装外套复合膜袋","北京福元医药股份有限公司","148.00 ","修改（支付标准）","招采变更",""]
[579,"XC07ABB087A001010183781","1","比索洛尔","口服常释剂型","","209839","富马酸比索洛尔片","无","片剂(薄膜衣片)","5mg","盒","20","药品包装用铝箔和聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片包装","浙江兄弟药业有限公司","11.56 ","启用","招采变更",""]
[580,"XR03ACF104L020010404111","2","福莫特罗","吸入剂","","210450","富马酸福莫特罗吸入溶液","无","吸入制剂","2ml:20μg(按(C₁₉H₂₄N₂O₄)₂•C₄H₄O₄计)","盒","10","本品包装在吸入液体制剂用低密度聚乙烯瓶中,密封于聚酯/铝/聚乙烯药用复合膜袋内","山东京卫制药有限公司","443.10 ","启用","招采变更",""]
[581,"XN05AHK094A010010179578","2","喹硫平","缓释控释剂型","","158212","富马酸喹硫平缓释片","无","缓释片","0.2g","盒","20","PVC＋PCTFE泡罩包装","Luye Pharma Limited","174.93 ","修改（招标信息）","招采变更",""]
[582,"XN05AHK094A010030179578","2","喹硫平","缓释控释剂型","","158207","富马酸喹硫平缓释片","无","缓释片","50mg","盒","20","PVC＋PCTFE泡罩包装","Luye Pharma Limited","60.53 ","修改（招标信息）","招采变更",""]
[583,"XN05AHK094A010010101066","2","喹硫平","缓释控释剂型","","208572","富马酸喹硫平缓释片","无","缓释片","200mg(按C21H25N3O2S计)","盒","30","铝塑泡罩包装","重庆药友制药有限责任公司","66.70 ","启用","招采变更",""]
[584,"XN05AHK094A010010104111","2","喹硫平","缓释控释剂型","","209900","富马酸喹硫平缓释片","无","片剂","200mg(按C₂₁H₂₅N₃O₂S计)","盒","20","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔","山东京卫制药有限公司","39.80 ","启用","招采变更",""]
[585,"XB05DAF612B020020100933","1","腹膜透析液","注射剂","","131787","腹膜透析液(乳酸盐)","无","注射剂","2000ml(2.5%)","袋","1","聚氯乙烯软袋","津药和平(天津)制药有限公司","24.38 ","修改（招标信息）","招采变更",""]
[586,"XV08CAG001B002020100639","2","钆贝葡胺","注射剂","","144350","钆贝葡胺注射液","莫迪司","注射液","15ml:7.935g钆贝葡胺(相当于钆贝酸5.010g、葡甲胺2.925g)","盒","1","中硼硅玻璃模制注射剂瓶,注射用氯化丁基橡胶塞/注射用卤化丁基橡胶塞(氯化)","上海博莱科信谊药业有限责任公司","189.69 ","修改（招标信息）","招采变更",""]
[587,"XV08CAG172B002010101523","2","钆特醇注射液","","","209617","钆特醇注射液","无","注射剂","15ml:4.1895g","盒","1","中硼硅玻璃模制注射剂瓶,注射液用覆聚四氟乙烯六氟丙烯的共聚物膜氯化丁基橡胶塞包装。","正大天晴药业集团股份有限公司","142.00 ","启用","招采变更",""]
[588,"XB05BCG162B002010109910","1","甘油果糖氯化钠","注射剂","","164010","甘油果糖氯化钠注射液","无","注射液","250ml","袋","1","五层共挤输液用袋","华夏生生药业(北京)有限公司","13.92 ","修改（包装材质）","招采变更",""]
[589,"XB05BCG162B002010409910","1","甘油果糖氯化钠","注射剂","","206319","甘油果糖氯化钠注射液","无","注射液","250ml","袋","1","三层共挤输液用袋","华夏生生药业(北京)有限公司","13.92 ","启用","招采变更",""]
[590,"XA10BBG069A001010305530","1","格列美脲","口服常释剂型","","131664","格列美脲片","安多美","片剂","2mg","盒","24","聚氯乙烯固体药用硬片(茶色)及药用铝箔包装","双鹤天安药业(贵州)股份有限公司","16.08","修改（招标信息）","招采变更",""]
[591,"XA10BBG070A010010501450","2","格列齐特","缓释控释剂型","","158048","格列齐特缓释片","无","片剂","30mg","盒","30","铝塑包装","江苏黄河药业股份有限公司","23.05 ","修改（招标信息）","招采变更",""]
[592,"XA03FAM120A001010200253","1","莫沙必利","口服常释剂型","","171060","枸橼酸莫沙必利片","无","片剂","5mg(以C21H25ClFN3O3·C6H8O7计)","盒","20","铝塑包装,外加复合膜袋","福建海西新药创制股份有限公司","14.81 ","修改（招标信息）","招采变更",""]
[593,"XA03FAM120A001010100253","1","莫沙必利","口服常释剂型","","170957","枸橼酸莫沙必利片","无","片剂","5mg(以C21H25ClFN3O3·C6H8O7计)","盒","10","铝塑包装,外加复合膜袋","福建海西新药创制股份有限公司","7.59 ","修改（招标信息）","招采变更",""]
[594,"XA03FAM120A001020200253","1","莫沙必利","口服常释剂型","","211132","枸橼酸莫沙必利片","无","片剂","5mg(以C21H25ClFN3O3·C6H8O7计)","盒","48","铝塑包装,外加复合膜袋","福建海西新药创制股份有限公司","34.42 ","修改（支付标准）","招采变更",""]
[595,"XN05BET010A001020182306","2","坦度螺酮","口服常释剂型","","210967","枸橼酸坦度螺酮片","无","片剂(薄膜衣片)","10mg","盒","21","聚氯乙烯固体药用硬片与药用铝箔包装","成都奥邦药业有限公司","40.00 ","启用","招采变更",""]
[596,"XN05BET010A001010182306","2","坦度螺酮","口服常释剂型","","210966","枸橼酸坦度螺酮片","无","片剂(薄膜衣片)","5mg","盒","21","聚氯乙烯固体药用硬片与药用铝箔包装","成都奥邦药业有限公司","23.53 ","启用","招采变更",""]
[597,"XL04AAT163A001010101594","2","托法替布","口服常释剂型","","171135","枸橼酸托法替布片","无","片剂","5mg(以C16H20N6O计)","瓶","28","口服固体药用高密度聚乙烯瓶包装","先声药业有限公司","44.77 ","修改（招标信息）","招采变更",""]
[598,"XL04AAT163A001010184209","2","托法替布","口服常释剂型","","205965","枸橼酸托法替布片","无","薄膜衣片","5mg(按C₁₆H₂₀N₆O计)","盒","14","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔)","西洲医药科技(浙江)有限公司","97.89 ","启用","招采变更",""]
[599,"XA10ABG159B002010100231","2","谷赖胰岛素","注射剂","","105902","谷赖胰岛素注射液","艾倍得","注射剂","3ml:300U/预填充笔SoloStar","盒","1","3ml溶液装于笔芯(无色玻璃)中,配有弹性橡胶活塞,外有一个带橡胶塞(弹性橡胶)的密封圈(铝制翻边)。该笔芯密封于一次性预填充笔中","Sanofi-Aventis Deutschland GmbH","41.42 ","停用","招采国码变更",""]
[600,"XA10ABG159B002020178820","2","谷赖胰岛素","注射剂","","105902","谷赖胰岛素注射液","艾倍得","注射剂","每毫升注射液含100单位谷赖胰岛素(相当于3.49mg)3ml:300U/预填充笔SoloStar","盒","1","3ml溶液装于笔芯(无色玻璃)中,配有弹性橡胶活塞,外有一个带橡胶塞(弹性橡胶)的密封圈(铝制翻边)。该笔芯密封于一次性预填充笔中。","Sanofi-Aventis Deutschland GmbH","41.42 ","启用","招采国码变更",""]
[601,"ZG03AAG0256010302667","1","骨刺丸(片、胶囊)","","","211418","骨刺丸","无","水蜜丸","每袋装6g(每100丸重5g)","盒","12","复合膜","河北万岁药业有限公司","19.80 ","启用","招采变更",""]
[602,"XA11CCG111B002010184044","2","骨化三醇","注射剂","","210354","骨化三醇注射液","无","注射剂","1ml:1μg","支","1","中硼硅玻璃安瓿(棕色)瓶装","成都国为生物医药有限公司","33.96 ","启用","招采变更",""]
[603,"ZA06EAG0493010404394","2","固本咳喘片(胶囊、颗粒)","","","211387","固本咳喘颗粒","无","颗粒剂","每袋装2g","盒","21","铝塑复合袋","杭州中美华东制药有限公司","57.14 ","启用","招采变更",""]
[604,"ZA12GAG0380010203510","1","冠心苏合丸(胶囊、软胶囊)","","","209098","冠心苏合丸","无","大蜜丸","/","盒","30","药用复合膜包装","辽源誉隆亚东药业有限责任公司","117.00 ","启用","招采变更",""]
[605,"ZA12GAH0121020201833","2","红花注射液","","限二级及以上医疗机构。","132420","红花注射液","无","注射液","20ml","支","1","玻璃安瓿","湖北民康制药有限公司","68.80 ","启用","招采变更",""]
[606,"XC07ABM062A010020209541","2","\"美托洛尔美托洛尔Ⅱ\"","缓释控释剂型","","174360","琥珀酸美托洛尔缓释片","无","片剂","47.5mg","盒","28","铝塑泡罩装置","合肥合源药业有限公司","24.99 ","启用","招采变更",""]
[607,"XJ04ABH107E001010101292","2","环丝氨酸","口服常释剂型","","209719","环丝氨酸胶囊","无","胶囊剂","0.25g","盒","30","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装；外套聚酯/铝/聚乙烯药品包装用复合膜、袋","沈阳红旗制药有限公司","688.80 ","修改（支付标准）","招采变更",""]
[608,"ZA16FAH0460020104670","2","黄莪胶囊","","","211586","黄莪胶囊","无","胶囊剂","每粒装0.4g","盒","24","铝塑板","浙江康恩贝制药股份有限公司","79.84 ","启用","招采变更",""]
[609,"XC04ADJ014B002010484043","2","己酮可可碱","注射剂","","209632","己酮可可碱注射液","无","注射剂","5ml:0.1g","支","1","中硼硅玻璃安瓿装","山东京卫制药有限公司","21.49 ","修改（支付标准）","招采变更",""]
[610,"XC04ADJ014B002010202829","2","己酮可可碱","注射剂","","206332","己酮可可碱注射液","无","注射液","5ml:0.1g","支","1","中硼硅玻璃安瓿包装","广州一品红制药有限公司","44.60 ","修改（企业名称）","招采变更",""]
[611,"ZA13AAJ0058030102123","2","加味逍遥丸(片、胶囊、颗粒)","","","205526","加味逍遥片","无","薄膜衣片","每片重0.31g(相当于饮片2g)","盒","180","药用铝箔/聚氯乙烯固体药用硬片包装","四川宝兴制药有限公司","441.59 ","启用","招采变更",""]
[612,"XL01BAJ025B002030102317","1","甲氨蝶呤","注射剂","","211595","甲氨蝶呤注射液","无","注射剂","10ml:1g","瓶","1","中硼硅玻璃管制注射剂瓶,注射液用覆乙烯四氟乙烯共聚物膜溴化丁基橡胶塞","四川汇宇制药股份有限公司","169.60 ","启用","招采变更",""]
[613,"XN07CAB046A001010102763","1","倍他司汀","口服常释剂型","","210582","甲磺酸倍他司汀片","无","片剂","6mg","盒","100","铝塑包装","石家庄四药有限公司","35.00 ","启用","招采变更",""]
[614,"XC02CAD177A010010403973","2","多沙唑嗪","缓释控释剂型","","211143","甲磺酸多沙唑嗪缓释片","无","缓释片","4mg(以C₂₃H₂₅N₅O₅计)","瓶","30","口服固体药用高密度聚乙烯瓶装(内加干燥剂)","华润双鹤利民药业(济南)有限公司","129.30 ","启用","招采变更",""]
[615,"XA03AXJ096B002010184227","2","间苯三酚","注射剂","","209527","间苯三酚注射液","无","注射剂","4ml:40mg(按C₆H₆O₃·2H₂O计)","支","1","中硼硅玻璃安瓿","浙江恒研医药科技有限公司","22.70 ","启用","招采变更",""]
[616,"XA03AXJ096B002010284272","2","间苯三酚","注射剂","","211478","间苯三酚注射液","无","注射剂","4ml:40mg(按C₆H₆O₃·2H₂O计)","支","1","中硼硅玻璃安瓿(5ml)","绪必迪药业(河北)有限公司","15.18 ","启用","招采变更",""]
[617,"ZA14AAJ0168010101874","2","健胃消食片","","","104747","健胃消食片","无","薄膜衣片","每片重0.8g","盒","32","聚氯乙烯固体药用硬片、药品包装用铝箔包装","湖北午时药业股份有限公司","6.20 ","启用","招采变更",""]
[618,"ZA17AAJ0242030102351","2","绞股蓝总甙片(胶囊)","","","210713","绞股蓝总甙片","无","片剂(胃溶薄膜衣片)","每片含绞股蓝总甙60mg","盒","48","铝塑泡罩","安康正大制药有限公司","67.28 ","启用","招采变更",""]
[619,"ZG01BAJ0524050105555","2","筋骨伤喷雾剂","","","209035","筋骨伤喷雾剂","无","喷雾剂","每1ml相当于饮片0.192g,含薄荷脑20mg(90ml/瓶)","盒","1","塑料瓶装","贵州远程制药有限责任公司","81.00 ","启用","招采变更",""]
[620,"ZA01AAJ0626020100994","2","九味羌活片(口服液)","","","211600","九味羌活口服液","无","合剂","每支装10ml","盒","8","低硼硅玻璃管制口服液体瓶包装","重庆迪康中药制药有限公司","77.33 ","启用","招采变更",""]
[621,"XC07ABM062B002010102000","1","美托洛尔","注射剂","","173515","酒石酸美托洛尔注射液","无","注射剂","5ml:酒石酸美托洛尔5mg与氯化钠45mg","支","1","中硼硅玻璃安瓿","宜昌人福药业有限责任公司","97.80 ","修改（招标信息）","招采变更",""]
[622,"XD05AXK013F001010180651","2","卡泊三醇","软膏剂","","210544","卡泊三醇软膏","无","软膏剂","0.005%(15g:0.75mg)(15g/支)","盒","1","铝质药用软膏管","福元药业有限公司","58.80 ","启用","招采变更",""]
[623,"XA10BKK130A001010104650","2","卡格列净","口服常释剂型","","209555","卡格列净片","无","薄膜衣片","100mg(以卡格列净无水物(C₂₄H₂₅FO₅S)计)","盒","14","铝塑泡罩包装","浙江华义制药有限公司","50.51 ","修改（支付标准）","招采变更",""]
[624,"XG02ADK026B002010202068","2","卡前列素氨丁三醇","注射剂","限生育保险。","207599","卡前列素氨丁三醇注射液","无","注射剂","1ml:250μg(按C₂₁H₃₆O₅计)","支","1","中硼硅玻璃安瓿","北京博恩特药业有限公司","215.00 ","修改（招标信息）","招采变更",""]
[625,"XG02ADK026B002010183450","2","卡前列素氨丁三醇","注射剂","限生育保险。","210046","卡前列素氨丁三醇注射液","无","注射剂","1ml:250μg(按C₂₁H₃₆O₅计)","支","1","中硼硅玻璃安瓿","广州瑞尔医药科技有限公司","212.00 ","修改（招标信息）","招采变更",""]
[626,"XN04BAK135A010010102763","2","卡左双多巴(左旋多巴/卡比多巴)","缓释控释剂型","","210329","卡左双多巴缓释片","无","片剂","每片含卡比多巴50mg和左旋多巴200mg","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","石家庄四药有限公司","49.50 ","启用","招采变更",""]
[627,"XL01EDK116E001020278718","2","克唑替尼胶囊","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌患者或 ROS1阳性的晚期非小细胞肺癌患者。","149302","克唑替尼胶囊","赛可瑞","胶囊剂","0.25g","瓶","60","HDPE瓶装","PFIZER EUROPE MA EEIG","10296.00","修改（医保和招标信息）","招采变更",""]
[628,"XL01EDK116E001010278718","2","克唑替尼胶囊","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌患者或 ROS1阳性的晚期非小细胞肺癌患者。","149301","克唑替尼胶囊","赛可瑞","胶囊剂","0.2g","瓶","60","HDPE瓶装","PFIZER EUROPE MA EEIG","8679.00","修改（医保和招标信息）","招采变更",""]
[629,"XN03AXL371B002010102068","2","拉考沙胺注射液","","","210264","拉考沙胺注射液","无","注射液","20ml:0.2g","盒","1","中硼硅玻璃管制注射剂瓶、注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞","成都通德药业有限公司","196.00 ","修改（医保和招标信息）","医保发〔2024〕33号",""]
[630,"XN03AXL371B002020283337","2","拉考沙胺注射液","","","209894","拉考沙胺注射液","无","注射剂","10ml:0.1g","支","1","中硼硅玻璃安瓿","舒美奇成都生物科技有限公司","115.76 ","启用","招采变更",""]
[631,"XA02BCL033E005010104942","2","兰索拉唑","口服常释剂型","","210854","兰索拉唑肠溶胶囊","无","肠溶胶囊","15mg","盒","14","聚氯乙烯固体药用硬片和药用铝箔包装","湖南九典制药股份有限公司","21.00 ","启用","招采变更",""]
[632,"XA02BCL043A012010402770","2","雷贝拉唑","口服常释剂型","","210862","雷贝拉唑钠肠溶片","无","肠溶片","20mg","盒","10","PVC铝塑＋枕包包装(聚氯乙烯固体药用硬片、药品包装用铝箔、聚酯/铝/聚乙烯药用复合膜),内置干燥剂","石药集团欧意药业有限公司","38.07 ","启用","招采变更",""]
[633,"XB01AFL056A001010178269","2","利伐沙班","口服常释剂型","","127472","利伐沙班片","拜瑞妥","薄膜衣片","10mg","盒","5","铝塑","德国Bayer AG(<拜耳医药保健有限公司>分包装)","96.60","停用","招采国码变更",""]
[634,"XB01AFL056A001020278262","2","利伐沙班","口服常释剂型","","127472","利伐沙班片","拜瑞妥","片剂","10mg","盒","5","铝塑水泡眼包装","Bayer AG","96.60","启用","招采国码变更",""]
[635,"XB01AFL056A001020178269","2","利伐沙班","口服常释剂型","","162313","利伐沙班片","拜瑞妥","薄膜衣片","15mg","盒","7","铝塑","德国Bayer AG","136.00","停用","招采国码变更",""]
[636,"XB01AFL056A001020578269","2","利伐沙班","口服常释剂型","","162313","利伐沙班片","拜瑞妥","片剂(薄膜衣片)","15mg","盒","7","铝塑水泡眼包装","Bayer AG","136.00","启用","招采国码变更",""]
[637,"XB01AFL056A001030100002","2","利伐沙班","口服常释剂型","","162312","利伐沙班片","拜瑞妥","薄膜衣片","20mg","盒","7","铝塑","德国Bayer AG","169.32","停用","招采国码变更",""]
[638,"XB01AFL056A001030578269","2","利伐沙班","口服常释剂型","","162312","利伐沙班片","拜瑞妥","片剂(薄膜衣片)","20mg","盒","7","铝塑水泡眼包装","Bayer AG","169.32","启用","招采国码变更",""]
[639,"XB01AFL056A001010283356","2","利伐沙班","口服常释剂型","","203805","利伐沙班片","无","片剂(薄膜衣片)","10mg(5片×2板/盒)","盒","10","药用铝箔、聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","翎耀生物科技(上海)有限公司","118.00 ","启用","招采变更",""]
[640,"XJ01XXL350B002020109639","2","利奈唑胺葡萄糖","注射剂","","211446","利奈唑胺葡萄糖注射液","无","注射剂","300ml:利奈唑胺0.6g与葡萄糖(按C6H12O6·H2O计)15.0g","盒","1","中硼硅玻璃输液瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞、输液瓶用铝塑组合盖","吉林省博大伟业制药有限公司","164.63 ","启用","招采变更",""]
[641,"XJ05AHA218E001030109920","2","奥司他韦","口服常释剂型","","201368","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C16H28N2O4计)","盒","6","铝塑铝包装(聚氯乙烯固体药用硬片、药用铝箔、聚酰胺/铝冷成型固体药用复合硬片)","中山万汉制药有限公司","19.97 ","修改（支付标准）","招采变更",""]
[642,"XJ05AHA218E001040109920","2","奥司他韦","口服常释剂型","","204877","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C₁₆H₂₈N₂O₄计)","盒","5","铝塑铝包装(聚氯乙烯固体药用硬片、药用铝箔、聚酰胺/铝冷成型固体药用复合硬片)","中山万汉制药有限公司","16.75 ","修改（支付标准）","招采变更",""]
[643,"XJ05AHA218E001010101495","2","奥司他韦","口服常释剂型","","207155","磷酸奥司他韦胶囊","无","胶囊剂","75mg(以C₁₆H₂₈N₂O₄计)","盒","10","铝塑泡罩包装","安徽贝克生物制药有限公司","77.90 ","启用","招采变更",""]
[644,"XJ05AHA218E001010100430","2","奥司他韦","口服常释剂型","","176193","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C16H28N2O4计)","盒","10","药品包装用铝箔和聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片泡罩","中润药业有限公司","127.00","修改（招标信息）","招采变更",""]
[645,"XJ05AHA218E001010200430","2","奥司他韦","口服常释剂型","","176226","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C16H28N2O4计)","盒","6","药品包装用铝箔和聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片泡罩","中润药业有限公司","77.64","修改（招标信息）","招采变更",""]
[646,"XJ05AHA218E001021509920","2","奥司他韦","口服常释剂型","","211451","磷酸奥司他韦胶囊","无","胶囊剂","45mg(按C₁₆H₂₈N₂O₄计)","盒","20","铝塑铝包装(聚氯乙烯固体药用硬片、药用铝箔、聚酰胺/铝冷成型固体药用复合硬片)","中山万汉制药有限公司","43.08 ","启用","招采变更",""]
[647,"XJ05AHA218E001011809920","2","奥司他韦","口服常释剂型","","211449","磷酸奥司他韦胶囊","无","胶囊剂","30mg(按C₁₆H₂₈N₂O₄计)","盒","20","铝塑铝包装(聚氯乙烯固体药用硬片、药用铝箔、聚酰胺/铝冷成型固体药用复合硬片)","中山万汉制药有限公司","31.57 ","启用","招采变更",""]
[648,"XJ05AHA218E001010580081","2","奥司他韦","口服常释剂型","","211319","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C16H28N2O4计)","盒","6","铝塑泡罩包装(药用铝箔与聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片)","博瑞制药(苏州)有限公司","42.18 ","启用","招采变更",""]
[649,"XJ05AHA218E001010201495","2","奥司他韦","口服常释剂型","","211253","磷酸奥司他韦胶囊","无","胶囊剂","75mg(以C₁₆H₂₈N₂O₄计)","盒","6","铝塑泡罩包装","安徽贝克生物制药有限公司","47.62 ","启用","招采变更",""]
[650,"XJ05AHA218E001010401495","2","奥司他韦","口服常释剂型","","211252","磷酸奥司他韦胶囊","无","胶囊剂","75mg(以C₁₆H₂₈N₂O₄计)","盒","12","铝塑泡罩包装","安徽贝克生物制药有限公司","92.86 ","启用","招采变更",""]
[651,"XJ05AHA218E001010104339","2","奥司他韦","口服常释剂型","","211348","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C₁₆H₂₈N₂O₄计)","盒","10","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装","安徽省先锋制药有限公司","78.00 ","启用","招采变更",""]
[652,"XJ05AHA218E001010604339","2","奥司他韦","口服常释剂型","","211346","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C₁₆H₂₈N₂O₄计)","盒","6","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装","安徽省先锋制药有限公司","47.68 ","启用","招采变更",""]
[653,"XJ05AHA218E001020104339","2","奥司他韦","口服常释剂型","","211350","磷酸奥司他韦胶囊","无","胶囊剂","30mg(按C₁₆H₂₈N₂O₄计)","盒","10","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装","安徽省先锋制药有限公司","38.70 ","启用","招采变更",""]
[654,"XJ05AHA218E001020183605","2","奥司他韦","口服常释剂型","","209871","磷酸奥司他韦胶囊","无","胶囊剂","30mg(按C₁₆H₂₈N₂O₄计)","盒","10","铝塑包装(PVC/PE/PVDC复合硬片和纸/聚酯/铝药用覆盖膜)","南京道群医药研发有限公司","48.00 ","启用","招采变更",""]
[655,"XJ05AHA218E001010382922","2","奥司他韦","口服常释剂型","","211173","磷酸奥司他韦胶囊","无","胶囊剂","75mg(按C₁₆H₂₈N₂O₄计)","盒","10","聚氯乙烯固体药用硬片、药用铝箔及药用复合膜包装","浙江普利药业有限公司","68.00 ","启用","招采变更",""]
[656,"XJ05AHA218N001010183585","2","奥司他韦","颗粒剂","","205791","磷酸奥司他韦颗粒","无","颗粒剂","0.9g(按C₁₆H₂₈N₂O₄计)","盒","1","口服固体药用高密度聚乙烯瓶","云南先施药业有限公司","197.20 ","修改（招标信息）","招采变更",""]
[657,"XA10BHX202A001010204647","2","西格列汀","口服常释剂型","","208283","磷酸西格列汀片","无","片剂","100mg(以西格列汀计)","盒","7","双铝包装","浙江华海药业股份有限公司","38.80 ","修改（支付标准）","招采变更",""]
[658,"XA10BHX202A001020203546","2","西格列汀","口服常释剂型","","210319","磷酸西格列汀片","无","片剂(薄膜衣片)","100mg(以西格列汀计)","盒","7","药用铝箔、聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","通化东宝药业股份有限公司","27.80 ","启用","招采变更",""]
[659,"XA10BHX202A001020103546","2","西格列汀","口服常释剂型","","210320","磷酸西格列汀片","无","片剂","100mg(以西格列汀计)","盒","14","药用铝箔、聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","通化东宝药业股份有限公司","54.21 ","启用","招采变更",""]
[660,"XA10BHX202A001010284223","2","西格列汀","口服常释剂型","","210455","磷酸西格列汀片","无","薄膜衣片","100mg(以西格列汀计)","盒","7","双铝包装","宁波美舒医药科技有限公司","38.85 ","启用","招采变更",""]
[661,"XA10BHX202A001010106632","2","西格列汀","口服常释剂型","","208939","磷酸西格列汀片","无","薄膜衣片","100mg(以西格列汀计)","盒","10","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","江苏德源药业股份有限公司","56.10 ","启用","招采变更",""]
[662,"XL04AXL155A001010404608","1","硫唑嘌呤","口服常释剂型","","172822","硫唑嘌呤片","无","片剂","50mg","盒","50","铝塑泡罩","浙江奥托康医药科技有限公司","37.80 ","修改（招标信息）","招采变更",""]
[663,"XM01AXA165E001010701503","2","氨基葡萄糖","口服常释剂型","","211525","硫酸氨基葡萄糖胶囊","无","硬胶囊","0.25克(以硫酸氨基葡萄糖计)或0.314克(以硫酸氨基葡萄糖氯化钠计)","盒","36","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药品包装用铝箔)","江苏万高药业股份有限公司","57.95 ","启用","招采变更",""]
[664,"XM01AXA165E001010801503","2","氨基葡萄糖","口服常释剂型","","211482","硫酸氨基葡萄糖胶囊","无","硬胶囊","0.25克(以硫酸氨基葡萄糖计)或0.314克(以硫酸氨基葡萄糖氯化钠计)","盒","48","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药品包装用铝箔)","江苏万高药业股份有限公司","76.46 ","启用","招采变更",""]
[665,"XM01AXA165E001011301503","2","氨基葡萄糖","口服常释剂型","","211484","硫酸氨基葡萄糖胶囊","无","硬胶囊","0.25克(以硫酸氨基葡萄糖计)或0.314克(以硫酸氨基葡萄糖氯化钠计)","盒","90","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药品包装用铝箔)","江苏万高药业股份有限公司","140.11 ","启用","招采变更",""]
[666,"XM01AXA165E001011901503","2","氨基葡萄糖","口服常释剂型","","211485","硫酸氨基葡萄糖胶囊","无","硬胶囊","0.25克(以硫酸氨基葡萄糖计)或0.314克(以硫酸氨基葡萄糖氯化钠计)","盒","120","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药品包装用铝箔)","江苏万高药业股份有限公司","184.86 ","启用","招采变更",""]
[667,"XM01AXA165E001012101503","2","氨基葡萄糖","口服常释剂型","","211486","硫酸氨基葡萄糖胶囊","无","硬胶囊","0.25克(以硫酸氨基葡萄糖计)或0.314克(以硫酸氨基葡萄糖氯化钠计)","盒","240","铝塑包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药品包装用铝箔)","江苏万高药业股份有限公司","360.48 ","启用","招采变更",""]
[668,"XM01AXA165E001010104565","2","氨基葡萄糖","口服常释剂型","","210448","硫酸氨基葡萄糖胶囊","无","胶囊剂","0.25g(以硫酸氨基葡萄糖计)或0.314g(以硫酸氨基葡萄糖氯化钠计)","盒","60","口服固体药用高密度聚乙烯瓶,瓶内含药用固体纸袋装硅胶干燥剂","宁波美诺华天康药业有限公司","94.80 ","启用","招采变更",""]
[669,"XA06ADL146P001020102670","1","硫酸镁","口服散剂","","168230","硫酸镁","无","散剂","20g","盒","2","聚酯/镀铝聚酯/聚乙烯药用复合膜","河北武罗药业有限公司","46.97 ","修改（招标信息）","招采变更",""]
[670,"XP01BAQ034A001010101645","2","羟氯喹","口服常释剂型","","209507","硫酸羟氯喹片","无","片剂(薄膜衣片)","0.2g","盒","24","药品包装用铝箔及聚氯乙烯固体药用硬片","苏州长征-欣凯制药有限公司","79.92 ","启用","招采变更",""]
[671,"XP01BAQ034A001010283285","2","羟氯喹","口服常释剂型","","211388","硫酸羟氯喹片","无","片剂(薄膜衣片)","0.2g","盒","10","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药品包装用铝箔包装","沈阳欣瑞制药有限公司","32.60 ","启用","招采变更",""]
[672,"XB01ACL190A001010502770","2","氯吡格雷","口服常释剂型","","166059","硫酸氢氯吡格雷片","无","薄膜衣片","75mg(按C16H16CINO2S计)","盒","14","药用铝箔-聚氯乙烯固体药用硬片包装,外套聚酯/铝/聚乙烯药品包装用复合膜,固体药用纸袋装硅胶干燥剂。","石药集团欧意药业有限公司","12.18 ","修改（招标信息）","招采变更",""]
[673,"XB01ACL190A001010402770","2","氯吡格雷","口服常释剂型","","165839","硫酸氢氯吡格雷片","无","薄膜衣片","75mg(按C16H16CINO2S计)","瓶","30","口服固体药用高密度聚乙烯瓶包装","石药集团欧意药业有限公司","25.38 ","修改（招标信息）","招采变更",""]
[674,"XB01ACL190A001080100553","2","氯吡格雷","口服常释剂型","","211590","硫酸氢氯吡格雷片","无","薄膜衣片","75mg(按C16H16ClNO2S计)","盒","35","双铝包装","浙江骏德生物科技有限公司","116.92 ","启用","招采变更",""]
[675,"XR03CCS048A001010201518","1","沙丁胺醇","口服常释剂型","","152793","硫酸沙丁胺醇片","无","片剂","2mg(按C13H21NO3计)","瓶","100","塑料瓶","苏州弘森药业股份有限公司","14.25 ","修改（招标信息）","招采变更",""]
[676,"XR03CCS048B002010101518","2","沙丁胺醇","注射剂","","155138","硫酸沙丁胺醇注射液","无","注射液","2ml:0.4mg(按C13H21NO3计)","瓶","1","玻璃安瓿","苏州弘森药业股份有限公司","23.18 ","修改（招标信息）","招采变更",""]
[677,"XR03ACT022L008010210349","2","特布他林","吸入剂","","176890","硫酸特布他林雾化吸入用溶液","无","吸入溶液剂","2ml:5mg","盒","10","中硼硅玻璃安瓿","河北仁合益康药业有限公司","9.57","修改（招标信息）","招采变更",""]
[678,"XR03ACT022L008010184156","2","特布他林","吸入剂","","207763","硫酸特布他林雾化吸入用溶液","无","吸入制剂","2ml:5mg","盒","24","外阻隔袋聚乙烯安瓿","四川奇裕医药科技有限公司","102.96 ","启用","招采变更",""]
[679,"XR03ACT022L008010283150","2","特布他林","吸入剂","","211182","硫酸特布他林雾化吸入用溶液","无","吸入制剂","1ml:2.5mg","盒","8","低密度聚乙烯瓶,密封于药用复合袋包装内","四川海梦智森生物制药有限公司","20.19 ","启用","招采变更",""]
[680,"XR03ACT022L008010383150","2","特布他林","吸入剂","","211183","硫酸特布他林雾化吸入用溶液","无","吸入制剂","1ml:2.5mg","盒","16","低密度聚乙烯瓶,密封于药用复合袋包装内","四川海梦智森生物制药有限公司","40.38 ","启用","招采变更",""]
[681,"XR03ACT022L008010483150","2","特布他林","吸入剂","","211184","硫酸特布他林雾化吸入用溶液","无","吸入制剂","1ml:2.5mg","盒","24","低密度聚乙烯瓶,密封于药用复合袋包装内","四川海梦智森生物制药有限公司","60.56 ","启用","招采变更",""]
[682,"XR03CCT022B002010100816","2","特布他林","注射剂","","174029","硫酸特布他林注射液","无","注射剂","1ml:0.5mg","支","1","中硼硅玻璃安瓿","上海旭东海普药业有限公司","44.60 ","修改（招标信息）","招采变更",""]
[683,"XA07AAX151A001020102503","2","新霉素","口服常释剂型","","211465","硫酸新霉素片","无","片剂","0.1g(10万单位)","盒","10","铝塑包装","西安利君制药有限责任公司","138.00 ","启用","招采变更",""]
[684,"XA10XXL154B002010302068","2","硫辛酸","注射剂","","211509","硫辛酸注射液","无","注射液","12ml:0.3g","支","1","中硼硅玻璃安瓿(棕色)","成都市海通药业有限公司","22.85 ","启用","招采变更",""]
[685,"XM03ACL264B002010200469","2","罗库溴铵","注射剂","","167788","罗库溴铵注射液","无","注射剂","5ml:50mg","支","1","中硼硅玻璃安瓿","广东嘉博制药有限公司","32.89 ","修改（招标信息）","招采变更",""]
[686,"XA16AXL178A001010102933","2","缓解消化道不适症状的复方OTC制剂","","◇","120113","铝镁颠茄片","无","片剂","复方","盒","48","铝塑泡罩包装","山西省临汾健民制药厂有限公司","43.68","修改（医保和招标信息）","招采变更",""]
[687,"XA16AXL178A001020202933","2","缓解消化道不适症状的复方OTC制剂","","◇","208308","铝镁颠茄片","无","片剂","复方","盒","96","铝塑泡罩包装","山西省临汾健民制药厂有限公司","85.18","修改（企业名称）","招采变更",""]
[688,"XA16AXL178A001020102933","2","缓解消化道不适症状的复方OTC制剂","","◇","211526","铝镁颠茄片","无","片剂","复方","盒","24","铝塑泡罩包装","山西省临汾健民制药厂有限公司","22.40 ","启用","招采变更",""]
[689,"XA02ADL183A005010303006","2","铝碳酸镁","咀嚼片","","205344","铝碳酸镁咀嚼片","无","片剂","0.5g","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔。","吉林天衡药业有限公司","24.92","修改（企业名称）","招采变更",""]
[690,"XA02ADL183A005010103006","2","铝碳酸镁","咀嚼片","","207929","铝碳酸镁咀嚼片","无","片剂","0.5g","盒","20","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔。","吉林天衡药业有限公司","16.61 ","修改（企业名称）","招采变更",""]
[691,"XA02ADL183A005010503006","2","铝碳酸镁","咀嚼片","","208121","铝碳酸镁咀嚼片","无","片剂","0.5g","盒","50","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔。","吉林天衡药业有限公司","41.53 ","修改（企业名称）","招采变更",""]
[692,"XA12BAL208N001010401966","1","氯化钾","颗粒剂","","208832","氯化钾颗粒","无","颗粒剂","每袋含氯化钾1.0g","盒","6","聚酯/铝/聚乙烯药用复合膜","武汉太福制药有限公司","38.58 ","修改（支付标准）","招采变更",""]
[693,"XA12BAL208N001010101966","1","氯化钾","颗粒剂","","209130","氯化钾颗粒","无","颗粒剂","每袋含氯化钾1.0g","盒","10","聚酯/铝/聚乙烯药用复合膜","武汉太福制药有限公司","64.30 ","修改（支付标准）","招采变更",""]
[694,"XA12BAL208N001010300299","1","氯化钾","颗粒剂","","211602","氯化钾颗粒","无","颗粒剂","每袋含氯化钾1.5g","盒","6","聚酯/铝/聚乙烯药用复合膜","广东九明制药有限公司","51.54 ","启用","招采变更",""]
[695,"XA12BAL208N001010800299","1","氯化钾","颗粒剂","","211603","氯化钾颗粒","无","颗粒剂","每袋含氯化钾1.5g","盒","4","聚酯/铝/聚乙烯药用复合膜","广东九明制药有限公司","34.36 ","启用","招采变更",""]
[696,"XA12BAL208N001020504506","1","氯化钾","颗粒剂","","211008","氯化钾颗粒","无","颗粒剂","每袋1.58g：含氯化钾1.5g","盒","12","聚酯/铝/聚乙烯药用复合膜、袋","海南烨徽源医药科技有限公司","104.16 ","启用","招采变更",""]
[697,"XA12BAL208N001020304506","1","氯化钾","颗粒剂","","211007","氯化钾颗粒","无","颗粒剂","每袋1.58g：含氯化钾1.5g","盒","6","聚酯/铝/聚乙烯药用复合膜、袋","海南烨徽源医药科技有限公司","52.08 ","启用","招采变更",""]
[698,"XA12BAL208N001020204506","1","氯化钾","颗粒剂","","211006","氯化钾颗粒","无","颗粒剂","每袋1.58g：含氯化钾1.5g","盒","4","聚酯/铝/聚乙烯药用复合膜、袋","海南烨徽源医药科技有限公司","34.72 ","启用","招采变更",""]
[699,"XA12BAL208N001020104506","1","氯化钾","颗粒剂","","209256","氯化钾颗粒","无","颗粒剂","每袋1.58g：含氯化钾1.5g","盒","2","聚酯/铝/聚乙烯药用复合膜、袋","海南烨徽源医药科技有限公司","17.36 ","启用","招采变更",""]
[700,"XA12BAL208N001021001966","1","氯化钾","颗粒剂","","209148","氯化钾颗粒","无","颗粒剂","每袋含氯化钾1.5g","盒","6","聚酯/铝/聚乙烯药用复合膜、袋","武汉太福制药有限公司","52.62 ","启用","招采变更",""]
[701,"XA12BAL208N001010600299","1","氯化钾","颗粒剂","","211430","氯化钾颗粒","无","颗粒剂","每袋含氯化钾1.5g","盒","8","聚酯/铝/聚乙烯药用复合膜","广东九明制药有限公司","68.72 ","启用","招采变更",""]
[702,"XG01ACL224A008020100085","2","氯喹那多普罗雌烯","阴道片","","176337","氯喹那多－普罗雌烯阴道片","无","阴道片","氯喹那多0.2g,普罗雌烯10mg","盒","3","铝铝泡罩包装","北京金城泰尔制药有限公司","89.25 ","修改（支付标准）","招采变更",""]
[703,"XR06AXL226A001010701510","1","氯雷他定","口服常释剂型","","211276","氯雷他定片","怡邦","片剂","10mg","盒","18","铝塑包装","江苏亚邦爱普森药业有限公司","35.24 ","启用","招采变更",""]
[704,"XR06AXL226K001020183409","2","氯雷他定","口服液体剂","","208504","氯雷他定糖浆","无","糖浆剂","60毫升:60毫克","盒","1","口服液体药用聚酯瓶","河北三禾实创生物科技有限公司","26.85 ","修改（招标信息）","招采变更",""]
[705,"XR06AXL226K001010183409","2","氯雷他定","口服液体剂","","208503","氯雷他定糖浆","无","糖浆剂","100毫升:100毫克","盒","1","口服液体药用聚酯瓶","河北三禾实创生物科技有限公司","43.09 ","修改（招标信息）","招采变更",""]
[706,"XN06ABF071A001010102763","2","氟伏沙明","口服常释剂型","","210797","马来酸氟伏沙明片","无","薄膜衣片","100mg","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","石家庄四药有限公司","104.50 ","启用","招采变更",""]
[707,"XR06ABL189B002010102763","2","氯苯那敏","注射剂","","207568","马来酸氯苯那敏注射液","无","注射液","1ml:10mg","支","1","中硼硅玻璃安瓿","石家庄四药有限公司","19.50 ","修改（支付标准）","招采变更",""]
[708,"XR06ABL189B002010102677","2","氯苯那敏","注射剂","","164332","马来酸氯苯那敏注射液","无","注射液","2ml:20mg","支","1","中硼硅玻璃安瓿","石家庄四药有限公司","33.15 ","修改（支付标准）","招采变更",""]
[709,"XC02KXM170A001010184207","2","马昔腾坦片","","限WHO功能分级Ⅱ级-Ⅲ级的肺动脉高压(WHO第1组)的患者。","206191","马昔腾坦片","无","薄膜衣片","10mg","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","普济生物科技(台州)有限公司","2824.00 ","修改（医保和招标信息）","招采变更",""]
[710,"XL04AAM033A012020285294","2","麦考酚钠","口服常释剂型","限器官移植后的抗排异反应。","211272","麦考酚钠肠溶片","无","片剂","0.18g(按C₁₇H₂₀O₆计)","瓶","50","高密度聚乙烯瓶,带儿童安全盖","Biocon Pharma Limited","325.00 ","启用","招采变更",""]
[711,"XR03DCM082N001010105407","2","孟鲁司特","颗粒剂","","211042","孟鲁司特钠颗粒","无","颗粒剂","4mg(以孟鲁司特计)","盒","10","聚酯/铝/聚乙烯药品包装用复合膜袋","江西仁齐制药有限公司","50.00 ","启用","招采变更",""]
[712,"XR03DCM082N001010202281","2","孟鲁司特","颗粒剂","","209783","孟鲁司特钠颗粒","无","颗粒剂","4mg(以孟鲁司特计)","盒","14","聚酯/铝/聚乙烯药用复合膜","亚宝药业四川制药有限公司","27.30 ","启用","招采变更",""]
[713,"XC08CAN045A001010201541","1","尼群地平","口服常释剂型","","202715","尼群地平片","无","片剂","10mg","盒","21","铝塑泡罩","山西立业制药有限公司","42.00 ","启用","招采变更",""]
[714,"ZA07AAN0128010103879","2","牛黄清心丸","","","172272","牛黄清心丸","无","大蜜丸","每丸重3g(培植牛黄、人工麝香)","盒","1","聚乙烯中药丸球壳","呼伦贝尔松鹿制药有限公司","165.66 ","启用","招采变更",""]
[715,"XN05AXP001A010010183251","2","帕利哌酮","缓释控释剂型","","210287","帕利哌酮缓释片","无","缓释片","3mg","盒","7","铝塑泡罩包装(由聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装)","深圳市泛谷药业股份有限公司","114.10 ","启用","招采变更",""]
[716,"XJ04ACP127E001010404798","2","帕司烟肼(对氨基水杨酸异烟肼)","口服常释剂型","","209606","帕司烟肼胶囊","无","硬胶囊剂","0.1g","盒","60","口服固体药用高密度聚乙烯瓶","轩豪益邦制药有限公司","41.60 ","启用","招采变更",""]
[717,"XA12AAP077B002010107677","1","葡萄糖酸钙","注射剂","","171298","葡萄糖酸钙注射液","无","注射剂","10ml:1g","支","1","低硼硅玻璃安瓿、纸盒","焦作市民康药业有限公司","1.20 ","修改（招标信息）","招采变更",""]
[718,"XB05BBP072B002100104042","1","葡萄糖","注射剂","","105626","葡萄糖注射液","无","注射液","50ml:5.0g(10%)","袋","1","非PVC膜+双管双塞","华仁药业股份有限公司","3.06","停用","招采国码变更",""]
[719,"XB05BBP072B002110204042","1","葡萄糖","注射剂","","105626","葡萄糖注射液","无","注射液","50ml:5.0g(10%)","袋","1","非PVC膜+双管双塞","华仁药业股份有限公司","3.06","启用","招采国码变更",""]
[720,"XS01BCP089G010010101564","2","普拉洛芬","滴眼剂","","203863","普拉洛芬滴眼液","无","眼用制剂","0.1%(5ml:5mg)","盒","1","棕色聚丙烯药用滴眼剂瓶","山东新鲁医药科技有限公司","30.50 ","修改（招标信息）","招采变更",""]
[721,"XS01BCP089G010010100290","2","普拉洛芬","滴眼剂","","210893","普拉洛芬滴眼液","无","眼用制剂","0.1%(5ml∶5mg)","盒","1","聚丙烯药用滴眼剂瓶","广东华南药业集团有限公司","32.20 ","启用","招采变更",""]
[722,"XS01BCP089G010010109920","2","普拉洛芬","滴眼剂","","210461","普拉洛芬滴眼液","无","眼用制剂","0.1%(5ml:5mg)(5ml/瓶)","盒","1","聚丙烯药用滴眼剂瓶","中山万汉制药有限公司","31.00 ","启用","招采变更",""]
[723,"XS01BCP089G010010104494","2","普拉洛芬","滴眼剂","","210516","普拉洛芬滴眼液","无","眼用制剂","0.1%(5ml:5mg)","盒","1","聚丙烯药用滴眼剂瓶","杭州民生药业股份有限公司","30.80 ","启用","招采变更",""]
[724,"XS01XAQ020E001010105530","2","羟苯磺酸","口服常释剂型","","131686","羟苯磺酸钙胶囊","安多明","硬胶囊","0.25g","盒","24","聚氯乙烯固体药用硬片及药用铝箔包装","双鹤天安药业(贵州)股份有限公司","17.17","修改（招标信息）","招采变更",""]
[725,"XS01XAQ020E001010205530","2","羟苯磺酸","口服常释剂型","","131695","羟苯磺酸钙胶囊","安多明","硬胶囊","0.25g","盒","48","聚氯乙烯固体药用硬片及药用铝箔包装","双鹤天安药业(贵州)股份有限公司","34.39","修改（招标信息）","招采变更",""]
[726,"XS01XAQ020E001020105530","2","羟苯磺酸","口服常释剂型","","209685","羟苯磺酸钙胶囊","无","硬胶囊","0.5g","盒","18","聚氯乙烯固体药用硬片及药用铝箔包装","双鹤天安药业(贵州)股份有限公司","24.60 ","修改（招标信息）","招采变更",""]
[727,"XB05AAQ164B002020301207","2","羟乙基淀粉(200/0.5)氯化钠/n羟乙基淀粉(130/0.4)氯化钠","注射剂","","126942","羟乙基淀粉130/0.4氯化钠注射液","无","注射剂","500ml:羟乙基淀粉130/0.430g与氯化钠4.5g","瓶","1","玻璃输液瓶","辽宁海神联盛制药有限公司","25.73 ","修改（招标信息）","招采变更",""]
[728,"XJ05AXD362A001010184134","2","氢溴酸氘瑞米德韦片","","限轻中度新型冠状病毒感染(COVID-19)的成年患者。","300403","氢溴酸氘瑞米德韦片","民得维","片剂","0.1g","盒","20","塑瓶包装:口服固体药用高密度聚乙烯瓶-圆形瓶、口服固体药用聚丙烯瓶盖-儿童安全塑料Argus Loc盖、药用固体纸袋装硅胶干燥剂。","上海旺实生物医药科技有限公司","263.89","修改（企业名称）","招采变更","国谈药品"]
[729,"XJ05AXD362A001010284134","2","氢溴酸氘瑞米德韦片","","限轻中度新型冠状病毒感染(COVID-19)的成年患者。","300404","氢溴酸氘瑞米德韦片","民得维","片剂","0.1g","盒","36","塑瓶包装:口服固体药用高密度聚乙烯瓶-圆形瓶、口服固体药用聚丙烯瓶盖-儿童安全塑料Argus Loc盖、药用固体纸袋装硅胶干燥剂。","上海旺实生物医药科技有限公司","475.00","修改（企业名称）","招采变更","国谈药品"]
[730,"XN06ABX016A001010181924","2","西酞普兰","口服常释剂型","","210855","氢溴酸西酞普兰片","无","薄膜衣片","20mg(按C20H21FN2O计)","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔","四川贝灵合益制药有限公司","32.66 ","启用","招采变更",""]
[731,"XN06ABX016A001010105589","2","西酞普兰","口服常释剂型","","116397","氢溴酸西酞普兰片","无","薄膜衣片","20mg","盒","12","热带铝/PVC/铝箔双铝泡罩包装","昆明积大制药股份有限公司","28.15 ","启用","招采变更",""]
[732,"ZF03AAQ0369010504903","2","清喉咽颗粒","","","211649","清喉咽颗粒","无","颗粒剂","每袋装18g","盒","7","聚酯/铝/聚乙烯药品包装用复合膜、袋","福寿堂制药有限公司","43.58 ","启用","招采变更",""]
[733,"XH01BAQ117B002010200526","1","去氨加压素","注射剂","","140082","去氨加压素注射液","无","注射液","按C₄₆H₆₄N₁₄O₁₂S₂计1ml:13.35μg","支","1","中硼硅玻璃安瓿包装","深圳翰宇药业股份有限公司","41.18 ","修改（支付标准）","招采变更",""]
[734,"XB02BBR019B001010102055","2","人纤维蛋白原","注射剂","","211194","人纤维蛋白原","无","注射剂","0.5g(25ml)/瓶","盒","1","玻璃瓶、丁基胶塞、铝塑盖","成都蓉生药业有限责任公司","880.00 ","启用","招采变更",""]
[735,"XA06ADR050X001010780528","2","乳果糖","口服液体剂","","211258","乳果糖口服溶液","无","口服溶液剂","每毫升含乳果糖667毫克(15毫升:10克)","盒","9","聚酯/铝/聚乙烯药用复合膜","北京麦康药业有限公司","47.85 ","启用","招采变更",""]
[736,"XJ01MAH100B002040101426","2","环丙沙星氯化钠","注射剂","","211151","乳酸环丙沙星氯化钠注射液","无","注射剂","100ml:乳酸环丙沙星(按C₁₇H₁₈FN₃O₃计)0.2g与氯化钠0.9g","袋","1","五层共挤输液用袋","江苏长江药业有限公司","33.00 ","启用","招采变更",""]
[737,"XA02BXR065A001010102013","2","瑞巴派特","口服常释剂型","","210833","瑞巴派特片","无","薄膜衣片","0.1g","盒","21","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","成都倍特药业股份有限公司","23.00 ","启用","招采变更",""]
[738,"XA02BXR065A001010184209","2","瑞巴派特","口服常释剂型","","209283","瑞巴派特片","无","薄膜衣片","0.1g","盒","21","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔包装","西洲医药科技(浙江)有限公司","23.40 ","启用","招采变更",""]
[739,"XA02BXR065A001010384209","2","瑞巴派特","口服常释剂型","","209286","瑞巴派特片","无","薄膜衣片","0.1g","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔包装","西洲医药科技(浙江)有限公司","33.00 ","启用","招采变更",""]
[740,"XL01EXR081A001010104522","2","瑞戈非尼片","","限：1.肝细胞癌二线治疗；2.转移性结直肠癌三线治疗；3.胃肠道间质瘤三线治疗。","210033","瑞戈非尼片","无","片剂(薄膜衣片)","40mg(按C₂₁H₁₅ClF₄N₄O₃计)","盒","28","口服固体药用高密度聚乙烯瓶、口服固体药用高密度聚乙烯干燥剂罐包装","湖南明瑞制药股份有限公司","3358.00 ","启用","招采变更",""]
[741,"XC10AAR069A001010600177","2","瑞舒伐他汀","口服常释剂型","","211665","瑞舒伐他汀钙片","无","片剂","5mg(按C22H28FN3O6S计)","盒","28","铝塑包装外套复合膜袋","北京福元医药股份有限公司","80.95 ","启用","招采变更",""]
[742,"XM01AHS002E001010204833","2","塞来昔布","口服常释剂型","","209363","塞来昔布胶囊","无","硬胶囊","0.2g","盒","18","聚氯乙烯固体药用硬片及药用铝箔包装","福州闽海药业有限公司","46.80 ","启用","招采变更",""]
[743,"XG04CAS235E001010105589","2","赛洛多辛","口服常释剂型","","206805","赛洛多辛胶囊","无","胶囊剂","4mg","盒","28","铝塑泡罩包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片,药用铝箔)。","昆明积大制药股份有限公司","35.28 ","启用","招采变更",""]
[744,"XC09DXS255A001010104606","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF≤40%)成人患者；2.原发性高血压。","210025","沙库巴曲缬沙坦钠片","无","片剂(薄膜衣片)","以沙库巴曲缬沙坦计:200mg(沙库巴曲97mg/缬沙坦103mg)","盒","12","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装,外套铝箔袋","浙江昂利康制药股份有限公司","52.42 ","修改（医保和招标信息）","招采变更",""]
[745,"XC09DXS255A001010204606","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF≤40%)成人患者；2.原发性高血压。","210571","沙库巴曲缬沙坦钠片","无","片剂(薄膜衣片)","以沙库巴曲缬沙坦计:200mg(沙库巴曲97mg/缬沙坦103mg)","盒","7","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装,外套铝箔袋","浙江昂利康制药股份有限公司","30.58 ","修改（医保和招标信息）","招采变更",""]
[746,"XC09DXS255A001010100100","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","162954","沙库巴曲缬沙坦钠片","诺欣妥","片剂","100mg(49mg/51mg)","盒","14","PVC/PVDC包装","Novartis Pharma Stein AG","42.56","停用","招采国码变更","国谈药品"]
[747,"XC09DXS255A001010378679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF≤40%)成人患者；2.原发性高血压。","162954","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计100mg(沙库巴曲49mg/缬沙坦51mg)","盒","14","PVC/PVDC包装","Novartis Pharma Schweiz AG","42.56","启用","招采国码变更",""]
[748,"XC09DXS255A001020100100","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF ≤ 40%)成人患者；2.原发性高血压。","166621","沙库巴曲缬沙坦钠片","诺欣妥","片剂","50mg(24mg/26mg)","盒","28","PVC/PVDC包装","Novartis Singapore Pharmaceutical Manufacturing Private.Ltd.","50.12","停用","招采国码变更","国谈药品"]
[749,"XC09DXS255A001020478679","2","沙库巴曲缬沙坦钠片","","限：1.射血分数降低的慢性心力衰竭(NYHA Ⅱ-Ⅳ级，LVEF≤40%)成人患者；2.原发性高血压。","166621","沙库巴曲缬沙坦钠片","诺欣妥","片剂","以沙库巴曲缬沙坦计50mg(沙库巴曲24mg/缬沙坦26mg)","盒","28","PVC/PVDC包装","Novartis Pharma Schweiz AG","50.12","启用","招采国码变更",""]
[750,"XR03AKS054L031010183037","2","沙美特罗替卡松","吸入剂","","210556","沙美特罗替卡松吸入粉雾剂","无","吸入制剂","每泡含昔萘酸沙美特罗50μg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松250μg,递送剂量为昔萘酸沙美特罗47µg(按C₂₅H₃₇NO₄计)与丙酸氟替卡松231µg","盒","60","条形双铝泡罩包装,外套铝箔袋","健康元药业集团股份有限公司","159.70 ","启用","招采变更",""]
[751,"ZA16CAS0382060105040","2","麝香追风膏","","","211097","麝香追风膏","无","橡胶贴膏","10cm×14cm(人工麝香)","盒","8","复合膜","湖南金寿制药有限公司","48.00 ","启用","招采变更",""]
[752,"XC03BAY169A001010301066","1","吲达帕胺","口服常释剂型","","165873","吲达帕胺片","无","片剂","2.5mg","盒","30","铝塑包装","重庆药友制药有限责任公司","1.59 ","修改（支付标准）","招采变更",""]
[753,"ZA09HAS0497020103422","1","生脉饮、生脉胶囊(颗粒)","","","207553","生脉颗粒","无","颗粒剂","每袋装10g","盒","6","药品包装用复合膜","吉林省辉南三和制药有限公司","118.80 ","启用","招采变更",""]
[754,"ZA09HAS1009010105607","2","生脉饮(人参方)","","","211466","生脉饮(人参方)","无","合剂","10ml","盒","10","玻璃瓶","云南白药集团股份有限公司","46.80 ","启用","招采变更",""]
[755,"ZI01AAS0616020305940","2","十五味龙胆花丸","","","211400","十五味龙胆花丸","无","丸剂","3g/10丸","盒","72","药用聚氯乙烯(PVC)硬片和药用铝箔(PTP)","青海琦鹰汉藏生物制药股份有限公司","44.78 ","启用","招采变更",""]
[756,"XV03ABS250B002010104735","2","舒更葡糖钠注射液","","","176323","舒更葡糖钠注射液","无","注射液","2ml:0.2g(按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算)","盒","1","中硼硅玻璃安瓿","浙江仙琚制药股份有限公司","134.00 ","修改（医保和招标信息）","招采变更",""]
[757,"XV03ABS250B002010204735","2","舒更葡糖钠注射液","","","176429","舒更葡糖钠注射液","无","注射液","5ml:0.5g(按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计算)","支","1","中硼硅玻璃安瓿","浙江仙琚制药股份有限公司","270.24 ","修改（医保和招标信息）","招采变更",""]
[758,"XV03ABS250B002010102000","2","舒更葡糖钠注射液","","","201342","舒更葡糖钠注射液","无","注射剂","按舒更葡糖钠活性实体与单-羟基舒更葡糖钠活性实体的总量计2ml:200mg","支","1","中硼硅玻璃安瓿","宜昌人福药业有限责任公司","120.00 ","修改（医保和招标信息）","招采变更",""]
[759,"XM01ABS120A012010283014","1","双氯芬酸","口服常释剂型","","210985","双氯芬酸钠肠溶片","无","肠溶片","25mg","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","福建海西新药创制股份有限公司","16.78 ","启用","招采变更",""]
[760,"XD11AXT002F001010102195","2","他克莫司","软膏剂","限中重度特应性皮炎患者的二线用药。","148343","他克莫司软膏","无","软膏剂","10g:10mg(0.1%)","盒","1","铝管","四川明欣药业有限责任公司","89.99 ","修改（招标信息）","招采变更",""]
[761,"XV03AET152A005010483033","2","碳酸镧","咀嚼片","","211237","碳酸镧咀嚼片","无","片剂","500mg(以镧计)","瓶","20","口服固体药用高密度聚乙烯瓶包装","仁合益康集团有限公司","54.41 ","启用","招采变更",""]
[762,"XB05XAT018B002020102763","1","碳酸氢钠","注射剂","","209582","碳酸氢钠注射液","无","注射剂","50ml:4.2g","袋","1","外阻隔袋三层共挤输液用袋","石家庄四药有限公司","14.80 ","启用","招采变更",""]
[763,"XL01BCT033E001010401445","2","替吉奥","口服常释剂型","","135617","替吉奥胶囊","无","胶囊剂","替加氟20mg,吉美嘧啶5.8mg,奥替拉西钾19.6mg","盒","42","采用聚氯乙烯固体药用硬片和药用铝箔密封包装,外包铝箔袋。","江苏恒瑞医药股份有限公司","218.96 ","修改（招标信息）","招采变更",""]
[764,"XL01BCT033E001010201445","2","替吉奥","口服常释剂型","","135618","替吉奥胶囊","无","胶囊剂","替加氟20mg,吉美嘧啶5.8mg,奥替拉西钾19.6mg","盒","12","聚氯乙烯固体药用硬片和药用铝箔密封包装,外包铝箔袋","江苏恒瑞医药股份有限公司","65.49 ","修改（招标信息）","招采变更",""]
[765,"XL01BCT033E001020301445","2","替吉奥","口服常释剂型","","135621","替吉奥胶囊","无","胶囊剂","替加氟25mg,吉美嘧啶7.25mg,奥替拉西钾24.5mg","盒","12","聚氯乙烯固体药用硬片和药用铝箔密封包装,外包铝箔袋","江苏恒瑞医药股份有限公司","77.69 ","修改（招标信息）","招采变更",""]
[766,"XL01BCT033E001020401445","2","替吉奥","口服常释剂型","","135622","替吉奥胶囊","无","胶囊剂","替加氟25mg,吉美嘧啶7.25mg,奥替拉西钾24.5mg","盒","28","聚氯乙烯固体药用硬片和药用铝箔密封包装,外包铝箔袋","江苏恒瑞医药股份有限公司","175.75 ","修改（招标信息）","招采变更",""]
[767,"XL01AXT041E001020101500","2","替莫唑胺","口服常释剂型","","101849","替莫唑胺胶囊","蒂清","硬胶囊","50mg","瓶","7","口服固体药用高密度聚乙烯瓶","江苏天士力帝益药业有限公司","369.75 ","修改（招标信息）","招采变更",""]
[768,"XL01AXT041E001010101500","2","替莫唑胺","口服常释剂型","","101856","替莫唑胺胶囊","蒂清","硬胶囊","100mg","瓶","5","口服固体药用高密度聚乙烯瓶","江苏天士力帝益药业有限公司","454.53 ","修改（招标信息）","招采变更",""]
[769,"XL01AXT041E001040201500","2","替莫唑胺","口服常释剂型","","170031","替莫唑胺胶囊","蒂清","胶囊剂","20mg","瓶","5","口服固体药用高密度聚乙烯瓶","江苏天士力帝益药业有限公司","132.58 ","修改（招标信息）","招采变更",""]
[770,"XA02BXT044E001010280406","2","替普瑞酮","口服常释剂型","","210792","替普瑞酮胶囊","无","胶囊剂","50mg","盒","40","聚氯乙烯固体药用硬片及药用铝箔包装","浙江核力欣健药业有限公司","44.98 ","启用","招采变更",""]
[771,"XJ01XDT045A025010100269","1","替硝唑","口服常释剂型","","113947","替硝唑片","无","片剂(薄膜衣)","0.5g","盒","8","铝塑","广东彼迪药业有限公司","5.50","停用","招采国码变更",""]
[772,"XJ01XDT045A017010200269","1","替硝唑","口服常释剂型","","113947","替硝唑片","无","片剂(素片)","0.5g","盒","8","铝塑包装","广东彼迪药业有限公司","5.50","启用","招采国码变更",""]
[773,"XJ01DCT066A006010200727","2","头孢丙烯","口服常释剂型","","135613","头孢丙烯分散片","无","分散片","0.25g","盒","6","铝塑","上海美优制药有限公司","27.25 ","启用","招采变更",""]
[774,"XJ01DCT072A010020104203","2","\"头孢克洛头孢克洛Ⅱ\"","缓释控释剂型","","211534","头孢克洛缓释片","新达罗","缓释片","0.375g(按C15H14ClN3O4S计)","盒","18","铝铝包装(玻璃纸/铝/聚乙烯药用复合膜、袋)","山东淄博新达制药有限公司","61.76 ","启用","招采变更",""]
[775,"XN03AXT110A001020104647","2","托吡酯","口服常释剂型","","172698","托吡酯片","无","片剂","100mg","瓶","60","塑瓶包装","浙江华海药业股份有限公司","214.55 ","修改（招标信息）","招采变更",""]
[776,"XL01XFW004E001010104121","1","维A酸","口服常释剂型","","210050","维A酸胶囊","无","胶囊剂","10mg","盒","10","铝塑铝泡罩包装(聚氯乙烯固体药用硬片和药用铝箔作为直接接触药品的内包装,外压聚酰胺/铝冷成型固体药用复合硬片)","山东良福制药有限公司","890.00 ","启用","招采变更",""]
[777,"XA10BHW104A001010504647","2","维格列汀","口服常释剂型","","210813","维格列汀片","无","片剂","50mg","盒","10","双铝包装","浙江华海药业股份有限公司","29.45 ","启用","招采变更",""]
[778,"XA11HAW041B002010200874","1","维生素B6","注射剂","","147222","维生素B6注射液","无","注射液","1ml:50mg","支","1","安瓿","津药和平(天津)制药有限公司","0.45 ","修改（支付标准）","招采变更",""]
[779,"XG03CAW089A001010104735","2","戊酸雌二醇","口服常释剂型","","210570","戊酸雌二醇片","无","片剂","1mg","盒","21","聚氯乙烯固体药用硬片和药用铝箔","浙江仙琚制药股份有限公司","24.95 ","启用","招采变更",""]
[780,"XR03ACS048L019010184211","1","沙丁胺醇","吸入剂","","210529","吸入用硫酸沙丁胺醇溶液","无","吸入制剂","2.5ml:5mg(按C13H21NO3计)","盒","10","内包装为低密度聚乙烯安瓿,外套聚酯/铝/聚乙烯药用复合袋","浙江百代医药科技有限公司","46.00 ","启用","招采变更",""]
[781,"XR05CBY116L019010201504","2","乙酰半胱氨酸","吸入剂","","201082","吸入用乙酰半胱氨酸溶液","无","吸入用溶液剂","3ml : 0.3g","盒","5","中硼硅玻璃安瓿瓶(棕色)","苏州朗易生物医药研究有限公司","66.30","修改（企业名称）","招采变更",""]
[782,"XR05CBY116L019010184221","2","乙酰半胱氨酸","吸入剂","","210431","吸入用乙酰半胱氨酸溶液","无","吸入制剂","3ml:0.3g","盒","10","中硼硅玻璃安瓿","浙江高跖医药科技股份有限公司","79.80 ","启用","招采变更",""]
[783,"XA10BDX223A001010103546","2","\"西格列汀二甲双胍Ⅰ西格列汀二甲双胍Ⅱ\"","口服常释剂型","","210321","西格列汀二甲双胍片(Ⅱ)","无","片剂","每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍850mg。","盒","28","药用铝箔、聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","通化东宝药业股份有限公司","79.12 ","启用","招采变更",""]
[784,"XA10BDX223A001010104565","2","\"西格列汀二甲双胍Ⅰ西格列汀二甲双胍Ⅱ\"","口服常释剂型","","210439","西格列汀二甲双胍片(Ⅱ)","无","片剂(薄膜衣片)","每片含磷酸西格列汀50mg(以西格列汀计)和盐酸二甲双胍850mg","盒","14","铝塑包装(聚三氟氯乙烯/聚氯乙烯固体药用复合硬片、药用铝箔)","宁波美诺华天康药业有限公司","58.80 ","启用","招采变更",""]
[785,"XA03AXX007X003010104672","2","西甲硅油","口服液体剂","限胃肠镜检查和腹部影像学检查。","210983","西甲硅油乳剂","无","口服乳剂","1ml(25滴)乳剂中含40mg西甲硅油(30ml/瓶)","盒","1","棕色玻璃瓶","浙江康莱特药业有限公司","29.68 ","启用","招采变更",""]
[786,"XB03BAX052E001010283748","1","腺苷钴胺","口服常释剂型","","210799","腺苷钴胺胶囊","无","胶囊剂","0.5mg","盒","6","聚氯乙烯固体药用硬片，药品包装用铝箔","北京远方通达医药技术有限公司","42.50 ","启用","招采变更",""]
[787,"XB03BAX052E001010583014","1","腺苷钴胺","口服常释剂型","","210984","腺苷钴胺胶囊","无","胶囊剂","0.5mg","盒","6","聚氯乙烯固体药用硬片和药用铝箔包装，外加复合膜袋","福建海西新药创制股份有限公司","42.60 ","启用","招采变更",""]
[788,"XB03BAX052E001010283085","1","腺苷钴胺","口服常释剂型","","211089","腺苷钴胺胶囊","无","胶囊剂","0.5mg","盒","6","铝塑泡罩包装，外附铝塑复合膜袋。","济南景笙科技有限公司","43.05 ","启用","招采变更",""]
[789,"ZF03AAX0537010503750","2","小儿咽扁颗粒","","","114622","小儿咽扁颗粒","无","颗粒剂","每袋装4g","盒","12","药品包装用复合膜","黑龙江龙桂制药有限公司","7.34 ","启用","招采变更",""]
[790,"XC09DBX206A001010101445","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","171235","缬沙坦氨氯地平片(I)","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔包装","江苏恒瑞医药股份有限公司","3.87 ","修改（招标信息）","招采变更",""]
[791,"XC09DBX206A001010601445","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","204193","缬沙坦氨氯地平片(I)","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔包装","江苏恒瑞医药股份有限公司","14.72 ","修改（支付标准）","招采变更",""]
[792,"XC09DBX206A001010400006","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","211303","缬沙坦氨氯地平片(I)","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","28","铝塑泡罩","北京百奥药业有限责任公司","126.69 ","启用","招采变更",""]
[793,"XC09DBX206A001010602763","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","205305","缬沙坦氨氯地平片(Ⅰ)","无","薄膜衣片","每片含缬沙坦80mg,氨氯地平5mg","盒","30","铝塑泡罩","石家庄四药有限公司","21.51 ","修改（支付标准）","招采变更",""]
[794,"XC09DBX206A001010402763","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","205289","缬沙坦氨氯地平片(Ⅰ)","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","21","铝塑泡罩","石家庄四药有限公司","15.25 ","修改（支付标准）","招采变更",""]
[795,"XC09DBX206A001010204655","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","209546","缬沙坦氨氯地平片(Ⅰ)","无","薄膜衣片","每片含缬沙坦80mg,氨氯地平5mg","盒","28","铝塑泡罩包装","浙江尖峰药业有限公司","49.72 ","启用","招采变更",""]
[796,"XC09DBX206A001010101012","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","175161","缬沙坦氨氯地平片（I）","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","7","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","广州一品红制药有限公司","2.82 ","修改（招标信息）","招采变更",""]
[797,"XC09DBX206A001010501445","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","202603","缬沙坦氨氯地平片（I）","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片/药用铝箔包装","江苏恒瑞医药股份有限公司","7.55 ","修改（招标信息）","招采变更",""]
[798,"XC09DBX206A001010105849","2","\"缬沙坦氨氯地平Ⅰ缬沙坦氨氯地平Ⅱ\"","口服常释剂型","","201914","缬沙坦氨氯地平片（Ⅰ）","无","片剂","每片含缬沙坦80mg,氨氯地平5mg","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","福建海西新药创制股份有限公司","14.55 ","修改（招标信息）","招采变更",""]
[799,"XC09CAX143E001010404960","1","缬沙坦","口服常释剂型","","160824","缬沙坦胶囊","无","硬胶囊","80mg","盒","28","铝塑","湖南千金湘江药业股份有限公司","6.96 ","修改（招标信息）","招采变更",""]
[800,"ZA06AAX0744010101874","2","杏苏止咳颗粒(糖浆、口服液)","","","104868","杏苏止咳糖浆","无","糖浆剂","每瓶装100毫升","瓶","1","口服液体药用聚酯瓶","湖北午时药业股份有限公司","8.77 ","启用","招采变更",""]
[801,"XV03ABY022L001010102680","1","亚硝酸异戊酯","吸入剂","","208609","亚硝酸异戊酯吸入剂","无","气雾剂","0.2ml","盒","10","棕色玻璃安瓿瓶","乐声药业石家庄有限公司","1760.00 ","启用","招采变更",""]
[802,"XA11HAY031A001010200322","2","烟酰胺","口服常释剂型","","204415","烟酰胺片","无","片剂","50mg","瓶","15","塑料瓶","三才石岐制药股份有限公司","9.16 ","修改（支付标准）","招采变更",""]
[803,"XC07ABA086B002010102763","2","艾司洛尔","注射剂","","209794","盐酸艾司洛尔注射液","无","注射剂","10ml:0.1g","支","1","聚丙烯安瓿","石家庄四药有限公司","29.98 ","启用","招采变更",""]
[804,"XR05CBA198X001010304363","2","氨溴索","口服液体剂","","206833","盐酸氨溴索口服溶液","无","口服溶液剂","10毫升:30毫克","盒","20","聚酯/铝/聚酯/聚乙烯口服液体药用灭菌型复合袋","安徽永生堂药业有限责任公司","60.90 ","修改（支付标准）","招采变更",""]
[805,"XR05CBA198B002010102829","2","氨溴索","注射剂","","172399","盐酸氨溴索注射液","无","注射剂","2ml:15mg","支","1","中硼硅玻璃安瓿(棕色)","广州一品红制药有限公司","0.99 ","修改（招标信息）","招采变更",""]
[806,"XS01GXA210G010010101652","2","奥洛他定","滴眼剂","","209976","盐酸奥洛他定滴眼液","无","眼用制剂","0.1%(5ml:5mg,按C₂₁H₂₃NO₃计)","盒","1","低密度聚乙烯药用滴眼剂瓶","苏州乐珠制药有限公司","36.00 ","启用","招采变更",""]
[807,"XC01CEA290B002010103282","2","盐酸奥普力农注射液","","","176264","盐酸奥普力农注射液","无","注射剂","5ml:5mg","支","1","中硼硅玻璃安瓿装","吉林四长制药有限公司","44.55 ","修改（支付标准）","招采变更",""]
[808,"XN04AAB061A001010105007","1","苯海索","口服常释剂型","","105342","盐酸苯海索片","无","片剂","2mg","瓶","100","口服固体药用高密度聚乙烯瓶","湖南中南制药有限责任公司","23.50 ","修改（招标信息）","招采变更",""]
[809,"XA10BGB091A006010105530","2","吡格列酮","口服常释剂型","","131671","盐酸吡格列酮分散片","无","分散片","30mg","盒","7","聚氯乙烯固体药用硬片(茶色)及药用铝箔包装","双鹤天安药业(贵州)股份有限公司","15.28","修改（招标信息）","招采变更",""]
[810,"XA10BGB091A006010205530","2","吡格列酮","口服常释剂型","","131678","盐酸吡格列酮分散片","无","分散片","30mg","盒","14","聚氯乙烯固体药用硬片(茶色)及药用铝箔包装","双鹤天安药业(贵州)股份有限公司","32.29","修改（招标信息）","招采变更",""]
[811,"XR05CBX169B002010202189","2","溴己新","注射剂","","172103","盐酸溴己新注射液","无","注射剂","2ml:4mg","支","1","中硼硅玻璃安瓿(棕色)","成都欣捷高新技术开发股份有限公司","7.58 ","修改（招标信息）","招采变更",""]
[812,"XC01CAD163B002010109910","1","多巴酚丁胺","注射剂","","210426","盐酸多巴酚丁胺注射液","无","注射剂","5ml∶100mg(按C₁₈H₂₃NO₃计)","支","1","中硼硅玻璃安瓿包装","华夏生生药业(北京)有限公司","32.70 ","启用","招采变更",""]
[813,"XN06DAD171A022010204083","2","多奈哌齐","口腔崩解片","限明确诊断的阿尔茨海默病。","161455","盐酸多奈哌齐口腔崩解片","无","口腔崩解片","5mg","盒","12","铝塑包装","山东方明药业集团股份有限公司","96.82 ","修改（招标信息）","招采变更",""]
[814,"XA10BAE021A012010105530","1","二甲双胍","口服常释剂型","","131632","盐酸二甲双胍肠溶片","无","肠溶片","0.25g","瓶","48","PE塑料瓶装","双鹤天安药业(贵州)股份有限公司","6.31","修改（招标信息）","招采变更",""]
[815,"XA10BAE021A012010205530","1","二甲双胍","口服常释剂型","","131633","盐酸二甲双胍肠溶片","无","肠溶片","0.25g","瓶","60","PE塑料瓶装","双鹤天安药业(贵州)股份有限公司","10.71","修改（招标信息）","招采变更",""]
[816,"XA10BAE021A012010305530","1","二甲双胍","口服常释剂型","","131637","盐酸二甲双胍肠溶片","无","肠溶片","0.25g","瓶","100","PE塑料瓶装","双鹤天安药业(贵州)股份有限公司","12.79","修改（招标信息）","招采变更",""]
[817,"XA10BAE021A012020105530","1","二甲双胍","口服常释剂型","","131641","盐酸二甲双胍肠溶片","无","肠溶片","0.5g","瓶","30","PE塑料瓶装","双鹤天安药业(贵州)股份有限公司","5.97","修改（招标信息）","招采变更",""]
[818,"XA10BAE021A012020205530","1","二甲双胍","口服常释剂型","","131648","盐酸二甲双胍肠溶片","无","肠溶片","0.5g","瓶","60","PE塑料瓶装","双鹤天安药业(贵州)股份有限公司","11.64","修改（招标信息）","招采变更",""]
[819,"XA10BAE021A012030205530","1","二甲双胍","口服常释剂型","","131650","盐酸二甲双胍肠溶片","无","肠溶片","0.85g","瓶","60","PE塑料瓶装","双鹤天安药业(贵州)股份有限公司","29.98","修改（招标信息）","招采变更",""]
[820,"XA04AAG064B002010102210","2","格拉司琼","注射剂","","173854","盐酸格拉司琼注射液","无","注射液","3ml:3mg","支","1","中硼硅玻璃安瓿","成都倍特药业股份有限公司","28.00 ","修改（招标信息）","招采变更",""]
[821,"XN05AXP020A001010200453","2","哌罗匹隆","口服常释剂型","","209934","盐酸哌罗匹隆片","无","片剂(薄膜衣片)","8mg","盒","30","药用铝箔＋聚氯乙烯固体药用硬片","丽珠集团丽珠制药厂","124.61 ","启用","招采变更",""]
[822,"XJ01MAH038A001010100928","1","环丙沙星","口服常释剂型","","100073","盐酸环丙沙星片","无","薄膜衣片","0.25g(按环丙沙星计)","盒","10","铝塑泡罩","天津市中央药业有限公司","7.51 ","启用","招采变更",""]
[823,"XN05AEL375A001010204647","2","盐酸鲁拉西酮片","","","204329","盐酸鲁拉西酮片","无","片剂","40mg(按C28H36N4O2S·HCl计)","盒","14","铝铝包装","浙江华海药业股份有限公司","56.45 ","修改（支付标准）","招采变更",""]
[824,"XN01BBL265B002030200469","2","罗哌卡因","注射剂","","138134","盐酸罗哌卡因注射液","无","注射剂","10ml:75mg","支","1","中硼硅玻璃安瓿装","广东嘉博制药有限公司","6.71 ","修改（招标信息）","招采变更",""]
[825,"XN01BBL265B002010200469","2","罗哌卡因","注射剂","","154153","盐酸罗哌卡因注射液","无","注射剂","10ml:100mg","支","1","中硼硅玻璃安瓿装","广东嘉博制药有限公司","8.36 ","修改（招标信息）","招采变更",""]
[826,"XN01BBL265B002040200469","2","罗哌卡因","注射剂","","168248","盐酸罗哌卡因注射液","无","注射剂","20ml:150mg(按C17H26N2O•HCl计)","支","1","安瓿瓶","广东嘉博制药有限公司","11.40 ","修改（招标信息）","招采变更",""]
[827,"XN01BBL265B002050200469","2","罗哌卡因","注射剂","","168247","盐酸罗哌卡因注射液","无","注射剂","20ml:200mg(按C17H26N2O•HCl计)","支","1","安瓿瓶","广东嘉博制药有限公司","14.21 ","修改（招标信息）","招采变更",""]
[828,"XL01DBM150B002010102087","2","米托蒽醌氯化钠","注射剂","","171897","盐酸米托蒽醌氯化钠注射液","无","注射液","100ml:5mg","瓶","1","玻璃瓶","四川美大康华康药业有限公司","1330.00 ","修改（招标信息）","招采变更",""]
[829,"XS01AEM122G010010102087","2","莫西沙星","滴眼剂","","211091","盐酸莫西沙星滴眼液","无","眼用制剂","0.5%(5ml:25mg,按C21H24FN3O4计)","盒","1","低密度聚乙烯药用滴眼剂瓶","四川美大康华康药业有限公司","25.00 ","启用","招采变更",""]
[830,"XS01AEM122G010010105816","2","莫西沙星","滴眼剂","","211214","盐酸莫西沙星滴眼液","无","眼用制剂","0.5%(0.4ml:2mg,按C₂₁H₂₄FN₃O₄计)","盒","10","聚乙烯安瓿瓶,外套聚酯/聚乙烯/铝/聚乙烯药用复合袋","海南斯达制药有限公司","31.82 ","启用","招采变更",""]
[831,"XS01AEM122G010010183611","2","莫西沙星","滴眼剂","","208682","盐酸莫西沙星滴眼液","无","滴眼液","0.5%(5ml:25mg,按C₂₁H₂₄FN₃O₄计)","盒","1","低密度聚乙烯药用滴眼剂瓶","江苏广承药业有限公司","23.90 ","启用","招采变更",""]
[832,"XJ01MAM134B002010178271","2","莫西沙星氯化钠","注射剂","","206238","盐酸莫西沙星氯化钠注射液","拜复乐","注射剂","250ml:莫西沙星0.4g与氯化钠2.0g","盒","1","无色玻璃瓶包装","Bayer Vital GmbH","190.00 ","修改（招标信息）","招采变更",""]
[833,"XJ01MAM134B002010102492","2","莫西沙星氯化钠","注射剂","","205433","盐酸莫西沙星氯化钠注射液","无","注射剂","250ml:莫西沙星0.4g与氯化钠2.0g","盒","1","直立式聚丙烯输液袋","西安京西双鹤药业有限公司","25.60 ","修改（支付标准）","招采变更",""]
[834,"XV03ABN007B002020100198","1","纳洛酮","注射剂","","210644","盐酸纳洛酮注射液","无","注射剂","2ml:2mg","支","1","中硼硅玻璃安瓿","广东星昊药业有限公司","39.98 ","启用","招采变更",""]
[835,"XN06ABP002A023020304111","2","帕罗西汀","肠溶缓释片","","209899","盐酸帕罗西汀肠溶缓释片","无","片剂(薄膜衣片)","25mg(按C₁₉H₂₀FNO₃计)","盒","30","铝塑泡罩包装","山东京卫制药有限公司","59.60 ","启用","招采变更",""]
[836,"XC07AAP101A001010100886","1","普萘洛尔","口服常释剂型","","164632","盐酸普萘洛尔片","无","片剂","10mg","瓶","100","口服固体药用高密度聚乙烯瓶","天津力生制药股份有限公司","19.80 ","启用","招采变更",""]
[837,"XC01CAS071B002010183383","1","肾上腺素","注射剂","","176564","盐酸肾上腺素注射液","无","注射剂","1ml︰1mg(按C9H13NO3计)","盒","1","预灌封注射器组合件(不带注射针),另配一次性使用无菌注射针。","武汉武药制药有限公司","29.70 ","修改（招标信息）","招采变更",""]
[838,"XC08DAW027B002010284534","1","维拉帕米","注射剂","","210218","盐酸维拉帕米注射液","无","注射剂","2ml:5mg","支","1","中硼硅玻璃安瓿","成都瑞尔医药科技有限公司","86.39 ","启用","招采变更",""]
[839,"XN06AXW067E003010300177","1","文拉法辛","缓释控释剂型","","211608","盐酸文拉法辛缓释胶囊","无","缓释胶囊","75mg","盒","28","铝塑","北京福元医药股份有限公司","69.81 ","启用","招采变更",""]
[840,"XN06AXW067E003020106652","1","文拉法辛","缓释控释剂型","","210578","盐酸文拉法辛缓释胶囊","无","胶囊剂","75mg(按C₁₇H₂₇NO₂计)","盒","14","铝塑包装","湖北多瑞药业有限公司","33.32 ","启用","招采变更",""]
[841,"XN06AXW067E003060183484","1","文拉法辛","缓释控释剂型","","209533","盐酸文拉法辛缓释胶囊","无","胶囊剂","75mg(按C17H27NO2计)2×10粒/板/盒","盒","20","聚氯乙烯固体药用硬片、药用铝箔。","吉林天衡药业有限公司","98.00 ","启用","招采变更",""]
[842,"XV03ABW091B002010200816","2","戊乙奎醚","注射剂","","310153","盐酸戊乙奎醚注射液","无","注射剂","1ml:1mg","支","1","中硼硅玻璃安瓿","上海旭东海普药业有限公司","40.00 ","修改（支付标准）","招采变更",""]
[843,"XV03ABW091B002010202066","2","戊乙奎醚","注射剂","","168677","盐酸戊乙奎醚注射液","无","注射液","1ml:1mg","支","1","中性硼硅玻璃安瓿包装","成都天台山制药股份有限公司","40.00 ","启用","招采变更",""]
[844,"XN05CMY323B002010102013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174040","盐酸右美托咪定氯化钠注射液","无","注射剂","20ml︰盐酸右美托咪定80μg(按C13H16N2计)与氯化钠0.18g","支","1","中硼硅玻璃安瓿","成都倍特药业股份有限公司","27.00 ","修改（支付标准）","招采变更","竞价药品"]
[845,"XN05CMY323B002020102013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174005","盐酸右美托咪定氯化钠注射液","无","注射剂","50ml:盐酸右美托咪定0.2mg(按C13H16N2计)与氯化钠0.45g","盒","1","中硼硅玻璃模制注射剂瓶、注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞、输液瓶用铝塑组合盖","成都倍特药业股份有限公司","54.45 ","修改（支付标准）","招采变更","竞价药品"]
[846,"XN05CMY323B002030102013","2","盐酸右美托咪定氯化钠注射液","","限：1.重症监护患者插管和机械通气时的镇静；2.非插管患者术前和/或术中以及其他程序镇静。","174006","盐酸右美托咪定氯化钠注射液","无","注射剂","100ml︰盐酸右美托咪定0.4mg(按C13H16N2计)与氯化钠0.9g","盒","1","中硼硅玻璃模制注射剂瓶、注射液用局部覆聚四氟乙烯膜氯化丁基橡胶塞、输液瓶用铝塑组合盖。1瓶/盒","成都倍特药业股份有限公司","92.57 ","修改（支付标准）","招采变更","竞价药品"]
[847,"XL02BGY096A001010178720","2","依西美坦","口服常释剂型","","141683","依西美坦片","阿诺新","片剂","25mg","盒","30","铝箔","意大利Pfizer Italia S.r.l.","1067.20 ","停用","招采国码变更",""]
[848,"XL02BGY096A001010378720","2","依西美坦","口服常释剂型","","141683","依西美坦片","阿诺新","片剂","25mg","盒","30","水泡眼包装(PVC/铝箔)","Pfizer Italia s.r.l.","1067.20 ","启用","招采国码变更",""]
[849,"XJ04AMY104A001010104681","2","\"乙胺吡嗪利福异烟乙胺吡嗪利福异烟Ⅱ\"","口服常释剂型","","155089","乙胺吡嗪利福异烟片(Ⅱ)","无","片剂","0.45g(每片含利福平75mg、异烟肼37.5mg、吡嗪酰胺200mg、盐酸乙胺丁醇137.5mg)","盒","60","铝塑包装","浙江苏可安药业有限公司","61.20 ","启用","招采变更",""]
[850,"XJ04AMY143E001010104681","2","异福酰胺","口服常释剂型","","155110","异福酰胺胶囊","无","硬胶囊","利福平0.12g,异烟肼80mg,吡嗪酰胺0.25g","盒","30","铝塑包装","浙江苏可安药业有限公司","73.50 ","启用","招采变更",""]
[851,"ZA16HAY0380020300371","2","益肾蠲痹丸","","","211653","益肾蠲痹丸","无","浓缩丸","每袋装8g","盒","3","镀铝复合膜包装","广东健泉大健康产业开发股份有限公司","94.00 ","启用","招采变更",""]
[852,"ZA04BAY0515010105172","2","银蒲解毒片","","","107288","银蒲解毒片","无","薄膜衣片","每片重0.36g","盒","24","PVC铝箔泡罩","广西玉林制药集团有限责任公司","28.86 ","启用","招采变更",""]
[853,"ZA12HAY0555030201123","2","银杏叶丸(片、颗粒、胶囊、软胶囊、滴丸、口服液、酊)","","","211553","银杏叶片","无","片剂","每片重0.5g(含总黄酮醇苷19.2mg、萜类内酯4.8mg)","盒","96","铝塑包装","大连美罗中药厂有限公司","131.45 ","启用","招采变更",""]
[854,"ZA12HAY0555010401123","2","银杏叶丸(片、颗粒、胶囊、软胶囊、滴丸、口服液、酊)","","","211552","银杏叶片","无","薄膜衣片","每片重0.5g(含总黄酮醇苷19.2mg、萜类内酯4.8mg)","盒","30","铝塑包装","大连美罗中药厂有限公司","42.86 ","启用","招采变更",""]
[855,"ZA12HAY0555010301123","2","银杏叶丸(片、颗粒、胶囊、软胶囊、滴丸、口服液、酊)","","","211150","银杏叶片","无","薄膜衣片","每片重0.5g(含总黄酮醇苷19.2mg、萜类内酯4.8mg)","盒","90","铝塑包装","大连美罗中药厂有限公司","123.52 ","启用","招采变更",""]
[856,"ZA09CAZ0150020203421","2","知柏地黄片(胶囊、颗粒)","","","211206","知柏地黄片","无","片剂(糖衣)","无","盒","24","铝塑包装","吉林省辉南长龙生化药业股份有限公司","44.44 ","启用","招采变更",""]
[857,"XB05BAZ033B002010103745","2","\"中/长链脂肪乳(C8-24)中/长链脂肪乳(C8-24Ve)\"","注射剂","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","173347","中/长链脂肪乳注射液(C8-24Ve)","无","注射剂","250ml:大豆油25g与中链甘油三酸酯25g","瓶","1","玻璃输液瓶装","石家庄四药有限公司","54.55 ","修改（招标信息）","招采变更",""]
[858,"XC01CAJ097B002010183116","1","间羟胺","注射剂","","210590","重酒石酸间羟胺注射液","无","注射剂","1ml:10mg(按C₉H₁₃NO₂计)","支","1","中硼硅玻璃安瓿","海南天盛保和生物科技有限公司","39.80 ","启用","招采变更",""]
[859,"XA02BCA081B001010102632","2","埃索美拉唑(艾司奥美拉唑)","注射剂","","211561","注射用艾司奥美拉唑钠","无","注射剂","40mg(按C17H19N3O3S计)","盒","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用卤化丁基橡胶塞(溴化)","河北一品制药股份有限公司","53.49 ","启用","招采变更",""]
[860,"XR03DXA305B001010183422","2","注射用奥马珠单抗","","限：1.经吸入型糖皮质激素和长效吸入型β2-肾上腺素受体激动剂治疗后，仍不能有效控制症状的中至重度持续性过敏性哮喘的6岁及以上患者，并需IgE(免疫球蛋白E)介导确诊证据；2.H1抗组胺药治疗后仍有症状的成人和青少年(12岁及以上)慢性自发性荨麻疹患者。","211555","注射用奥马珠单抗","恩益坦","注射剂","150mg/瓶","盒","1","瓶装冻干粉:澄清、无色I类玻璃瓶,带有丁基橡胶塞和蓝色易拉密封盖。","石药集团巨石生物制药有限公司","1168.00 ","启用","招采变更","国谈药品"]
[861,"XL01XAA215B001010180426","2","奥沙利铂","注射剂","","147103","注射用奥沙利铂","乐沙定","冻干粉针剂","50mg","瓶","1","玻璃瓶","比利时Laboratoires Thissen","1760.00","停用","招采国码变更",""]
[862,"XL01XAA215B001010278821","2","奥沙利铂","注射剂","","147103","注射用奥沙利铂","乐沙定","注射剂","50mg","盒","1","玻璃瓶,氯丁基橡胶盖","Sanofi-Aventis France","1760.00 ","启用","招采国码变更",""]
[863,"XA05BAC059B014010400356","2","促肝细胞生长素","注射剂","限AST或ALT大于120U/L的患者。","204326","注射用促肝细胞生长素","无","冻干粉针","20mg","瓶","1","管制抗生素玻璃瓶","一品红生物医药有限公司","44.00 ","修改（支付标准）","招采变更",""]
[864,"XA05BAC059B001010102557","2","促肝细胞生长素","注射剂","限AST或ALT大于120U/L的患者。","209538","注射用促肝细胞生长素","无","注射剂","20mg","支","1","低硼硅玻璃管制注射剂瓶,注射用冷冻干燥无菌粉末用卤化丁基橡胶塞","河北智同生物制药股份有限公司","44.50 ","修改（支付标准）","招采变更",""]
[865,"XJ01DDL014B001010184135","2","拉氧头孢","注射剂","限有明确药敏试验证据或重症感染的患者。","209361","注射用拉氧头孢钠","无","注射剂","1.0g(按C₂₀H₂₀N₆O₉S计)","瓶","1","中硼硅玻璃管制注射剂瓶和注射用冷冻干燥无菌粉末用氯化丁基橡胶塞包装","杭州沐源生物医药科技有限公司","76.15 ","启用","招采变更",""]
[866,"XN02BAL023B001040103356","2","赖氨匹林","注射剂","","208515","注射用赖氨匹林","无","注射剂","按赖氨匹林(C15H22N2O6)计0.9g","瓶","1","中硼硅玻璃管制注射剂瓶,注射用无菌粉末用卤化丁基橡胶塞(溴化)和抗生素瓶用铝塑组合盖。","吉林敖东洮南药业股份有限公司","98.00 ","启用","招采变更",""]
[867,"XM01ACL238B001010184617","2","氯诺昔康","注射剂","","209932","注射用氯诺昔康","无","注射剂","8mg","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用卤化丁基橡胶塞(溴化)、抗生素瓶用铝塑组合盖","山东如至生物医药科技有限公司","117.50 ","启用","招采变更",""]
[868,"XA02BCP025B001010101012","2","泮托拉唑","注射剂","","174018","注射用泮托拉唑钠","无","冻干粉针","40mg(按C16H15F2N3O4S计)","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞","广州一品红制药有限公司","3.50 ","修改（招标信息）","招采变更",""]
[869,"XL01XGP043B001010101523","2","硼替佐米","注射剂","","163501","注射用硼替佐米","无","注射剂","1.0mg","盒","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用溴化丁基橡胶塞","正大天晴药业集团股份有限公司","229.38 ","修改（支付标准）","招采变更",""]
[870,"XL01XGP043B001030101523","2","硼替佐米","注射剂","","163502","注射用硼替佐米","无","注射剂","3.5mg","盒","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用溴化丁基橡胶塞","正大天晴药业集团股份有限公司","598.49 ","修改（支付标准）","招采变更",""]
[871,"XJ01CEQ054B001030205280","1","青霉素","注射剂","","145920","注射用青霉素钠","无","注射剂","0.96g(160万单位)(按C₁₆H₁₇N₂NaO₄S计)","瓶","1","中硼硅玻璃模制注射剂瓶和注射用无苗粉未用卤化丁基橡胶塞","江西东风药业股份有限公司","6.41 ","启用","招采变更",""]
[872,"XJ01CEQ054B001020205280","1","青霉素","注射剂","","145919","注射用青霉素钠","无","注射剂","0.48g(80万单位)(按C₁₆H₁₇N₂NaO₄S计)","瓶","1","中硼硅玻璃模制注射剂瓶和注射用无菌粉末用卤化丁基橡胶塞","江西东风药业股份有限公司","3.77 ","启用","招采变更",""]
[873,"XH01CBS078B001010309592","2","生长抑素","注射剂","","210024","注射用生长抑素","无","注射剂","3mg","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用聚对二甲苯镀膜溴化丁基橡胶塞和抗生素瓶用铝塑组合盖包装","朗天药业(湖北)有限公司","28.80 ","启用","招采变更",""]
[874,"XM05BAZ079B004010101425","2","唑来膦酸","注射剂","","203193","注射用唑来膦酸浓溶液","无","注射剂","5ml:4mg(按C₅H₁₀N₂O₇P₂计)","盒","1","中硼硅玻璃安瓿","江苏奥赛康药业有限公司","450.00 ","修改（支付标准）","招采变更",""]
[875,"XJ01XAT037B001010102697","2","替考拉宁","注射剂","限甲氧西林耐药阳性球菌感染的二线治疗。","155485","注射用替考拉宁","无","注射剂","0.2g(20万单位)","盒","1","西林瓶","华北制药股份有限公司","148.00 ","启用","招采变更",""]
[876,"XL01AXT041B001010102317","2","注射用替莫唑胺","","","176637","注射用替莫唑胺","无","注射剂","0.1g","盒","1","中硼硅玻璃模制注射剂瓶、注射制剂用溴化丁基橡胶塞、铝塑组合盖","上海汇伦江苏药业有限公司","149.00","修改（招标信息）","招采变更",""]
[877,"XJ01DCT070B001040104339","1","头孢呋辛","注射剂","","148497","注射用头孢呋辛钠","无","注射剂","1.5g(按C₁₆H₁₆N₄O₈S计)","盒","1","采用中硼硅玻璃模制注射剂瓶和注射用无菌粉末用覆聚乙烯-四氟乙烯膜溴化丁基橡胶塞包装","安徽省先锋制药有限公司","16.83 ","启用","招采变更",""]
[878,"XJ01DCT070B001070104339","1","头孢呋辛","注射剂","","211353","注射用头孢呋辛钠","无","注射剂","0.25g(按C₁₆H₁₆N₄O₈S计)","盒","1","采用中硼硅玻璃模制注射剂瓶和注射用无菌粉末用覆聚乙烯-四氟乙烯膜溴化丁基橡胶塞包装。","安徽省先锋制药有限公司","4.27 ","启用","招采变更",""]
[879,"XJ01DCT070B001010105758","1","头孢呋辛","注射剂","","111578","注射用头孢呋辛钠","无","注射剂","0.75g(按C16H16N4O8S计)","盒","1","中硼硅玻璃模制注射剂瓶,注射用无菌粉末用覆乙烯四氟乙烯共聚物膜溴化丁基橡胶塞和抗生素用铝塑组合盖","海口市制药厂有限公司","7.40 ","启用","招采变更",""]
[880,"XJ01DCT076B001010104791","2","头孢美唑","注射剂","","135414","注射用头孢美唑钠","美之全","注射剂","0.5g(按C15H17N7O5S3计)","盒","1","中性硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜溴化丁基橡胶塞(BF1),抗生素瓶用铝塑组合盖","福建省福抗药业股份有限公司","11.46 ","修改（招标信息）","招采变更",""]
[881,"XJ01DCT076B001020104791","2","头孢美唑","注射剂","","135415","注射用头孢美唑钠","美之全","注射剂","1.0g(按C15H17N7O5S3计)","盒","1","中性硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜溴化丁基橡胶塞(BF1),抗生素瓶用铝塑组合盖","福建省福抗药业股份有限公司","19.48 ","修改（招标信息）","招采变更",""]
[882,"XJ01DCT076B001030104791","2","头孢美唑","注射剂","","135416","注射用头孢美唑钠","美之全","注射剂","2.0g(按C15H17N7O5S3计)","盒","1","中性硼硅玻璃管制注射剂瓶、注射用无菌粉末用覆乙烯四氟乙烯共聚物膜溴化丁基橡胶塞(BF1),抗生素瓶用铝塑组合盖。","福建省福抗药业股份有限公司","33.12 ","修改（招标信息）","招采变更",""]
[883,"XJ01DCT078B001010204651","2","头孢米诺","注射剂","","200683","注射用头孢米诺钠","无","注射剂","按C16H21N7O7S3计0.5g","瓶","1","中硼硅玻璃管制注射剂瓶和注射用无菌粉末用覆聚酯膜溴化丁基橡胶塞包装","浙江惠迪森药业有限公司","5.40 ","修改（支付标准）","招采变更",""]
[884,"XJ01DCT078B001020204651","2","头孢米诺","注射剂","","200688","注射用头孢米诺钠","无","注射剂","按C16H21N7O7S3计1.0g","瓶","1","中硼硅玻璃管制注射剂瓶和注射用无菌粉末用覆聚酯膜溴化丁基橡胶塞包装","浙江惠迪森药业有限公司","9.18 ","修改（支付标准）","招采变更",""]
[885,"XJ01DDT104B001030200978","2","头孢唑肟","注射剂","","125728","注射用头孢唑肟钠","益保世灵","注射剂","按C13H13N5O5S2计1.0g","瓶","1","低硼硅玻璃管制注射瓶装","西南药业股份有限公司","49.91 ","启用","招采变更",""]
[886,"XJ01DDT104B001010200978","2","头孢唑肟","注射剂","","125724","注射用头孢唑肟钠","益保世灵","注射剂","按C13H13N5O5S2计0.5g","盒","1","低硼硅玻璃管制注射瓶装","西南药业股份有限公司","29.36 ","启用","招采变更",""]
[887,"XJ01DDT104B001010284135","2","头孢唑肟","注射剂","","211069","注射用头孢唑肟钠","无","注射剂","0.5g(按C₁₃H₁₃N₅O₅S₂计)","瓶","1","中硼硅玻璃管制注射剂瓶，注射用无菌粉末用局部覆聚四氟乙烯膜氯化丁基橡胶塞","杭州沐源生物医药科技有限公司","17.61 ","启用","招采变更",""]
[888,"XJ01DDT104B001030105793","2","头孢唑肟","注射剂","","117747","注射用头孢唑肟钠","无","溶媒结晶","按C13H13N5O5S2计1.0g","瓶","1","玻璃管制注射剂瓶","海南灵康制药有限公司","24.65 ","启用","招采变更",""]
[889,"XJ01DDT094B001010104651","2","头孢他啶","注射剂","","205787","注射用头孢他啶","无","注射剂","1.0g","瓶","1","中硼硅玻璃管制注射剂瓶和注射用无菌粉末用覆聚酯膜卤化丁基橡胶塞","浙江惠迪森药业有限公司","9.99 ","修改（支付标准）","招采变更",""]
[890,"XM03ACW026B003010102066","1","维库溴铵","注射剂","","126716","注射用维库溴铵","无","注射用无菌粉末","4mg","瓶","1","管制抗生素玻璃瓶","成都天台山制药股份有限公司","7.49 ","启用","招采变更",""]
[891,"XL01DBB116B001010104641","2","表柔比星","注射剂","","144125","注射用盐酸表柔比星","艾达生","注射剂","10mg","盒","1","中硼硅玻璃管制注射剂瓶","瀚晖制药有限公司","78.68 ","修改（招标信息）","招采变更",""]
[892,"XL01DBB116B001010204641","2","表柔比星","注射剂","","165581","注射用盐酸表柔比星","无","注射剂","10mg","盒","1","中硼硅玻璃管制注射剂瓶,纸盒","浙江海正药业股份有限公司","78.80 ","启用","招采变更",""]
[893,"XR05CBX169B001010402557","2","溴己新","注射剂","","211520","注射用盐酸溴己新","无","注射剂","4mg","瓶","1","低硼硅玻璃管制注射剂瓶,注射用冷冻干燥无菌粉末用卤化丁基橡胶塞","河北智同生物制药股份有限公司","5.99 ","启用","招采变更",""]
[894,"XR05CBX169B001010300356","2","溴己新","注射剂","","156935","注射用盐酸溴己新","无","注射剂","4mg","瓶","1","管制抗生素玻璃瓶","一品红生物医药有限公司","5.98 ","启用","招采变更",""]
[895,"XJ01AAD193B001010105755","2","多西环素","注射剂","限无法使用多西环素口服制剂的患者。","127248","注射用盐酸多西环素","无","注射剂","0.1g","瓶","1","管制抗生素瓶装","海口奇力制药股份有限公司","39.40 ","修改（招标信息）","招采变更",""]
[896,"XL01DBM109B001010101561","2","米托蒽醌","注射剂","","202886","注射用盐酸米托蒽醌","无","注射剂","5mg(以C22H28N4O6计)","瓶","1","中硼硅玻璃管制注射剂瓶包装","海南先声再明医药股份有限公司","1350.00 ","修改（招标信息）","招采变更",""]
[897,"XG04BXZ059B002020101815","2","左卡尼汀","注射剂","","210751","左卡尼汀注射液","无","注射剂","5ml:1g","支","1","中硼硅玻璃安瓿(棕色)","华中药业股份有限公司","7.28 ","启用","招采变更",""]
[898,"XC01CXZ065B002010102877","2","左西孟旦","注射剂","限规范治疗效果不佳的急性失代偿性心力衰竭短期治疗。","210754","左西孟旦注射液","无","注射剂","5ml:12.5mg","盒","1","中硼硅玻璃模制注射剂瓶，注射液用覆聚乙烯-四氟乙烯膜氯化丁基橡胶塞，抗生素瓶用铝塑组合盖","山西德元堂药业有限公司","1248.00 ","启用","招采变更",""]
[899,"XS01AEZ074G010010102680","1","左氧氟沙星","滴眼剂","","122323","左氧氟沙星滴眼液","无","滴眼液","5ml:24.4mg","盒","1","塑料瓶包装","河北创健药业有限公司","19.00","修改（招标信息）","招采变更",""]
[900,"XS01AEZ074G010070102680","1","左氧氟沙星","滴眼剂","","155224","左氧氟沙星滴眼液","无","滴眼液","6ml:29.28mg","盒","1","塑料瓶包装","河北创健药业有限公司","17.75","修改（招标信息）","招采变更",""]
[901,"XS01AEZ074G010050102680","1","左氧氟沙星","滴眼剂","","155225","左氧氟沙星滴眼液","无","滴眼液","15ml:73.2mg","盒","1","塑料瓶包装","河北创健药业有限公司","41.47","修改（招标信息）","招采变更",""]
[902,"XS01AEZ074G010040102680","1","左氧氟沙星","滴眼剂","","155226","左氧氟沙星滴眼液","无","滴眼剂","12ml:58.56mg","盒","1","塑料瓶包装","河北创健药业有限公司","41.96","修改（招标信息）","招采变更",""]
[903,"XS01AEZ074G010040209920","1","左氧氟沙星","滴眼剂","","209541","左氧氟沙星滴眼液","无","眼用制剂","0.488%(0.4ml:1.952mg)(按C18H20FN3O4计)","盒","10","低密度聚乙烯药用滴眼剂瓶,外套铝箔袋","中山万汉制药有限公司","24.90 ","启用","招采变更",""]
[904,"XS01AEZ074G010040109920","1","左氧氟沙星","滴眼剂","","209257","左氧氟沙星滴眼液","无","眼用制剂","0.488%(0.4ml:1.952mg)(按C18H20FN3O4计)","盒","15","低密度聚乙烯药用滴眼剂瓶,外套铝箔袋","中山万汉制药有限公司","37.35 ","启用","招采变更",""]
[905,"XS01AEZ074G010010104303","1","左氧氟沙星","滴眼剂","","211300","左氧氟沙星滴眼液","无","眼用制剂","0.488%(5ml:24.4mg)(按C18H20FN3O4计)","盒","1","低密度聚乙烯药用滴眼剂瓶","安徽环球药业股份有限公司","6.95 ","启用","招采变更",""]
[906,"XJ01MAZ083B002010100475","2","左氧氟沙星氯化钠","注射剂","","176924","左氧氟沙星氯化钠注射液","无","注射剂","100ml∶左氧氟沙星(按C18H20FN3O4计)0.5g与氯化钠0.9g","袋","1","五层共挤输液用膜(I)制袋","广州绿十字制药股份有限公司","17.50 ","修改（招标信息）","招采变更",""]
[907,"XJ01MAZ074A001020183370","1","左氧氟沙星","口服常释剂型","","205900","左氧氟沙星片","无","薄膜衣片","0.5g(按C₁₈H₂₀FN₃O₄计)","盒","4","铝塑泡罩包装(聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔)","珠海市汇通达医药有限公司","26.00 ","启用","招采变更",""]
[908,"XN03AXZ075A010010104647","2","左乙拉西坦","缓释控释剂型","","170322","左乙拉西坦缓释片","无","片剂","0.5g","盒","20","铝塑包装","浙江华海药业股份有限公司","128.08 ","修改（招标信息）","招采变更",""]
[909,"XN03AXZ075B004010103398","2","左乙拉西坦","注射剂","","174398","左乙拉西坦注射用浓溶液","无","注射液","5ml:500mg","支","1","中硼硅玻璃安瓿","吉林省博大制药股份有限公司","24.60 ","修改（招标信息）","招采变更",""]
[910,"ZA12HAX0868010405603","2","血塞通片（颗粒、胶囊、软胶囊、滴丸、分散片）","","","107177","血塞通软胶囊","无","胶囊剂","每粒装0.33g(含三七总皂苷60mg)","盒","24","药用铝塑包装","昆明华润圣火药业有限公司","24.18 ","修改（招标信息）","招采变更",""]
[911,"ZA12HAX0868010705603","2","血塞通片（颗粒、胶囊、软胶囊、滴丸、分散片）","","","173835","血塞通软胶囊","无","胶囊剂","每粒装0.33g(含三七总皂苷60mg)","盒","60","口服固体药用高密度聚乙烯瓶","昆明华润圣火药业有限公司","58.46 ","修改（招标信息）","招采变更",""]
[912,"XA11CCA017E002010304036","2","阿法骨化醇","口服常释剂型","","123273","阿法骨化醇软胶囊","盖诺真","软胶囊剂","0.25μg","盒","40","铝塑包装(药用铝箔＋聚氯乙烯固体药用硬片)，外套聚酯/铝/聚乙烯药用复合膜袋","青岛国信制药有限公司","36.69 ","启用","招采变更",""]
[913,"XV08ABD113B002010100621","2","碘克沙醇","注射剂","","171477","碘克沙醇注射液","无","注射剂","100ml:32g(I)","盒","1","玻璃瓶装,瓶塞为卤化丁基胶塞(氯化)","上海司太立制药有限公司","138.33 ","修改（招标信息）","招采变更",""]
[914,"XL01BCJ011B001010205847","2","吉西他滨","注射剂","","113098","注射用盐酸吉西他滨","无","注射剂","0.2g(按吉西他滨计)","支","1","中性硼硅玻璃管制注射剂瓶","齐鲁制药(海南)有限公司","12.00 ","修改（招标信息）","招采变更",""]
[915,"XL01BCJ011B001020305847","2","吉西他滨","注射剂","","113104","注射用盐酸吉西他滨","无","注射剂","1.0g(以吉西他滨计)","支","1","中性硼硅玻璃管制注射剂瓶","齐鲁制药(海南)有限公司","41.14 ","修改（招标信息）","招采变更",""]
[916,"XL01CDD194B002030101749","2","多西他赛","注射剂","","211491","多西他赛注射液","无","注射剂","1.0ml:20mg","盒","1","玻璃瓶","扬子江药业集团有限公司","30.00 ","启用","招采变更",""]
[917,"XA02BCA211E005010205776","1","奥美拉唑","口服常释剂型","","115900","奥美拉唑肠溶胶囊","无","胶囊剂(肠溶)","20mg","瓶","14","口服固体药用高密度聚乙烯瓶装(带干燥剂)","海南海灵化学制药有限公司","2.07 ","修改（招标信息）","招采变更",""]
[918,"XN03AXZ075B004020101453","2","左乙拉西坦","注射剂","","168657","左乙拉西坦注射用浓溶液","无","注射剂","5ml∶500mg","支","1","中硼硅玻璃安瓿","济川药业集团有限公司","24.60 ","修改（招标信息）","招采变更",""]
[919,"XN05AHL195A001010101436","1","氯氮平","口服常释剂型","","102491","氯氮平片","无","片剂","25mg","瓶","100","口服固体药用高密度聚乙烯瓶","江苏恩华药业股份有限公司","3.47 ","修改（招标信息）","招采变更",""]
[920,"XL01XEJ008A001010105847","2","吉非替尼","口服常释剂型","","162693","吉非替尼片","无","薄膜衣片","0.25g","盒","10","铝塑","齐鲁制药(海南)有限公司","150.00","停用","招采国码变更",""]
[921,"XL01EBJ008A001010105847","2","吉非替尼","口服常释剂型","","162693","吉非替尼片","无","片剂","0.25g","盒","10","铝塑","齐鲁制药（海南）有限公司","118.47 ","启用","招采国码变更",""]
[922,"XC10AAA067A001010105847","2","阿托伐他汀","口服常释剂型","","165980","阿托伐他汀钙片","无","薄膜衣片","以C33H35FN2O5计10mg","盒","14","铝塑包装","齐鲁制药(海南)有限公司","1.68 ","修改（招标信息）","招采变更",""]
[923,"XC10AAA067A001020105847","2","阿托伐他汀","口服常释剂型","","166065","阿托伐他汀钙片","无","薄膜衣片","以C33H35FN2O5计20mg","盒","14","铝塑包装","齐鲁制药(海南)有限公司","2.86 ","修改（招标信息）","招采变更",""]
[924,"XC10AAA067A001010305847","2","阿托伐他汀","口服常释剂型","","172654","阿托伐他汀钙片","无","薄膜衣片","以C33H35FN2O5计10mg","瓶","90","口服固体药用高密度聚乙烯瓶","齐鲁制药(海南)有限公司","10.09 ","修改（招标信息）","招采变更",""]
[925,"XC10AAA067A001020305847","2","阿托伐他汀","口服常释剂型","","172655","阿托伐他汀钙片","无","薄膜衣片","以C33H35FN2O5计20mg","瓶","90","口服固体药用高密度聚乙烯瓶","齐鲁制药(海南)有限公司","17.15 ","修改（招标信息）","招采变更",""]
[926,"XL01BCK023A001020104021","2","卡培他滨","口服常释剂型","","154633","卡培他滨片","无","薄膜衣片","0.5g","盒","12","铝塑枕式包装内加干燥剂","齐鲁制药有限公司","22.14 ","修改（招标信息）","招采变更",""]
[927,"XL01BCK023A001010104021","2","卡培他滨","口服常释剂型","","162926","卡培他滨片","无","薄膜衣片","0.15g","盒","10","铝塑枕式包装内加干燥剂","齐鲁制药有限公司","7.39 ","修改（招标信息）","招采变更",""]
[928,"XJ05AFT043A001010104021","2","替诺福韦二吡呋酯","口服常释剂型","","162925","富马酸替诺福韦二吡呋酯片","无","片剂","0.3g","瓶","30","口服固体药用高密度聚乙烯瓶包装,内加药用固体纸袋装硅胶干燥剂","齐鲁制药有限公司","8.61 ","修改（招标信息）","招采变更",""]
[929,"XN06ABF098E001010200834","1","氟西汀","口服常释剂型","","141607","盐酸氟西汀胶囊","奥麦伦","胶囊剂","20mg(按C17H18F3NO计)","盒","14","铝塑板装","上海上药中西制药有限公司","30.66 ","修改（招标信息）","招采变更",""]
[930,"XJ01MAM134B002010102180","2","莫西沙星氯化钠","注射剂","","165616","盐酸莫西沙星氯化钠注射液","无","注射剂","250ml:盐酸莫西沙星(按C21H24FN3O4计)0.4g与氯化钠2.0g","袋","1","直立式聚丙烯输液袋","四川科伦药业股份有限公司","14.40 ","修改（招标信息）","招采变更",""]
[931,"XN06ABX016A001010202292","2","西酞普兰","口服常释剂型","","107152","氢溴酸西酞普兰片","无","片剂","20mg","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","四川科伦药业股份有限公司","32.84 ","修改（招标信息）","招采变更",""]
[932,"XN06ABX016A001010302292","2","西酞普兰","口服常释剂型","","107158","氢溴酸西酞普兰片","无","片剂","20mg","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","四川科伦药业股份有限公司","64.04 ","修改（招标信息）","招采变更",""]
[933,"XN06ABS066A001010304647","2","舍曲林","口服常释剂型","","103170","盐酸舍曲林片","乐元","片剂","50mg(按C17H17Cl2N计)","盒","28","双铝","浙江华海药业股份有限公司","20.16 ","修改（招标信息）","招采变更",""]
[934,"XC09CAL245A001020304647","2","氯沙坦","口服常释剂型","","172741","氯沙坦钾片","无","片剂","50mg","盒","21","双铝箔","浙江华海制药科技有限公司","11.46 ","修改（支付标准）","招采变更",""]
[935,"XN06ABP002A001010504647","1","帕罗西汀","口服常释剂型","","172695","盐酸帕罗西汀片","乐友","片剂","20mg(按C19H20FN03计算)","盒","30","铝塑包装","浙江华海制药科技有限公司","35.70 ","修改（招标信息）","招采变更",""]
[936,"XC09CAL245A001010404647","2","氯沙坦","口服常释剂型","","176014","氯沙坦钾片","无","片剂","100mg","盒","28","双铝箔","浙江华海制药科技有限公司","25.70 ","修改（招标信息）","招采变更",""]
[937,"XC09AAL030A001010204647","2","赖诺普利","口服常释剂型","","202288","赖诺普利片","无","片剂","10mg","瓶","100","塑瓶包装","浙江华海药业股份有限公司","21.78 ","修改（招标信息）","招采变更",""]
[938,"XC09AAL030A001010104647","2","赖诺普利","口服常释剂型","","103221","赖诺普利片","无","片剂","10mg","瓶","28","塑瓶包装","浙江华海药业股份有限公司","6.39 ","修改（招标信息）","招采变更",""]
[939,"XC09CAL245A001010204647","2","氯沙坦","口服常释剂型","","166112","氯沙坦钾片","无","片剂","100mg","盒","14","双铝箔","浙江华海制药科技有限公司","13.18 ","修改（招标信息）","招采变更",""]
[940,"XC09CAL245A001020404647","2","氯沙坦","口服常释剂型","","166113","氯沙坦钾片","无","片剂","50mg","盒","28","双铝箔","浙江华海制药科技有限公司","15.12 ","修改（招标信息）","招采变更",""]
[941,"XA07BCM081P001010204636","1","蒙脱石","口服散剂","","138589","蒙脱石散","肯特令","散剂","每袋含蒙脱石3g","盒","12","复合膜袋装","浙江仟源海力生制药有限公司","3.47 ","修改（招标信息）","招采变更",""]
[942,"XL01EAY059E001010301523","2","伊马替尼","口服常释剂型","","164741","甲磺酸伊马替尼胶囊","无","胶囊剂","0.1g(按C29H31N7O计算)","盒","60","药用铝箔和聚氯乙烯/聚偏二氯乙烯固体药用复合硬片","正大天晴药业集团股份有限公司","266.90 ","修改（招标信息）","招采变更",""]
[943,"XL01BCA300B001010101523","2","阿扎胞苷","注射剂","","165951","注射用阿扎胞苷","无","注射剂","100mg","盒","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用溴化丁基橡胶塞、抗生素瓶用铝塑组合盖","正大天晴药业集团南京顺欣制药有限公司","175.00 ","修改（招标信息）","招采变更",""]
[944,"XN03AXZ075X001010109568","2","左乙拉西坦","口服液体剂","","165162","左乙拉西坦口服溶液","无","口服溶液剂","150ml:15g","盒","1","口服液体药用聚酯瓶(茶色)","重庆圣华曦药业股份有限公司","37.62 ","修改（招标信息）","招采变更",""]
[945,"XC09DBA407A001010100553","2","阿利沙坦酯氨氯地平片","","限原发性高血压。","209661","阿利沙坦酯氨氯地平片","无","薄膜衣片","每片含阿利沙坦酯240mg与苯磺酸氨氯地平(按氨氯地平计)5mg。","盒","7","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","深圳信立泰药业股份有限公司","28.14 ","启用","招采变更","国谈药品"]
[946,"XB01ACB040A010010184364","2","贝前列素钠缓释片","","限WHO功能分级Ⅰ级-Ⅲ级的肺动脉高压(PAH，WHO第1组)的患者，以改善患者的运动能力。","203020","贝前列素钠缓释片","无","片剂","60μg","盒","100","铝塑泡罩包装(聚氯乙烯固体药用硬片和药用铝箔)","Toray Industries, Inc.","708.00 ","启用","招采变更","国谈药品"]
[947,"XN02BFM187A001010179008","2","苯磺酸美洛加巴林片","","限成人糖尿病性周围神经病理性疼痛。","211588","苯磺酸美洛加巴林片","德力静","薄膜衣片","按C₁₂H₁₉NO₂计5mg","盒","30","PP硬片＋药用铝箔-PP型制成的泡罩包装,外套聚酯/聚乙烯/铝/聚乙烯药品包装用复合袋,袋内置入固体药用纸/聚乙烯复合袋装分子筛干燥剂。","DAIICHI SANKYO CO.,LTD.","105.00 ","启用","招采变更","国谈药品"]
[948,"XN02BFM187A001020179008","2","苯磺酸美洛加巴林片","","限成人糖尿病性周围神经病理性疼痛。","211860","苯磺酸美洛加巴林片","德力静","薄膜衣片","按C₁₂H₁₉NO₂计2.5mg","盒","30","PP硬片＋药用铝箔-PP型制成的泡罩包装,外套聚酯/聚乙烯/铝/聚乙烯药品包装用复合袋,袋内置入固体药用纸/聚乙烯复合袋装分子筛干燥剂。","DAIICHI SANKYO CO.,LTD.","61.80 ","启用","招采变更","国谈药品"]
[949,"XN01BBB164B018020204948","2","布比卡因脂质体注射液","","限：1.12岁及以上的患者单剂量浸润产生术后局部镇痛；2. 成人肌间沟臂丛神经阻滞产生术后区域镇痛。","210958","布比卡因脂质体注射液","无","注射剂","10ml:133mg","盒","1","中硼硅玻璃管制注射剂瓶,注射制剂用氯化丁基橡胶塞及抗生素瓶用铝塑组合盖","湖南科伦制药有限公司","213.47 ","启用","招采变更","国谈药品"]
[950,"XH02ABB165E005010184851","2","布地奈德肠溶胶囊","","限具有进展风险的原发性免疫球蛋白A肾病(IgAN)成人患者。","211966","布地奈德肠溶胶囊","无","肠溶胶囊","4mg","瓶","120","高密度聚乙烯瓶包装,配儿童防护盖。","Everest Medicines (Singapore) Pte. Ltd.","5000.40 ","启用","招采变更","国谈药品"]
[951,"XN03AXB264A001020105337","2","布立西坦片","","限16岁及以上癫痫患者部分性发作的单药治疗和添加治疗。","212006","布立西坦片","无","片剂(薄膜衣片)","25mg","盒","28","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","江西科睿药业有限公司","118.72 ","启用","招采变更","国谈药品"]
[952,"XN06ABA225X001010179426","2","草酸艾司西酞普兰口服溶液","","","212034","草酸艾司西酞普兰口服溶液","无","口服溶液剂","240ml:240mg(按C₂₀H₂₁FN₂O计)","盒","1","聚对苯二甲酸乙二醇酯瓶,配有聚丙烯儿童安全盖(含衬垫),附带聚丙烯量杯,240ml/瓶,1瓶/盒。","Hetero Labs Limited","61.52 ","启用","招采变更","竞价药品"]
[953,"XL04AAD372A001010279518","2","氘可来昔替尼片","","限适合系统治疗或光疗的成年中重度斑块状银屑病患者。","211952","氘可来昔替尼片","颂狄多","片剂","6mg","盒","28","聚三氟氯乙烯/聚氯乙烯固体药品包装用复合硬片及药用铝箔包装。","Bristol-Myers Squibb Pharma EEIG","1484.00 ","启用","招采变更","国谈药品"]
[954,"XN05CFD373E001010104658","2","地达西尼胶囊","","限失眠患者。","212058","地达西尼胶囊","无","胶囊剂","2.5mg","盒","3","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装,外套聚酯/铝/聚乙烯药用复合膜袋。","浙江京新药业股份有限公司","41.64 ","启用","招采变更","国谈药品"]
[955,"XN05CFD373E001010304658","2","地达西尼胶囊","","限失眠患者。","211989","地达西尼胶囊","无","胶囊剂","2.5mg","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装,外套聚酯/铝/聚乙烯药用复合膜袋。","浙江京新药业股份有限公司","194.32 ","启用","招采变更","国谈药品"]
[956,"XV03ACD216N001010183949","2","地拉罗司颗粒","","限：1.年龄大于2岁的β-地中海贫血患者；2.10岁及10岁以上非输血依赖性地中海贫血综合征患者。","310162","地拉罗司颗粒","无","颗粒剂","180mg","盒","30","聚酯/铝/聚乙烯药用复合膜、袋","MSN Laboratories Private Limited","720.00 ","启用","招采变更","国谈药品"]
[957,"XN07XXD130E002010302774","2","丁苯酞软胶囊","","限新发的急性缺血性脑卒中患者在发作72小时内开始使用，支付不超过20天。","106162","丁苯酞软胶囊","恩必普","软胶囊","0.1g","盒","12","铝塑包装,","石药集团恩必普药业有限公司","38.88 ","启用","招采变更","国谈药品"]
[958,"ZA04BAE0094010284570","2","儿茶上清丸","","清热退火，解毒敛疮，止痛。用于轻型复发性阿弗他溃疡上焦实热证。症见：口舌生疮，溃疡疼痛，口渴欲饮，口粘口臭，舌质红，舌苔黄或黄腻，脉弦洪或弦数。","211969","儿茶上清丸","无","丸剂(浓缩丸)","每丸重0.14g(相当于饮片0.16g)","盒","32","口服固体药用高密度聚乙烯瓶","湖北齐进药业有限公司","44.48 ","启用","招采变更","国谈药品"]
[959,"ZA04BAE0094010584570","2","儿茶上清丸","","清热退火，解毒敛疮，止痛。用于轻型复发性阿弗他溃疡上焦实热证。症见：口舌生疮，溃疡疼痛，口渴欲饮，口粘口臭，舌质红，舌苔黄或黄腻，脉弦洪或弦数。","305110","儿茶上清丸","无","丸剂(浓缩丸)","每丸重0.14g(相当于饮片0.16g)","盒","64","口服固体药用高密度聚乙烯瓶","湖北齐进药业有限公司","88.96 ","启用","招采变更","国谈药品"]
[960,"ZA04BAE0094020184570","2","儿茶上清丸","","清热退火，解毒敛疮，止痛。用于轻型复发性阿弗他溃疡上焦实热证。症见：口舌生疮，溃疡疼痛，口渴欲饮，口粘口臭，舌质红，舌苔黄或黄腻，脉弦洪或弦数。","305120","儿茶上清丸","无","丸剂(浓缩丸)","每丸重0.14g(相当于饮片0.16g)","盒","80","口服固体药用高密度聚乙烯瓶","湖北齐进药业有限公司","111.20 ","启用","招采变更","国谈药品"]
[961,"XA10BDE083A001010106632","2","二甲双胍恩格列净片（Ⅲ）","","限2型糖尿病患者。","208942","二甲双胍恩格列净片(Ⅲ)","无","片剂(薄膜衣片)","每片含盐酸二甲双胍850mg和恩格列净5mg","盒","30","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片/药用铝箔","江苏德源药业股份有限公司","31.50 ","启用","招采变更","竞价药品"]
[962,"XA10BDE086A001010183916","2","二甲双胍恩格列净片（Ⅵ）","","限2型糖尿病患者。","212024","二甲双胍恩格列净片(Ⅵ)","无","片剂(薄膜衣片)","每片含盐酸二甲双胍1000mg与恩格列净12.5mg","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","湖南慧泽生物医药科技有限公司","24.22 ","启用","招采变更","竞价药品"]
[963,"XA10BDE086A001010104021","2","二甲双胍恩格列净片（Ⅵ）","","限2型糖尿病患者。","211985","二甲双胍恩格列净片(Ⅵ)","无","薄膜衣片","每片含盐酸二甲双胍1000mg与恩格列净12.5mg","盒","30","口服固体药用高密度聚乙烯瓶和固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","47.70 ","启用","招采变更","竞价药品"]
[964,"XC10ABF728E003010401062","2","非诺贝特酸胆碱缓释胶囊","","限：成人控制饮食基础上：1.降低重度高甘油三酯血症患者甘油三酯(TG)水平；2.原发性高胆固醇血症或混合型血脂异常患者的治疗。","211857","非诺贝特酸胆碱缓释胶囊","无","缓释胶囊","135mg(按C₁₇H₁₅ClO₄计)","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔为内包装材料,外套聚酯/铝/聚乙烯药用复合膜。","广州市联瑞制药有限公司","44.10 ","启用","招采变更","竞价药品"]
[965,"XC10ABF728E003010483238","2","非诺贝特酸胆碱缓释胶囊","","限：成人控制饮食基础上：1.降低重度高甘油三酯血症患者甘油三酯(TG)水平；2.原发性高胆固醇血症或混合型血脂异常患者的治疗。","211965","非诺贝特酸胆碱缓释胶囊","无","缓释胶囊","45mg(按C₁₇H₁₅ClO₄计)","盒","24","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔为内包装材料,外套聚酯/铝/聚乙烯药用复合膜。","广州市联瑞制药有限公司","32.64 ","启用","招采变更","竞价药品"]
[966,"XN05ADF085X001010105999","2","氟哌啶醇口服溶液","","限：1.急、慢性各型精神分裂症、躁狂症、抽动秽语综合症的成人患者；2.13至17岁青少年精神分裂症患者；3.6至17岁儿童和青少年孤独症或广泛性发育障碍的攻击行为；4.10至17岁儿童和青少年的抽动障碍。","211957","氟哌啶醇口服溶液","无","口服溶液剂","100ml:200mg","盒","1","口服液体药用高密度聚乙烯瓶和药用聚酯/铝/聚乙烯封口垫片","新疆特丰药业股份有限公司","39.00 ","启用","招采变更","国谈药品"]
[967,"XA10BKF741A001010100153","2","脯氨酸加格列净片","","限2型糖尿病患者。","208080","脯氨酸加格列净片","惠优静","薄膜衣片","按C₂₅H₂₉ClO₆计:25mg","盒","14","聚氯乙烯固体药用硬片及药用铝箔包装","惠升生物制药股份有限公司","51.52 ","启用","招采变更","国谈药品"]
[968,"XA10BKF741A001020100153","2","脯氨酸加格列净片","","限2型糖尿病患者。","208081","脯氨酸加格列净片","惠优静","薄膜衣片","按C₂₅H₂₉ClO₆计:50mg","盒","14","聚氯乙烯固体药用硬片及药用铝箔包装","惠升生物制药股份有限公司","87.64 ","启用","招采变更","国谈药品"]
[969,"XN02AXT219B002010101445","2","富马酸泰吉利定注射液","","限腹部手术后中重度疼痛。","207669","富马酸泰吉利定注射液","艾苏特","注射液","1ml:1mg(按C₂₈H₃₈N₂O₂计)","瓶","1","本品所用包装为中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖。","江苏恒瑞医药股份有限公司","124.60 ","启用","招采变更","国谈药品"]
[970,"XN02AXT219B002020101445","2","富马酸泰吉利定注射液","","限腹部手术后中重度疼痛。","207670","富马酸泰吉利定注射液","艾苏特","注射液","5ml:5mg(按C₂₈H₃₈N₂O₂计)","瓶","1","本品所用包装为中硼硅玻璃管制注射剂瓶、注射液用覆聚四氟乙烯/六氟丙烯的共聚物膜氯化丁基橡胶塞和抗生素瓶用铝塑组合盖。","江苏恒瑞医药股份有限公司","427.17 ","启用","招采变更","国谈药品"]
[971,"XA10BDH123A010010183086","2","恒格列净二甲双胍缓释片(Ⅰ)","","限2型糖尿病患者。","207651","恒格列净二甲双胍缓释片(Ⅰ)","无","薄膜衣片","脯氨酸恒格列净5mg(按C₂₂H₂₄ClFO₇计)与盐酸二甲双胍500mg(按C₄H₁₁N₅·HCl计)","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片、药品包装用铝箔","山东盛迪医药有限公司","108.90 ","启用","招采变更","国谈药品"]
[972,"XA10BDH122A010010183086","2","恒格列净二甲双胍缓释片(Ⅱ)","","限2型糖尿病患者。","207650","恒格列净二甲双胍缓释片(Ⅱ)","无","片剂","脯氨酸恒格列净5mg(按C₂₂H₂₄ClFO₇计)与盐酸二甲双胍1000mg(按C₄H₁₁N₅·HCl计)","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片、药品包装用铝箔","山东盛迪医药有限公司","112.50 ","启用","招采变更","国谈药品"]
[973,"ZA03BAJ0752010101463","2","济川煎颗粒","","","211961","济川煎颗粒","无","颗粒剂","每袋装7g(相当于饮片21.82g)","盒","10","聚酯/铝/聚乙烯药用复合膜","江苏康缘药业股份有限公司","112.60 ","启用","招采变更","国谈药品"]
[974,"XL04AAB259A001010284830","2","甲磺酸贝舒地尔片","","限对糖皮质激素或其他系统治疗应答不充分的12岁及以上慢性移植物抗宿主病患者。","207705","甲磺酸贝舒地尔片","易来克","片剂(薄膜衣片)","0.2g(按C₂₆H₂₄N₆O₂计)","瓶","30","口服固体药用高密度聚乙烯瓶和聚丙烯儿童安全组合瓶盖包装,内置药用高密度聚乙烯干燥剂罐。","Kadmon Pharmaceuticals, LLC","7440.00 ","启用","招采变更","国谈药品"]
[975,"XL01EBR133E001010183120","2","甲磺酸瑞齐替尼胶囊","","限既往经表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的治疗。","211734","甲磺酸瑞齐替尼胶囊","瑞必达","胶囊剂","30mg(按C₂₇H₃₀N₆O₃计)","盒","30","口服固体药用高密度聚乙烯瓶及聚丙烯儿童安全组合瓶盖系统包装","上海倍而达药业有限公司","941.40 ","启用","招采变更","国谈药品"]
[976,"ZA04BAJ0499010101795","2","金银花口服液","","","166687","金银花口服液","无","合剂","每1ml相当于饮片90mg,10ml/支","盒","6","PET/PVDC/LDPE","真奥金银花药业有限公司","17.64 ","启用","招采变更","国谈药品"]
[977,"ZA06BCJ0753010383234","2","九味止咳口服液","","","212050","九味止咳口服液","无","合剂","每1ml相当于饮片2.14g(每支装10ml)","盒","20","钠钙玻璃管制口服液体瓶;口服制剂用氯化丁基橡胶胶塞;口服液瓶用铝塑组合盖。","卓和药业集团股份有限公司","83.00 ","启用","招采变更","国谈药品"]
[978,"XB05ZBL402B001010183618","2","磷/碳酸氢钠血滤置换液","","限：1.连续性肾脏替代治疗(CRRT)期间用于急性肾损伤的治疗；2.肾脏替代治疗启动后，当pH、钾和磷酸盐浓度恢复正常时的急性后期治疗。","211975","磷/碳酸氢钠血滤置换液","无","注射剂","5000ml","袋","1","本品的非PVC内包装袋由三层共挤输液用膜、三层共挤输液用管、血滤置换液用聚碳酸酯端管塞、血滤置换液用加药口组合件、血滤置换液用鲁尔接头组合件制成,次级包装为高阻隔外包装袋","Baxter Holding B.V.","101.80 ","启用","招采变更","国谈药品"]
[979,"XL01EXL405E001020178262","2","硫酸拉罗替尼胶囊","","限经充分验证的检测方法诊断为携带神经营养酪氨酸受体激酶(NTRK)融合基因且不包括已知获得性耐药突变的实体瘤：患有局部晚期、转移性疾病或手术切除可能导致严重并发症的患者，或无满意替代治疗或既往治疗失败的患者。","211924","硫酸拉罗替尼胶囊","维泰凯","胶囊剂","100mg(按C21H22F2N6O2计)","瓶","56","高密度聚乙烯(HDPE)瓶,配有防儿童开启的聚丙烯(PP)盖","Bayer AG","14512.40 ","启用","招采变更","国谈药品"]
[980,"XL01EXL405X001010178262","2","硫酸拉罗替尼口服溶液","","限经充分验证的检测方法诊断为携带神经营养酪氨酸受体激酶(NTRK)融合基因且不包括已知获得性耐药突变的实体瘤：患有局部晚期、转移性疾病或手术切除可能导致严重并发症的患者，或无满意替代治疗或既往治疗失败的患者。","211940","硫酸拉罗替尼口服溶液","无","口服溶液剂","50ml:1.0g(按C₂₁H₂₂F₂N₆O₂计)","盒","2","钠钙玻璃模制药瓶(棕色),配有防儿童开启的聚丙烯(PP)盖","Bayer AG","5183.00 ","启用","招采变更","国谈药品"]
[981,"XN05BAL406A001010102000","2","氯巴占片","","限2岁及以上Lennox-Gastaut综合征(LGS)患者癫痫发作的联合治疗。","212018","氯巴占片","无","片剂","10mg","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","宜昌人福药业有限责任公司","59.08 ","启用","招采变更","国谈药品"]
[982,"XN07XXL378E002010104021","2","氯苯唑酸葡胺软胶囊","","限成人转甲状腺素蛋白淀粉样变性多发性神经病I期症状患者。","211926","氯苯唑酸葡胺软胶囊","无","软胶囊","20mg(按C₁₄H₇Cl₂NO₃·C₇H₁₇NO₅计)","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔泡罩","齐鲁制药有限公司","3639.00 ","启用","招采变更","竞价药品"]
[983,"XJ05AXM176X006010181735","2","玛巴洛沙韦干混悬剂","","限5至12岁以下单纯性甲型和乙型流感儿童患者。","208300","玛巴洛沙韦干混悬剂","无","干混悬剂","40mg","盒","1","琥珀色玻璃瓶、口服药用聚乙烯儿童安全盖。","Roche Pharma (Schweiz) AG","193.00 ","启用","招采变更","国谈药品"]
[984,"XC01EBM186E001010185316","2","玛伐凯泰胶囊","","限纽约心脏协会(NYHA)心功能分级Ⅱ-Ⅲ级的梗阻性肥厚型心肌病(oHCM)成人患者。","211904","玛伐凯泰胶囊","迈凡妥","胶囊剂","2.5mg","盒","28","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片及药用铝箔包装","Bristol-Myers Squibb Australia Pty Ltd","4381.16 ","启用","招采变更","国谈药品"]
[985,"XC01EBM186E001020185316","2","玛伐凯泰胶囊","","限纽约心脏协会(NYHA)心功能分级Ⅱ-Ⅲ级的梗阻性肥厚型心肌病(oHCM)成人患者。","211905","玛伐凯泰胶囊","迈凡妥","胶囊剂","5mg","盒","28","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片及药用铝箔包装","Bristol-Myers Squibb Australia Pty Ltd","7448.00 ","启用","招采变更","国谈药品"]
[986,"XC01EBM186E001030185316","2","玛伐凯泰胶囊","","限纽约心脏协会(NYHA)心功能分级Ⅱ-Ⅲ级的梗阻性肥厚型心肌病(oHCM)成人患者。","211906","玛伐凯泰胶囊","迈凡妥","胶囊剂","10mg","盒","28","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片及药用铝箔包装","Bristol-Myers Squibb Australia Pty Ltd","12661.60 ","启用","招采变更","国谈药品"]
[987,"XC01EBM186E001040185316","2","玛伐凯泰胶囊","","限纽约心脏协会(NYHA)心功能分级Ⅱ-Ⅲ级的梗阻性肥厚型心肌病(oHCM)成人患者。","211907","玛伐凯泰胶囊","迈凡妥","胶囊剂","15mg","盒","28","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片及药用铝箔包装","Bristol-Myers Squibb Australia Pty Ltd","17270.12 ","启用","招采变更","国谈药品"]
[988,"XA07ECM053E013010183683","2","美沙拉秦肠溶缓释胶囊","","","212037","美沙拉秦肠溶缓释胶囊","无","缓释胶囊","0.375g","瓶","20","口服固体药用高密度聚乙烯塑料瓶、口服固体药用聚丙烯瓶盖","江苏安必生制药有限公司","99.60 ","启用","招采变更","国谈药品"]
[989,"XA05BAM076N001010401957","2","门冬氨酸鸟氨酸颗粒","","限因急、慢性肝病如肝硬化、脂肪肝、肝炎所致的高血氨症。","211862","门冬氨酸鸟氨酸颗粒","瑞甘","颗粒剂","3g","盒","21","SP复合膜袋装","武汉启瑞药业有限公司","82.95 ","启用","招采变更","国谈药品"]
[990,"ZA01BAN0120010103719","2","牛黄清感胶囊","","","115047","牛黄清感胶囊","无","硬胶囊","每粒装0.3g人工牛黄","盒","24","铝塑包装","黑龙江澳利达奈德制药有限公司","15.12 ","启用","招采变更","国谈药品"]
[991,"ZA16BAQ0646010184378","2","秦威颗粒","","清热除湿祛风，活血通络止痛。用于急性痛风性关节炎风湿郁热证，症见关节疼痛、关节肿胀、关节局部发热、口渴喜饮，舌质红、苔黄、脉滑数。","212022","秦威颗粒","无","颗粒剂","每1g相当于饮片2.5g(每袋装12g)","盒","12","聚酯/铝/聚乙烯药品包装用复合膜","成都华西天然药物有限公司","99.12 ","启用","招采变更","国谈药品"]
[992,"XL01EXR131E001010279060","2","瑞普替尼胶囊","","限ROS1阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","211309","瑞普替尼胶囊","奥凯乐","胶囊剂","40mg","瓶","120","口服药用高密度聚乙烯瓶(配有防儿童开启的聚丙烯盖)","Bristol-Myers Squibb Company","5894.40 ","启用","招采变更","国谈药品"]
[993,"XC10BAR128A001010282826","2","瑞舒伐他汀依折麦布片(Ⅰ)","","限：1.他汀类药物单药治疗LDL-C无法达标的成人原发性(杂合子型家族性或非家族性)高胆固醇血症或混合性高脂血症患者；2.降低纯合子型家族性高胆固醇血症(HoFH)患者的TC和LDL-C水平。","207709","瑞舒伐他汀依折麦布片(I)","无","片剂","每片含瑞舒伐他汀钙10mg(按瑞舒伐他汀计)与依折麦布10mg","盒","30","吸入粉雾剂用铝塑泡罩、药用铝箔包装","Sanofi-Aventis Ireland Limited T/A SANOFI","93.00 ","启用","招采变更","国谈药品"]
[994,"XL04ACS271B002020178679","2","司库奇尤单抗注射液","","限：1.符合系统治疗或光疗指征的中度至重度斑块状银屑病的6岁及以上患者；2.常规治疗疗效欠佳的强直性脊柱炎的成年患者；3. 既往传统的改善病情抗风湿药(cDMARDs)疗效不佳或不耐受的活动性银屑病关节炎成人患者。","165615","司库奇尤单抗注射液","可善挺","注射剂","1ml:0.15g","盒","1","预装式自动注射笔","Novartis Pharma Schweiz AG","778.65 ","启用","招采变更","国谈药品"]
[995,"XL04ADT002N001010183516","2","他克莫司颗粒","","限：1.预防?童肝脏或肾脏移植术后的移植物排斥反应；2.治疗?童肝脏或肾脏移植术后应用其他免疫抑制药物无法控制的移植物排斥反应。","211911","他克莫司颗粒","无","颗粒剂","1mg","盒","50","聚酯/铝/聚乙烯药用复合袋包装","杭州中美华东制药江东有限公司","771.50 ","启用","招采变更","竞价药品"]
[996,"XM01AET056V006010504942","2","酮洛芬凝胶贴膏","","限骨关节炎。","211953","酮洛芬凝胶贴膏","无","贴膏剂","每贴(14×10cm)含膏体13g,含酮洛芬30mg","盒","6","聚酯/铝/流延聚丙烯药用复合膜袋","湖南九典制药股份有限公司","52.08 ","启用","招采变更","国谈药品"]
[997,"ZD01BAW0372010100474","2","温经汤颗粒","","","211973","温经汤颗粒","无","颗粒剂","每袋相当于饮片20g(每袋装10g)","盒","9","聚酯/铝/聚乙烯药品包装用复合膜","华润三九医药股份有限公司","108.00 ","启用","招采变更","国谈药品"]
[998,"XA10BDX252A010010282990","2","西格列汀二甲双胍缓释片","","","211798","西格列汀二甲双胍缓释片","无","片剂(薄膜衣片)","每片含磷酸西格列汀50mg(以C₁₆H₁₅F₆N₅O计)和盐酸二甲双胍500mg","瓶","28","口服固体药用高密度聚乙烯瓶,药用固体纸袋装硅胶干燥剂","上海安必生制药技术有限公司","96.60 ","启用","招采变更","竞价药品"]
[999,"XA10BDX223A010020183135","2","西格列汀二甲双胍缓释片(Ⅱ)","","","211605","西格列汀二甲双胍缓释片(Ⅱ)","无","片剂","每片含磷酸西格列汀50mg(以C16H15F6N5O计)和盐酸二甲双胍1000mg","盒","28","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","江苏宣泰药业有限公司","97.16 ","启用","招采变更","国谈药品"]
[1000,"XA10BDX223A010020283135","2","西格列汀二甲双胍缓释片(Ⅱ)","","","211607","西格列汀二甲双胍缓释片(Ⅱ)","无","片剂","每片含磷酸西格列汀50mg(以C16H15F6N5O计)和盐酸二甲双胍1000mg","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","江苏宣泰药业有限公司","48.58 ","启用","招采变更","国谈药品"]
[1001,"ZA01CAX0950010201453","2","小儿豉翘清热糖浆","","","211993","小儿豉翘清热糖浆","无","糖浆剂","每支装10ml(相当于饮片7.462g)","盒","10","钠钙玻璃管制口服液体瓶装","济川药业集团有限公司","58.50 ","启用","招采变更","国谈药品"]
[1002,"ZA01CAX0950010101453","2","小儿豉翘清热糖浆","","","211990","小儿豉翘清热糖浆","无","糖浆剂","每支装10ml(相当于饮片7.462g)","盒","6","钠钙玻璃管制口服液体瓶装","济川药业集团有限公司","35.10 ","启用","招采变更","国谈药品"]
[1003,"XA10BAE096A010010281227","2","盐酸二甲双胍缓释片(Ⅳ)","","","206906","盐酸二甲双胍缓释片(Ⅳ)","无","缓释片","1.0g","瓶","90","口服固体药用高密度聚乙烯瓶","武汉久安药物研究院有限公司","105.30 ","启用","招采变更","国谈药品"]
[1004,"XR06AXF024X006010101453","2","盐酸非索非那定干混悬剂","","","212023","盐酸非索非那定干混悬剂","无","口服混悬剂","30mg","盒","30","聚酯/铝/聚乙烯药用复合膜袋装包装","济川药业集团有限公司","47.40 ","启用","招采变更","国谈药品"]
[1005,"XR06AXF024X006020101453","2","盐酸非索非那定干混悬剂","","","212019","盐酸非索非那定干混悬剂","无","口服混悬剂","15mg","盒","30","聚酯/铝/聚乙烯药用复合膜袋装包装","济川药业集团有限公司","27.90 ","启用","招采变更","国谈药品"]
[1006,"XL01EXK151A001020278679","2","盐酸卡马替尼片","","限未经系统治疗的携带间质上皮转化因子(MET)外显子14跳跃突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","210595","盐酸卡马替尼片","妥瑞达","片剂(薄膜衣片)","200mg(以C₂₃H₁₇FN₆O计)","盒","120","聚氯乙烯/聚三氟氯乙烯固体药用复合硬片及药用铝箔包装","Novartis Pharma Schweiz AG","14280.00 ","启用","招采变更","国谈药品"]
[1007,"XV03AXN130A022010184364","2","盐酸纳呋拉啡口崩片","","限现有治疗疗效不理想的血液透析患者的瘙痒症。","211954","盐酸纳呋拉啡口崩片","无","片剂","2.5μg","盒","14","聚氯乙烯固体药用硬片及药用铝箔包装","Toray Industries, Inc.","379.12 ","启用","招采变更","国谈药品"]
[1008,"XN02AAQ159A010010102000","2","盐酸氢吗啡酮缓释片","","限成人重度疼痛。","212015","盐酸氢吗啡酮缓释片","无","缓释片","8mg","瓶","20","口服固体药用高密度聚乙烯瓶,内附固体药用聚丙烯罐装硅胶干燥剂和药用棉卷,20片/瓶。","宜昌人福药业有限责任公司","273.20 ","启用","招采变更","国谈药品"]
[1009,"XL01EXT216A001010179323","2","盐酸特泊替尼片","","限携带间质上皮转化因子(MET)外显子14跳跃突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","207437","盐酸特泊替尼片","拓得康","薄膜衣片","225mg(按C₂₉H₂₈N₆O₂计)","盒","60","聚氯乙烯/聚乙烯/聚偏二氯乙烯/聚乙烯/聚氯乙烯固体药用复合硬片＋泡罩箔(Blisterfoil)制成的铝塑泡罩包装","Merck (Schweiz) AG","15120.00 ","启用","招采变更","国谈药品"]
[1010,"ZA13AAY0789010102729","2","一贯煎颗粒","","","211991","一贯煎颗粒","无","颗粒剂","每袋装12g(相当于饮片15.55g)","盒","6","聚酯/铝/聚丙烯药品包装用复合膜","神威药业集团有限公司","55.32 ","启用","招采变更","国谈药品"]
[1011,"XC10BAY348A001010179034","2","依折麦布阿托伐他汀钙片(Ⅱ)","","限：1.他汀类药物单药治疗LDL-C无法达标的成人原发性(杂合子型家族性或非家族性)高胆固醇血症或混合性高脂血症患者；2.降低纯合子型家族性高胆固醇血症(HoFH)患者的TC和LDL-C水平。","211786","依折麦布阿托伐他汀钙片(Ⅱ)","无","片剂","每片含依折麦布10mg与阿托伐他汀钙20mg(以阿托伐他汀计)","盒","10","铝/铝泡罩","N.V. Organon","32.40 ","启用","招采变更","国谈药品"]
[1012,"XN05AXA028B001010179080","2","注射用阿立哌唑","","","207908","注射用阿立哌唑","无","注射剂","0.4g(按C₂₃H₂₇Cl₂N₃O₂计)","盒","1","双室预灌封注射器组合件(无注射针)包装","Otsuka Pharmaceutical Co.,Ltd.","892.16 ","启用","招采变更","国谈药品"]
[1013,"XN05AXA028B001020179080","2","注射用阿立哌唑","","","211959","注射用阿立哌唑","无","注射剂","0.3g(按C₂₃H₂₇Cl₂N₃O₂计)","盒","1","双室预灌封注射器组合件(无注射针)包装","Otsuka Pharmaceutical Co.,Ltd.","715.81 ","启用","招采变更","国谈药品"]
[1014,"XJ01DIT192B001010183103","2","注射用头孢比罗酯钠","","限成人以下感染方予支付：1.医院获得性肺炎(HAP)，但呼吸机相关性肺炎(VAP)除外；2.社区获得性肺炎(CAP)。","202542","注射用头孢比罗酯钠","赛比普","冻干粉针剂","500mg","瓶","1","中硼硅玻璃管制注射剂瓶,氯丁基橡胶塞和铝朔组合盖","Basilea Pharmaceutica Deutschland GmbH","160.00 ","启用","招采变更","国谈药品"]
[1015,"XJ01DDT214B002010100108","2","注射用头孢哌酮钠舒巴坦钠/氯化钠注射液","","","211967","注射用头孢哌酮钠舒巴坦钠/氯化钠注射液","无","注射剂","粉体室:1.0g(C₂₅H₂₇N₉O₈S₂0.5g与C₈H₁₁NO₅S0.5g)；液体室:100ml∶氯化钠0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","20.10 ","启用","招采变更","国谈药品"]
[1016,"XJ01DDT214B002020100108","2","注射用头孢哌酮钠舒巴坦钠/氯化钠注射液","","","211968","注射用头孢哌酮钠舒巴坦钠/氯化钠注射液","无","注射剂","粉体室:2.0g(C₂₅H₂₇N₉O₈S₂1.0g与C₈H₁₁NO₅S1.0g)；液体室:100ml∶氯化钠0.9g","袋","1","三层共挤输液用双室袋","北京锐业制药有限公司","23.67 ","启用","招采变更","国谈药品"]
[1017,"XL01CDZ107B001010182039","2","注射用紫杉醇聚合物胶束","","限联合铂类用于表皮生长因子受体(EGFR)基因突变阴性和间变性淋巴瘤激酶(ALK)阴性、不可手术切除的局部晚期或转移性非小细胞肺癌(NSCLC)患者的一线治疗。","207012","注射用紫杉醇聚合物胶束","无","注射剂","30mg","盒","1","中硼硅玻璃管制注射瓶","上海谊众药业股份有限公司","376.00 ","启用","招采变更","国谈药品"]
[1018,"XN05AXZ114B002010178537","2","棕榈帕利哌酮酯注射液(6M)","","限接受过棕榈帕利哌酮酯注射液(3M)至少3个月充分治疗的成人精神分裂症患者。","211498","棕榈帕利哌酮酯注射液(6M)","无","注射剂","按帕利哌酮(C23H27FN4O3)计5.0mL：1000mg","盒","1","环烯烃共聚物塑料注射器","Janssen-Cilag International NV","9337.01 ","启用","招采变更","国谈药品"]
[1019,"XN05AXZ114B002020178537","2","棕榈帕利哌酮酯注射液(6M)","","限接受过棕榈帕利哌酮酯注射液(3M)至少3个月充分治疗的成人精神分裂症患者。","211500","棕榈帕利哌酮酯注射液(6M)","无","注射剂","按帕利哌酮(C₂₃H₂₇FN₄O₃)计3.5ml：700mg","盒","1","环烯烃共聚物塑料注射器","Janssen-Cilag International NV","7106.00 ","启用","招采变更","国谈药品"]
[1020,"XN05CCS273K001010183361","2","水合氯醛糖浆","","限儿童检查、操作前的镇静、催眠。","306110","水合氯醛糖浆","无","糖浆剂","10ml:1g","盒","1","钠钙玻璃管制口服液体瓶与口服液瓶用铝塑组合盖包装。10ml/支。本品包装配备塑料液体给药器(规格5ml,每一小刻度为0.1ml)和塑料吸管。","海南鹏康药业有限公司","46.50 ","启用","招采变更","国谈药品"]
[1021,"XJ02ACA397E001010184811","2","奥特康唑胶囊","","限重度外阴阴道假丝酵母菌病(VVC)。","206016","奥特康唑胶囊","无","胶囊剂","0.15g","盒","18","聚氯乙烯固体药用硬片、药用铝箔","eVENUS PHARMACEUTICAL LABORATORIES INC.","1896.84 ","启用","招采变更","国谈药品"]
[1022,"XN03AXB264A001010105337","2","布立西坦片","","限16岁及以上癫痫患者部分性发作的单药治疗和添加治疗。","210787","布立西坦片","无","片剂(薄膜衣片)","50mg","盒","28","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片和药用铝箔包装","江西科睿药业有限公司","201.88 ","启用","招采变更","国谈药品"]
[1023,"XL01FCD337B002030178537","2","达雷妥尤单抗注射液(皮下注射)","","限：1.与来那度胺和地塞米松联合用药或与硼替佐米、美法仑和泼尼松联合用药治疗不适合自体干细胞移植的新诊断的多发性骨髓瘤成年患者；2.与来那度胺和地塞米松联合用药或与硼替佐米和地塞米松联合用药治疗既往至少接受过一线治疗的多发性骨髓瘤成年患者；3.与泊马度胺和地塞米松联合用药治疗既往接受过至少一线治疗(包括来那度胺和蛋白酶体抑制剂)的多发性骨髓瘤患者；4.单药治疗复发和难治性多发性骨髓瘤成年患者，患者既往接受过包括蛋白酶体抑制剂和免疫调节剂的治疗且最后一次治疗时出现疾病进展；5.新诊断的原发性轻链型淀粉样变患者。本方案不适合也不推荐用于患有NYHA ⅢB级或Ⅳ级心脏疾病或Mayo ⅢB期的原发性轻链型淀粉样变患者。","205865","达雷妥尤单抗注射液(皮下注射)","兆珂速","注射剂","1800mg(15ml)/瓶","盒","1","配有橡胶密封塞和铝制易掀盖的1型玻璃小瓶,内装15mL溶液,其中含1,800mg达雷妥尤单抗。","Janssen-Cilag International NV","10448.00 ","启用","招采变更","国谈药品"]
[1024,"XL01EBR132A001010201583","2","甲磺酸瑞厄替尼片","","限既往经表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的治疗。","210289","甲磺酸瑞厄替尼片","无","片剂(薄膜衣片)","100mg(按C₃₁H₃₇N₇O₂计)","瓶","20","口服固体药用高密度聚乙烯瓶、口服药用聚丙烯压旋盖及药用聚酯/铝/聚乙烯封口垫片包装","南京圣和药业股份有限公司","1983.60 ","启用","招采变更","国谈药品"]
[1025,"XN07XXL378E002010301606","2","氯苯唑酸葡胺软胶囊","","限成人转甲状腺素蛋白淀粉样变性多发性神经病I期症状患者。","209772","氯苯唑酸葡胺软胶囊","无","软胶囊","20mg(按C₁₄H₇Cl₂NO₃·C₇H₁₇NO₅计)","盒","14","口服固体药用高密度聚乙烯瓶包装","南京正大天晴制药有限公司","1890.00 ","启用","招采变更","竞价药品"]
[1026,"XN07XXL378E002010401606","2","氯苯唑酸葡胺软胶囊","","限成人转甲状腺素蛋白淀粉样变性多发性神经病I期症状患者。","209775","氯苯唑酸葡胺软胶囊","无","软胶囊","20mg(按C₁₄H₇Cl₂NO₃·C₇H₁₇NO₅计)","盒","30","口服固体药用高密度聚乙烯瓶包装","南京正大天晴制药有限公司","4050.00 ","启用","招采变更","竞价药品"]
[1027,"XJ05AXM184A001010284503","2","马立巴韦片","","限治疗造血干细胞移植或实体器官移植后巨细胞病毒(CMV)感染和/或疾病，且对一种或多种既往治疗(更昔洛韦、缬更昔洛韦、西多福韦或膦甲酸钠)难治(伴或不伴基因型耐药)的成人患者。","207243","马立巴韦片","无","片剂(薄膜衣片)","0.2g","盒","56","白色方形高密度聚乙烯瓶、防儿童开启密封安全盖包装。","Takeda Pharmaceuticals U.S.A., Inc.","24416.00 ","启用","招采变更","国谈药品"]
[1028,"XL01EET220E001010184591","2","妥拉美替尼胶囊","","限含抗PD-1/PD-L1治疗失败的NRAS基因突变的晚期黑色素瘤患者。","208875","妥拉美替尼胶囊","科露平","胶囊剂","3mg","盒","56","口服固体药用高密度聚乙烯瓶＋口服固体药用高密度聚乙烯防潮组合盖包装","上海科州药物股份有限公司","5501.40 ","启用","招采变更","国谈药品"]
[1029,"XL01FEX254B002010181463","2","西妥昔单抗β注射液","","限与FOLFIRI方案联合用于一线治疗RAS/BRAF基因野生型的转移性结直肠癌。","210398","西妥昔单抗β注射液","恩立妥","注射剂","100mg(10ml)/瓶","盒","1","西林瓶","泰州迈博太科药业有限公司","780.00 ","启用","招采变更","国谈药品"]
[1030,"XA10AEY357B002010178997","2","依柯胰岛素注射液","","限其他胰岛素或口服药难以控制的2型糖尿病患者。","211227","依柯胰岛素注射液","诺和期","注射剂","1ml:700单位(畅充)","盒","1","由聚丙烯、聚甲醛、聚碳酸酯和丙烯腈丁二烯苯乙烯制成的一次性预填充多剂量注射笔，内含装有1ml、1.5ml或3ml溶液的玻璃套筒(1型玻璃)，笔芯带有一个活塞(氯化丁基)和一个橡胶垫片(溴化丁基/聚异戊","Novo Nordisk A/S","279.00 ","启用","招采变更","国谈药品"]
[1031,"ZF02AAX0946010181119","2","益气通窍丸","","","209199","益气通窍丸","无","丸剂","每20丸重3g(相当于饮片9.12g)","盒","240","口服固体药用高密度聚乙烯瓶","扬子江药业集团四川海蓉药业有限公司","90.96 ","启用","招采变更","国谈药品"]
[1032,"XV03AFQ178B001010105849","2","注射用盐酸曲拉西利","","限既往未接受过系统性化疗的广泛期小细胞肺癌(在接受含铂类药物联合依托泊苷方案治疗前给药)患者。","210423","注射用盐酸曲拉西利","无","注射剂","300mg(按C24H30N8O计)","盒","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥无菌粉末用覆聚四氟乙烯/乙烯共聚物膜氯化丁基橡胶塞、抗生素瓶用铝塑组合盖。","海南先声药业有限公司","466.00 ","启用","招采变更","国谈药品"]
[1033,"XJ05AXA401A001010184739","2","阿泰特韦片/利托那韦片组合包装","","限轻中度新型冠状病毒感染(COVID-19)的成年患者。","206751","阿泰特韦片/利托那韦片组合包装","泰中定","薄膜衣片","阿泰特韦片0.15g/利托那韦片0.1g","盒","20","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔","福建广生中霖生物科技有限公司","455.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1034,"XN03AGA357P001010283655","2","氨己烯酸口服溶液用散","","限婴儿痉挛症。","175614","氨己烯酸口服溶液用散","无","散剂","每袋500mg","盒","30","复合袋包装","Aucta Pharmaceuticals, Inc.","870.00","修改（企业名称）","招采变更","竞价药品"]
[1035,"XJ02ACA397E001010284811","2","奥特康唑胶囊","","限重度外阴阴道假丝酵母菌病(VVC)。","206157","奥特康唑胶囊","无","胶囊剂","0.15g","盒","7","聚氯乙烯固体药用硬片、药用铝箔","eVENUS PHARMACEUTICAL LABORATORIES INC.","737.66 ","启用","招采变更","国谈药品"]
[1036,"XN02BFK150E001010183791","2","苯磺酸克利加巴林胶囊","","限：1.治疗成人糖尿病性周围神经病理性疼痛；2.带状疱疹后神经痛。","209036","苯磺酸克利加巴林胶囊","思美宁","胶囊剂","20mg(以C₁₂H₁₉NO₂计)","盒","8","药用铝箔和聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片","海思科医药集团股份有限公司","44.40 ","启用","招采变更","国谈药品"]
[1037,"XA10BHF743A001010100553","2","苯甲酸福格列汀片","","","210658","苯甲酸福格列汀片","信立汀","片剂","6mg(按C₁₇H₁₉FN₆O计)","盒","14","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片＋药用铝箔制成的泡罩包装,外套双向拉伸聚酯/铝/聚乙烯药品包装用复合袋,袋内置固体药用纸袋装干燥剂。","深圳信立泰药业股份有限公司","33.32 ","启用","招采变更","国谈药品"]
[1038,"XA10BHF743A001020100553","2","苯甲酸福格列汀片","","","210660","苯甲酸福格列汀片","信立汀","片剂","12mg(按C₁₇H₁₉FN₆O计)","盒","7","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片＋药用铝箔制成的泡罩包装,外套双向拉伸聚酯/铝/聚乙烯药品包装用复合袋,袋内置固体药用纸袋装干燥剂。","深圳信立泰药业股份有限公司","28.35 ","启用","招采变更","国谈药品"]
[1039,"XA10BHF743A001020200553","2","苯甲酸福格列汀片","","","210920","苯甲酸福格列汀片","信立汀","片剂","12mg(按C₁₇H₁₉FN₆O计)","盒","14","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片＋药用铝箔制成的泡罩包装,外套双向拉伸聚酯/铝/聚乙烯药品包装用复合袋,袋内置固体药用纸袋装干燥剂。","深圳信立泰药业股份有限公司","56.70 ","启用","招采变更","国谈药品"]
[1040,"XL01EXB260E001010284325","2","伯瑞替尼肠溶胶囊","","限：1.具有间质-上皮转化因子(MET)外显子14跳变的局部晚期或转移性非小细胞肺癌患者；2.既往治疗失败的具有PTPRZ1-MET融合基因的IDH突变型星形细胞瘤(WHO4级)或有低级别病史的胶质母细胞瘤成人患者。","206852","伯瑞替尼肠溶胶囊","无","肠溶胶囊","100mg","盒","60","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片＋药用铝箔制成的双铝泡罩包装,外套聚酯/铝/聚乙烯药用复合袋。","北京浦润奥生物科技有限责任公司","8010.00 ","启用","招采变更","国谈药品"]
[1041,"XL04AAD372A001010179518","2","氘可来昔替尼片","","限适合系统治疗或光疗的成年中重度斑块状银屑病患者。","208076","氘可来昔替尼片","颂狄多","片剂","6mg","盒","7","聚三氟氯乙烯/聚氯乙烯固体药品包装用复合硬片及药用铝箔包装。","Bristol-Myers Squibb Pharma EEIG","371.00 ","启用","招采变更","国谈药品"]
[1042,"XN05CFD373E001010204658","2","地达西尼胶囊","","限失眠患者。","207985","地达西尼胶囊","无","胶囊剂","2.5mg","盒","7","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装,外套聚酯/铝/聚乙烯药用复合膜袋。","浙江京新药业股份有限公司","97.16 ","启用","招采变更","国谈药品"]
[1043,"XL01FFE099B002010183422","2","恩朗苏拜单抗注射液","","限既往接受含铂化疗治疗失败的PD-L1表达阳性(CPS≥1)的复发或转移性宫颈癌患者。","209893","恩朗苏拜单抗注射液","恩舒幸","注射剂","100mg(10ml)/瓶","盒","1","中性硼硅玻璃管制注射剂瓶、注射制剂用氯化丁基橡胶塞","石药集团巨石生物制药有限公司","570.00 ","启用","招采变更","国谈药品"]
[1044,"XS01LAF740G003010181735","2","法瑞西单抗注射液","","\"限：1.糖尿病性黄斑水肿(DME)；2.新生血管性(湿性)年龄相关性黄斑变性(nAMD)；3.继发于视网膜分支静脉阻塞(BRVO)的黄斑水肿。应同时符合以下条件：1.需三级综合医院眼科或二级及以上眼科专科医院医师处方；2.首次处方时病眼基线矫正视力0.05-0.5；3.事前审查后方可用，初次申请需有血管造影或OCT(全身情况不允许的患者可以提供OCT血管成像)证据；4.每眼累计最多支付9支，第1年度最多支付5支。阿柏西普、雷珠单抗、康柏西普、法瑞西单抗的药品支数合并计算。\"","207179","法瑞西单抗注射液","罗视佳","眼用制剂","0.05ml(6mg)/瓶","盒","1","西林瓶装","Roche Pharma (Schweiz) AG","3608.00 ","启用","招采变更","国谈药品"]
[1045,"XC10ABF728E003010180487","2","非诺贝特酸胆碱缓释胶囊","","限：成人控制饮食基础上：1.降低重度高甘油三酯血症患者甘油三酯(TG)水平；2.原发性高胆固醇血症或混合型血脂异常患者的治疗。","208472","非诺贝特酸胆碱缓释胶囊","无","硬胶囊","135mg","盒","10","铝塑泡罩包装","ABBOTT LABORATORIES LIMITED","31.50 ","启用","招采变更","竞价药品"]
[1046,"XC10ABF728E003010301062","2","非诺贝特酸胆碱缓释胶囊","","限：成人控制饮食基础上：1.降低重度高甘油三酯血症患者甘油三酯(TG)水平；2.原发性高胆固醇血症或混合型血脂异常患者的治疗。","207360","非诺贝特酸胆碱缓释胶囊","无","缓释胶囊","135mg(按C₁₇H₁₅ClO₄计)","盒","7","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片、药用铝箔为内包装材料,外套聚酯/铝/聚乙烯药用复合膜。","广州市联瑞制药有限公司","22.05 ","启用","招采变更","竞价药品"]
[1047,"XA10BKF741A001010200153","2","脯氨酸加格列净片","","限2型糖尿病患者。","208082","脯氨酸加格列净片","惠优静","片剂(薄膜衣片)","按C₂₅H₂₉ClO₆计:25mg","盒","7","聚氯乙烯固体药用硬片及药用铝箔包装","惠升生物制药股份有限公司","25.76 ","启用","招采变更","国谈药品"]
[1048,"XA10BKF741A001020200153","2","脯氨酸加格列净片","","限2型糖尿病患者。","208083","脯氨酸加格列净片","惠优静","片剂(薄膜衣片)","按C₂₅H₂₉ClO₆计:50mg","盒","7","聚氯乙烯固体药用硬片及药用铝箔包装","惠升生物制药股份有限公司","43.82 ","启用","招采变更","国谈药品"]
[1049,"XL01EXA406E001010301523","2","富马酸安奈克替尼胶囊","","限ROS1阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","209040","富马酸安奈克替尼胶囊","安柏尼","胶囊剂","0.1g(按C₂₃H₂₄Cl₂FN₅O₂计)","盒","28","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药用铝箔","正大天晴药业集团股份有限公司","1682.80 ","启用","招采变更","国谈药品"]
[1050,"XL01EJG196E001010184411","2","戈利昔替尼胶囊","","限既往至少接受过一线系统性治疗的复发或难治的外周T细胞淋巴瘤(r/r PTCL)成人患者。","209822","戈利昔替尼胶囊","高瑞哲","胶囊剂","0.15g(按C₂₅H₃₁N₉O₂计)","盒","30","口服固体药用高密度聚乙烯瓶及聚丙烯儿童安全组合瓶盖系统。","迪哲(江苏)医药股份有限公司","15360.00 ","启用","招采变更","国谈药品"]
[1051,"XL01EDY355E001010101523","2","枸橼酸依奉阿克胶囊","","限未经过间变性淋巴瘤激酶(ALK)抑制剂治疗的ALK阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","209905","枸橼酸依奉阿克胶囊","安洛晴","胶囊剂","100mg(按C₂₄H₂₆Cl₂FN₅O₂计)","盒","28","本品采用聚酰胺铝聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","正大天晴药业集团股份有限公司","767.20 ","启用","招采变更","国谈药品"]
[1052,"XG03DAH124B002010103315","2","黄体酮注射液(Ⅱ)","","限辅助生殖技术(ART)中黄体酮的补充治疗，适用于不能使用或不能耐受阴道制剂的女性。","209826","黄体酮注射液(Ⅱ)","无","注射剂","1.112ml:25mg","瓶","1","中硼硅玻璃管制注射剂瓶,注射液用卤化丁基橡胶塞(溴化),抗生素瓶用铝塑组合盖包装","长春金赛药业有限责任公司","14.86 ","启用","招采变更","国谈药品"]
[1053,"ZA06BCJ0753010183234","2","九味止咳口服液","","","208279","九味止咳口服液","无","合剂","每1ml相当于饮片2.14g(每支装10ml)","盒","10","钠钙玻璃管制口服液体瓶；口服制剂用氯化丁基橡胶胶塞；口服液瓶用铝塑组合盖。","卓和药业集团股份有限公司","41.50 ","启用","招采变更","国谈药品"]
[1054,"ZA06BCJ0753010283234","2","九味止咳口服液","","","208931","九味止咳口服液","无","合剂","每1ml相当于饮片2.14g(每支装10ml)","盒","6","钠钙玻璃管制口服液体瓶；口服制剂用氯化丁基橡胶胶塞；口服液瓶用铝塑组合盖。","卓和药业集团股份有限公司","24.90 ","启用","招采变更","国谈药品"]
[1055,"XL01FFK143B002010182957","2","卡度尼利单抗注射液","","既往接受含铂化疗治疗失败的复发或转移性宫颈癌患者的治疗。","176395","卡度尼利单抗注射液","开坦尼","注射剂","125mg(10mL)/瓶","盒","1","中硼硅玻璃管制注射剂瓶、注射液用溴化丁基橡胶塞","康方药业有限公司","1860.00 ","启用","招采变更","国谈药品"]
[1056,"XA10BHK152A001010183791","2","考格列汀片","","","209686","考格列汀片","倍长平","片剂(薄膜衣片)","5mg","盒","4","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔包装","海思科医药集团股份有限公司","136.64 ","启用","招采变更","国谈药品"]
[1057,"XM05BXN129B002010181272","2","纳鲁索拜单抗注射液","","限不可手术切除或手术切除可能导致严重功能障碍的骨巨细胞瘤成人患者。","205763","纳鲁索拜单抗注射液","津立生","注射液","120mg(1.6mL)/瓶","盒","1","注射液用覆聚四氟乙烯/六氟丙烯共聚物膜氯化丁基橡胶塞、中硼硅玻璃管制注射剂瓶","上海津曼特生物科技有限公司","1150.00 ","启用","招采变更","国谈药品"]
[1058,"XL01XYP150B002010181735","2","帕妥珠曲妥珠单抗注射液(皮下注射)","","限：1.HER2阳性、局部晚期、炎性或早期乳腺癌患者(直径＞2cm或淋巴结阳性)的新辅助治疗；2.具有高复发风险HER2阳性早期乳腺癌患者的辅助治疗；3.既往未接受过针对转移性乳腺癌的抗HER2治疗或者化疗的HER2阳性、转移性或不可切除的局部复发性乳腺癌患者。","210765","帕妥珠曲妥珠单抗注射液(皮下注射)","赫双妥","注射液","维持剂量(10ml):帕妥珠单抗600mg与曲妥珠单抗600mg","盒","1","西林瓶","Roche Pharma(Schweiz)AG","7567.00 ","启用","招采变更","国谈药品"]
[1059,"XL01XYP150B002020181735","2","帕妥珠曲妥珠单抗注射液(皮下注射)","","限：1.HER2阳性、局部晚期、炎性或早期乳腺癌患者(直径＞2cm或淋巴结阳性)的新辅助治疗；2.具有高复发风险HER2阳性早期乳腺癌患者的辅助治疗；3.既往未接受过针对转移性乳腺癌的抗HER2治疗或者化疗的HER2阳性、转移性或不可切除的局部复发性乳腺癌患者。","210766","帕妥珠曲妥珠单抗注射液(皮下注射)","赫双妥","注射液","负荷剂量(15ml):帕妥珠单抗1200mg与曲妥珠单抗600mg","盒","1","西林瓶","Roche Pharma(Schweiz)AG","10321.14 ","启用","招采变更","国谈药品"]
[1060,"XL01XCS284B002010181453","2","赛帕利单抗注射液","","限：1.既往接受含铂化疗治疗失败的复发或转移性且PD-L1表达阳性(CPS≥1)的宫颈癌患者；2.至少经过二线系统化疗的复发或难治性经典型霍奇金淋巴瘤成人患者。","174956","赛帕利单抗注射液","誉妥","注射剂","120mg(4ml)/瓶","瓶","1","中性硼硅玻璃管制注射剂瓶装","广州誉衡生物科技有限公司","762.80 ","启用","招采变更","国谈药品"]
[1061,"XL01EBS297A001020182407","2","舒沃替尼片","","限既往经含铂化疗治疗时或治疗后出现疾病进展，或不耐受含铂化疗，并且检测确认存在表皮生长因子受体(EGFR)20号外显子插入突变的局部晚期或转移性非小细胞肺癌(NSCLC)的成人患者。","206767","舒沃替尼片","舒沃哲","薄膜衣片","150mg","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片＋药用铝箔形成的泡罩包装","迪哲(江苏)医药股份有限公司","4160.24 ","启用","招采变更","国谈药品"]
[1062,"XN03AXS296X006010102763","2","司替戊醇干混悬剂","","限婴儿严重肌阵挛性癫痫(SMEI，Dravet综合征)患者。","205154","司替戊醇干混悬剂","无","口服混悬剂","250mg","盒","30","纸/铝/聚乙烯药用复合膜","石家庄四药有限公司","566.40 ","启用","招采变更","国谈药品"]
[1063,"XN03AXS296X006020102763","2","司替戊醇干混悬剂","","限婴儿严重肌阵挛性癫痫(SMEI，Dravet综合征)患者。","205288","司替戊醇干混悬剂","无","口服混悬剂","500mg","盒","30","纸/铝/聚乙烯药用复合膜","石家庄四药有限公司","963.00 ","启用","招采变更","国谈药品"]
[1064,"ZE03AAT0321010102767","2","通络明目胶囊","","限2型糖尿病视网膜病变单纯性型。","210878","通络明目胶囊","无","胶囊剂","每粒装0.4g(相当于饮片2.21g)","盒","36","聚氯乙烯固体药用硬片、药用铝箔","石家庄以岭药业股份有限公司","78.12 ","启用","招采变更","国谈药品"]
[1065,"XC10AXT212B002010181451","2","托莱西单抗注射液","","限在接受中等剂量或中等剂量以上他汀类药物治疗，仍无法达到低密度脂蛋白胆固醇(LDL-C)目标的原发性高胆固醇血症(包括杂合子型家族性和非家族性高胆固醇血症)和混合型血脂异常的成人患者。","205325","托莱西单抗注射液","信必乐","注射剂","150mg(1ml)/支(预充式自动注射笔)","盒","1","预充式自动注射笔","信达生物制药(苏州)有限公司","286.00 ","启用","招采变更","国谈药品"]
[1066,"ZA06BCX0949010101946","2","小儿紫贝宣肺糖浆","","","207829","小儿紫贝宣肺糖浆","无","糖浆剂","每1ml相当于饮片0.72g(每瓶装100ml)","盒","1","口服液体药用聚酯瓶包装","健民药业集团股份有限公司","86.70 ","启用","招采变更","国谈药品"]
[1067,"XA10BAE096A010010181227","2","盐酸二甲双胍缓释片(Ⅳ)","","","206905","盐酸二甲双胍缓释片(Ⅳ)","无","缓释片","1.0g","瓶","30","口服固体药用高密度聚乙烯瓶","武汉久安药物研究院有限公司","35.10 ","启用","招采变更","国谈药品"]
[1068,"XN06AXT204A010010204139","2","盐酸托鲁地文拉法辛缓释片","","","177144","盐酸托鲁地文拉法辛缓释片","若欣林","片剂","40mg(按C24H31NO3·HCl计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","山东绿叶制药有限公司","67.48 ","启用","招采变更","国谈药品"]
[1069,"XN06AXT204A010020204139","2","盐酸托鲁地文拉法辛缓释片","","","177145","盐酸托鲁地文拉法辛缓释片","若欣林","片剂","80mg(按C24H31NO3·HCl计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔","山东绿叶制药有限公司","114.66 ","启用","招采变更","国谈药品"]
[1070,"XL04AJY353E001010278679","2","盐酸伊普可泮胶囊","","限既往未接受过补体抑制剂治疗的阵发性睡眠性血红蛋白尿症(PNH)成人患者。","209052","盐酸伊普可泮胶囊","飞赫达","胶囊剂","200mg(按C₂₅H₃₀N₂O₄计)","盒","56","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片及药用铝箔包装。","Novartis Pharma Schweiz AG","16990.40 ","启用","招采变更","国谈药品"]
[1071,"XC03DAY344A001010283302","2","依普利酮片","","","206006","依普利酮片","无","薄膜衣片","25mg","瓶","14","口服固体药用高密度聚乙烯瓶","南京卡文迪许生物工程技术有限公司","17.22 ","启用","招采变更","国谈药品"]
[1072,"XC03DAY344A001010483302","2","依普利酮片","","","206007","依普利酮片","无","薄膜衣片","25mg","瓶","30","口服固体药用高密度聚乙烯瓶","南京卡文迪许生物工程技术有限公司","36.90 ","启用","招采变更","国谈药品"]
[1073,"XL01FXY354B002010185204","2","依沃西单抗注射液","","限经表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗后进展的EGFR基因突变阳性的局部晚期或转移性非鳞状非小细胞肺癌(NSCLC)患者的治疗。","209552","依沃西单抗注射液","依达方","注射剂","100mg(10mL)/瓶","盒","1","中硼硅玻璃管制注射剂瓶","康方赛诺医药有限公司","736.00 ","启用","招采变更","国谈药品"]
[1074,"ZA14BAZ0572010105337","2","枳实总黄酮片","","","206236","枳实总黄酮片","无","薄膜衣片","每片重0.29g(含枳实总黄酮95mg)","盒","24","聚氯乙烯固体药用硬片、药用铝箔","江西青峰药业有限公司","59.76 ","启用","招采变更","国谈药品"]
[1075,"XB02BCC176T002010181829","2","重组人凝血酶","","限成人经标准外科止血技术(如缝合、结扎或电凝)控制出血无效或不可行，促进手术创面渗血或毛细血管和小静脉出血的止血。","207251","重组人凝血酶","无","涂剂","5000IU/支","盒","1","中硼硅玻璃管制注射剂瓶、注射制剂用氯化丁基橡胶塞和抗生素瓶用铝塑组合盖","苏州泽璟生物制药股份有限公司","373.00 ","启用","招采变更","国谈药品"]
[1076,"XL01XXA398B001010101938","2","注射用埃普奈明","","限既往接受过至少2种系统性治疗方案的复发或难治性多发性骨髓瘤成人患者，既往含免疫调节剂方案难治的患者不宜接受本联合方案治疗。","207100","注射用埃普奈明","沙艾特","注射剂","100mg(8,000,000U)/瓶","盒","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用溴化丁基胶塞、铝塑组合盖","武汉海特生物制药股份有限公司","352.00 ","启用","招采变更","国谈药品"]
[1077,"XL01FDD365B001010182561","2","注射用德曲妥珠单抗","","限：1.既往接受过一种或一种以上抗HER2药物治疗的不可切除或转移性HER2阳性成人乳腺癌患者；2.既往在转移性疾病阶段接受过至少一种系统治疗的，或在辅助化疗期间或完成辅助化疗之后6个月内复发的，不可切除或转移性HER2低表达(IHC 1+或IHC 2+/ISH-)成人乳腺癌患者。","203675","注射用德曲妥珠单抗","优赫得","注射剂","100mg/瓶","盒","1","I型琥珀色玻璃瓶,氟树脂层压的丁基橡胶瓶塞。","Daiichi Sankyo Europe GmbH","3480.00 ","启用","招采变更","国谈药品"]
[1078,"XN01AXL392B001020102000","2","注射用磷丙泊酚二钠","","限成人全身麻醉的诱导。","174048","注射用磷丙泊酚二钠","无","注射剂","0.5g(按C13H19Na2O5P计)","支","1","中硼硅玻璃管制注射剂瓶","宜昌人福药业有限责任公司","42.38 ","启用","招采变更","国谈药品"]
[1079,"XB02BXL422B001010104021","2","注射用罗普司亭N01","","限对其他治疗(例如皮质类固醇、免疫球蛋白)治疗反应不佳的成人(≥18周岁)慢性原发免疫性血小板减少症(ITP)患者。","208671","注射用罗普司亭N01","无","注射剂","250μg/瓶","盒","1","中硼硅玻璃管制注射剂瓶包装","齐鲁制药有限公司","1475.00 ","启用","招采变更","国谈药品"]
[1080,"XJ01DDT215B002010104948","2","注射用头孢他啶阿维巴坦钠/氯化钠注射液","","","206780","注射用头孢他啶阿维巴坦钠/氯化钠注射液","无","即配型粉液双室袋注射剂","粉体室:2.5g(C₂₂H₂₂N₆O₇S₂2.0g与C₇H₁₁N₃O₆S0.5g)；液体室:100ml:0.9g","袋","1","三层共挤(粉-液)输液用袋","湖南科伦制药有限公司","326.00 ","启用","招采变更","国谈药品"]
[1081,"XL01FXW129B001010181735","2","注射用维泊妥珠单抗","","限：1.既往未经治疗的弥漫大B细胞淋巴瘤(DLBCL)成人患者；2.不适合接受造血干细胞移植的复发或难治性弥漫大B细胞淋巴瘤(DLBCL)成人患者。","300420","注射用维泊妥珠单抗","优罗华","注射剂","30mg/瓶","盒","1","西林瓶装","Roche Pharma (Schweiz)AG","5821.00 ","启用","招采变更","国谈药品"]
[1082,"XD11AHA379A001010178718","2","阿布昔替尼片","","限其他系统治疗(如激素或生物制剂)应答不佳或不适宜上述治疗的难治性、中重度特应性皮炎成人和12岁及以上青少年患者。","310062","阿布昔替尼片","希必可","片剂","50mg","瓶","14","高密度聚乙烯瓶包装","Pfizer Inc.","556.64 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1083,"XD11AHA379A001020178718","2","阿布昔替尼片","","限其他系统治疗(如激素或生物制剂)应答不佳或不适宜上述治疗的难治性、中重度特应性皮炎成人和12岁及以上青少年患者。","176071","阿布昔替尼片","希必可","片剂","100mg","瓶","14","高密度聚乙烯瓶包装","Pfizer Inc.","946.40 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1084,"XD11AHA379A001030178718","2","阿布昔替尼片","","限其他系统治疗(如激素或生物制剂)应答不佳或不适宜上述治疗的难治性、中重度特应性皮炎成人和12岁及以上青少年患者。","310063","阿布昔替尼片","希必可","片剂","200mg","瓶","14","高密度聚乙烯瓶包装","Pfizer Inc.","1608.88 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1085,"XA04AAA202M002010101445","2","昂丹司琼口溶膜","","","174922","昂丹司琼口溶膜","无","膜剂","4mg","盒","10","纸/铝/沙林药用复合膜","江苏恒瑞医药股份有限公司","113.50 ","修改（支付标准）","招采变更","国谈药品"]
[1086,"XA04AAA202M002020101445","2","昂丹司琼口溶膜","","","174923","昂丹司琼口溶膜","无","膜剂","8mg","盒","10","纸/铝/沙林药用复合膜","江苏恒瑞医药股份有限公司","193.00 ","修改（支付标准）","招采变更","国谈药品"]
[1087,"XA04AAA202M002020201445","2","昂丹司琼口溶膜","","","177086","昂丹司琼口溶膜","无","膜剂","8mg","盒","6","纸/铝/沙林药用复合膜","江苏恒瑞医药股份有限公司","115.80 ","修改（支付标准）","招采变更","国谈药品"]
[1088,"XL01XCA371B002010179584","2","奥法妥木单抗注射液","","限成人复发型多发性硬化(RMS)。","175237","奥法妥木单抗注射液","全欣达","注射剂","20mg(0.4ml)/支","盒","1","奥法妥木单抗注射液装在一次性玻璃注射器中,该注射器配有不锈钢针头、柱塞和硬质针头护套,溶液量为0.4mL。注射器已被装配到预充式自动注射笔中。","Novartis Pharmaceuticals  Corporation","6018.00 ","修改（招标信息）","招采变更","国谈药品"]
[1089,"XL01XEA368A001010181522","2","奥雷巴替尼片","","限T315I突变的慢性髓细胞白血病慢性期或加速期的成年患者。","176010","奥雷巴替尼片","耐立克","片剂","10mg","瓶","60","口服固体药用高密度聚乙烯瓶及聚丙烯儿童安全组合瓶盖系统","江苏宣泰药业有限公司","14340.00","停用","招采国码变更","国谈药品"]
[1090,"XL01EAA368A001010181522","2","奥雷巴替尼片","","限：1.对一代和二代酪氨酸激酶抑制剂耐药和/或不耐受的慢性髓细胞白血病慢性期成年患者；2.T315I突变的慢性髓细胞白血病慢性期或加速期的成年患者。","176010","奥雷巴替尼片","耐立克","片剂","10mg","瓶","60","口服固体药用高密度聚乙烯瓶及聚丙烯儿童安全组合瓶盖系统","广州顺健生物医药科技有限公司","12906.00 ","启用","招采国码变更","国谈药品"]
[1091,"XN01BBB164B018010104948","2","布比卡因脂质体注射液","","限：1.12岁及以上的患者单剂量浸润产生术后局部镇痛；2. 成人肌间沟臂丛神经阻滞产生术后区域镇痛。","210957","布比卡因脂质体注射液","无","注射剂","20ml:266mg","盒","1","中硼硅玻璃管制注射剂瓶,注射制剂用氯化丁基橡胶塞及抗生素瓶用铝塑组合盖","湖南科伦制药有限公司","362.90 ","修改（支付标准）","招采变更","国谈药品"]
[1092,"XR03ALB240L028010179096","2","布地格福吸入气雾剂","","限慢性阻塞性肺疾病。","168454","布地格福吸入气雾剂","无","气雾剂","每瓶120揿,每揿含布地奈德160μg,格隆铵7.2μg和富马酸福莫特罗4.8μg","盒","1","本品采用定量定压式吸入器(包装系统)包装,包括以计量阀门密封的带有内涂层的铝罐,剂量指示装置,干燥流路以及带有防尘帽的塑料揿压器。每个吸入器单独包装在内含干燥剂的铝箔层袋中。外包装为纸盒。","AstraZeneca AB","233.00 ","修改（招标信息）","招采变更","国谈药品"]
[1093,"ZA09GAC0085010102384","2","参龙宁心胶囊","","限冠心病和成年人恢复期病毒型心肌炎出现的轻度或中度室性过早搏动见上述证候者。","133051","参龙宁心胶囊","无","胶囊剂","每粒装0.5g","盒","36","药用铝塑泡罩包装","陕西健民制药有限公司","12.60 ","修改（招标信息）","招采变更","国谈药品"]
[1094,"ZA09GAC0085010202384","2","参龙宁心胶囊","","限冠心病和成年人恢复期病毒型心肌炎出现的轻度或中度室性过早搏动见上述证候者。","133052","参龙宁心胶囊","无","胶囊剂","0.5g","盒","60","铝塑板、纸盒","陕西健民制药有限公司","21.00 ","修改（招标信息）","招采变更","国谈药品"]
[1095,"XV01AAC173X003010101415","2","肠内营养乳剂(SP)","","需经营养风险筛查，明确具有营养风险，且应为不能经饮食补充足够营养的患者方予支付。","175738","肠内营养乳剂(SP)","无","口服乳剂","500ml","袋","1","聚酯/聚酯-氧化硅/流延聚丙烯肠内营养乳剂用复合袋装","费森尤斯卡比华瑞制药有限公司","68.40 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1096,"ZA12HAD0076010205701","2","丹灯通脑软胶囊","","","171753","丹灯通脑软胶囊","无","软胶囊剂","每粒装0.55g","瓶","36","塑料瓶","云南神威施普瑞药业有限公司","22.32 ","修改（招标信息）","招采变更","国谈药品"]
[1097,"ZA12HAD0076010305701","2","丹灯通脑软胶囊","","","171758","丹灯通脑软胶囊","无","软胶囊剂","每粒装0.55g","瓶","72","塑料瓶","云南神威施普瑞药业有限公司","44.64 ","修改（招标信息）","招采变更","国谈药品"]
[1098,"XN07XXD221B002010102774","2","丁苯酞氯化钠注射液","","限新发的急性缺血性脑卒中患者在发作48小时内开始使用，支付不超过14天。","119796","丁苯酞氯化钠注射液","无","注射剂","100ml:丁苯酞25mg与氯化钠0.9g","瓶","1","玻璃瓶","石药集团恩必普药业有限公司","102.16 ","修改（招标信息）","招采变更","国谈药品"]
[1099,"XN07XXD130E002010102774","2","丁苯酞软胶囊","","限新发的急性缺血性脑卒中患者在发作72小时内开始使用，支付不超过20天。","106156","丁苯酞软胶囊","恩必普","软胶囊","0.1g","瓶","24","聚酯塑料瓶","石药集团恩必普药业有限公司","77.76 ","修改（招标信息）","招采变更","国谈药品"]
[1100,"XN07XXD130E002010202774","2","丁苯酞软胶囊","","限新发的急性缺血性脑卒中患者在发作72小时内开始使用，支付不超过20天。","162414","丁苯酞软胶囊","恩必普","软胶囊","0.1g","瓶","36","聚酯塑料瓶","石药集团恩必普药业有限公司","116.64 ","修改（招标信息）","招采变更","国谈药品"]
[1101,"XN07XXD130E002010402774","2","丁苯酞软胶囊","","限新发的急性缺血性脑卒中患者在发作72小时内开始使用，支付不超过20天。","176832","丁苯酞软胶囊","恩必普","软胶囊","0.1g","瓶","60","聚酯塑料瓶","石药集团恩必普药业有限公司","194.40 ","修改（招标信息）","招采变更","国谈药品"]
[1102,"XD11AHD344B002010282507","2","度普利尤单抗注射液","","限对传统治疗无效、有禁忌或不耐受的中重度特应性皮炎患者，需按说明书用药。","171001","度普利尤单抗注射液","达必妥","注射剂","300mg(2.0mL)/支(预充式注射器)","盒","1","2mL(300mg)溶液装于带有一个固定不锈钢针头的预充式注射器(1型透明玻璃)中,预充式注射器带有针头防护的安全装置。","Sanofi-aventis groupe","1508.00 ","修改（招标信息）","招采变更","国谈药品"]
[1103,"XD11AHD344B002020182507","2","度普利尤单抗注射液","","限对传统治疗无效、有禁忌或不耐受的中重度特应性皮炎患者，需按说明书用药。","174451","度普利尤单抗注射液","达必妥","注射剂","200mg(1.14mL)/支(预充式注射器)","盒","1","1.14mL(200mg)溶液装于带有一个固定不锈钢针头的预充式注射器(1型透明玻璃)中,预充式注射器带有针头防护的安全装置。","Sanofi-aventis groupe","1105.60 ","修改（招标信息）","招采变更","国谈药品"]
[1104,"XJ05ARD349A001010179325","2","多拉米替片","","限艾滋病病毒感染。","310070","多拉米替片","无","片剂","每片含多拉韦林100mg、拉米夫定300mg和富马酸替诺福韦二吡呋酯300mg","瓶","30","高密度聚乙烯瓶","Merck Sharp & Dohme B.V.","837.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1105,"XC03DAF731A001010278262","2","非奈利酮片","","限2型糖尿病相关的慢性肾脏病成人患者。","177142","非奈利酮片","可申达","片剂","10mg","盒","14","药用铝箔,聚氯乙烯/聚偏二氯乙烯固体药用复合硬片包装","Bayer AG","90.30 ","修改（支付标准）","招采变更","国谈药品"]
[1106,"XC03DAF731A001010378262","2","非奈利酮片","","限2型糖尿病相关的慢性肾脏病成人患者。","204499","非奈利酮片","可申达","片剂","10mg","盒","28","药用铝箔,聚氯乙烯/聚偏二氯乙烯固体药用复合硬片包装","Bayer AG","180.60 ","修改（支付标准）","招采变更","国谈药品"]
[1107,"XA10BKH120A001010101445","2","脯氨酸恒格列净片","","限成人2型糖尿病患者。","174731","脯氨酸恒格列净片","瑞沁","片剂","5mg（按C22H24ClFO7计）","盒","10","采用聚氯乙烯固体药用硬片加药用铝箔,外加纸盒包装。","江苏恒瑞医药股份有限公司","34.90 ","修改（支付标准）","招采变更","国谈药品"]
[1108,"XA10BKH120A001020101445","2","脯氨酸恒格列净片","","限成人2型糖尿病患者。","174730","脯氨酸恒格列净片","瑞沁","片剂","10mg（按C22H24ClFO7计）","盒","10","采用聚氯乙烯固体药用硬片加药用铝箔,外加纸盒包装。","江苏恒瑞医药股份有限公司","59.30 ","修改（支付标准）","招采变更","国谈药品"]
[1109,"XS01XAF240G002010101322","2","复方电解质眼内冲洗液","","","163170","复方电解质眼内冲洗液","世可","溶液剂(眼用)","250ml","瓶","1","玻璃瓶","沈阳兴齐眼药股份有限公司","29.81 ","修改（支付标准）","招采变更","国谈药品"]
[1110,"XS01XAF240G002020101322","2","复方电解质眼内冲洗液","","","163168","复方电解质眼内冲洗液","世可","溶液剂(眼用)","500ml瓶装480ml(第Ⅰ部分)及30ml瓶装20ml(第Ⅱ部分)","瓶","1","玻璃瓶","沈阳兴齐眼药股份有限公司","50.68 ","修改（支付标准）","招采变更","国谈药品"]
[1111,"XL01EBA328A001010501444","2","甲磺酸阿美替尼片","","限：1.表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗；2.既往经EGFR酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展,并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性非小细胞肺癌成人患者的治疗。","168880","甲磺酸阿美替尼片","阿美乐","片剂","55mg(按C30H35N7O2计)","盒","20","聚氯乙烯固体药用硬片和药用铝箔包装,加药用固体纸袋装硅胶干燥剂,外套聚酯/铝/聚乙烯药用复合膜袋","江苏豪森药业集团有限公司","1854.80 ","修改（招标信息）","招采变更","国谈药品"]
[1112,"XL01EBB256E001010104611","2","甲磺酸贝福替尼胶囊","","限：1.表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R)置换突变的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者的一线治疗；2.既往经表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI)治疗时或治疗后出现疾病进展，并且经检测确认存在EGFR T790M突变阳性的局部晚期或转移性非小细胞肺癌(NSCLC)成人患者。","204779","甲磺酸贝福替尼胶囊","赛美纳","胶囊剂","25mg(按C29H32F3N7O2计)","盒","40","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片、药品包装用铝箔包装","贝达药业股份有限公司","2051.20 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1113,"XL01XED340E001010278672","2","甲磺酸达拉非尼胶囊","","限：1.BRAF V600 突变阳性不可切除或转移性黑色素瘤：联合曲美替尼适用于治疗BRAF V600 突变阳性的不可切除或转移性黑色素瘤患者；2.BRAF V600 突变阳性黑色素瘤的术后辅助治疗：联合曲美替尼适用于BRAF V600 突变阳性的III期黑色素瘤患者完全切除后的辅助治疗；3.BRAF V600突变阳性的转移性非小细胞肺癌：联合曲美替尼适用于治疗BRAF V600突变阳性的转移性非小细胞肺癌患者。","171673","甲磺酸达拉非尼胶囊","泰菲乐","胶囊剂","50mg(以C23H20F3N5O2S2计)","瓶","120","配有聚丙烯螺旋瓶盖和硅胶干燥剂的不透明白色高密度聚乙烯瓶中","Novartis Europharm Limited","6510.00 ","修改（招标信息）","招采变更","国谈药品"]
[1114,"XL01XED340E001020278672","2","甲磺酸达拉非尼胶囊","","限：1.BRAF V600 突变阳性不可切除或转移性黑色素瘤：联合曲美替尼适用于治疗BRAF V600 突变阳性的不可切除或转移性黑色素瘤患者；2.BRAF V600 突变阳性黑色素瘤的术后辅助治疗：联合曲美替尼适用于BRAF V600 突变阳性的III期黑色素瘤患者完全切除后的辅助治疗；3.BRAF V600突变阳性的转移性非小细胞肺癌：联合曲美替尼适用于治疗BRAF V600突变阳性的转移性非小细胞肺癌患者。","171678","甲磺酸达拉非尼胶囊","泰菲乐","胶囊剂","75mg(以C23H20F3N5O2S2计)","瓶","120","包装于配有聚丙烯螺旋瓶盖和硅胶干燥剂的不透明白色高密度聚乙烯瓶中","Novartis Europharm Limited","8880.00 ","修改（招标信息）","招采变更","国谈药品"]
[1115,"XL01EAF716A001020201444","2","甲磺酸氟马替尼片","","限费城染色体阳性的慢性髓性白血病(Ph+ CML)慢性期成人患者。","166680","甲磺酸氟马替尼片","豪森昕福","片剂(薄膜衣片)","0.2g(以甲磺酸氟马替尼计)","盒","30","铝塑包装","江苏豪森药业集团有限公司","1749.90 ","修改（招标信息）","招采变更","国谈药品"]
[1116,"ZA17AAJ0229010202729","2","降脂通络软胶囊","","活血行气，降脂祛浊。用于高脂血症属血瘀气滞证者，症见胸胁胀痛、心前区刺痛、胸闷、舌尖边有瘀点或瘀斑、脉弦或涩。","104430","降脂通络软胶囊","无","软胶囊剂","每粒含姜黄素类化合物50mg","瓶","36","聚乙烯塑料瓶","神威药业集团有限公司","25.20 ","修改（招标信息）","招采变更","国谈药品"]
[1117,"ZA17AAJ0229010302729","2","降脂通络软胶囊","","活血行气，降脂祛浊。用于高脂血症属血瘀气滞证者，症见胸胁胀痛、心前区刺痛、胸闷、舌尖边有瘀点或瘀斑、脉弦或涩。","171762","降脂通络软胶囊","无","软胶囊剂","每粒含姜黄素类化合物50mg","瓶","60","聚乙烯塑料瓶","神威药业集团有限公司","42.00 ","修改（招标信息）","招采变更","国谈药品"]
[1118,"ZA04BAJ0499010201795","2","金银花口服液","","","166686","金银花口服液","无","合剂","每1ml相当于饮片90mg,10ml/支","盒","10","聚对苯二甲酸乙二醇酯/聚偏二氯乙烯/低密度聚乙烯口服液体药用复合硬片(PET/PVDC/LDPE),聚酯(PET)/铝(Al)/聚酯(PET)/聚乙烯(PE)口服液体药用灭菌型复合膜","真奥金银花药业有限公司","29.40 ","修改（招标信息）","招采变更","国谈药品"]
[1119,"ZA04BAJ0499020101795","2","金银花口服液","","","150609","金银花口服液","无","合剂","每1ml相当于饮片90mg,20ml/支","盒","6","聚对苯二甲酸乙二醇酯/聚偏二氯乙烯/低密度聚乙烯口服液体药用复合硬片(PET/PVDC/LDPE),聚酯(PET)/铝(Al)/聚酯(PET)/聚乙烯(PE)口服液体药用灭菌型复合膜","真奥金银花药业有限公司","30.00 ","修改（招标信息）","招采变更","国谈药品"]
[1120,"ZA04BAJ0499020201795","2","金银花口服液","","","156070","金银花口服液","无","合剂","每1ml相当于饮片90mg,20ml/支","盒","10","聚酯(PET)/铝(Al)/聚酯(PET)/聚乙烯(PE)口服液体药用灭菌型复合膜","真奥金银花药业有限公司","50.00 ","修改（招标信息）","招采变更","国谈药品"]
[1121,"ZA04BAJ0499020301795","2","金银花口服液","","","171771","金银花口服液","无","合剂","每1ml相当于饮片90mg,20ml/支","盒","30","聚对苯二甲酸乙二醇酯/聚偏二氯乙烯/低密度聚乙烯口服液体药用复合硬片(PET/PVDC/LDPE),聚酯(PET)/铝(Al)/聚酯(PET)/聚乙烯(PE)口服液体药用灭菌型复合膜","真奥金银花药业有限公司","150.00 ","修改（招标信息）","招采变更","国谈药品"]
[1122,"ZA04BAJ0499020401795","2","金银花口服液","","","171772","金银花口服液","无","合剂","每1ml相当于饮片90mg,20ml/支","盒","18","聚酯(PET)/铝(Al)/聚酯(PET)/聚乙烯(PE)口服液体药用灭菌型复合膜","真奥金银花药业有限公司","90.00 ","修改（招标信息）","招采变更","国谈药品"]
[1123,"XA10BJJ237B002010101444","2","聚乙二醇洛塞那肽注射液","","限二甲双胍等口服降糖药或胰岛素控制效果不佳的BMI≥25的患者，首次处方时需由二级及以上医疗机构专科医师开具处方。","165851","聚乙二醇洛塞那肽注射液","孚来美","注射剂","0.5ml:0.1mg(以C187H288N50O59S计)","盒","1","笔式注射器单独包装。笔芯(卡式瓶)由笔式注射器用硼硅玻璃套筒、笔式注射器用溴化丁基橡胶活塞、笔式注射器用铝盖(含垫片)组成","江苏豪森药业集团有限公司","81.76 ","修改（招标信息）","招采变更","国谈药品"]
[1124,"XA10BJJ237B002020101444","2","聚乙二醇洛塞那肽注射液","","限二甲双胍等口服降糖药或胰岛素控制效果不佳的BMI≥25的患者，首次处方时需由二级及以上医疗机构专科医师开具处方。","165852","聚乙二醇洛塞那肽注射液","孚来美","注射剂","0.5ml:0.2mg(以C187H288N50O59S计)","盒","1","笔式注射器单独包装。笔芯(卡式瓶)由笔式注射器用硼硅玻璃套筒、笔式注射器用溴化丁基橡胶活塞、笔式注射器用铝盖(含垫片)组成","江苏豪森药业集团有限公司","139.00 ","修改（招标信息）","招采变更","国谈药品"]
[1125,"ZC01AAK0036010104672","2","康莱特注射液","","限二级及以上医疗机构。","135793","康莱特注射液","无","注射液","100ml:10g","瓶","1","玻璃输液瓶","浙江康莱特药业有限公司","128.90 ","修改（招标信息）","招采变更","国谈药品"]
[1126,"XB06ACL388B002010183281","2","拉那利尤单抗注射液","","限12岁及以上患者预防遗传性血管性水肿(HAE)发作。","173531","拉那利尤单抗注射液","达泽优","注射剂","300mg/2ml(150mg/ml)","瓶","1","单剂量玻璃小瓶","Takeda Pharmaceuticals U.S.A., Inc.","14155.00 ","修改（招标信息）","招采变更","国谈药品"]
[1127,"ZA04BAL0021020101749","2","蓝芩口服液","","","101214","蓝芩口服液","无","合剂","每1毫升相当于饮片2.12克(每支装10ml)","盒","6","钠钙玻璃管制口服液瓶装","扬子江药业集团江苏龙凤堂中药有限公司","33.96 ","修改（招标信息）","招采变更","国谈药品"]
[1128,"ZA04BAL0021020201749","2","蓝芩口服液","","","171724","蓝芩口服液","无","合剂","每1毫升相当于饮片2.12克(每支装10ml)","盒","7","钠钙玻璃管制口服液瓶装","扬子江药业集团江苏龙凤堂中药有限公司","39.62 ","修改（招标信息）","招采变更","国谈药品"]
[1129,"ZA04BAL0021020301749","2","蓝芩口服液","","","151762","蓝芩口服液","无","合剂","每1毫升相当于饮片2.12克(每支装10ml)","盒","12","钠钙玻璃管制口服液瓶","扬子江药业集团江苏龙凤堂中药有限公司","67.92 ","修改（招标信息）","招采变更","国谈药品"]
[1130,"ZA04BAL0021020401749","2","蓝芩口服液","","","172191","蓝芩口服液","无","合剂","每1毫升相当于饮片2.12克(每支装10ml)","盒","9","钠钙玻璃管制口服液瓶","扬子江药业集团江苏龙凤堂中药有限公司","50.94 ","修改（招标信息）","招采变更","国谈药品"]
[1131,"XN07XXL068X002010178532","2","利鲁唑口服混悬液","","限肌萎缩侧索硬化(ALS)。","176836","利鲁唑口服混悬液","无","口服混悬剂","300ml:1.5g","盒","1","采用琥珀色玻璃瓶(III型)包装,配有儿童防护螺旋盖和注射器适配器。盒内配有10ml口服给药注射器。","ITALFARMACO, S.A.","520.00 ","修改（支付标准）","招采变更","国谈药品"]
[1132,"XL01XEL356A001010278672","2","磷酸芦可替尼片","","限：1.中危或高危的原发性骨髓纤维化(PMF)(亦称为慢性特发性骨髓纤维化)、真性红细胞增多症继发的骨髓纤维化(PPV-MF)或原发性血小板增多症继发的骨髓纤维化(PET-MF)的成年患者；2.对糖皮质激素或其他系统治疗应答不充分的12岁及以上急性移植物抗宿主病(急性GVHD)或慢性移植物抗宿主病(慢性GVHD)患者。","163085","磷酸芦可替尼片","捷恪卫","片剂","5mg","盒","60","PVC/PCTFE-铝泡罩包装","Novartis Europharm Limited","2940.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1133,"XL01EDL404A001010382879","2","洛拉替尼片","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌患者。","176081","洛拉替尼片","博瑞纳","片剂","25mg","盒","90","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片,药用铝箔","Pfizer Europe MA EEIG","13485.60 ","修改（招标信息）","招采变更","国谈药品"]
[1134,"XL01EDL404A001020282879","2","洛拉替尼片","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌患者。","176080","洛拉替尼片","博瑞纳","片剂","100mg","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片,药用铝箔。","Pfizer Europe MA EEIG","12990.90 ","修改（招标信息）","招采变更","国谈药品"]
[1135,"XR03DXM177B002010182649","2","美泊利珠单抗注射液","","限：1.成人和12岁及以上青少年重度嗜酸粒细胞性哮喘(SEA)的维持治疗；2.成人嗜酸性肉芽肿性多血管炎(EGPA)。","310084","美泊利珠单抗注射液","新可来","注射剂","100mg(1ml)/支(单剂量预充式自动注射器)","盒","1","单剂量预充式自动注射器","GlaxoSmithKline Trading Services Limited","2880.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1136,"ZA01BAN0120010203719","2","牛黄清感胶囊","","","118473","牛黄清感胶囊","无","硬胶囊","每粒装0.3g人工牛黄","盒","36","铝塑包装","黑龙江澳利达奈德制药有限公司","22.68 ","修改（招标信息）","招采变更","国谈药品"]
[1137,"ZA01BAN0120010303719","2","牛黄清感胶囊","","","171752","牛黄清感胶囊","无","硬胶囊","每粒装0.3g人工牛黄","盒","48","铝塑包装","黑龙江澳利达奈德制药有限公司","30.24 ","修改（招标信息）","招采变更","国谈药品"]
[1138,"ZA13BAQ0642010101946","2","七蕊胃舒胶囊","","","175735","七蕊胃舒胶囊","无","胶囊剂","每粒装0.5g(相当于饮片0.5g)","盒","24","聚氯乙烯固体药用硬片/药用铝箔包装","健民药业集团股份有限公司","72.24 ","修改（支付标准）","招采变更","国谈药品"]
[1139,"ZA13BAQ0642010301946","2","七蕊胃舒胶囊","","","310092","七蕊胃舒胶囊","无","胶囊剂","每粒装0.5g(相当于饮片0.5g)","盒","12","聚氯乙烯固体药用硬片/药用铝箔包装","健民药业集团股份有限公司","36.12 ","修改（支付标准）","招采变更","国谈药品"]
[1140,"ZA09GAQ0641010104085","2","芪蛭益肾胶囊","","","174758","芪蛭益肾胶囊","无","胶囊剂","0.38g（相当于饮片2.86g）","瓶","45","口服固体药用高密度聚乙烯瓶","山东凤凰制药股份有限公司","97.65 ","修改（支付标准）","招采变更","国谈药品"]
[1141,"XL01XEQ175A001010378672","2","曲美替尼片","","限：1.BRAF V600 突变阳性不可切除或转移性黑色素瘤：联合甲磺酸达拉非尼适用于治疗BRAF V600 突变阳性的不可切除或转移性黑色素瘤患者；2.BRAF V600 突变阳性黑色素瘤的术后辅助治疗：联合甲磺酸达拉非尼适用于BRAF V600 突变阳性的III期黑色素瘤患者完全切除后的辅助治疗；3.BRAF V600突变阳性的转移性非小细胞肺癌：联合甲磺酸达拉非尼适用于治疗BRAF V600突变阳性的转移性非小细胞肺癌患者。","171676","曲美替尼片","迈吉宁","片剂","按C26H23FIN5O4计2mg","瓶","30","高密度聚乙烯(HDPE)瓶,配有防止儿童开启的聚丙烯瓶盖。","Novartis Europharm Limited","8878.80 ","修改（招标信息）","招采变更","国谈药品"]
[1142,"XL01XEQ175A001010478672","2","曲美替尼片","","限：1.BRAF V600 突变阳性不可切除或转移性黑色素瘤：联合甲磺酸达拉非尼适用于治疗BRAF V600 突变阳性的不可切除或转移性黑色素瘤患者；2.BRAF V600 突变阳性黑色素瘤的术后辅助治疗：联合甲磺酸达拉非尼适用于BRAF V600 突变阳性的III期黑色素瘤患者完全切除后的辅助治疗；3.BRAF V600突变阳性的转移性非小细胞肺癌：联合甲磺酸达拉非尼适用于治疗BRAF V600突变阳性的转移性非小细胞肺癌患者。","171675","曲美替尼片","迈吉宁","片剂","按C26H23FIN5O4计0.5mg","瓶","30","高密度聚乙烯(HDPE)瓶,配有防止儿童开启的聚丙烯瓶盖。","Novartis Europharm Limited","3072.30 ","修改（招标信息）","招采变更","国谈药品"]
[1143,"ZI01AAR0193010105871","2","如意珍宝片","","","156014","如意珍宝片","无","薄膜衣片","每片重0.5g(人工牛黄、人工麝香)","盒","30","口服固体药用高密度聚乙烯瓶","甘肃奇正藏药有限公司","53.70 ","修改（招标信息）","招采变更","国谈药品"]
[1144,"XL01EXR114A001010183506","2","瑞派替尼片","","限既往接受过3种或以上激酶抑制剂(包括伊马替尼)的晚期胃肠间质瘤(GIST)成人患者。","172507","瑞派替尼片","擎乐","片剂","50mg(C24H21BrFN5O2)","瓶","30","高密度聚乙烯(HDPE)瓶包装","Deciphera Pharmaceuticals, LLC","4910.70 ","修改（招标信息）","招采变更","国谈药品"]
[1145,"ZA09GAS1081010182917","2","桑枝总生物碱片","","","171116","桑枝总生物碱片","无","片剂","每片含桑枝总生物碱以1-脱氧野尻霉素计为50mg","盒","24","聚三氟氯乙烯/聚氯乙烯固体药用复合硬片、药用铝箔","北京五和博澳药业股份有限公司","94.08 ","修改（招标信息）","招采变更","国谈药品"]
[1146,"XL04ACS271B002040178679","2","司库奇尤单抗注射液","","限：1.符合系统治疗或光疗指征的中度至重度斑块状银屑病的6岁及以上患者；2.常规治疗疗效欠佳的强直性脊柱炎的成年患者；3. 既往传统的改善病情抗风湿药(cDMARDs)疗效不佳或不耐受的活动性银屑病关节炎成人患者。","203517","司库奇尤单抗注射液","可善挺","注射剂","0.5ml:75mg","盒","1","预装式注射器","Novartis Pharma Schweiz AG","458.03 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1147,"XL04ACS271B002050178679","2","司库奇尤单抗注射液","","限：1.符合系统治疗或光疗指征的中度至重度斑块状银屑病的6岁及以上患者；2.常规治疗疗效欠佳的强直性脊柱炎的成年患者；3. 既往传统的改善病情抗风湿药(cDMARDs)疗效不佳或不耐受的活动性银屑病关节炎成人患者。","203518","司库奇尤单抗注射液","可善挺","注射液","2ml:300mg","盒","1","预装式自动注射笔","Novartis Pharma Schweiz AG","1323.71 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1148,"XL04ACS271B002030178679","2","司库奇尤单抗注射液","","限：1.符合系统治疗或光疗指征的中度至重度斑块状银屑病的6岁及以上患者；2.常规治疗疗效欠佳的强直性脊柱炎的成年患者；3. 既往传统的改善病情抗风湿药(cDMARDs)疗效不佳或不耐受的活动性银屑病关节炎成人患者。","300417","司库奇尤单抗注射液","可善挺","注射剂","1ml:150mg","盒","1","预装式自动注射笔","Novartis Pharma Schweiz AG","778.65 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1149,"XA02BCT200A001010104141","2","替戈拉生片","","限：1.反流性食管炎；2.十二指肠溃疡。","175715","替戈拉生片","泰欣赞","片剂","50mg","盒","7","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片,药用铝箔。","山东罗欣药业集团股份有限公司","74.06 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1150,"XA02BCT200A001010204141","2","替戈拉生片","","限：1.反流性食管炎；2.十二指肠溃疡。","175716","替戈拉生片","泰欣赞","片剂","50mg","盒","14","聚氯乙烯/聚偏二氯乙烯固体药用复合硬片,药用铝箔。","山东罗欣药业集团股份有限公司","148.12 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1151,"ZA09GAT0209010102551","2","通脉降糖胶囊","","","119368","通脉降糖胶囊","无","胶囊剂","每粒装0.4g","盒","60","铝塑板装","保定天浩制药有限公司","27.60 ","修改（招标信息）","招采变更","国谈药品"]
[1152,"ZA09GAT0209010202551","2","通脉降糖胶囊","","","171763","通脉降糖胶囊","无","胶囊剂","每粒装0.4g","盒","36","铝塑板装","保定天浩制药有限公司","16.56 ","修改（招标信息）","招采变更","国谈药品"]
[1153,"XL01XEW108A001010181735","2","维莫非尼片","","限BRAF V600 突变阳性的不可切除或转移性黑色素瘤患者。","163022","维莫非尼片","佐博伏","片剂","240mg","盒","56","铝塑泡罩包装","Roche Registration GmbH","3976.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1154,"XL01XXW122A001010183266","2","维奈克拉片","","限成人急性髓系白血病患者。","171946","维奈克拉片","唯可来","薄膜衣片","10mg","盒","14","使用聚氯乙烯/聚乙烯/聚三氟氯乙烯(PVC/PE/PCTFE)铝箔泡罩包装。","AbbVie Inc.","248.36 ","修改（招标信息）","招采变更","国谈药品"]
[1155,"XL01XXW122A001020183266","2","维奈克拉片","","限成人急性髓系白血病患者。","171947","维奈克拉片","唯可来","薄膜衣片","50mg","盒","7","使用聚氯乙烯/聚乙烯/聚三氟氯乙烯(PVC/PE/PCTFE)铝箔泡罩包装。","AbbVie Inc.","425.74 ","修改（招标信息）","招采变更","国谈药品"]
[1156,"XL01XXW122A001040183266","2","维奈克拉片","","限成人急性髓系白血病患者。","171948","维奈克拉片","唯可来","薄膜衣片","100mg","盒","14","使用聚氯乙烯/聚乙烯/聚三氟氯乙烯(PVC/PE/PCTFE)铝箔泡罩包装","AbbVie Inc.","1447.60 ","修改（招标信息）","招采变更","国谈药品"]
[1157,"XL01XXW122A001040383266","2","维奈克拉片","","限成人急性髓系白血病患者。","310120","维奈克拉片","唯可来","薄膜衣片","100mg","盒","28","使用聚氯乙烯/聚乙烯/聚三氟氯乙烯(PVC/PE/PCTFE)铝箔泡罩包装","AbbVie Inc.","2895.20 ","修改（招标信息）","招采变更","国谈药品"]
[1158,"XL04AAW126A010010282925","2","乌帕替尼缓释片","","限：1.12岁及以上患者难治性、中重度特应性皮炎的二线治疗；2.活动性银屑病关节炎成人患者的二线治疗；3.中重度活动性类风湿关节炎成人患者的二线治疗；4.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性溃疡性结肠炎成人患者；5.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性克罗恩病成人患者；6.对非甾体抗炎药(NSAID)应答不佳且存在客观炎症征象(表现为C反应蛋白[CRP]升高和/或磁共振成像[MRI]异常)的活动性放射学阴性中轴型脊柱关节炎(nr-axSpA)成人患者；7.对一种或多种TNF抑制剂应答不佳或不耐受的活动性强直性脊柱炎(AS，放射学阳性中轴型脊柱关节炎)成人患者。","176881","乌帕替尼缓释片","瑞福","薄膜衣片","15mg(按C17H19F3N6O计)","盒","28","PVC/PE/PCTFE铝塑泡罩包装","AbbVie Deutschland GmbH & Co. KG","1833.44 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1159,"XL04AAW126A010020182925","2","乌帕替尼缓释片","","限：1.12岁及以上患者难治性、中重度特应性皮炎的二线治疗；2.活动性银屑病关节炎成人患者的二线治疗；3.中重度活动性类风湿关节炎成人患者的二线治疗；4.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性溃疡性结肠炎成人患者；5.对一种或多种TNF抑制剂应答不佳或不耐受或禁忌的中度至重度活动性克罗恩病成人患者；6.对非甾体抗炎药(NSAID)应答不佳且存在客观炎症征象(表现为C反应蛋白[CRP]升高和/或磁共振成像[MRI]异常)的活动性放射学阴性中轴型脊柱关节炎(nr-axSpA)成人患者；7.对一种或多种TNF抑制剂应答不佳或不耐受的活动性强直性脊柱炎(AS，放射学阳性中轴型脊柱关节炎)成人患者。","310076","乌帕替尼缓释片","瑞福","片剂","30mg(按C17H19F3N6O计)","盒","28","PVC/PE/PCTFE铝塑泡罩包装","AbbVie Deutschland GmbH & Co. KG","3116.96 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1160,"ZG01AAW0370010110146","2","五虎口服液","","","171686","五虎口服液","无","合剂","每支装10ml(相当于饮片6g)","盒","5","钠钙玻璃管制口服液体瓶、口服液瓶用铝塑组合盖","江苏九旭药业有限公司","56.55 ","修改（招标信息）","招采变更","国谈药品"]
[1161,"ZG01AAW0370010210146","2","五虎口服液","","","171687","五虎口服液","无","合剂","每支装10ml(相当于饮片6g)","盒","10","钠钙玻璃管制口服液体瓶、口服液瓶用铝塑组合盖","江苏九旭药业有限公司","113.10 ","修改（招标信息）","招采变更","国谈药品"]
[1162,"XL01XXX228A001010109758","2","西达本胺片","","限：1.既往至少接受过一次全身化疗的复发或难治的外周T细胞淋巴瘤(PTCL)患者；2.联合R-CHOP(利妥昔单抗、环磷酰胺、阿霉素、长春新碱和强的松)用于MYC和BCL2表达阳性的既往未经治疗的弥漫大B细胞淋巴瘤(DLBCL)患者。","162910","西达本胺片","爱谱沙","片剂","5mg","盒","24","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","深圳微芯生物科技股份有限公司","6600.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1163,"XA10BDX252A010010201606","2","西格列汀二甲双胍缓释片","","","206752","西格列汀二甲双胍缓释片","无","缓释片","每片含磷酸西格列汀100mg(按C16H15F6N5O计)和盐酸二甲双胍1000mg","瓶","15","口服固体药用高密度聚乙烯瓶、固体药用聚乙烯瓶装硅胶干燥剂包装","南京正大天晴制药有限公司","87.69 ","修改（招标信息）","招采变更","竞价药品"]
[1164,"ZA06BCX0942010104920","2","小儿荆杏止咳颗粒","","","168293","小儿荆杏止咳颗粒","无","颗粒剂","每袋装5g(相当于饮片18.33g)","盒","3","药用铝塑复合膜袋包装","湖南方盛制药股份有限公司","32.13 ","修改（招标信息）","招采变更","国谈药品"]
[1165,"ZA06BCX0942010204920","2","小儿荆杏止咳颗粒","","","167829","小儿荆杏止咳颗粒","无","颗粒剂","每袋装5g(相当于饮片18.33g)","盒","4","药用铝塑复合膜袋包装","湖南方盛制药股份有限公司","42.84 ","修改（招标信息）","招采变更","国谈药品"]
[1166,"ZA06BCX0942010304920","2","小儿荆杏止咳颗粒","","","167828","小儿荆杏止咳颗粒","无","颗粒剂","每袋装5g(相当于饮片18.33g)","盒","6","药用铝塑复合膜袋包装","湖南方盛制药股份有限公司","64.26 ","修改（招标信息）","招采变更","国谈药品"]
[1167,"ZG03AAX0947010104920","2","玄七健骨片","","","175741","玄七健骨片","无","片剂","每片重0.45g（相当于饮片2.83g）","盒","12","聚氯乙烯固体药用硬片、药用铝箔包装","湖南方盛制药股份有限公司","33.84 ","修改（支付标准）","招采变更","国谈药品"]
[1168,"ZG03AAX0947010204920","2","玄七健骨片","","","310093","玄七健骨片","无","片剂","每片重0.45g（相当于饮片2.83g）","盒","24","聚氯乙烯固体药用硬片、药用铝箔","湖南方盛制药股份有限公司","67.68 ","修改（支付标准）","招采变更","国谈药品"]
[1169,"XJ05AXA011N001010101466","2","盐酸阿比多尔颗粒","","限流感重症高危人群及重症患者的抗流感病毒治疗。","138521","盐酸阿比多尔颗粒","壮彤","颗粒剂","0.1g","盒","6","复合膜包装","江苏涟水制药有限公司","17.40 ","修改（招标信息）","招采变更","国谈药品"]
[1170,"XJ05AXA011N001010201466","2","盐酸阿比多尔颗粒","","限流感重症高危人群及重症患者的抗流感病毒治疗。","168531","盐酸阿比多尔颗粒","壮彤","颗粒剂","0.1g","盒","9","复合膜包装","江苏涟水制药有限公司","26.10 ","修改（招标信息）","招采变更","国谈药品"]
[1171,"XJ05AXA011N001010301466","2","盐酸阿比多尔颗粒","","限流感重症高危人群及重症患者的抗流感病毒治疗。","168532","盐酸阿比多尔颗粒","壮彤","颗粒剂","0.1g","盒","12","复合膜包装","江苏涟水制药有限公司","34.80 ","修改（招标信息）","招采变更","国谈药品"]
[1172,"XL01XEA314E001010182435","2","盐酸阿来替尼胶囊","","限：1.间变性淋巴瘤激酶(ALK)阳性的ⅠB期至ⅢA期非小细胞肺癌患者术后辅助治疗；2.间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌患者。","165183","盐酸阿来替尼胶囊","安圣莎","胶囊剂","150mg(按C₃₀H₃₄N₄O₂计)","盒","224","双铝泡罩包装","Roche Registration GmbH","12299.84 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1173,"XN07XXT211A001020184820","2","盐酸替洛利生片","","限发作性睡病成人患者。","206648","盐酸替洛利生片","无","薄膜衣片","18mg","盒","30","口服固体药用高密度聚乙烯瓶,聚丙烯盖和低密度乙烯盖(含干燥剂)包装。","Bioprojet Pharma","1197.30 ","修改（招标信息）","招采变更","国谈药品"]
[1174,"XN07XXT211A001010184820","2","盐酸替洛利生片","","限发作性睡病成人患者。","206647","盐酸替洛利生片","无","薄膜衣片","4.5mg","盒","30","口服固体药用高密度聚乙烯瓶,聚丙烯盖和低密度乙烯盖(含干燥剂)包装。","Bioprojet Pharma","414.30 ","修改（招标信息）","招采变更","国谈药品"]
[1175,"XJ01DDT197N001010379170","2","盐酸头孢卡品酯颗粒","","","310067","盐酸头孢卡品酯颗粒","无","颗粒剂","50mg(按C17H19N5O6S2计)","盒","6","玻璃纸/低密度聚乙烯/铝/低密度聚乙烯复合膜(SP)","SHIONOGI & Co., LTD.","83.10 ","修改（招标信息）","招采变更","国谈药品"]
[1176,"XL01EDY342A001010104021","2","伊鲁阿克片","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","204556","伊鲁阿克片","启欣可","薄膜衣片","60mg","盒","90","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","11745.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1177,"XL01EDY342A001010204021","2","伊鲁阿克片","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","204569","伊鲁阿克片","启欣可","薄膜衣片","60mg","盒","30","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","3915.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1178,"XL01EDY342A001020104021","2","伊鲁阿克片","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","206575","伊鲁阿克片","启欣可","薄膜衣片","30mg","盒","30","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","2302.80 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1179,"XL01EDY342A001020204021","2","伊鲁阿克片","","限间变性淋巴瘤激酶(ALK)阳性的局部晚期或转移性非小细胞肺癌(NSCLC)患者。","206576","伊鲁阿克片","启欣可","薄膜衣片","30mg","盒","90","口服固体药用高密度聚乙烯瓶包装(内含固体药用纸袋装硅胶干燥剂)","齐鲁制药有限公司","6908.40 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1180,"XL04AAY335B002010184095","2","伊奈利珠单抗注射液","","限抗水通道蛋白4(AQP4)抗体阳性的视神经脊髓炎谱系疾病(NMOSD)成人患者。","175798","伊奈利珠单抗注射液","昕越","注射液","100mg(10mL)/小瓶","瓶","1","西林瓶","Horizon Therapeutics Ireland DAC","21137.50 ","修改（招标信息）","招采变更","国谈药品"]
[1181,"XN07XXY322B004010201594","2","依达拉奉右莰醇注射用浓溶液","","限新发的急性缺血性脑卒中患者在发作48小时内开始使用，支付不超过14天。","171065","依达拉奉右莰醇注射用浓溶液","无","注射剂","5ml∶依达拉奉10mg与右莰醇2.5mg","支","1","中硼硅玻璃安瓿","先声药业有限公司","29.68 ","修改（支付标准）","招采变更","国谈药品"]
[1182,"XL04ABY251B002010278724","2","依那西普注射液","","限诊断明确的类风湿关节炎经传统DMARDs治疗3-6个月疾病活动度下降低于50%者；诊断明确的强直性脊柱炎(不含放射学前期中轴性脊柱关节炎)NSAIDs充分治疗3个月疾病活动度下降低于50%者。","170492","依那西普注射液","恩利","注射剂","0.47ml:25mg","支","1","预填充注射器:硼硅酸盐I型玻璃,AISI304型不锈钢27号针头,覆有ETFE膜的溴丁基橡胶","Pfizer Europe MA EEIG","181.45 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1183,"XL04ABY251B002020178724","2","依那西普注射液","","限诊断明确的类风湿关节炎经传统DMARDs治疗3-6个月疾病活动度下降低于50%者；诊断明确的强直性脊柱炎(不含放射学前期中轴性脊柱关节炎)NSAIDs充分治疗3个月疾病活动度下降低于50%者。","165342","依那西普注射液","恩利","注射剂","0.94ml:50mg","盒","2","每盒包装中包括2支依那西普注射液","Pfizer Europe MA EEIG","616.94 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1184,"XB05BAZ097B002030102180","2","中长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","175870","中长链脂肪乳/氨基酸（16）/葡萄糖（36%）注射液","无","注射剂","625ml［中长链脂肪乳注射液125ml；复方氨基酸（16）注射液250ml；复方葡萄糖（36％）注射液250ml］","袋","1","本品采用外阻隔三层共挤输液用三室袋装,内外袋间含脱氧剂。","四川科伦药业股份有限公司","90.00 ","修改（支付标准）","招采变更","国谈药品"]
[1185,"XB05BAZ097B002040102180","2","中长链脂肪乳/氨基酸(16)/葡萄糖(36%)注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或“肠内营养剂”补充足够营养的住院患者方予支付。","175868","中长链脂肪乳/氨基酸（16）/葡萄糖（36%）注射液","无","注射剂","1250ml［中长链脂肪乳注射液250ml；复方氨基酸（16）注射液500ml；复方葡萄糖（36％）注射液500ml］","袋","1","本品采用外阻隔三层共挤输液用三室袋装,内外袋间含脱氧剂。","四川科伦药业股份有限公司","153.00 ","修改（支付标准）","招采变更","国谈药品"]
[1186,"XB01ADA066B001010178302","2","注射用阿替普酶","","限急性心肌梗死发病12小时内、脑梗死发病3小时内的溶栓治疗。","147504","注射用阿替普酶","爱通立","注射剂","20mg/支","盒","1","无色玻璃瓶","Boehringer Ingelheim Pharma GmbH & Co. KG","1685.94 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1187,"XB01ADA066B001020178302","2","注射用阿替普酶","","限急性心肌梗死发病12小时内、脑梗死发病3小时内的溶栓治疗。","147505","注射用阿替普酶","爱通立","注射剂","50mg/支","盒","1","无色玻璃瓶","Boehringer Ingelheim Pharma GmbH & Co. KG","3400.00 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1188,"ZA12GAZ0403070100722","2","注射用丹参多酚酸盐","","限二级及以上医疗机构。","145868","注射用丹参多酚酸盐","无","注射剂","每瓶装50mg(含丹参乙酸镁40mg)","瓶","1","西林瓶","上海绿谷制药有限公司","27.19 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1189,"ZA12GAZ0403080100722","2","注射用丹参多酚酸盐","","限二级及以上医疗机构。","145867","注射用丹参多酚酸盐","无","注射剂","每瓶装100mg(含丹参乙酸镁80mg)","瓶","1","西林瓶","上海绿谷制药有限公司","46.23 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1190,"ZA12GAZ0403090100722","2","注射用丹参多酚酸盐","","限二级及以上医疗机构。","145865","注射用丹参多酚酸盐","无","注射剂","每瓶装200mg(含丹参乙酸镁160mg)","瓶","1","西林瓶","上海绿谷制药有限公司","78.59 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1191,"XB01AXN121B001010110101","2","注射用甲磺酸萘莫司他","","","171667","注射用甲磺酸萘莫司他","无","注射剂","10mg","瓶","1","中硼硅玻璃管制注射剂瓶、注射用冷冻干燥用氯化丁基橡胶塞","江苏杜瑞制药有限公司","10.60 ","修改（支付标准）","招采变更","国谈药品"]
[1192,"XB01AXN121B001010210101","2","注射用甲磺酸萘莫司他","","","171668","注射用甲磺酸萘莫司他","无","注射剂","50mg","瓶","1","中硼硅玻璃管制注射剂瓶,注射用冷冻干燥用氯化丁基橡胶塞","江苏杜瑞制药有限公司","36.34 ","修改（支付标准）","招采变更","国谈药品"]
[1193,"XL01XGK141B001010183680","2","注射用卡非佐米","","限与地塞米松联合适用于治疗复发或难治性多发性骨髓瘤成人患者，患者既往至少接受过2种治疗，包括蛋白酶体抑制剂和免疫调节剂。","310075","注射用卡非佐米","凯洛斯","注射剂","60mg/瓶","盒","1","本品包装于I型玻璃瓶内,用涂有氟聚合物薄膜的氯化丁基橡胶塞密封","Onyx Pharmaceuticals,Inc.","2042.28 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1194,"XB03XAL398B001010184022","2","注射用罗特西普","","限β-地中海贫血成人患者。","176088","注射用罗特西普","利布洛泽","注射剂","25mg","盒","1","玻璃瓶","Celgene Corporation","2380.00 ","修改（招标信息）","招采变更","国谈药品"]
[1195,"XB01ADC157B001010109781","2","注射用重组人TNK组织型纤溶酶原激活剂","","限急性心肌梗死发病6小时内、急性缺血性卒中4.5小时内的溶栓治疗。","163437","注射用重组人TNK组织型纤溶酶原激活剂","明复乐","注射剂","1.0x10⁷IU/16mg/支","盒","1","10ml注射剂瓶,10ml注射剂瓶冻干胶塞","石药集团明复乐药业(广州)有限公司","3333.03 ","修改（医保和招标信息）","招采变更","国谈药品"]
[1196,"XN05AXZ101B002010182023","2","棕榈帕利哌酮酯注射液(3M)","","限接受过棕榈酸帕利哌酮注射液(1个月剂型)至少4个月充分治疗的精神分裂症患者。","164459","棕榈帕利哌酮酯注射液(3M)","善妥达","注射液","按帕利哌酮(C23H27FN4O3)计,2.625ml:525mg","盒","1","环烯烃共聚物塑料注射器","Janssen-Cilag International NV","4834.55 ","修改（招标信息）","招采变更","国谈药品"]
[1197,"XN05AXZ101B002030182023","2","棕榈帕利哌酮酯注射液(3M)","","限接受过棕榈酸帕利哌酮注射液(1个月剂型)至少4个月充分治疗的精神分裂症患者。","164458","棕榈帕利哌酮酯注射液(3M)","善妥达","注射液","按帕利哌酮(C23H27FN4O3计),1.315ml:263mg","盒","1","环烯烃共聚物塑料注射器","Janssen-Cilag International NV","2848.00 ","修改（招标信息）","招采变更","国谈药品"]
[1198,"XN05AXZ101B002040182023","2","棕榈帕利哌酮酯注射液(3M)","","限接受过棕榈酸帕利哌酮注射液(1个月剂型)至少4个月充分治疗的精神分裂症患者。","164460","棕榈帕利哌酮酯注射液(3M)","善妥达","注射液","按帕利哌酮(C23H27FN4O3计),1.75ml:350mg","盒","1","环烯烃共聚物塑料注射器","Janssen-Cilag International NV","3544.48 ","修改（招标信息）","招采变更","国谈药品"]
[1199,"ZA10CAJ0749010202767","2","解郁除烦胶囊","","","310089","解郁除烦胶囊","无","胶囊剂","每粒装0.4g（相当于饮片1.55g）","盒","36","聚氯乙烯固体药用硬片、药用铝箔","石家庄以岭药业股份有限公司","70.56","停用","招采国码变更","国谈药品"]
[1200,"ZA13AAJ0749010202767","2","解郁除烦胶囊","","","310089","解郁除烦胶囊","无","胶囊剂","每粒装0.4g(相当于饮片1.55g)","盒","36","聚氯乙烯固体药用硬片、药用铝箔","石家庄以岭药业股份有限公司","66.60 ","启用","招采国码变更","国谈药品"]
[1201,"ZA10DAY0786020102767","2","益肾养心安神片","","","310090","益肾养心安神片","无","片剂","每片重0.4g（相当于饮片1.4g）","盒","36","聚氯乙烯固体药用硬片、药用铝箔包装","石家庄以岭药业股份有限公司","74.88","停用","招采国码变更","国谈药品"]
[1202,"ZA10AAY0786010202767","2","益肾养心安神片","","","310090","益肾养心安神片","无","片剂","每片重0.4g(相当于饮片1.4g)","盒","36","聚氯乙烯固体药用硬片、药用铝箔包装","石家庄以岭药业股份有限公司","70.92 ","启用","招采国码变更","国谈药品"]
[1203,"XL04ACW114B002010104520",2,"乌司奴单抗注射液",null,"限：1.对环孢素、甲氨喋呤(MTX)等其他系统性治疗或PUVA(补骨脂素和紫外线A)不应答、有禁忌或无法耐受的成年中重度斑块状银屑病患者；2.对其他系统性治疗或光疗应答不足或无法耐受的6岁及以上儿童和青少年(体重60公斤至100公斤)中重度斑块状银屑病患者；3.对传统治疗或肿瘤坏死因子α(TNFα)拮抗剂应答不足、失应答或无法耐受的成年中重度活动性克罗恩病患者。",211760,"乌司奴单抗注射液","赛乐信","注射剂","预充式注射器:45mg(0.5ml)/支","盒",1,"本品存放于1ml的I型玻璃注射器内,并配备固定的不锈钢针头,以及含干燥聚异戊二烯橡胶的针头保护帽。本品每个包装中含有1支预充式注射器。","杭州中美华东制药有限公司",{"v":3614,"d":"3614.00"},"启用","招采变更","国谈药品"]
[1204,"XB05BAU006B002020300454","2","ω-3鱼油中/长链脂肪乳注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","171600","ω-3鱼油中/长链脂肪乳注射液","无","注射剂","250ml","瓶","1","中硼硅玻璃输液瓶、注射液用卤化丁基橡胶塞包装。","深圳市海滨制药有限公司","109.65 ","启用","医保发〔2024〕33号",""]
[1205,"XB05BAU006B002010300454","2","ω-3鱼油中/长链脂肪乳注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","171602","ω-3鱼油中/长链脂肪乳注射液","无","注射剂","100ml","瓶","1","中硼硅玻璃输液瓶、注射液用卤化丁基橡胶塞包装。","深圳市海滨制药有限公司","54.37 ","启用","医保发〔2024〕33号",""]
[1206,"XB05BAU006B002010179001","2","ω-3鱼油中/长链脂肪乳注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","170652","ω-3鱼油中/长链脂肪乳注射液","无","注射剂","100ml","瓶","1","含有丁基橡胶塞的Ⅱ型玻璃瓶","B.Braun Melsungen AG","54.37 ","启用","医保发〔2024〕33号",""]
[1207,"XB05BAU006B002020179001","2","ω-3鱼油中/长链脂肪乳注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","170653","ω-3鱼油中/长链脂肪乳注射液","无","注射剂","250ml","瓶","1","含有丁基橡胶塞的Ⅱ型玻璃瓶","B.Braun Melsungen AG","109.65 ","启用","医保发〔2024〕33号",""]
[1208,"XB05BAU006B002010102180","2","ω-3鱼油中/长链脂肪乳注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","173875","ω-3鱼油中/长链脂肪乳注射液","无","注射剂","100ml","瓶","1","玻璃输液瓶装","四川科伦药业股份有限公司","54.37 ","启用","医保发〔2024〕33号",""]
[1209,"XB05BAU006B002020102180","2","ω-3鱼油中/长链脂肪乳注射液","","需经营养风险筛查，明确具有营养风险，且不能经饮食或使用“肠内营养剂”补充足够营养的住院患者方予支付。","173874","ω-3鱼油中/长链脂肪乳注射液","无","注射剂","250ml","瓶","1","玻璃输液瓶装","四川科伦药业股份有限公司","109.65 ","启用","医保发〔2024〕33号",""]
[1210,"XA02BCA349E001010104646","2","奥美拉唑碳酸氢钠胶囊（Ⅱ）","","限活动性良性胃溃疡。","206230","奥美拉唑碳酸氢钠胶囊(Ⅱ)","无","胶囊剂","每粒含奥美拉唑40mg与碳酸氢钠1100mg","盒","30","口服固体高密度聚乙烯瓶装","浙江花园药业有限公司","38.94 ","启用","医保发〔2024〕33号",""]
[1211,"ZA10DAA0089010201622","2","安神补脑片(胶囊、颗粒、液)","","","137341","安神补脑胶囊","无","胶囊剂","每粒装0.28g","盒","24","塑料瓶","精华制药集团股份有限公司","37.89 ","启用","招采变更",""]
[1212,"ZA10DAA0092020103425","2","安神补脑片（胶囊、颗粒、液）","","","127720","安神补脑片","无","薄膜衣片","0.31g","盒","24","铝箔","吉林省集安益盛药业股份有限公司","51.32","停用","招采国码变更",""]
[1213,"ZA10DAA0092030103425","2","安神补脑片(胶囊、颗粒、液)","","","127720","安神补脑片","无","片剂(薄膜衣)","每片重0.31g","盒","24","药品包装用PTP铝箔,聚氯乙烯固体药用硬片","吉林省集安益盛药业股份有限公司","42.96 ","启用","招采国码变更",""]
[1214,"ZA10DAA0094010104011","2","安神补脑片（胶囊、颗粒、液）","","","131372","安神补脑液","无","口服液","每支装10ml","盒","10","口服液锁口瓶,口服液用氯化丁基橡胶垫。","鲁南厚普制药有限公司","18.22 ","修改（招标信息）","招采变更",""]
[1215,"ZA10DAA0094010103357","2","安神补脑片（胶囊、颗粒、液）","","","140589","安神补脑液","无","合剂","每支装10ml(含维生素B15mg)","盒","10","钠钙玻璃管制口服液体瓶,口服液瓶铝塑组合盖","吉林敖东延边药业股份有限公司","18.20 ","修改（招标信息）","招采变更",""]
[1216,"ZA10DAA0094010303357","2","安神补脑片（胶囊、颗粒、液）","","","140590","安神补脑液","无","合剂","每支装10ml(含维生素B15mg)","盒","20","钠钙玻璃管制口服液体瓶,口服液瓶铝塑组合盖","吉林敖东延边药业股份有限公司","36.40 ","修改（招标信息）","招采变更",""]
[1217,"ZA10DAA0094010703357","2","安神补脑片(胶囊、颗粒、液)","","","207475","安神补脑液","无","合剂","每支装10ml(含维生素B1 5mg)","盒","24","钠钙玻璃管制口服液体瓶,口服液瓶铝塑组合盖","吉林敖东延边药业股份有限公司","43.68 ","修改（支付标准）","招采变更",""]
[1218,"ZA10DAA0094010403357","2","安神补脑片（胶囊、颗粒、液）","","","170514","安神补脑液","无","合剂","每支装10ml(含维生素B15mg)","盒","40","钠钙玻璃管制口服液体瓶,口服液瓶铝塑组合盖","吉林敖东延边药业股份有限公司","72.80 ","修改（招标信息）","招采变更",""]
[1219,"ZF02AAH0421010100365","1","藿胆丸（片、滴丸）","","","135230","藿胆丸","无","丸剂(水丸)","36g","瓶","1","塑料瓶装","广东雷允上药业有限公司","17.38 ","修改（招标信息）","招采变更",""]
[1220,"ZF02AAH0421010100311","1","藿胆丸（片、滴丸）","","","161565","藿胆丸","无","水丸","36g","瓶","1","塑料瓶","广东逢春制药有限公司","20.00","停用","招采国码变更",""]
[1221,"ZF02AAH0421020100311","1","藿胆丸(片、滴丸)","","","161565","藿胆丸","无","丸剂(水丸)","每瓶装36克","瓶","1","塑料瓶","广东逢春制药有限公司","16.67 ","启用","招采国码变更",""]
[1222,"ZF02AAH0421010200311","1","藿胆丸(片、滴丸)","","","172369","藿胆丸","无","水丸","每瓶装36克","盒","2","塑料瓶","广东逢春制药有限公司","33.34 ","修改（招标信息）","招采变更",""]
[1223,"ZF02AAH0421010300311","1","藿胆丸(片、滴丸)","","","172368","藿胆丸","无","水丸","每瓶装36克","瓶","3","塑料瓶","广东逢春制药有限公司","50.01 ","修改（招标信息）","招采变更",""]
[1224,"ZF02AAS1048010101749","2","散风通窍滴丸","","","165750","散风通窍滴丸","无","滴丸","每20丸重0.76g(每1g相当于饮片5.99g)","盒","100","药用复合膜袋装","扬子江药业集团江苏龙凤堂中药有限公司","52.50 ","修改（招标信息）","招采变更",""]
[1225,"ZF02AAS1048010201749","2","散风通窍滴丸","","","172616","散风通窍滴丸","无","滴丸","每20丸重0.76g(每1g相当于饮片5.99g)","盒","60","药用复合膜袋","扬子江药业集团江苏龙凤堂中药有限公司","32.09 ","修改（招标信息）","招采变更",""]
[1226,"XB02BXA307A001010104111","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","210997","艾曲泊帕乙醇胺片","无","片剂(薄膜衣片)","25mg(按C25H22N404计)","盒","10","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","山东京卫制药有限公司","760.00 ","启用","招采变更",""]
[1227,"XB02BXA307A001010304111","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","210998","艾曲泊帕乙醇胺片","无","片剂(薄膜衣片)","25mg(按C25H22N404计)","盒","30","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片及药用铝箔包装","山东京卫制药有限公司","2280.00 ","启用","招采变更",""]
[1228,"XB02BXA307A001010284183","2","艾曲泊帕乙醇胺片","","限：1.既往对糖皮质激素、免疫球蛋白等治疗反应不佳的成人和6岁及以上儿童慢性免疫性(特发性)血小板减少症(ITP)患者；2.既往对免疫抑制治疗缓解不充分的重型再生障碍性贫血(SAA)患者。","211724","艾曲泊帕乙醇胺片","无","片剂(薄膜衣片)","25mg(按C₂₅H₂₂N₄O₄计)","盒","14","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药用铝箔包装","嘉亨(珠海横琴)医药科技有限公司","1512.00 ","启用","招采变更",""]
[1229,"XN05ALA161X001010100548","2","氨磺必利口服溶液","","","211339","氨磺必利口服溶液","无","口服溶液剂","60ml:6g","盒","1","钠钙玻璃模制药瓶、口服药用聚丙烯压旋盖,本品附带口服给药器。","广州大光制药有限公司","132.00 ","启用","招采变更",""]
[1230,"XN03AXB239A001020401503","2","吡仑帕奈片","","","211432","吡仑帕奈片","无","片剂(薄膜衣片)","4mg","盒","28","聚氯乙烯固体药用硬片和药品包装用铝箔包装","江苏万高药业股份有限公司","191.80 ","启用","招采变更",""]
[1231,"XN03AXB239A001010401503","2","吡仑帕奈片","","","211431","吡仑帕奈片","无","片剂(薄膜衣片)","2mg","盒","28","聚氯乙烯固体药用硬片和药品包装用铝箔包装","江苏万高药业股份有限公司","112.70 ","启用","招采变更",""]
[1232,"XA12BAF601B002010203087","2","复合磷酸氢钾注射液","","","211583","复合磷酸氢钾注射液","无","注射液","2ml:磷酸二氢钾0.4354g与磷酸氢二钾0.639g","支","1","低硼硅玻璃安瓿","百正药业股份有限公司","12.50 ","启用","招采变更",""]
[1233,"XL04AXE092E005010105847","2","富马酸二甲酯肠溶胶囊","","限成人复发型多发性硬化(RMS)。","211427","富马酸二甲酯肠溶胶囊","无","胶囊剂","240mg","盒","60","瓶装(口服固体药用高密度聚乙烯瓶)","齐鲁制药(海南)有限公司","3300.00 ","启用","招采变更",""]
[1234,"XB02BXA336A001010204021","2","马来酸阿伐曲泊帕片","","限择期行诊断性操作或者手术的慢性肝病相关血小板减少症的成年患者。","211629","马来酸阿伐曲泊帕片","无","薄膜衣片","20mg(按C₂₉H₃₄Cl₂N₆O₃S₂计)","盒","10","口服固体药用高密度聚乙烯瓶和固体药用纸袋装硅胶干燥剂","齐鲁制药有限公司","1374.05 ","启用","招采变更",""]
[1235,"XL01EHN120A001010101425","2","马来酸奈拉替尼片","","限人类表皮生长因子受体2(HER2)阳性的早期乳腺癌成年患者，在接受含曲妥珠单抗辅助治疗之后的强化辅助治疗。","211721","马来酸奈拉替尼片","无","薄膜衣片","40mg(按C30H29ClN6O3计)","盒","60","聚酰胺/铝/聚氯乙烯冷冲压成型固体药用复合硬片和药品包装用铝箔","江苏奥赛康药业有限公司","1875.00 ","启用","招采变更",""]
[1236,"XC02KXM170A001010300816","2","马昔腾坦片","","限WHO功能分级Ⅱ级-Ⅲ级的肺动脉高压(WHO第1组)的患者。","211572","马昔腾坦片","无","片剂(薄膜衣片)","10mg","盒","30","聚氯乙烯/聚乙烯/聚偏二氯乙烯固体药用复合硬片和药用铝箔","上海旭东海普药业有限公司","2940.00 ","启用","招采变更",""]
[1237,"XH01BAQ117X001010183242","2","去氨加压素口服溶液","","","210875","去氨加压素口服溶液","无","口服溶液剂","15ml:5.4mg(按C₄₆H₆₄N₁₄O₁₂S₂计)","盒","1","钠钙玻璃模制药瓶、药用低密度聚乙烯瓶盖(内盖)、口服液体药用高密度聚乙烯瓶盖(外盖)","锦州奥鸿药业有限责任公司","298.60 ","启用","招采变更",""]
[1238,"XC01EBR118B002010101570","2","瑞加诺生注射液","","","211571","瑞加诺生注射液","无","注射剂","5ml:0.4mg(按C₁₅H₁₈N₈O₅计)","盒","1","环烯烃共聚物(乙烯-降冰片烯)预灌封注射器组合件包装","南京健友生化制药股份有限公司","796.00 ","启用","招采变更",""]
[1239,"ZA01BAS0788040503373","2","疏清颗粒","","","211360","疏清颗粒","无","颗粒剂","每袋装3g","盒","18","药用复合膜","吉林华康药业股份有限公司","23.04 ","启用","招采变更",""]
[1240,"XR03ACB127L020010283585","2","盐酸丙卡特罗吸入溶液","","","211652","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","5","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合袋","云南先施药业有限公司","51.45 ","启用","招采变更",""]
[1241,"XR03ACB127L020010183585","2","盐酸丙卡特罗吸入溶液","","","211650","盐酸丙卡特罗吸入溶液","无","吸入制剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","10","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合袋","云南先施药业有限公司","102.90 ","启用","招采变更",""]
[1242,"XR03ACB127L020020183585","2","盐酸丙卡特罗吸入溶液","","","211654","盐酸丙卡特罗吸入溶液","无","吸入制剂","按C₁₆H₂₂N₂O₃·HCl·½H₂O计0.5ml:50μg","盒","5","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合袋","云南先施药业有限公司","76.05 ","启用","招采变更",""]
[1243,"XR03ACB127L020020283585","2","盐酸丙卡特罗吸入溶液","","","211655","盐酸丙卡特罗吸入溶液","无","吸入制剂","按C₁₆H₂₂N₂O₃·HCl·½H₂O计0.5ml:50μg","盒","10","内包装为低密度聚乙烯安瓿,密封于聚酯/铝/聚乙烯药用复合袋","云南先施药业有限公司","152.10 ","启用","招采变更",""]
[1244,"XR03ACB127L020020182770","2","盐酸丙卡特罗吸入溶液","","","211604","盐酸丙卡特罗吸入溶液","无","吸入用溶液剂","0.3ml:30μg(按C₁₆H₂₂N₂O₃·HCl·½H₂O计)","盒","10","吸入溶液用低密度聚乙烯瓶,密封于聚酯/铝/聚乙烯药品包装用复合袋。","南京华盖制药有限公司","104.10 ","启用","招采变更",""]
[1245,"XN05BAA050A001010101436","1","阿普唑仑","口服常释剂型","","","阿普唑仑片","无","片剂","0.4mg","盒","20","铝塑泡罩板","江苏恩华药业股份有限公司","","停用","国家数据变更","毒麻精放类药品"]
[1246,"XN05BAA050A001010301436","1","阿普唑仑","口服常释剂型","","","阿普唑仑片","无","片剂","0.4mg","瓶","20","口服固体药用高密度聚乙烯瓶(规格50ml)加固体药用高密度聚乙烯非织造布(泰维克)袋装干燥剂(规格3g)","江苏恩华药业股份有限公司","","启用","医保发〔2024〕33号","毒麻精放类药品"]
[1247,"XN05CDA087A001010502770","1","艾司唑仑","口服常释剂型","","","艾司唑仑片","无","片剂","1mg","盒","14","药用铝箔-聚氯乙烯固体药用硬片包装","石药集团欧意药业有限公司","","启用","医保发〔2024〕33号","毒麻精放类药品"]
[1248,"XN02AFN098B002020102000","2","纳布啡","注射剂","限复合麻醉。","","盐酸纳布啡注射液","瑞静","注射剂","1ml:10mg","支","1","中硼硅玻璃安瓿","宜昌人福药业有限责任公司","","启用","医保发〔2024〕33号","毒麻精放类药品"]